organic sodium salt - Ontology Report - Rat Genome Database

Submit Data | Help | Video Tutorials | News | Publications | Download | REST API | Citing RGD | Contact

CHEBI ONTOLOGY - ANNOTATIONS

{{ watchLinkText }}

The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/. The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.

Term:	organic sodium salt	go back to main search page
Accession:	CHEBI:38700	browse the term
Synonyms:	related_synonym:	organic sodium salts

show annotations for term's descendants Sort by:
Rat (1377) Mouse (1412) Human (1443) Chinchilla (0) Bonobo (0) Dog (1) Squirrel (0) Pig (12) Green Monkey (0) Naked Mole-rat (0) All
Genes (1443)

acid red 29

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

albumin

affects binding

chromotrope 2R binds to ALB protein

NCBI chr 4:73,404,287...73,421,482
Ensembl chr 4:73,397,114...73,421,482

chloramine T

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

CD86 molecule

increases expression

chloramine-T results in increased expression of CD86 protein

NCBI chr 3:122,055,362...122,121,136
Ensembl chr 3:122,055,362...122,121,139

G

glutathione peroxidase 1

increases expression

chloramine-T results in increased expression of GPX1 protein

NCBI chr 3:49,357,176...49,358,353
Ensembl chr 3:49,357,174...49,358,605

G

heme oxygenase 1

increases expression

chloramine-T results in increased expression of HMOX1 mRNA

NCBI chr22:35,381,096...35,394,207
Ensembl chr22:35,380,361...35,394,214

G

potassium voltage-gated channel subfamily H member 2

multiple interactions

chloramine-T results in increased oxidation of and results in decreased activity of KCNH2 protein

NCBI chr 7:150,944,961...150,978,321
Ensembl chr 7:150,944,961...150,978,321

G

methionine sulfoxide reductase A

decreases response to substance
multiple interactions

MSRA protein results in decreased susceptibility to chloramine-T
S-methylcysteine promotes the reaction [MSRA protein results in decreased susceptibility to chloramine-T]

NCBI chr 8:10,054,292...10,428,891
Ensembl chr 8:10,054,292...10,428,891

G

neurogranin

multiple interactions
affects phosphorylation

Dithiothreitol inhibits the reaction [chloramine-T affects the phosphorylation of NRGN protein]

NCBI chr11:124,739,942...124,747,210
Ensembl chr11:124,739,942...124,747,210

G

peroxiredoxin 1

increases expression

chloramine-T results in increased expression of PRDX1 protein

NCBI chr 1:45,511,051...45,522,890
Ensembl chr 1:45,510,914...45,542,732

G

selectin P

decreases expression

chloramine-T results in decreased expression of SELP protein

NCBI chr 1:169,588,849...169,630,124
Ensembl chr 1:169,588,849...169,630,193

G

superoxide dismutase 2

increases expression

chloramine-T results in increased expression of SOD2 protein

NCBI chr 6:159,669,069...159,762,281
Ensembl chr 6:159,669,069...159,762,529

disodium cromoglycate

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

ATP binding cassette subfamily C member 4 (PEL blood group)

multiple interactions

[adefovir co-treated with Probenecid co-treated with Cromolyn Sodium] affects the expression of ABCC4 protein; Cromolyn Sodium inhibits the reaction [Purines analog results in decreased expression of MRP4 protein]

PMID:35114312 PMID:36464070

NCBI chr13:95,019,835...95,301,451
Ensembl chr13:95,019,835...95,301,475

G

ATP binding cassette subfamily G member 2 (JR blood group)

multiple interactions
increases expression

Cromolyn Sodium inhibits the reaction [Purines analog results in decreased expression of ABCG2 protein]
Cromolyn Sodium results in increased expression of ABCG2 protein

NCBI chr 4:88,090,264...88,231,626
Ensembl chr 4:88,090,150...88,231,628

G

actin alpha 2, smooth muscle

multiple interactions

Cromolyn Sodium inhibits the reaction [[adefovir co-treated with Probenecid] results in increased expression of ACTA2 protein]

NCBI chr10:88,935,074...88,991,337
Ensembl chr10:88,935,074...88,991,339

G

adiponectin, C1Q and collagen domain containing

increases expression

Cromolyn Sodium results in increased expression of ADIPOQ protein

NCBI chr 3:186,842,710...186,858,463
Ensembl chr 3:186,842,704...186,858,463

G

adenosine A3 receptor

decreases activity

Cromolyn Sodium results in decreased activity of ADORA3 protein

NCBI chr 1:111,499,429...111,503,633
Ensembl chr 1:111,499,429...111,503,633

G

angiotensinogen

multiple interactions

Cromolyn Sodium inhibits the reaction [[Probenecid co-treated with adefovir] results in increased expression of AGT protein]; Cromolyn Sodium inhibits the reaction [Purines analog results in increased secretion of AGT protein]

PMID:35114312 PMID:36464070

NCBI chr 1:230,702,523...230,745,583
Ensembl chr 1:230,690,776...230,745,576

G

AKT serine/threonine kinase 1

multiple interactions

[Cromolyn Sodium co-treated with Chitosan] inhibits the reaction [Dimethylhydrazines results in increased expression of AKT1 protein]

NCBI chr14:104,769,349...104,795,748
Ensembl chr14:104,769,349...104,795,751

G

BCL2 apoptosis regulator

multiple interactions

[Cromolyn Sodium co-treated with Chitosan] inhibits the reaction [Dimethylhydrazines results in increased expression of BCL2 protein]

NCBI chr18:63,123,346...63,320,090
Ensembl chr18:63,123,346...63,320,128

G

calcitonin related polypeptide alpha

multiple interactions

Cromolyn Sodium inhibits the reaction [Paclitaxel results in increased expression of CALCA protein]

NCBI chr11:14,966,668...14,972,351
Ensembl chr11:14,966,622...14,972,354

G

cystatin C

multiple interactions

Cromolyn Sodium inhibits the reaction [[adefovir co-treated with Probenecid] results in increased expression of CST3 protein]

NCBI chr20:23,626,706...23,637,955
Ensembl chr20:23,626,706...23,638,473

G

catenin beta 1

multiple interactions

[Cromolyn Sodium co-treated with Chitosan] inhibits the reaction [Dimethylhydrazines results in increased expression of CTNNB1 protein]

NCBI chr 3:41,199,505...41,240,443
Ensembl chr 3:41,194,741...41,260,096

G

cathepsin D

multiple interactions

[pristane co-treated with Cromolyn Sodium] results in increased expression of CTSD protein

NCBI chr11:1,752,755...1,763,927
Ensembl chr11:1,752,752...1,764,573

G

DNA methyltransferase 1

decreases expression

Cromolyn Sodium results in decreased expression of DNMT1 mRNA; Cromolyn Sodium results in decreased expression of DNMT1 protein

NCBI chr19:10,133,346...10,194,953
Ensembl chr19:10,133,342...10,231,286

G

G protein-coupled receptor 35

affects localization
multiple interactions

Cromolyn Sodium affects the localization of GPR35 protein
Cromolyn Sodium binds to and results in increased activity of GPR35 protein
2-hydroxy-4-(4-(5-(2-methyl-3-phenylprop-2-enylidene)-4-oxo-2-sulfanylidene-1,3-thiazolidin-3-yl)butanoylamino)benzoic acid inhibits the reaction [Cromolyn Sodium affects the localization of GPR35 protein]; 2-hydroxy-4-(4-(5-(2-methyl-3-phenylprop-2-enylidene)-4-oxo-2-sulfanylidene-1,3-thiazolidin-3-yl)butanoylamino)benzoic acid inhibits the reaction [Cromolyn Sodium binds to and results in increased activity of GPR35 protein]; Cromolyn Sodium binds to and results in increased activity of GPR35 protein; methyl 5-((tert-butylcarbamothioylhydrazinylidene)methyl)-1-(2,4-difluorophenyl)pyrazole-4-carboxylate inhibits the reaction [Cromolyn Sodium affects the localization of GPR35 protein]; methyl 5-((tert-butylcarbamothioylhydrazinylidene)methyl)-1-(2,4-difluorophenyl)pyrazole-4-carboxylate inhibits the reaction [Cromolyn Sodium binds to and results in increased activity of GPR35 protein]

PMID:20919992 PMID:22967846

NCBI chr 2:240,605,430...240,633,159
Ensembl chr 2:240,605,430...240,633,159

G

glutathione peroxidase 1

multiple interactions

Cromolyn Sodium inhibits the reaction [Purines analog results in decreased expression of GPX1 protein]

NCBI chr 3:49,357,176...49,358,353
Ensembl chr 3:49,357,174...49,358,605

G

glycogen synthase kinase 3 beta

multiple interactions

[Cromolyn Sodium co-treated with Chitosan] inhibits the reaction [Dimethylhydrazines results in increased expression of GSK3B protein]

NCBI chr 3:119,821,321...120,094,447
Ensembl chr 3:119,821,321...120,094,994

G

INS-IGF2 readthrough

increases expression

Cromolyn Sodium results in increased expression of INS1 protein

NCBI chr11:2,129,117...2,161,209
Ensembl chr11:2,132,538...2,161,209

G

mitogen-activated protein kinase 1

decreases phosphorylation

Cromolyn Sodium results in decreased phosphorylation of MAPK1 protein

NCBI chr22:21,759,657...21,867,680
Ensembl chr22:21,759,657...21,867,680

G

mitogen-activated protein kinase 3

multiple interactions
decreases phosphorylation

[Cromolyn Sodium co-treated with Chitosan] inhibits the reaction [Dimethylhydrazines results in increased expression of MAPK3 protein]
Cromolyn Sodium results in decreased phosphorylation of MAPK3 protein

PMID:28732690 PMID:35961540

NCBI chr16:30,114,105...30,123,220
Ensembl chr16:30,114,105...30,123,506

G

methyltransferase 3, N6-adenosine-methyltransferase complex catalytic subunit

decreases expression

Cromolyn Sodium results in decreased expression of METTL3 mRNA; Cromolyn Sodium results in decreased expression of METTL3 protein

NCBI chr14:21,498,138...21,511,340
Ensembl chr14:21,498,133...21,511,342

G

matrix metallopeptidase 2

multiple interactions
increases expression

Cromolyn Sodium inhibits the reaction [Norepinephrine results in increased expression of MMP2 mRNA]
Cromolyn Sodium results in increased expression of MMP2 mRNA

NCBI chr16:55,478,830...55,506,691
Ensembl chr16:55,389,700...55,506,691

G

proopiomelanocortin

multiple interactions

Cromolyn Sodium inhibits the reaction [POMC results in increased secretion of Corticosterone]

NCBI chr 2:25,160,860...25,168,580
Ensembl chr 2:25,160,853...25,168,903

G

RELA proto-oncogene, NF-kB subunit

multiple interactions

[Cromolyn Sodium co-treated with Chitosan] inhibits the reaction [Dimethylhydrazines results in increased expression of RELA protein]

NCBI chr11:65,653,601...65,663,857
Ensembl chr11:65,653,599...65,663,090

G

renin

multiple interactions

Cromolyn Sodium inhibits the reaction [Purines analog results in increased secretion of REN protein]

NCBI chr 1:204,154,819...204,166,337
Ensembl chr 1:204,154,819...204,190,324

G

resistin

decreases expression

Cromolyn Sodium results in decreased expression of RETN protein

NCBI chr19:7,669,049...7,670,455
Ensembl chr19:7,669,049...7,670,455

G

solute carrier family 22 member 12

multiple interactions

Cromolyn Sodium inhibits the reaction [Purines analog results in decreased expression of SLC22A12 protein]

NCBI chr11:64,591,220...64,602,344
Ensembl chr11:64,590,641...64,602,353

G

solute carrier family 22 member 6

multiple interactions

[adefovir co-treated with Probenecid co-treated with Cromolyn Sodium] affects the expression of SLC22A6 protein; Cromolyn Sodium inhibits the reaction [Purines analog results in decreased expression of SLC22A6 protein]

PMID:35114312 PMID:36464070

NCBI chr11:62,976,597...62,984,967
Ensembl chr11:62,936,385...62,984,967

G

solute carrier family 22 member 8

multiple interactions

[adefovir co-treated with Probenecid co-treated with Cromolyn Sodium] results in increased expression of SLC22A8 protein; Cromolyn Sodium inhibits the reaction [[adefovir co-treated with Probenecid] results in decreased expression of SLC22A8 protein]; Cromolyn Sodium inhibits the reaction [Purines analog results in decreased expression of SLC22A8 protein]

PMID:35114312 PMID:36464070

NCBI chr11:62,992,824...63,015,841
Ensembl chr11:62,989,154...63,015,841

G

superoxide dismutase 1

multiple interactions

Cromolyn Sodium inhibits the reaction [Purines analog results in decreased expression of SOD1 protein]

NCBI chr21:31,659,693...31,668,931
Ensembl chr21:31,659,666...31,668,931

G

tachykinin precursor 1

multiple interactions

Cromolyn Sodium inhibits the reaction [Paclitaxel results in increased expression of TAC1 protein]

NCBI chr 7:97,732,086...97,740,472
Ensembl chr 7:97,732,084...97,740,472

G

transforming growth factor beta 1

multiple interactions
increases secretion

[1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine co-treated with Cromolyn Sodium] results in increased secretion of TGFB1 protein; [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine co-treated with masitinib co-treated with Cromolyn Sodium] results in increased secretion of TGFB1 protein; [masitinib co-treated with Cromolyn Sodium] results in increased secretion of TGFB1 protein
Cromolyn Sodium inhibits the reaction [[adefovir co-treated with Probenecid] results in increased expression of TGFB1 protein]
Cromolyn Sodium results in increased secretion of TGFB1 protein

PMID:35007524 PMID:35114312

NCBI chr19:41,330,323...41,353,922
Ensembl chr19:41,301,587...41,353,922

G

tumor necrosis factor

multiple interactions

Cromolyn Sodium inhibits the reaction [[hydroquinone results in increased expression of TNF protein] which results in increased susceptibility to Methacholine Chloride]

NCBI chr 6:31,575,565...31,578,336
Ensembl chr 6:31,575,565...31,578,336

eosin YS dye

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

iodotyrosine deiodinase

multiple interactions

Eosine Yellowish-(YS) inhibits the reaction [IYD protein results in increased metabolism of Monoiodotyrosine]

NCBI chr 6:150,369,012...150,405,969
Ensembl chr 6:150,368,892...150,405,969

erythrosin B

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

ATP binding cassette subfamily B member 1

decreases activity

Erythrosine results in decreased activity of ABCB1 protein

NCBI chr 7:87,503,017...87,713,295
Ensembl chr 7:87,503,017...87,713,323

G

caspase 9

multiple interactions

[Tartrazine co-treated with Erythrosine] affects the expression of CASP9 mRNA

NCBI chr 1:15,491,401...15,524,912
Ensembl chr 1:15,490,832...15,526,534

G

cyclin D1

increases expression

Erythrosine results in increased expression of CCND1 protein

NCBI chr11:69,641,156...69,654,474
Ensembl chr11:69,641,156...69,654,474

G

cyclin dependent kinase 2

increases activity

Erythrosine results in increased activity of CDK2 protein

PMID:8927716 PMID:9168006

NCBI chr12:55,966,830...55,972,789
Ensembl chr12:55,966,781...55,972,789

G

cytochrome P450 family 19 subfamily A member 1

decreases activity

Erythrosine results in decreased activity of CYP19A1 protein

NCBI chr15:51,208,057...51,338,596
Ensembl chr15:51,208,057...51,338,601

G

cytochrome P450 family 3 subfamily A member 4

decreases activity

Erythrosine results in decreased activity of CYP3A4 protein

NCBI chr 7:99,756,967...99,784,184
Ensembl chr 7:99,756,960...99,784,248

G

FOS like 1, AP-1 transcription factor subunit

increases expression

Erythrosine results in increased expression of FOSL1 protein

NCBI chr11:65,892,049...65,900,545
Ensembl chr11:65,892,049...65,900,573

G

glutathione S-transferase pi 1

multiple interactions

Erythrosine inhibits the reaction [GSTP1 protein results in increased metabolism of 1-chloro-2,4-dinitrobenzene-glutathione conjugate]

NCBI chr11:67,583,812...67,586,653
Ensembl chr11:67,583,742...67,586,656

G

hepatitis A virus cellular receptor 1

multiple interactions

[Tartrazine co-treated with Erythrosine] affects the expression of HAVCR1 mRNA

NCBI chr 5:157,029,413...157,069,407
Ensembl chr 5:157,026,742...157,069,396

G

hematopoietic prostaglandin D synthase

decreases activity

Erythrosine results in decreased activity of HPGDS protein

NCBI chr 4:94,298,535...94,342,836
Ensembl chr 4:94,298,535...94,342,876

G

iodotyrosine deiodinase

decreases activity

Erythrosine results in decreased activity of IYD protein

NCBI chr 6:150,369,012...150,405,969
Ensembl chr 6:150,368,892...150,405,969

G

Jun proto-oncogene, AP-1 transcription factor subunit

increases expression

Erythrosine results in increased expression of JUN protein

NCBI chr 1:58,780,791...58,784,047
Ensembl chr 1:58,776,845...58,784,048

G

orosomucoid 1

increases expression

Erythrosine results in increased expression of ORM1 protein

NCBI chr 9:114,323,098...114,326,479
Ensembl chr 9:114,323,098...114,326,479

G

phosphate regulating endopeptidase X-linked

increases expression

Erythrosine results in increased expression of PHEX protein

NCBI chr X:22,032,325...22,251,310
Ensembl chr X:22,032,325...22,494,713

G

tumor necrosis factor

multiple interactions

[Tartrazine co-treated with Erythrosine] results in increased expression of TNF mRNA

NCBI chr 6:31,575,565...31,578,336
Ensembl chr 6:31,575,565...31,578,336

G

tumor protein p53

increases activity

Erythrosine results in increased activity of TP53 protein

NCBI chr17:7,668,421...7,687,490
Ensembl chr17:7,661,779...7,687,538

G

thyrotropin releasing hormone

multiple interactions

Erythrosine promotes the reaction [TRH protein results in increased expression of TSHB protein]

NCBI chr 3:129,974,720...129,977,935
Ensembl chr 3:129,974,688...129,977,935

G

thyroid stimulating hormone subunit beta

multiple interactions

Erythrosine promotes the reaction [TRH protein results in increased expression of TSHB protein]

NCBI chr 1:115,029,826...115,034,309
Ensembl chr 1:115,029,826...115,034,302

G

UDP glucuronosyltransferase family 1 member A6

decreases activity

Erythrosine results in decreased activity of UGT1A6 protein

NCBI chr 2:233,691,702...233,773,300
Ensembl chr 2:233,691,607...233,773,300

G

UDP glucuronosyltransferase family 2 member B7

decreases activity

Erythrosine results in decreased activity of UGT2B7 protein

NCBI chr 4:69,051,375...69,112,987
Ensembl chr 4:69,051,363...69,112,987

G

vascular endothelial growth factor A

increases expression

Erythrosine results in increased expression of VEGFA protein

NCBI chr 6:43,770,211...43,786,487
Ensembl chr 6:43,770,184...43,786,487

Fast green FCF

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

iodotyrosine deiodinase

multiple interactions

Fast Green FCF inhibits the reaction [IYD protein results in increased metabolism of Monoiodotyrosine]

NCBI chr 6:150,369,012...150,405,969
Ensembl chr 6:150,368,892...150,405,969

indigo carmine

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

aryl hydrocarbon receptor

multiple interactions
affects binding

Indigo Carmine binds to and results in increased activity of AHR protein
Indigo Carmine binds to AHR protein

PMID:11425848 PMID:15001395

NCBI chr 7:17,298,652...17,346,147
Ensembl chr 7:16,916,359...17,346,152

G

cholinergic receptor nicotinic alpha 4 subunit

multiple interactions

[ponceau 4R co-treated with Allura Red AC Dye co-treated with 6-hydroxy-5-((p- sulfophenyl)azo)-2-naphthalenesulfonic acid disodium salt co-treated with Tartrazine co-treated with Amaranth Dye co-treated with brilliant blue co-treated with Indigo Carmine] results in decreased expression of CHRNA4 protein

NCBI chr20:63,343,223...63,361,349
Ensembl chr20:63,343,223...63,378,401

G

cholinergic receptor nicotinic beta 2 subunit

multiple interactions

[ponceau 4R co-treated with Allura Red AC Dye co-treated with 6-hydroxy-5-((p- sulfophenyl)azo)-2-naphthalenesulfonic acid disodium salt co-treated with Tartrazine co-treated with Amaranth Dye co-treated with brilliant blue co-treated with Indigo Carmine] results in increased expression of CHRNB2 protein

NCBI chr 1:154,567,778...154,580,013
Ensembl chr 1:154,567,778...154,580,013

G

cytochrome P450 family 1 subfamily A member 1

increases activity
increases expression
multiple interactions

Indigo Carmine results in increased activity of CYP1A1 protein
Indigo Carmine results in increased expression of CYP1A1 mRNA
Indigo Carmine inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A1 protein]

PMID:15001395 PMID:15882963 PMID:18493746

NCBI chr15:74,719,542...74,725,528
Ensembl chr15:74,719,542...74,725,536

G

glutamate ionotropic receptor NMDA type subunit 2A

multiple interactions

[ponceau 4R co-treated with Allura Red AC Dye co-treated with 6-hydroxy-5-((p- sulfophenyl)azo)-2-naphthalenesulfonic acid disodium salt co-treated with Tartrazine co-treated with Amaranth Dye co-treated with brilliant blue co-treated with Indigo Carmine] results in decreased expression of GRIN2A protein; [ponceau 4R co-treated with Allura Red AC Dye co-treated with 6-hydroxy-5-((p- sulfophenyl)azo)-2-naphthalenesulfonic acid disodium salt co-treated with Tartrazine co-treated with Amaranth Dye co-treated with brilliant blue co-treated with Indigo Carmine] results in increased expression of GRIN2A protein

NCBI chr16:9,753,404...10,182,908
Ensembl chr16:9,753,404...10,182,928

merbromin

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

carbonic anhydrase 2

decreases activity

Merbromin results in decreased activity of CA2 protein

NCBI chr 8:85,464,007...85,481,493
Ensembl chr 8:85,463,968...85,481,493

G

glutathione S-transferase alpha 3

multiple interactions

Merbromin inhibits the reaction [GSTA3 protein results in increased metabolism of 1-chloro-2,4-dinitrobenzene-glutathione conjugate]

NCBI chr 6:52,896,646...52,909,698
Ensembl chr 6:52,896,639...52,909,698

G

glutathione S-transferase pi 1

multiple interactions

Merbromin inhibits the reaction [GSTP1 protein results in increased metabolism of 1-chloro-2,4-dinitrobenzene-glutathione conjugate]

NCBI chr11:67,583,812...67,586,653
Ensembl chr11:67,583,742...67,586,656

metamizole sodium

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

corticotropin releasing hormone

multiple interactions

Dipyrone inhibits the reaction [IL1B protein results in increased secretion of CRH protein]; Dipyrone inhibits the reaction [IL6 protein results in increased secretion of CRH protein]; Dipyrone inhibits the reaction [Lipopolysaccharides results in increased secretion of CRH protein]; Dipyrone inhibits the reaction [TNF protein results in increased secretion of CRH protein]

NCBI chr 8:66,176,376...66,178,464
Ensembl chr 8:66,176,376...66,178,464

G

epidermal growth factor receptor

multiple interactions

Dipyrone promotes the reaction [Hydrochloric Acid results in increased expression of EGFR protein]

NCBI chr 7:55,019,017...55,211,628
Ensembl chr 7:55,019,017...55,211,628

G

interleukin 1 beta

multiple interactions

Dipyrone inhibits the reaction [IL1B protein results in increased secretion of CRH protein]

NCBI chr 2:112,829,751...112,836,779
Ensembl chr 2:112,829,751...112,836,816

G

interleukin 6

multiple interactions

Dipyrone inhibits the reaction [IL6 protein results in increased secretion of CRH protein]

NCBI chr 7:22,727,200...22,731,998
Ensembl chr 7:22,725,884...22,732,002

G

prostaglandin-endoperoxide synthase 1

decreases activity

Dipyrone analog results in decreased activity of PTGS1 protein; Dipyrone results in decreased activity of PTGS1 protein

PMID:12242329 PMID:16141368

NCBI chr 9:122,370,533...122,395,703
Ensembl chr 9:122,370,530...122,395,703

G

transforming growth factor alpha

multiple interactions

Dipyrone promotes the reaction [Hydrochloric Acid results in increased expression of TGFA protein]

NCBI chr 2:70,447,284...70,553,826
Ensembl chr 2:70,447,284...70,554,193

G

tumor necrosis factor

multiple interactions

Dipyrone inhibits the reaction [TNF protein results in increased secretion of CRH protein]

NCBI chr 6:31,575,565...31,578,336
Ensembl chr 6:31,575,565...31,578,336

monosodium L-glutamate

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

ATP binding cassette subfamily A member 1

multiple interactions

[Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of ABCA1 mRNA

NCBI chr 9:104,781,006...104,928,155
Ensembl chr 9:104,781,006...104,928,155

G

ATP binding cassette subfamily B member 4

multiple interactions

[Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of ABCB4 mRNA

NCBI chr 7:87,365,896...87,476,027
Ensembl chr 7:87,401,696...87,480,435

G

ATP binding cassette subfamily C member 2

multiple interactions

[Sodium Glutamate co-treated with Bezafibrate] results in increased expression of ABCC2 mRNA

NCBI chr10:99,782,640...99,852,594
Ensembl chr10:99,782,640...99,852,594

G

ATP binding cassette subfamily D member 1

multiple interactions

[Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of ABCD1 mRNA; [Fats, Unsaturated co-treated with Sodium Glutamate] affects the expression of ABCD1 mRNA

NCBI chr X:153,724,856...153,744,755
Ensembl chr X:153,724,856...153,744,755

G

ATP binding cassette subfamily D member 2

multiple interactions

[Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of ABCD2 mRNA

NCBI chr12:39,531,025...39,619,803
Ensembl chr12:39,550,033...39,619,803

G

acetyl-CoA acyltransferase 1

multiple interactions

[Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of ACAA1B mRNA

NCBI chr 3:38,122,715...38,137,127
Ensembl chr 3:38,103,129...38,137,242

G

acetyl-CoA carboxylase alpha

decreases phosphorylation
increases expression
multiple interactions

Sodium Glutamate results in decreased phosphorylation of ACACA protein
Sodium Glutamate results in increased expression of ACACA mRNA; Sodium Glutamate results in increased expression of ACACA protein
3-(4-(4-(3-methyl-1-phenyl-1H-pyrazol-5-yl)piperazin-1-yl)pyrrolidin-2-ylcarbonyl)thiazolidine affects the reaction [[Dietary Fats co-treated with Sodium Glutamate] affects the expression of ACACA mRNA]; [Dietary Fats co-treated with Sodium Glutamate] affects the expression of ACACA mRNA; SRT1720 inhibits the reaction [Sodium Glutamate results in increased expression of ACACA mRNA]; SRT1720 inhibits the reaction [Sodium Glutamate results in increased expression of ACACA protein]

PMID:19724016 PMID:22415589 PMID:26670228

NCBI chr17:37,084,992...37,406,836
Ensembl chr17:37,084,992...37,406,836

G

acetyl-CoA carboxylase beta

multiple interactions

[Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of ACACB mRNA

NCBI chr12:109,111,189...109,268,226
Ensembl chr12:109,116,587...109,268,226

G

acyl-CoA dehydrogenase long chain

multiple interactions

[Sodium Glutamate co-treated with Trans Fatty Acids] results in increased expression of ACADL mRNA

NCBI chr 2:210,187,923...210,225,447
Ensembl chr 2:210,187,126...210,225,447

G

acyl-CoA dehydrogenase medium chain

increases expression
multiple interactions

Sodium Glutamate results in increased expression of ACADM mRNA
SRT1720 inhibits the reaction [Sodium Glutamate results in increased expression of ACADM mRNA]

NCBI chr 1:75,724,709...75,763,679
Ensembl chr 1:75,724,431...75,787,575

G

acyl-CoA dehydrogenase short chain

multiple interactions

[Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of ACADS mRNA; [Fats, Unsaturated co-treated with Sodium Glutamate] affects the expression of ACADS mRNA; [Sodium Glutamate co-treated with Trans Fatty Acids] results in increased expression of ACADS mRNA

PMID:19001666 PMID:23783067

NCBI chr12:120,725,826...120,740,008
Ensembl chr12:120,725,774...120,740,008

G

acyl-CoA dehydrogenase very long chain

multiple interactions

[Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of ACADVL mRNA; [Fats, Unsaturated co-treated with Sodium Glutamate] affects the expression of ACADVL mRNA

NCBI chr17:7,217,125...7,225,266
Ensembl chr17:7,217,125...7,225,266

G

acetylcholinesterase (Yt blood group)

multiple interactions
increases expression

Lycopene inhibits the reaction [Sodium Glutamate results in increased activity of ACHE protein]
Sodium Glutamate results in increased expression of ACHE mRNA

PMID:20928830 PMID:26900785

NCBI chr 7:100,889,994...100,896,994
Ensembl chr 7:100,889,994...100,896,974

G

ATP citrate lyase

multiple interactions

[Sodium Glutamate co-treated with Trans Fatty Acids] results in increased expression of ACLY mRNA

NCBI chr17:41,866,917...41,930,545
Ensembl chr17:41,866,917...41,930,542

G

aconitase 1

multiple interactions

[Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of ACO1 mRNA; [Fats, Unsaturated co-treated with Sodium Glutamate] affects the expression of ACO1 mRNA

NCBI chr 9:32,384,643...32,454,769
Ensembl chr 9:32,384,603...32,454,769

G

acyl-CoA thioesterase 1

multiple interactions

[Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of ACOT1 mRNA

NCBI chr14:73,490,933...73,543,796
Ensembl chr14:73,537,143...73,543,796

G

acyl-CoA thioesterase 12

increases expression

Sodium Glutamate results in increased expression of ACOT12 mRNA

NCBI chr 5:81,308,609...81,394,134
Ensembl chr 5:81,329,996...81,394,179

G

acyl-CoA thioesterase 2

multiple interactions
increases expression

[Sodium Glutamate co-treated with High Fructose Corn Syrup] results in increased expression of ACOT2 mRNA
Sodium Glutamate results in increased expression of ACOT2 mRNA

NCBI chr14:73,567,620...73,575,658
Ensembl chr14:73,567,620...73,575,658

G

acyl-CoA thioesterase 4

multiple interactions
increases expression

[Sodium Glutamate co-treated with High Fructose Corn Syrup] results in increased expression of ACOT4 mRNA
Sodium Glutamate results in increased expression of ACOT4 mRNA

NCBI chr14:73,591,873...73,595,766
Ensembl chr14:73,591,873...73,595,766

G

acyl-CoA oxidase 1

multiple interactions

[Taurine co-treated with Sodium Glutamate] results in increased expression of ACOX1 mRNA
[Sodium Glutamate co-treated with Bezafibrate] results in increased expression of ACOX1 mRNA

PMID:21549692 PMID:26092479

NCBI chr17:75,941,507...75,979,166
Ensembl chr17:75,941,507...75,979,177

G

acrosin

increases expression

Sodium Glutamate results in increased expression of ACR mRNA

NCBI chr22:50,738,204...50,745,339
Ensembl chr22:50,738,196...50,745,339

G

acyl-CoA synthetase bubblegum family member 1

increases expression

Sodium Glutamate results in increased expression of ACSBG1 mRNA

NCBI chr15:78,167,468...78,234,565
Ensembl chr15:78,167,468...78,245,688

G

acyl-CoA synthetase family member 2

multiple interactions

[Trans Fatty Acids co-treated with Sodium Glutamate] results in increased expression of ACSF2 mRNA

NCBI chr17:50,426,218...50,474,845
Ensembl chr17:50,426,158...50,474,845

G

acyl-CoA synthetase long chain family member 3

multiple interactions

[Sodium Glutamate co-treated with Trans Fatty Acids] results in increased expression of ACSL3 mRNA

NCBI chr 2:222,861,036...222,944,639
Ensembl chr 2:222,860,942...222,944,639

G

activin A receptor type 2B

increases expression

Sodium Glutamate results in increased expression of ACVR2B mRNA

NCBI chr 3:38,453,890...38,493,142
Ensembl chr 3:38,453,890...38,493,142

G

ADAM metallopeptidase domain 5 (pseudogene)

increases expression

Sodium Glutamate results in increased expression of ADAM5 mRNA

NCBI chr 8:39,314,632...39,417,378
Ensembl chr 8:39,314,591...39,417,378

G

ADAM metallopeptidase with thrombospondin type 1 motif 7

increases expression

Sodium Glutamate results in increased expression of ADAMTS7 mRNA

NCBI chr15:78,759,206...78,811,464
Ensembl chr15:78,759,206...78,811,464

G

ADAMTS like 3

decreases expression

Sodium Glutamate results in decreased expression of ADAMTSL3 mRNA

NCBI chr15:83,654,123...84,039,842
Ensembl chr15:83,654,088...84,039,842

G

adenylate cyclase 5

increases expression

Sodium Glutamate results in increased expression of ADCY5 mRNA

NCBI chr 3:123,282,296...123,449,090
Ensembl chr 3:123,282,296...123,449,090

G

adhesion G protein-coupled receptor E1

multiple interactions

[Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of ADGRE1 mRNA

NCBI chr19:6,887,579...6,940,450
Ensembl chr19:6,887,566...6,940,459

G

adiponectin, C1Q and collagen domain containing

decreases expression
multiple interactions

Sodium Glutamate results in decreased expression of ADIPOQ protein
[Sodium Glutamate co-treated with Pioglitazone] results in increased expression of ADIPOQ protein; [Sodium Glutamate co-treated with Plant Extracts] results in decreased expression of ADIPOQ mRNA; Bezafibrate inhibits the reaction [Sodium Glutamate results in decreased expression of ADIPOQ protein]; fructooligosaccharide inhibits the reaction [Sodium Glutamate results in decreased expression of ADIPOQ protein]

PMID:21549692 PMID:27918843 PMID:32103741

NCBI chr 3:186,842,710...186,858,463
Ensembl chr 3:186,842,704...186,858,463

G

adenosine A1 receptor

multiple interactions

[Sodium Glutamate co-treated with Trans Fatty Acids] results in increased expression of ADORA1 mRNA

NCBI chr 1:203,127,726...203,167,405
Ensembl chr 1:203,090,654...203,167,405

G

adrenoceptor alpha 1A

multiple interactions

[Sodium Glutamate co-treated with Trans Fatty Acids] results in increased expression of ADRA1A mRNA

NCBI chr 8:26,748,150...26,867,379
Ensembl chr 8:26,748,150...26,867,278

G

adrenoceptor alpha 1D

decreases expression

Sodium Glutamate results in decreased expression of ADRA1D mRNA

NCBI chr20:4,220,630...4,249,287
Ensembl chr20:4,220,630...4,249,287

G

agouti related neuropeptide

decreases expression

Sodium Glutamate results in decreased expression of AGRP mRNA

NCBI chr16:67,482,571...67,483,547
Ensembl chr16:67,482,571...67,483,547

G

aryl hydrocarbon receptor

increases expression

Sodium Glutamate results in increased expression of AHR mRNA

PMID:19001666 PMID:22078008

NCBI chr 7:17,298,652...17,346,147
Ensembl chr 7:16,916,359...17,346,152

G

apoptosis inducing factor mitochondria associated 3

increases expression

Sodium Glutamate results in increased expression of AIFM3 mRNA

NCBI chr22:20,965,172...20,981,358
Ensembl chr22:20,965,108...20,981,360

G

aldo-keto reductase family 1 member A1

increases expression

Sodium Glutamate results in increased expression of AKR1A1 mRNA; Sodium Glutamate results in increased expression of AKR1A1 protein

NCBI chr 1:45,550,826...45,570,049
Ensembl chr 1:45,550,543...45,570,049

G

aldo-keto reductase family 1 member C1

increases expression

Sodium Glutamate results in increased expression of AKR1C20 mRNA

NCBI chr10:4,963,415...4,983,283
Ensembl chr10:4,963,253...4,983,283

G

aldo-keto reductase family 1 member C4

increases expression

Sodium Glutamate results in increased expression of AKR1C6 mRNA

NCBI chr10:5,196,837...5,218,949
Ensembl chr10:5,195,462...5,218,949

G

AKT serine/threonine kinase 1

multiple interactions
increases expression
decreases phosphorylation

Tea inhibits the reaction [Sodium Glutamate results in decreased phosphorylation of AKT1 protein]
Sodium Glutamate results in increased expression of AKT1 protein

PMID:29679905 PMID:36732937

NCBI chr14:104,769,349...104,795,748
Ensembl chr14:104,769,349...104,795,751

G

aldehyde dehydrogenase 1 family member A1

multiple interactions
increases expression

[Sodium Glutamate co-treated with High Fructose Corn Syrup] results in increased expression of ALDH1A1 mRNA
Sodium Glutamate results in increased expression of ALDH1A1 mRNA

NCBI chr 9:72,900,671...72,953,053
Ensembl chr 9:72,900,671...73,080,442

G

aldehyde dehydrogenase 1 family member A3

increases expression

Sodium Glutamate results in increased expression of ALDH1A3 mRNA

NCBI chr15:100,879,831...100,916,626
Ensembl chr15:100,877,714...100,916,626

G

aldehyde dehydrogenase 1 family member L2

multiple interactions

[Sodium Glutamate co-treated with High Fructose Corn Syrup] results in increased expression of ALDH1L2 mRNA

NCBI chr12:105,019,790...105,084,458
Ensembl chr12:105,019,784...105,107,643

G

aldehyde dehydrogenase 3 family member A1

decreases expression

Sodium Glutamate results in decreased expression of ALDH3A1 mRNA

NCBI chr17:19,737,984...19,748,298
Ensembl chr17:19,737,984...19,748,943

G

ALG6 alpha-1,3-glucosyltransferase

multiple interactions

[Trans Fatty Acids co-treated with Sodium Glutamate] results in increased expression of ALG6 mRNA

NCBI chr 1:63,367,627...63,438,553
Ensembl chr 1:63,367,575...63,438,553

G

arachidonate 15-lipoxygenase

multiple interactions
increases expression

[Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of ALOX15 mRNA; [Sodium Glutamate co-treated with High Fructose Corn Syrup] results in increased expression of ALOX15 mRNA
Sodium Glutamate results in increased expression of ALOX15 mRNA

PMID:20111022 PMID:23783067

NCBI chr17:4,630,919...4,641,678
Ensembl chr17:4,630,919...4,642,294

G

autophagy and beclin 1 regulator 1

increases expression

Sodium Glutamate results in increased expression of AMBRA1 mRNA

NCBI chr11:46,396,412...46,594,023
Ensembl chr11:46,396,414...46,594,125

G

amylase alpha 2A

multiple interactions
increases expression

[Trans Fatty Acids co-treated with Sodium Glutamate] results in increased expression of AMY1 mRNA
Sodium Glutamate results in increased expression of AMY1 mRNA

NCBI chr 1:103,616,651...103,625,780
Ensembl chr 1:103,617,427...103,625,780

G

annexin A1

decreases expression

Sodium Glutamate results in decreased expression of ANXA1 mRNA

NCBI chr 9:73,151,865...73,170,393
Ensembl chr 9:73,151,865...73,170,393

G

adaptor related protein complex 1 subunit mu 2

increases expression

Sodium Glutamate results in increased expression of AP1M2 mRNA

NCBI chr19:10,572,671...10,587,312
Ensembl chr19:10,572,671...10,587,315

G

amyloid beta precursor protein binding family B member 1

increases expression

Sodium Glutamate results in increased expression of APBB1 mRNA

NCBI chr11:6,395,124...6,419,453
Ensembl chr11:6,395,125...6,419,414

G

adipocyte plasma membrane associated protein

multiple interactions

[Trans Fatty Acids co-treated with Sodium Glutamate] results in increased expression of APMAP mRNA

NCBI chr20:24,962,925...24,992,751
Ensembl chr20:24,962,925...24,992,751

G

apolipoprotein C2

multiple interactions

[Sodium Glutamate co-treated with High Fructose Corn Syrup] results in increased expression of APOC2 mRNA

NCBI chr19:44,946,051...44,949,565
Ensembl chr19:44,946,035...44,949,565

G

apolipoprotein D

multiple interactions
increases expression

[Sodium Glutamate co-treated with Trans Fatty Acids] results in decreased expression of APOD mRNA
Sodium Glutamate results in increased expression of APOD mRNA

PMID:19001666 PMID:20111022

NCBI chr 3:195,568,705...195,583,940
Ensembl chr 3:195,568,705...195,584,033

G

apolipoprotein E

increases expression
multiple interactions

Sodium Glutamate results in increased expression of APOE mRNA; Sodium Glutamate results in increased expression of APOE protein
6-methyl-2-(phenylethynyl)pyridine inhibits the reaction [Sodium Glutamate results in increased expression of APOE mRNA]

NCBI chr19:44,905,796...44,909,393
Ensembl chr19:44,905,791...44,909,393

G

ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 3

increases expression

Sodium Glutamate results in increased expression of ARAP3 mRNA

NCBI chr 5:141,653,402...141,682,230
Ensembl chr 5:141,653,401...141,682,230

G

activity regulated cytoskeleton associated protein

multiple interactions

[Trans Fatty Acids co-treated with Sodium Glutamate] results in increased expression of ARC mRNA

NCBI chr 8:142,611,049...142,614,479
Ensembl chr 8:142,611,049...142,614,479

G

arginase 2

increases expression

Sodium Glutamate results in increased expression of ARG2 mRNA

NCBI chr14:67,619,920...67,651,708
Ensembl chr14:67,619,920...67,651,708

G

Rho guanine nucleotide exchange factor 1

increases expression

Sodium Glutamate results in increased expression of ARHGEF1 mRNA

NCBI chr19:41,883,184...41,930,141
Ensembl chr19:41,883,173...41,930,150

G

arylsulfatase B

decreases expression

Sodium Glutamate results in decreased expression of ARSB mRNA

NCBI chr 5:78,777,209...78,985,958
Ensembl chr 5:78,777,209...78,986,087

G

ATPase Na+/K+ transporting subunit alpha 3

multiple interactions

[Sodium Glutamate co-treated with Trans Fatty Acids] results in increased expression of ATP1A3 mRNA

NCBI chr19:41,966,582...41,994,230
Ensembl chr19:41,966,582...41,997,497

G

ATPase plasma membrane Ca2+ transporting 3

increases expression

Sodium Glutamate results in increased expression of ATP2B3 mRNA

NCBI chr X:153,517,642...153,582,929
Ensembl chr X:153,517,642...153,582,939

G

ATPase copper transporting beta

increases expression

Sodium Glutamate results in increased expression of ATP7B mRNA

NCBI chr13:51,932,669...52,012,132
Ensembl chr13:51,930,436...52,012,125

G

axin 1

decreases expression

Sodium Glutamate results in decreased expression of AXIN1 mRNA

NCBI chr16:287,440...352,723
Ensembl chr16:287,440...352,723

G

BMP and activin membrane bound inhibitor

decreases expression

Sodium Glutamate results in decreased expression of BAMBI mRNA

NCBI chr10:28,677,521...28,682,932
Ensembl chr10:28,677,510...28,682,932

G

BCL2 associated X, apoptosis regulator

multiple interactions
increases expression

Lycopene inhibits the reaction [Sodium Glutamate results in increased expression of BAX mRNA]
[Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of BAX mRNA; [Fats, Unsaturated co-treated with Sodium Glutamate] affects the expression of BAX mRNA

PMID:23783067 PMID:26900785

NCBI chr19:48,954,875...48,961,798
Ensembl chr19:48,954,815...48,961,798

G

BRCA2 and CDKN1A interacting protein

increases expression
multiple interactions

Sodium Glutamate results in increased expression of BCCIP mRNA
[Trans Fatty Acids co-treated with Sodium Glutamate] results in increased expression of BCCIP mRNA

NCBI chr10:125,823,546...125,853,695
Ensembl chr10:125,823,546...125,853,695

G

butyrylcholinesterase

multiple interactions
increases activity

Lycopene inhibits the reaction [Sodium Glutamate results in increased activity of BCHE protein]

NCBI chr 3:165,772,904...165,837,423
Ensembl chr 3:165,772,904...165,837,462

G

BCL2 apoptosis regulator

multiple interactions
increases expression
decreases expression

[Homocysteine co-treated with Sodium Glutamate] affects the expression of BCL2 mRNA; [Homocysteine co-treated with Sodium Glutamate] affects the expression of BCL2 protein; Folic Acid affects the reaction [[Homocysteine co-treated with Sodium Glutamate] affects the expression of BCL2 mRNA]; Folic Acid affects the reaction [[Homocysteine co-treated with Sodium Glutamate] affects the expression of BCL2 protein]; Lycopene inhibits the reaction [Sodium Glutamate results in decreased expression of BCL2 mRNA]
Sodium Glutamate results in increased expression of BCL2 mRNA
SB 203580 inhibits the reaction [Sodium Glutamate results in increased expression of BCL2 mRNA]

PMID:16782274 PMID:22169520 PMID:26900785

NCBI chr18:63,123,346...63,320,090
Ensembl chr18:63,123,346...63,320,128

G

BCL2 like 11

multiple interactions
increases expression

[Sodium Glutamate co-treated with Trans Fatty Acids] results in decreased expression of BCL2L11 mRNA
Sodium Glutamate results in increased expression of BCL2L11 mRNA

NCBI chr 2:111,120,914...111,168,445
Ensembl chr 2:111,119,378...111,168,444

G

BEN domain containing 3

increases expression

Sodium Glutamate results in increased expression of BEND3 mRNA

NCBI chr 6:107,065,182...107,115,515
Ensembl chr 6:107,065,182...107,115,515

G

bridging integrator 3

multiple interactions

[Trans Fatty Acids co-treated with Sodium Glutamate] results in increased expression of BIN3 mRNA

NCBI chr 8:22,620,418...22,669,121
Ensembl chr 8:22,620,418...22,669,148

G

BMI1 proto-oncogene, polycomb ring finger

multiple interactions
increases expression

[Trans Fatty Acids co-treated with Sodium Glutamate] results in increased expression of BMI1 mRNA
Sodium Glutamate results in increased expression of BMI1 mRNA

NCBI chr10:22,321,099...22,331,484
Ensembl chr10:22,321,099...22,331,484

G

BCL2 interacting protein 5

increases expression

Sodium Glutamate results in increased expression of BNIP5 mRNA

NCBI chr 6:36,315,761...36,336,888
Ensembl chr 6:36,315,761...36,336,888

G

BOP1 ribosomal biogenesis factor

increases expression

Sodium Glutamate results in increased expression of BOP1 mRNA

NCBI chr 8:144,262,045...144,291,438
Ensembl chr 8:144,262,045...144,291,438

G

BR serine/threonine kinase 2

increases expression

Sodium Glutamate results in increased expression of BRSK2 mRNA

NCBI chr11:1,389,934...1,462,689
Ensembl chr11:1,389,899...1,462,689

G

basic leucine zipper and W2 domains 2

increases expression

Sodium Glutamate results in increased expression of BZW2 mRNA

NCBI chr 7:16,646,181...16,706,517
Ensembl chr 7:16,646,131...16,706,523

G

C1q and TNF related 1

decreases expression

Sodium Glutamate results in decreased expression of C1QTNF1 mRNA

NCBI chr17:79,022,934...79,049,788
Ensembl chr17:79,022,814...79,049,788

G

carbonic anhydrase 2

decreases expression

Sodium Glutamate results in decreased expression of CAR2 mRNA

NCBI chr 8:85,464,007...85,481,493
Ensembl chr 8:85,463,968...85,481,493

G

carbonic anhydrase 5B

decreases expression

Sodium Glutamate results in decreased expression of CAR5B mRNA

NCBI chr X:15,738,270...15,788,411
Ensembl chr X:15,688,830...15,788,411

G

calcium binding protein 2

multiple interactions

[Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of CABP2 mRNA; [Fats, Unsaturated co-treated with Sodium Glutamate] affects the expression of CABP2 mRNA

NCBI chr11:67,518,912...67,523,446
Ensembl chr11:67,518,912...67,524,517

G

calcium voltage-gated channel subunit alpha1 A

multiple interactions

[Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of CACNA1A mRNA; [Fats, Unsaturated co-treated with Sodium Glutamate] affects the expression of CACNA1A mRNA

NCBI chr19:13,206,442...13,506,479
Ensembl chr19:13,206,442...13,633,025

G

calcium voltage-gated channel subunit alpha1 I

multiple interactions

[Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of CACNA1I mRNA; [Fats, Unsaturated co-treated with Sodium Glutamate] affects the expression of CACNA1I mRNA

NCBI chr22:39,570,753...39,689,735
Ensembl chr22:39,570,753...39,689,735

G

calcium voltage-gated channel auxiliary subunit alpha2delta 4

multiple interactions

[Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of CACNA2D4 mRNA; [Fats, Unsaturated co-treated with Sodium Glutamate] affects the expression of CACNA2D4 mRNA

NCBI chr12:1,791,963...1,918,652
Ensembl chr12:1,791,963...1,918,666

G

calcium voltage-gated channel auxiliary subunit beta 2

multiple interactions

[Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of CACNB2 mRNA; [Fats, Unsaturated co-treated with Sodium Glutamate] affects the expression of CACNB2 mRNA

NCBI chr10:18,140,424...18,543,557
Ensembl chr10:18,140,424...18,543,557

G

calcium voltage-gated channel auxiliary subunit gamma 4

multiple interactions

[Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of CACNG4 mRNA; [Fats, Unsaturated co-treated with Sodium Glutamate] affects the expression of CACNG4 mRNA

NCBI chr17:66,964,707...67,033,398
Ensembl chr17:66,964,707...67,033,398

G

calcium voltage-gated channel auxiliary subunit gamma 8

multiple interactions

[Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of CACNG8 mRNA; [Fats, Unsaturated co-treated with Sodium Glutamate] affects the expression of CACNG8 mRNA

NCBI chr19:53,962,937...53,990,215
Ensembl chr19:53,962,937...53,990,215

G

calcium homeostasis modulator family member 2

multiple interactions

[Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of CALHM2 mRNA; [Fats, Unsaturated co-treated with Sodium Glutamate] affects the expression of CALHM2 mRNA

NCBI chr10:103,446,786...103,452,370
Ensembl chr10:103,446,786...103,452,402

G

calreticulin

decreases expression

Sodium Glutamate results in decreased expression of CALR mRNA

NCBI chr19:12,938,609...12,944,489
Ensembl chr19:12,938,578...12,944,489

G

calreticulin 3

multiple interactions

[Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of CALR3 mRNA; [Fats, Unsaturated co-treated with Sodium Glutamate] affects the expression of CALR3 mRNA

NCBI chr19:16,479,061...16,496,167
Ensembl chr19:16,479,061...16,496,167

G

calcium/calmodulin dependent protein kinase II alpha

increases expression

Sodium Glutamate results in increased expression of CAMK2A mRNA

NCBI chr 5:150,219,491...150,290,130
Ensembl chr 5:150,219,491...150,290,093

G

calcium/calmodulin dependent protein kinase II beta

increases expression

Sodium Glutamate results in increased expression of CAMK2B mRNA

NCBI chr 7:44,217,154...44,326,013
Ensembl chr 7:44,210,019...44,334,577

G

calcium modulating ligand

decreases expression

Sodium Glutamate results in decreased expression of CAMLG mRNA

NCBI chr 5:134,738,548...134,752,157
Ensembl chr 5:134,738,495...134,752,157

G

calcium activated nucleotidase 1

multiple interactions

[Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of CANT1 mRNA; [Fats, Unsaturated co-treated with Sodium Glutamate] affects the expression of CANT1 mRNA

NCBI chr17:78,991,716...79,009,764
Ensembl chr17:78,991,716...79,009,867

G

calcyphosine 2

increases expression

Sodium Glutamate results in increased expression of CAPS2 mRNA

NCBI chr12:75,275,979...75,390,901
Ensembl chr12:75,275,979...75,390,928

G

caspase 6

multiple interactions

[Sodium Glutamate co-treated with High Fructose Corn Syrup] results in increased expression of CASP6 mRNA

NCBI chr 4:109,664,388...109,709,767
Ensembl chr 4:109,688,622...109,703,583

G

caspase 9

multiple interactions

[Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of CASP9 mRNA; [Fats, Unsaturated co-treated with Sodium Glutamate] affects the expression of CASP9 mRNA

NCBI chr 1:15,491,401...15,524,912
Ensembl chr 1:15,490,832...15,526,534

G

catalase

multiple interactions
increases expression
decreases activity
increases activity
decreases expression

[Plant Extracts co-treated with Sodium Glutamate] results in increased activity of CAT protein; Sodium Glutamate results in increased expression of and results in decreased activity of CAT protein; SRT1720 inhibits the reaction [Sodium Glutamate results in increased expression of CAT mRNA]; SRT1720 inhibits the reaction [Sodium Glutamate results in increased expression of CAT protein]; Tea inhibits the reaction [Sodium Glutamate results in decreased activity of CAT protein]
Sodium Glutamate results in increased expression of CAT mRNA; Sodium Glutamate results in increased expression of CAT protein
Sodium Glutamate results in increased activity of CAT protein
Sodium Glutamate results in decreased expression of CAT mRNA
Lycopene inhibits the reaction [Sodium Glutamate results in increased activity of CAT protein]; Lycopene inhibits the reaction [Sodium Glutamate results in increased expression of CAT mRNA]

PMID:19724016 PMID:25473020 PMID:26319613 PMID:26900785 PMID:29679905 More...

NCBI chr11:34,438,934...34,472,060
Ensembl chr11:34,438,934...34,472,060

G

cation channel sperm associated 1

increases expression

Sodium Glutamate results in increased expression of CATSPER1 mRNA

NCBI chr11:66,016,752...66,026,479
Ensembl chr11:66,016,752...66,026,479

G

cation channel sperm associated 2

increases expression

Sodium Glutamate results in increased expression of CATSPER2 mRNA

NCBI chr15:43,628,503...43,648,884
Ensembl chr15:43,628,503...43,668,118

G

carbonyl reductase 1

increases activity

Sodium Glutamate results in increased activity of CBR1 protein

NCBI chr21:36,070,024...36,073,164
Ensembl chr21:36,069,941...36,073,166

G

coiled-coil domain containing 138

increases expression

Sodium Glutamate results in increased expression of CCDC138 mRNA

NCBI chr 2:108,786,750...108,885,485
Ensembl chr 2:108,786,757...108,885,477

G

coiled-coil domain containing 30

increases expression

Sodium Glutamate results in increased expression of CCDC30 mRNA

NCBI chr 1:42,456,107...42,657,190
Ensembl chr 1:42,463,221...42,657,190

G

coiled-coil domain 39 molecular ruler complex subunit

increases expression

Sodium Glutamate results in increased expression of CCDC39 mRNA

NCBI chr 3:180,614,008...180,679,489
Ensembl chr 3:180,602,858...180,684,942

G

coiled-coil domain containing 60

increases expression

Sodium Glutamate results in increased expression of CCDC60 mRNA

NCBI chr12:119,334,729...119,541,040
Ensembl chr12:119,334,712...119,541,040

G

C-C motif chemokine ligand 2

multiple interactions
increases expression
decreases expression

[Fats, Unsaturated co-treated with Sodium Glutamate] results in increased expression of CCL2 protein; [Sodium Glutamate co-treated with Aspartame] inhibits the reaction [Fats, Unsaturated results in increased expression of CCL2 protein]; SRT1720 inhibits the reaction [Sodium Glutamate results in increased expression of CCL2 mRNA]; SRT1720 inhibits the reaction [Sodium Glutamate results in increased expression of CCL2 protein]
Sodium Glutamate results in increased expression of CCL2 mRNA; Sodium Glutamate results in increased expression of CCL2 protein
Sodium Glutamate results in decreased expression of CCL2 mRNA

PMID:19724016 PMID:20111022 PMID:23783067

NCBI chr17:34,255,285...34,257,203
Ensembl chr17:34,255,274...34,257,208

G

C-C motif chemokine ligand 21

increases expression
multiple interactions

Sodium Glutamate results in increased expression of CCL21A mRNA
[Sodium Glutamate co-treated with High Fructose Corn Syrup] results in decreased expression of CCL21A mRNA

NCBI chr 9:34,709,005...34,710,136
Ensembl chr 9:34,709,005...34,710,136

G

C-C motif chemokine ligand 23

multiple interactions

[Trans Fatty Acids co-treated with Sodium Glutamate] results in increased expression of CCL9 mRNA

NCBI chr17:36,013,058...36,017,972
Ensembl chr17:36,013,056...36,017,972

G

cyclin D2

affects expression
multiple interactions

Sodium Glutamate affects the expression of CCND2 mRNA
[Sodium Glutamate co-treated with Trans Fatty Acids] results in increased expression of CCND2 mRNA

PMID:19001666 PMID:28954212

NCBI chr12:4,273,762...4,305,353
Ensembl chr12:4,269,771...4,305,353

G

cyclin D3

decreases expression
multiple interactions
increases expression

Sodium Glutamate results in decreased expression of CCND3 mRNA
[Sodium Glutamate co-treated with High Fructose Corn Syrup] results in increased expression of CCND3 mRNA
Sodium Glutamate results in increased expression of CCND3 mRNA

PMID:20111022 PMID:22078008

NCBI chr 6:41,934,933...42,050,035
Ensembl chr 6:41,934,934...42,050,357

G

cyclin G1

multiple interactions

[Sodium Glutamate co-treated with Trans Fatty Acids] results in increased expression of CCNG1 mRNA

NCBI chr 5:163,437,571...163,457,640
Ensembl chr 5:163,437,569...163,446,151

G

CD80 molecule

multiple interactions

[Sodium Glutamate co-treated with Trans Fatty Acids] results in decreased expression of CD80 mRNA

NCBI chr 3:119,524,293...119,559,614
Ensembl chr 3:119,524,293...119,559,614

G

CD81 molecule

multiple interactions

[Sodium Glutamate co-treated with High Fructose Corn Syrup] results in increased expression of CD81 mRNA

NCBI chr11:2,376,180...2,397,397
Ensembl chr11:2,376,177...2,397,802

G

CD86 molecule

multiple interactions

[Sodium Glutamate co-treated with Trans Fatty Acids] results in decreased expression of CD86 mRNA

NCBI chr 3:122,055,362...122,121,136
Ensembl chr 3:122,055,362...122,121,139

G

CUB domain containing protein 2

increases expression

Sodium Glutamate results in increased expression of CDCP2 mRNA

NCBI chr 1:54,132,687...54,153,000
Ensembl chr 1:54,132,687...54,153,770

G

cadherin 1

increases expression

Sodium Glutamate results in increased expression of CDH1 mRNA

NCBI chr16:68,737,292...68,835,537
Ensembl chr16:68,737,292...68,835,537

G

cyclin dependent kinase 5

multiple interactions

[Sodium Glutamate co-treated with Trans Fatty Acids] results in increased expression of CDK5 mRNA

NCBI chr 7:151,053,815...151,057,897
Ensembl chr 7:151,053,815...151,057,897

G

cyclin dependent kinase inhibitor 1A

multiple interactions

[Sodium Glutamate co-treated with Trans Fatty Acids] affects the expression of CDKN1A mRNA

NCBI chr 6:36,676,463...36,687,332
Ensembl chr 6:36,676,460...36,687,337

G

cyclin dependent kinase inhibitor 1B

multiple interactions

[Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of CDKN1B mRNA

NCBI chr12:12,717,368...12,722,369
Ensembl chr12:12,685,498...12,722,369

G

cyclin dependent kinase inhibitor 1C

multiple interactions

[Sodium Glutamate co-treated with Trans Fatty Acids] results in decreased expression of CDKN1C mRNA

NCBI chr11:2,883,218...2,885,775
Ensembl chr11:2,883,213...2,885,775

G

cyclin dependent kinase inhibitor 2A

decreases expression
increases expression

Sodium Glutamate results in decreased expression of CDKN2A mRNA; Sodium Glutamate results in decreased expression of CDKN2A protein
Sodium Glutamate results in increased expression of CDKN2A mRNA

PMID:22078008 PMID:28954212

NCBI chr 9:21,967,752...21,995,324
Ensembl chr 9:21,967,752...21,995,301

G

cyclin dependent kinase inhibitor 2B

increases expression
multiple interactions

Sodium Glutamate results in increased expression of CDKN2B mRNA
[Sodium Glutamate co-treated with Trans Fatty Acids] results in increased expression of CDKN2B mRNA

PMID:19001666 PMID:28954212

NCBI chr 9:22,002,903...22,009,313
Ensembl chr 9:22,002,903...22,009,305

G

cyclin dependent kinase inhibitor 2D

decreases expression

Sodium Glutamate results in decreased expression of CDKN2D mRNA

NCBI chr19:10,566,460...10,568,979
Ensembl chr19:10,566,460...10,569,059

G

CDP-diacylglycerol synthase 1

increases expression

Sodium Glutamate results in increased expression of CDS1 mRNA

NCBI chr 4:84,583,127...84,651,334
Ensembl chr 4:84,583,127...84,651,334

G

centrosomal protein 76

multiple interactions

[Trans Fatty Acids co-treated with Sodium Glutamate] results in increased expression of CEP76 mRNA

NCBI chr18:12,661,956...12,702,777
Ensembl chr18:12,661,833...12,702,777

G

complement factor D

multiple interactions
decreases activity
decreases expression

[Caffeine co-treated with Ephedrine] affects the reaction [Sodium Glutamate results in decreased expression of CFD mRNA]; [Caffeine co-treated with Ephedrine] affects the reaction [Sodium Glutamate results in decreased expression of CFD protein]; [Sodium Glutamate co-treated with Trans Fatty Acids] results in increased expression of CFD mRNA
Sodium Glutamate results in decreased activity of CFD protein
Sodium Glutamate results in decreased expression of CFD mRNA; Sodium Glutamate results in decreased expression of CFD protein

PMID:2307116 PMID:2734615 PMID:2798420 PMID:3299706 PMID:7961801 More...

NCBI chr19:859,664...863,641
Ensembl chr19:859,453...867,884

G

glycoprotein hormones, alpha polypeptide

multiple interactions

Sodium Glutamate inhibits the reaction [CGA protein results in increased secretion of 7-hydroxyprogesterone]; Sodium Glutamate inhibits the reaction [CGA protein results in increased secretion of Androstenedione]

NCBI chr 6:87,085,498...87,095,106
Ensembl chr 6:87,085,498...87,095,106

G

calcium homeostasis endoplasmic reticulum protein

multiple interactions

[Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of CHERP mRNA; [Fats, Unsaturated co-treated with Sodium Glutamate] affects the expression of CHERP mRNA

NCBI chr19:16,517,894...16,542,437
Ensembl chr19:16,517,894...16,542,437

G

charged multivesicular body protein 5

multiple interactions

[Trans Fatty Acids co-treated with Sodium Glutamate] results in increased expression of CHMP5 mRNA

NCBI chr 9:33,265,049...33,282,070
Ensembl chr 9:33,264,879...33,282,070

G

cholinergic receptor nicotinic beta 3 subunit

increases expression

Sodium Glutamate results in increased expression of CHRNB3 mRNA

NCBI chr 8:42,697,366...42,737,407
Ensembl chr 8:42,697,366...42,737,407

G

carbohydrate sulfotransferase 1

multiple interactions

[Sodium Glutamate co-treated with Trans Fatty Acids] results in increased expression of CHST1 mRNA

NCBI chr11:45,647,689...45,665,622
Ensembl chr11:45,647,689...45,665,622

G

component of inhibitor of nuclear factor kappa B kinase complex

decreases expression
increases phosphorylation
multiple interactions

Sodium Glutamate results in decreased expression of CHUK mRNA
Sodium Glutamate results in increased phosphorylation of CHUK protein
Atorvastatin inhibits the reaction [Sodium Glutamate results in increased phosphorylation of CHUK protein]

PMID:19800637 PMID:28954212

NCBI chr10:100,186,319...100,229,596
Ensembl chr10:100,188,300...100,229,596

G

cytosolic iron-sulfur assembly component 2A

multiple interactions

[Trans Fatty Acids co-treated with Sodium Glutamate] results in increased expression of CIAO2A mRNA

NCBI chr15:64,072,565...64,093,838
Ensembl chr15:64,072,565...64,093,857

G

circadian associated repressor of transcription

multiple interactions

[Sodium Glutamate co-treated with Trans Fatty Acids] results in increased expression of CIART mRNA

NCBI chr 1:150,282,554...150,287,093
Ensembl chr 1:150,282,543...150,287,093

G

cell death inducing DFFA like effector a

multiple interactions

[Sodium Glutamate co-treated with Trans Fatty Acids] results in increased expression of CIDEA mRNA

NCBI chr18:12,254,361...12,277,595
Ensembl chr18:12,254,361...12,277,595

G

cell death inducing DFFA like effector c

increases expression
multiple interactions

Sodium Glutamate results in increased expression of CIDEC mRNA
[Sodium Glutamate co-treated with Trans Fatty Acids] results in increased expression of CIDEC mRNA

NCBI chr 3:9,866,710...9,880,253
Ensembl chr 3:9,866,711...9,880,255

G

creatine kinase B

increases activity
multiple interactions

Sodium Glutamate results in increased activity of CKB protein
Lycopene inhibits the reaction [Sodium Glutamate results in increased activity of CKB protein]

NCBI chr14:103,519,667...103,522,830
Ensembl chr14:103,519,667...103,522,833

G

claspin

increases expression

Sodium Glutamate results in increased expression of CLSPN mRNA

NCBI chr 1:35,720,213...35,769,978
Ensembl chr 1:35,720,218...35,769,978

G

calsyntenin 3

multiple interactions

[Sodium Glutamate co-treated with Trans Fatty Acids] results in increased expression of CLSTN3 mRNA

NCBI chr12:7,129,093...7,158,945
Ensembl chr12:7,129,698...7,158,945

G

C-X9-C motif containing 1

multiple interactions

[Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of CMC1 mRNA; [Fats, Unsaturated co-treated with Sodium Glutamate] affects the expression of CMC1 mRNA

NCBI chr 3:28,241,619...28,325,142
Ensembl chr 3:28,241,584...28,325,142

G

chemerin chemokine-like receptor 1

decreases expression

Sodium Glutamate results in decreased expression of CMKLR1 mRNA

NCBI chr12:108,288,046...108,339,311
Ensembl chr12:108,288,044...108,339,317

G

cornichon family member 4

multiple interactions

[Trans Fatty Acids co-treated with Sodium Glutamate] results in increased expression of CNIH4 mRNA

NCBI chr 1:224,356,803...224,379,452
Ensembl chr 1:224,356,858...224,379,459

G

cyclin and CBS domain divalent metal cation transport mediator 3

decreases expression

Sodium Glutamate results in decreased expression of CNNM3 mRNA

NCBI chr 2:96,816,268...96,837,466
Ensembl chr 2:96,816,245...96,835,382

G

cytochrome c oxidase assembly factor 7

increases expression

Sodium Glutamate results in increased expression of COA7 mRNA

NCBI chr 1:52,684,449...52,698,347
Ensembl chr 1:52,684,449...52,698,347

G

collagen type I alpha 1 chain

decreases expression

Sodium Glutamate results in decreased expression of COL1A1 mRNA

NCBI chr17:50,184,101...50,201,631
Ensembl chr17:50,184,101...50,201,632

G

collagen type III alpha 1 chain

decreases expression

Sodium Glutamate results in decreased expression of COL3A1 mRNA

NCBI chr 2:188,974,373...189,012,746
Ensembl chr 2:188,974,373...189,012,746

G

cartilage oligomeric matrix protein

decreases expression
multiple interactions

Sodium Glutamate results in decreased expression of COMP mRNA
[Trans Fatty Acids co-treated with Sodium Glutamate] results in increased expression of COMP mRNA

NCBI chr19:18,782,773...18,791,305
Ensembl chr19:18,782,773...18,791,305

G

catechol-O-methyltransferase

increases expression

Sodium Glutamate results in increased expression of COMT mRNA

NCBI chr22:19,941,772...19,969,975
Ensembl chr22:19,941,371...19,969,975

G

COP9 signalosome subunit 3

multiple interactions
increases expression

[Trans Fatty Acids co-treated with Sodium Glutamate] results in increased expression of COPS3 mRNA
Sodium Glutamate results in increased expression of COPS3 mRNA

NCBI chr17:17,246,616...17,281,246
Ensembl chr17:17,246,616...17,281,273

G

coenzyme Q10B

multiple interactions

[Trans Fatty Acids co-treated with Sodium Glutamate] results in increased expression of COQ10B mRNA

NCBI chr 2:197,453,552...197,475,310
Ensembl chr 2:197,453,493...197,475,310

G

coactosin like F-actin binding protein 1

decreases expression

Sodium Glutamate results in decreased expression of COTL1 mRNA

NCBI chr16:84,565,596...84,618,078
Ensembl chr16:84,565,596...84,618,078

G

cytochrome c oxidase copper chaperone COX11

multiple interactions

[Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of COX11 mRNA; [Fats, Unsaturated co-treated with Sodium Glutamate] affects the expression of COX11 mRNA

NCBI chr17:54,951,902...54,968,785
Ensembl chr17:54,951,902...54,968,703

G

cytochrome c oxidase subunit 4I2

multiple interactions

[Sodium Glutamate co-treated with High Fructose Corn Syrup] results in increased expression of COX4I2 mRNA

NCBI chr20:31,637,912...31,645,006
Ensembl chr20:31,637,912...31,645,006

G

cytochrome c oxidase subunit 7A1

multiple interactions

[Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of COX7A1 mRNA; [Fats, Unsaturated co-treated with Sodium Glutamate] affects the expression of COX7A1 mRNA

NCBI chr19:36,150,922...36,152,447
Ensembl chr19:36,150,922...36,152,449

G

cytochrome c oxidase subunit 7A2 like

increases expression

Sodium Glutamate results in increased expression of COX7A2L mRNA

NCBI chr 2:42,335,559...42,368,957
Ensembl chr 2:42,333,546...42,425,088

G

cytochrome c oxidase subunit 8B, pseudogene

decreases expression
multiple interactions

Sodium Glutamate results in decreased expression of COX8B mRNA
[Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of COX8B mRNA; [Fats, Unsaturated co-treated with Sodium Glutamate] affects the expression of COX8B mRNA; [Sodium Glutamate co-treated with Trans Fatty Acids] results in increased expression of COX8B mRNA

PMID:19001666 PMID:23783067

NCBI chr11:253,417...256,972
Ensembl chr11:253,446...253,558

G

copine 2

increases expression

Sodium Glutamate results in increased expression of CPNE2 mRNA

NCBI chr16:57,092,583...57,148,369
Ensembl chr16:57,092,583...57,148,369

G

carnitine palmitoyltransferase 1A

multiple interactions
decreases expression

Taurine inhibits the reaction [Sodium Glutamate results in decreased expression of CPT1A mRNA]
[Sodium Glutamate co-treated with Bezafibrate] results in increased expression of CPT1A mRNA

PMID:21549692 PMID:26092479

NCBI chr11:68,754,620...68,844,277
Ensembl chr11:68,754,620...68,844,410

G

carnitine palmitoyltransferase 1B

multiple interactions
increases expression

[Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of CPT1B mRNA; [Fats, Unsaturated co-treated with Sodium Glutamate] affects the expression of CPT1B mRNA; [Sodium Glutamate co-treated with Trans Fatty Acids] results in increased expression of CPT1B mRNA; SRT1720 inhibits the reaction [Sodium Glutamate results in increased expression of CPT1B mRNA]

PMID:19001666 PMID:19724016 PMID:23783067

NCBI chr22:50,568,861...50,578,612
Ensembl chr22:50,568,861...50,578,465

G

carnitine palmitoyltransferase 1C

multiple interactions

[Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of CPT1C mRNA

NCBI chr19:49,690,662...49,713,731
Ensembl chr19:49,690,898...49,713,731

G

carnitine palmitoyltransferase 2

multiple interactions

[Sodium Glutamate co-treated with Trans Fatty Acids] results in increased expression of CPT2 mRNA

NCBI chr 1:53,196,824...53,214,197
Ensembl chr 1:53,196,792...53,214,197

G

carboxypeptidase Z

increases expression

Sodium Glutamate results in increased expression of CPZ mRNA

NCBI chr 4:8,592,765...8,619,752
Ensembl chr 4:8,592,660...8,619,759

G

carnitine O-acetyltransferase

multiple interactions

[Sodium Glutamate co-treated with Trans Fatty Acids] results in increased expression of CRAT mRNA

NCBI chr 9:129,094,794...129,110,793
Ensembl chr 9:129,094,142...129,111,189

G

cAMP responsive element binding protein 1

affects expression
increases expression
multiple interactions
decreases phosphorylation

Sodium Glutamate affects the expression of CREB1 mRNA
Sodium Glutamate results in increased expression of CREB1 mRNA
6-methyl-2-(phenylethynyl)pyridine inhibits the reaction [Sodium Glutamate results in increased expression of CREB1 mRNA]; Dizocilpine Maleate inhibits the reaction [Sodium Glutamate results in increased expression of CREB1 mRNA]
[Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of CREB1 mRNA
Sodium Glutamate results in decreased phosphorylation of CREB1 protein

PMID:23783067 PMID:28954212 PMID:31981724

NCBI chr 2:207,529,962...207,605,988
Ensembl chr 2:207,529,737...207,605,988

G

CREB binding protein

decreases expression

Sodium Glutamate results in decreased expression of CREBBP mRNA

NCBI chr16:3,725,054...3,880,713
Ensembl chr16:3,725,054...3,880,713

G

cysteine rich with EGF like domains 2

multiple interactions
decreases expression

[Trans Fatty Acids co-treated with Sodium Glutamate] results in increased expression of CRELD2 mRNA
Sodium Glutamate results in decreased expression of CRELD2 mRNA

NCBI chr22:49,918,634...49,927,537
Ensembl chr22:49,918,167...49,927,540

G

corticotropin releasing hormone

decreases expression

Sodium Glutamate results in decreased expression of CRH mRNA

NCBI chr 8:66,176,376...66,178,464
Ensembl chr 8:66,176,376...66,178,464

G

cytotoxic and regulatory T cell molecule

increases expression

Sodium Glutamate results in increased expression of CRTAM mRNA

NCBI chr11:122,838,500...122,872,643
Ensembl chr11:122,838,500...122,872,643

G

cartilage associated protein

decreases expression

Sodium Glutamate results in decreased expression of CRTAP mRNA

NCBI chr 3:33,114,014...33,147,773
Ensembl chr 3:33,114,014...33,147,773

G

cryptochrome circadian regulator 1

decreases expression

Sodium Glutamate results in decreased expression of CRY1 mRNA

NCBI chr12:106,991,364...107,093,549
Ensembl chr12:106,991,364...107,093,549

G

crystallin beta-gamma domain containing 1

increases expression

Sodium Glutamate results in increased expression of CRYBG1 mRNA

NCBI chr 6:106,360,717...106,572,017
Ensembl chr 6:106,360,717...106,572,017

G

colony stimulating factor 1

multiple interactions

[Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of CSF1 mRNA

NCBI chr 1:109,910,506...109,930,992
Ensembl chr 1:109,910,242...109,930,992

G

colony stimulating factor 2 receptor subunit beta

multiple interactions

[EPO protein co-treated with Sodium Glutamate] affects the expression of CSF2RB mRNA

NCBI chr22:36,913,628...36,940,439
Ensembl chr22:36,913,628...36,940,439

G

chymotrypsinogen B2

increases expression

Sodium Glutamate results in increased expression of CTRB1 mRNA

NCBI chr16:75,204,103...75,207,161
Ensembl chr16:75,204,103...75,207,161

G

C-X3-C motif chemokine receptor 1

increases expression

Sodium Glutamate results in increased expression of CX3CR1 mRNA

NCBI chr 3:39,263,494...39,292,966
Ensembl chr 3:39,263,495...39,281,735

G

C-X-C motif chemokine ligand 9

multiple interactions

[Sodium Glutamate co-treated with Trans Fatty Acids] results in increased expression of CXCL9 mRNA

NCBI chr 4:76,001,275...76,007,509
Ensembl chr 4:76,001,275...76,007,509

G

cytochrome b5 type B

multiple interactions

[Sodium Glutamate co-treated with Trans Fatty Acids] results in increased expression of CYB5B mRNA

NCBI chr16:69,424,619...69,466,264
Ensembl chr16:69,398,402...69,466,264

G

cytochrome P450 family 1 subfamily A member 2

multiple interactions

[Sodium Glutamate co-treated with gallocatechol co-treated with Catechin co-treated with epigallocatechin gallate co-treated with epicatechin gallate co-treated with gallocatechol co-treated with gallocatechin gallate] affects the expression of CYP1A2 mRNA; [Sodium Glutamate co-treated with Tea] affects the expression of CYP1A2 mRNA

NCBI chr15:74,748,845...74,756,607
Ensembl chr15:74,748,845...74,756,607

G

cytochrome P450 family 20 subfamily A member 1

increases expression

Sodium Glutamate results in increased expression of CYP20A1 mRNA

NCBI chr 2:203,239,018...203,306,026
Ensembl chr 2:203,238,977...203,306,026

G

cytochrome P450 family 2 subfamily A member 13

multiple interactions

Sodium Glutamate results in increased expression of and results in increased activity of CYP2A1 protein

NCBI chr19:41,088,451...41,096,195
Ensembl chr19:41,088,451...41,096,195

G

cytochrome P450 family 2 subfamily A member 6

multiple interactions

[Sodium Glutamate co-treated with gallocatechol co-treated with Catechin co-treated with epigallocatechin gallate co-treated with epicatechin gallate co-treated with gallocatechol co-treated with gallocatechin gallate] affects the expression of CYP2A5 mRNA; [Sodium Glutamate co-treated with Tea] affects the expression of CYP2A5 mRNA

NCBI chr19:40,843,541...40,850,447
Ensembl chr19:40,843,541...40,850,447

G

cytochrome P450 family 2 subfamily B member 6

multiple interactions
increases expression

[Sodium Glutamate co-treated with gallocatechol co-treated with Catechin co-treated with epigallocatechin gallate co-treated with epicatechin gallate co-treated with gallocatechol co-treated with gallocatechin gallate] affects the expression of CYP2B10 mRNA; [Sodium Glutamate co-treated with High Fructose Corn Syrup] results in increased expression of CYP2B10 mRNA; [Sodium Glutamate co-treated with Tea] affects the expression of CYP2B10 mRNA; [Sodium Glutamate co-treated with Trans Fatty Acids] results in increased expression of CYP2B10 mRNA
Sodium Glutamate results in increased expression of CYP2B10 mRNA

PMID:19001666 PMID:20111022 PMID:25663641

NCBI chr19:40,991,282...41,018,398
Ensembl chr19:40,991,282...41,018,398

G

cytochrome P450 family 2 subfamily C member 18

decreases expression
multiple interactions
increases expression
decreases activity

Sodium Glutamate results in decreased expression of CYP2C11 mRNA
[Sodium Glutamate co-treated with GH1 protein] results in decreased splicing of CYP2C11 mRNA; [Sodium Glutamate co-treated with GH1 protein] results in increased splicing of CYP2C11 mRNA; [Sodium Glutamate co-treated with GH1 protein] results in increased ubiquitination of CYP2C11 protein; GH1 protein affects the reaction [Sodium Glutamate results in decreased activity of CYP2C11 protein]; GH1 protein affects the reaction [Sodium Glutamate results in decreased expression of CYP2C11 mRNA]; GH1 protein inhibits the reaction [Sodium Glutamate results in decreased activity of CYP2C11 protein]; Sodium Glutamate inhibits the reaction [GH1 protein results in increased expression of CYP2C11 protein]; Sodium Glutamate results in increased expression of and affects the splicing of CYP2C11 mRNA alternative form; Sodium Glutamate results in increased expression of and results in decreased splicing of CYP2C11 mRNA; Sodium Glutamate results in increased expression of and results in increased activity of CYP2C11 protein
Sodium Glutamate results in increased expression of CYP2C11 mRNA; Sodium Glutamate results in increased expression of CYP2C11 mRNA alternative form; Sodium Glutamate results in increased expression of CYP2C11 protein

PMID:7476908 PMID:7965769 PMID:8496838 PMID:11089541 PMID:25697375

NCBI chr10:94,683,729...94,736,190
Ensembl chr10:94,683,729...94,736,190

G

cytochrome P450 family 2 subfamily C member 8

multiple interactions
increases expression

[Sodium Glutamate co-treated with gallocatechol co-treated with Catechin co-treated with epigallocatechin gallate co-treated with epicatechin gallate co-treated with gallocatechol co-treated with gallocatechin gallate] affects the expression of CYP2C29 mRNA
Sodium Glutamate results in increased expression of CYP2C29 mRNA

PMID:20111022 PMID:25663641

NCBI chr10:95,036,772...95,069,497
Ensembl chr10:95,036,772...95,069,497

G

cytochrome P450 family 2 subfamily C member 9

multiple interactions

[Sodium Glutamate co-treated with Tea] affects the expression of CYP2C9 mRNA

NCBI chr10:94,938,658...94,990,091
Ensembl chr10:94,938,658...94,990,091

G

cytochrome P450 family 2 subfamily D member 6

multiple interactions

[Sodium Glutamate co-treated with gallocatechol co-treated with Catechin co-treated with epigallocatechin gallate co-treated with epicatechin gallate co-treated with gallocatechol co-treated with gallocatechin gallate] affects the expression of CYP2D22 mRNA; [Sodium Glutamate co-treated with Tea] affects the expression of CYP2D22 mRNA

NCBI chr22:42,126,499...42,130,810
Ensembl chr22:42,126,499...42,130,865

G

cytochrome P450 family 2 subfamily E member 1

multiple interactions

[Sodium Glutamate co-treated with gallocatechol co-treated with Catechin co-treated with epigallocatechin gallate co-treated with epicatechin gallate co-treated with gallocatechol co-treated with gallocatechin gallate] affects the expression of CYP2E1 mRNA; [Sodium Glutamate co-treated with Tea] affects the expression of CYP2E1 mRNA

NCBI chr10:133,527,363...133,539,123
Ensembl chr10:133,520,406...133,561,220

G

cytochrome P450 family 3 subfamily A member 4

multiple interactions

GH1 protein inhibits the reaction [Sodium Glutamate results in decreased expression of and results in decreased activity of CYP3A2 protein]; Sodium Glutamate results in decreased expression of and results in decreased activity of CYP3A2 protein

NCBI chr 7:99,756,967...99,784,184
Ensembl chr 7:99,756,960...99,784,248

G

cytochrome P450 family 3 subfamily A member 5

decreases expression
multiple interactions

Sodium Glutamate results in decreased expression of CYP3A9 mRNA
[Sodium Glutamate co-treated with gallocatechol co-treated with Catechin co-treated with epigallocatechin gallate co-treated with epicatechin gallate co-treated with gallocatechol co-treated with gallocatechin gallate] affects the expression of CYP3A13 mRNA; [Sodium Glutamate co-treated with Tea] affects the expression of CYP3A13 mRNA

PMID:20928830 PMID:25663641

NCBI chr 7:99,648,194...99,679,996
Ensembl chr 7:99,648,194...99,679,996

G

cytochrome P450 family 3 subfamily A member 7

multiple interactions

[Sodium Glutamate co-treated with gallocatechol co-treated with Catechin co-treated with epigallocatechin gallate co-treated with epicatechin gallate co-treated with gallocatechol co-treated with gallocatechin gallate] affects the expression of CYP3A13 mRNA; [Sodium Glutamate co-treated with Tea] affects the expression of CYP3A13 mRNA

NCBI chr 7:99,705,036...99,735,196
Ensembl chr 7:99,705,036...99,735,196

G

cytochrome P450 family 46 subfamily A member 1

multiple interactions
increases expression

6-methyl-2-(phenylethynyl)pyridine inhibits the reaction [Sodium Glutamate results in increased expression of CYP46A1 mRNA]; Dizocilpine Maleate inhibits the reaction [Sodium Glutamate results in increased expression of CYP46A1 mRNA]; Dizocilpine Maleate inhibits the reaction [Sodium Glutamate results in increased expression of CYP46A1 protein]
Sodium Glutamate results in increased expression of CYP46A1 mRNA; Sodium Glutamate results in increased expression of CYP46A1 protein

NCBI chr14:99,684,298...99,727,301
Ensembl chr14:99,684,298...99,727,301

G

cytochrome P450 family 7 subfamily A member 1

increases expression
multiple interactions

Sodium Glutamate results in increased expression of CYP7A1 mRNA
[Sodium Glutamate co-treated with High Fructose Corn Syrup] results in increased expression of CYP7A1 mRNA

PMID:19001666 PMID:20111022

NCBI chr 8:58,490,178...58,500,163
Ensembl chr 8:58,490,178...58,500,163

G

dysbindin domain containing 1

increases expression

Sodium Glutamate results in increased expression of DBNDD1 mRNA

NCBI chr16:90,004,871...90,019,890
Ensembl chr16:90,004,871...90,019,890

G

dynactin subunit 1

increases expression

Sodium Glutamate results in increased expression of DCTN1 mRNA

NCBI chr 2:74,361,155...74,391,866
Ensembl chr 2:74,361,154...74,392,087

G

dicarbonyl and L-xylulose reductase

increases expression

Sodium Glutamate results in increased expression of DCXR mRNA

NCBI chr17:82,035,858...82,037,697
Ensembl chr17:82,035,136...82,037,709

G

DEAD-box helicase 19B

increases expression

Sodium Glutamate results in increased expression of DDX19B mRNA

NCBI chr16:70,289,767...70,335,305
Ensembl chr16:70,289,663...70,335,305

G

defensin beta 1

multiple interactions

[Sodium Glutamate co-treated with Trans Fatty Acids] results in increased expression of DEFB1 mRNA

NCBI chr 8:6,870,592...6,877,936
Ensembl chr 8:6,870,592...6,877,936

G

DEP domain containing 1B

multiple interactions

[Trans Fatty Acids co-treated with Sodium Glutamate] results in increased expression of DEPDC1B mRNA

NCBI chr 5:60,596,912...60,700,166
Ensembl chr 5:60,596,912...60,700,190

G

D-glutamate cyclase

multiple interactions

[Sodium Glutamate co-treated with Trans Fatty Acids] results in increased expression of DGLUCY mRNA

NCBI chr14:91,060,333...91,225,632
Ensembl chr14:91,060,333...91,225,632

G

diablo IAP-binding mitochondrial protein

multiple interactions

[Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of DIABLO mRNA; [Fats, Unsaturated co-treated with Sodium Glutamate] affects the expression of DIABLO mRNA

NCBI chr12:122,207,662...122,227,456
Ensembl chr12:122,207,668...122,226,062

G

delta like non-canonical Notch ligand 1

decreases expression

Sodium Glutamate results in decreased expression of DLK1 mRNA

NCBI chr14:100,726,892...100,738,224
Ensembl chr14:100,725,705...100,738,224

G

distal-less homeobox 5

increases expression

Sodium Glutamate results in increased expression of DLX5 mRNA

NCBI chr 7:97,020,396...97,024,831
Ensembl chr 7:97,020,396...97,024,950

G

DnaJ heat shock protein family (Hsp40) member A1

decreases expression
multiple interactions

Sodium Glutamate results in decreased expression of DNAJA1 mRNA
[Trans Fatty Acids co-treated with Sodium Glutamate] results in increased expression of DNAJA1 mRNA

NCBI chr 9:33,025,273...33,039,907
Ensembl chr 9:33,025,273...33,039,907

G

DnaJ heat shock protein family (Hsp40) member C27

multiple interactions

[Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of DNAJC27 mRNA; [Fats, Unsaturated co-treated with Sodium Glutamate] affects the expression of DNAJC27 mRNA

NCBI chr 2:24,943,636...24,972,094
Ensembl chr 2:24,943,636...24,972,094

G

dynein axonemal light chain 1

increases expression

Sodium Glutamate results in increased expression of DNAL1 mRNA

NCBI chr14:73,644,986...73,703,732
Ensembl chr14:73,644,875...73,703,732

G

dolichyldiphosphatase 1

decreases expression

Sodium Glutamate results in decreased expression of DOLPP1 mRNA

NCBI chr 9:129,081,111...129,090,438
Ensembl chr 9:129,081,111...129,090,438

G

dihydropyrimidinase

increases expression

Sodium Glutamate results in increased expression of DPYS mRNA

NCBI chr 8:104,379,431...104,467,055
Ensembl chr 8:104,330,324...104,467,055

G

desmoplakin

multiple interactions
increases expression

[Sodium Glutamate co-treated with Trans Fatty Acids] results in decreased expression of DSP mRNA
Sodium Glutamate results in increased expression of DSP mRNA

NCBI chr 6:7,541,671...7,586,714
Ensembl chr 6:7,541,338...7,586,714

G

dual oxidase 2

increases expression

Sodium Glutamate results in increased expression of DUOX2 mRNA

NCBI chr15:45,092,650...45,114,172
Ensembl chr15:45,092,650...45,114,172

G

dynein light chain Tctex-type 3

multiple interactions

[Trans Fatty Acids co-treated with Sodium Glutamate] results in increased expression of DYNLT3 mRNA

NCBI chr X:37,838,836...37,847,571
Ensembl chr X:37,836,757...37,847,571

G

DAZ interacting zinc finger protein 1

increases expression

Sodium Glutamate results in increased expression of DZIP1 mRNA

NCBI chr13:95,578,202...95,644,706
Ensembl chr13:95,578,202...95,644,706

G

E2F transcription factor 1

multiple interactions

[Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of E2F1 mRNA; [Fats, Unsaturated co-treated with Sodium Glutamate] affects the expression of E2F1 mRNA

NCBI chr20:33,675,477...33,686,385
Ensembl chr20:33,675,477...33,686,385

G

E2F transcription factor 3

multiple interactions

[Sodium Glutamate co-treated with Trans Fatty Acids] results in increased expression of E2F3 mRNA

NCBI chr 6:20,401,879...20,493,714
Ensembl chr 6:20,401,879...20,493,714

G

endothelin converting enzyme like 1

increases expression

Sodium Glutamate results in increased expression of ECEL1 mRNA

NCBI chr 2:232,479,827...232,487,834
Ensembl chr 2:232,479,827...232,487,834

G

enoyl-CoA hydratase 1

multiple interactions

[Sodium Glutamate co-treated with High Fructose Corn Syrup] results in increased expression of ECH1 mRNA

NCBI chr19:38,815,422...38,831,794
Ensembl chr19:38,815,422...38,831,841

G

ephrin A1

increases expression

Sodium Glutamate results in increased expression of EFNA1 mRNA

NCBI chr 1:155,127,876...155,134,899
Ensembl chr 1:155,127,876...155,134,899

G

epidermal growth factor receptor

decreases expression
multiple interactions

Sodium Glutamate results in decreased expression of EGFR mRNA
[Sodium Glutamate co-treated with Trans Fatty Acids] results in decreased expression of EGFR mRNA

PMID:19001666 PMID:28954212

NCBI chr 7:55,019,017...55,211,628
Ensembl chr 7:55,019,017...55,211,628

G

enoyl-CoA hydratase and 3-hydroxyacyl CoA dehydrogenase

multiple interactions

[Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of EHHADH mRNA; [Fats, Unsaturated co-treated with Sodium Glutamate] affects the expression of EHHADH mRNA; [Sodium Glutamate co-treated with Trans Fatty Acids] results in increased expression of EHHADH mRNA

PMID:19001666 PMID:23783067

NCBI chr 3:185,190,624...185,254,049
Ensembl chr 3:185,190,624...185,281,990

G

eukaryotic translation initiation factor 2 alpha kinase 4

multiple interactions
increases expression

[Trans Fatty Acids co-treated with Sodium Glutamate] results in increased expression of EIF2AK4 mRNA
Sodium Glutamate results in increased expression of EIF2AK4 mRNA

NCBI chr15:39,934,115...40,035,591
Ensembl chr15:39,934,115...40,035,591

G

eukaryotic translation initiation factor 4E binding protein 2

decreases expression

Sodium Glutamate results in decreased expression of EIF4EBP2 mRNA

NCBI chr10:70,404,145...70,428,618
Ensembl chr10:70,404,145...70,428,618

G

elastase, neutrophil expressed

increases expression

Sodium Glutamate results in increased expression of ELANE mRNA

NCBI chr19:852,303...856,243
Ensembl chr19:851,014...856,247

G

engulfment and cell motility 3

increases expression

Sodium Glutamate results in increased expression of ELMO3 mRNA

NCBI chr16:67,199,131...67,204,004
Ensembl chr16:67,199,111...67,204,029

G

ELOVL fatty acid elongase 6

multiple interactions

3-(4-(4-(3-methyl-1-phenyl-1H-pyrazol-5-yl)piperazin-1-yl)pyrrolidin-2-ylcarbonyl)thiazolidine affects the reaction [[Dietary Fats co-treated with Sodium Glutamate] affects the expression of ELOVL6 mRNA]; [Dietary Fats co-treated with Sodium Glutamate] affects the expression of ELOVL6 mRNA

NCBI chr 4:110,045,846...110,199,202
Ensembl chr 4:110,045,846...110,199,199

G

elastin microfibril interfacer 1

increases expression

Sodium Glutamate results in increased expression of EMILIN1 mRNA

NCBI chr 2:27,078,615...27,086,403
Ensembl chr 2:27,078,615...27,086,403

G

epithelial membrane protein 1

decreases expression
multiple interactions

Sodium Glutamate results in decreased expression of EMP1 mRNA
[Trans Fatty Acids co-treated with Sodium Glutamate] results in increased expression of EMP1 mRNA

NCBI chr12:13,196,726...13,219,941
Ensembl chr12:13,196,723...13,219,941

G

epoxide hydrolase 2

multiple interactions

[Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of EPHX2 mRNA; [Fats, Unsaturated co-treated with Sodium Glutamate] affects the expression of EPHX2 mRNA

NCBI chr 8:27,491,143...27,548,626
Ensembl chr 8:27,490,781...27,545,564

G

erythropoietin

multiple interactions
affects expression
increases expression

[EPO protein co-treated with Sodium Glutamate] affects the expression of CSF2RB mRNA; [EPO protein co-treated with Sodium Glutamate] results in increased expression of EPO protein; [EPO protein co-treated with Sodium Glutamate] results in increased expression of EPOR mRNA; [EPO protein co-treated with Sodium Glutamate] results in increased expression of EPOR protein; EPO protein inhibits the reaction [Sodium Glutamate results in increased expression of EPO mRNA]
Sodium Glutamate affects the expression of EPO protein

NCBI chr 7:100,720,468...100,723,700
Ensembl chr 7:100,720,468...100,723,700

G

erythropoietin receptor

multiple interactions
increases expression

[EPO protein co-treated with Sodium Glutamate] results in increased expression of EPOR mRNA; [EPO protein co-treated with Sodium Glutamate] results in increased expression of EPOR protein
Sodium Glutamate results in increased expression of EPOR protein

NCBI chr19:11,377,207...11,384,314
Ensembl chr19:11,377,207...11,384,342

G

erb-b2 receptor tyrosine kinase 3

increases expression
multiple interactions

Sodium Glutamate results in increased expression of ERBB3 mRNA
[Sodium Glutamate co-treated with Trans Fatty Acids] results in decreased expression of ERBB3 mRNA

NCBI chr12:56,080,108...56,103,505
Ensembl chr12:56,076,799...56,103,505

G

ER lipid raft associated 1

multiple interactions

[Trans Fatty Acids co-treated with Sodium Glutamate] results in increased expression of ERLIN1 mRNA

NCBI chr10:100,150,094...100,186,029
Ensembl chr10:100,150,094...100,186,033

G

estrogen related receptor beta

increases expression

Sodium Glutamate results in increased expression of ESRRB mRNA

NCBI chr14:76,310,777...76,501,837
Ensembl chr14:76,310,712...76,501,837

G

exosome component 8

multiple interactions

[Trans Fatty Acids co-treated with Sodium Glutamate] results in increased expression of EXOSC8 mRNA

NCBI chr13:37,000,786...37,009,614
Ensembl chr13:36,998,816...37,025,881

G

enhancer of zeste 1 polycomb repressive complex 2 subunit

multiple interactions

[Trans Fatty Acids co-treated with Sodium Glutamate] results in decreased expression of EZH1 mRNA

NCBI chr17:42,700,275...42,745,040
Ensembl chr17:42,700,275...42,745,049

G

FA core complex associated protein 24

decreases expression

Sodium Glutamate results in decreased expression of FAAP24 mRNA

NCBI chr19:32,972,242...32,978,229
Ensembl chr19:32,972,209...32,978,229

G

fatty acid binding protein 5

multiple interactions

[Sodium Glutamate co-treated with Trans Fatty Acids] results in increased expression of FABP5 mRNA

NCBI chr 8:81,280,536...81,284,775
Ensembl chr 8:81,280,536...81,284,777

G

fatty acid desaturase 1

increases expression
multiple interactions

Sodium Glutamate results in increased expression of FADS1 mRNA
[Sodium Glutamate co-treated with Trans Fatty Acids] results in increased expression of FADS1 mRNA

NCBI chr11:61,799,627...61,817,003
Ensembl chr11:61,799,627...61,829,318

G

fatty acid desaturase 2

increases expression

Sodium Glutamate results in increased expression of FADS2 mRNA

NCBI chr11:61,816,203...61,867,354
Ensembl chr11:61,792,980...61,867,354

G

Fas apoptotic inhibitory molecule

multiple interactions

[Sodium Glutamate co-treated with High Fructose Corn Syrup] results in increased expression of FAIM mRNA

NCBI chr 3:138,608,771...138,633,376
Ensembl chr 3:138,608,606...138,633,376

G

Fas apoptotic inhibitory molecule 2

increases expression

Sodium Glutamate results in increased expression of FAIM2 mRNA

NCBI chr12:49,866,896...49,903,900
Ensembl chr12:49,866,896...49,904,217

G

family with sequence similarity 78 member B

decreases expression

Sodium Glutamate results in decreased expression of FAM78B mRNA

NCBI chr 1:166,055,918...166,167,001
Ensembl chr 1:166,057,426...166,167,001

G

FANCD2 and FANCI associated nuclease 1

affects methylation

Sodium Glutamate affects the methylation of FAN1 gene

NCBI chr15:30,903,852...30,943,108
Ensembl chr15:30,890,559...30,943,108

G

Fas ligand

multiple interactions
increases expression

SB 203580 inhibits the reaction [Sodium Glutamate results in increased expression of FASL mRNA]

NCBI chr 1:172,659,103...172,666,876
Ensembl chr 1:172,659,103...172,666,876

G

fatty acid synthase

increases expression
multiple interactions

Sodium Glutamate results in increased expression of FASN mRNA; Sodium Glutamate results in increased expression of FASN protein
[Sodium Glutamate co-treated with Trans Fatty Acids] results in increased expression of FASN mRNA; fructooligosaccharide inhibits the reaction [Sodium Glutamate results in increased expression of FASN mRNA]; SRT1720 inhibits the reaction [Sodium Glutamate results in increased expression of FASN mRNA]; SRT1720 inhibits the reaction [Sodium Glutamate results in increased expression of FASN protein]

PMID:19001666 PMID:19724016 PMID:26092479 PMID:32103741

NCBI chr17:82,078,338...82,098,236
Ensembl chr17:82,078,338...82,098,294

G

FAT atypical cadherin 3

decreases expression

Sodium Glutamate results in decreased expression of FAT3 mRNA

NCBI chr11:92,224,818...92,896,473
Ensembl chr11:92,224,818...92,896,473

G

fibulin 1

decreases expression

Sodium Glutamate results in decreased expression of FBLN1 mRNA

NCBI chr22:45,502,883...45,601,135
Ensembl chr22:45,502,238...45,601,135

G

fibrillin 2

increases expression

Sodium Glutamate results in increased expression of FBN2 mRNA

NCBI chr 5:128,257,909...128,538,245
Ensembl chr 5:128,257,909...128,659,185

G

F-box protein 15

affects methylation

Sodium Glutamate affects the methylation of FBXO15 gene

NCBI chr18:74,073,368...74,147,834
Ensembl chr18:74,073,353...74,147,843

G

F-box protein 41

increases expression

Sodium Glutamate results in increased expression of FBXO41 mRNA

NCBI chr 2:73,254,690...73,284,478
Ensembl chr 2:73,254,682...73,284,478

G

farnesyl diphosphate synthase

multiple interactions

[Sodium Glutamate co-treated with Trans Fatty Acids] results in increased expression of FDPS mRNA

NCBI chr 1:155,308,866...155,320,665
Ensembl chr 1:155,308,748...155,320,666

G

fibroblast growth factor 2

multiple interactions

[Sodium Glutamate co-treated with Trans Fatty Acids] results in increased expression of FGF2 mRNA

NCBI chr 4:122,826,682...122,898,236
Ensembl chr 4:122,826,682...122,898,236

G

fibroblast growth factor 21

multiple interactions

[Sodium Glutamate co-treated with Trans Fatty Acids] results in increased expression of FGF21 mRNA

NCBI chr19:48,755,524...48,758,330
Ensembl chr19:48,755,524...48,758,333

G

fibroblast growth factor 8

multiple interactions

[Sodium Glutamate co-treated with Trans Fatty Acids] results in increased expression of FGF8 mRNA

NCBI chr10:101,770,109...101,780,369
Ensembl chr10:101,770,109...101,780,371

G

fibroblast growth factor receptor 2

increases expression

Sodium Glutamate results in increased expression of FGFR2 mRNA

NCBI chr10:121,478,330...121,598,458
Ensembl chr10:121,478,332...121,598,458

G

fms related receptor tyrosine kinase 1

decreases expression

Sodium Glutamate results in decreased expression of FLT1 protein

NCBI chr13:28,300,346...28,495,128
Ensembl chr13:28,300,346...28,495,145

G

flavin containing dimethylaniline monoxygenase 2

increases expression
multiple interactions

Sodium Glutamate results in increased expression of FMO2 mRNA
[Sodium Glutamate co-treated with High Fructose Corn Syrup] results in increased expression of FMO2 mRNA; [Sodium Glutamate co-treated with Trans Fatty Acids] results in increased expression of FMO2 mRNA

PMID:19001666 PMID:20111022

NCBI chr 1:171,185,208...171,212,686
Ensembl chr 1:171,185,249...171,212,686

G

fibromodulin

increases expression

Sodium Glutamate results in increased expression of FMOD mRNA

NCBI chr 1:203,340,628...203,351,122
Ensembl chr 1:203,340,628...203,351,758

G

folate receptor beta

decreases expression

Sodium Glutamate results in decreased expression of FOLR2 mRNA

NCBI chr11:72,216,794...72,221,950
Ensembl chr11:72,216,601...72,221,950

G

Fos proto-oncogene, AP-1 transcription factor subunit

decreases expression

Sodium Glutamate results in decreased expression of FOS mRNA

NCBI chr14:75,278,828...75,282,230
Ensembl chr14:75,278,826...75,282,230

G

forkhead box B2

increases expression

Sodium Glutamate results in increased expression of FOXB2 mRNA

NCBI chr 9:77,019,655...77,020,953
Ensembl chr 9:77,019,655...77,020,953

G

forkhead box O3

multiple interactions

[Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of FOXO3 mRNA

NCBI chr 6:108,559,825...108,684,774
Ensembl chr 6:108,559,835...108,684,774

G

forkhead box P4

decreases expression

Sodium Glutamate results in decreased expression of FOXP4 mRNA

NCBI chr 6:41,546,381...41,602,384
Ensembl chr 6:41,546,381...41,602,384

G

follicle stimulating hormone subunit beta

decreases secretion

Sodium Glutamate results in decreased secretion of FSHB protein

NCBI chr11:30,231,014...30,235,194
Ensembl chr11:30,231,014...30,235,261

G

formimidoyltransferase cyclodeaminase

increases expression

Sodium Glutamate results in increased expression of FTCD mRNA

NCBI chr21:46,136,262...46,155,579
Ensembl chr21:46,136,160...46,155,579

G

FXYD domain containing ion transport regulator 6

multiple interactions

[Trans Fatty Acids co-treated with Sodium Glutamate] results in increased expression of FXYD6 mRNA

NCBI chr11:117,836,981...117,877,430
Ensembl chr11:117,836,976...117,877,486

G

G0/G1 switch 2

multiple interactions

[Sodium Glutamate co-treated with High Fructose Corn Syrup] results in increased expression of G0S2 mRNA

NCBI chr 1:209,675,412...209,676,390
Ensembl chr 1:209,675,412...209,676,390

G

glucose-6-phosphate dehydrogenase

multiple interactions

[Sodium Glutamate co-treated with Trans Fatty Acids] results in increased expression of G6PDX mRNA

NCBI chr X:154,531,390...154,547,569
Ensembl chr X:154,517,825...154,547,572

G

glutamate decarboxylase 1

decreases expression
increases expression

Sodium Glutamate results in decreased expression of GAD1 mRNA
Sodium Glutamate results in increased expression of GAD1 protein

NCBI chr 2:170,813,210...170,861,151
Ensembl chr 2:170,813,213...170,861,151

G

glutamate decarboxylase 2

decreases expression
affects expression
increases expression

Sodium Glutamate results in decreased expression of GAD2 protein
Sodium Glutamate affects the expression of GAD2 protein
Sodium Glutamate results in increased expression of GAD2 mRNA

NCBI chr10:26,216,372...26,304,558
Ensembl chr10:26,216,665...26,304,558

G

growth arrest and DNA damage inducible beta

multiple interactions
increases expression

[Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of GADD45B mRNA; [Sodium Glutamate co-treated with High Fructose Corn Syrup] results in increased expression of GADD45B mRNA
Sodium Glutamate results in increased expression of GADD45B mRNA

PMID:19001666 PMID:20111022 PMID:23783067

NCBI chr19:2,476,127...2,478,257
Ensembl chr19:2,476,122...2,478,259

G

UDP-galactose-4-epimerase

multiple interactions

[Sodium Glutamate co-treated with Trans Fatty Acids] results in increased expression of GALE mRNA

NCBI chr 1:23,795,599...23,800,754
Ensembl chr 1:23,795,599...23,800,781

G

galactokinase 1

multiple interactions
increases expression

[Sodium Glutamate co-treated with High Fructose Corn Syrup] results in increased expression of GALK1 mRNA; [Sodium Glutamate co-treated with Trans Fatty Acids] results in increased expression of GALK1 mRNA
Sodium Glutamate results in increased expression of GALK1 mRNA

PMID:19001666 PMID:20111022

NCBI chr17:75,751,469...75,765,192
Ensembl chr17:75,751,594...75,765,236

G

polypeptide N-acetylgalactosaminyltransferase 10

decreases expression

Sodium Glutamate results in decreased expression of GALNT10 mRNA

NCBI chr 5:154,190,733...154,420,984
Ensembl chr 5:154,190,730...154,420,984

G

galanin like peptide

increases expression

Sodium Glutamate results in increased expression of GALP mRNA

NCBI chr19:56,176,008...56,185,775
Ensembl chr19:56,176,008...56,185,775

G

growth arrest specific 2 like 1

decreases expression

Sodium Glutamate results in decreased expression of GAS2L1 mRNA

NCBI chr22:29,306,650...29,312,787
Ensembl chr22:29,306,618...29,312,787

G

1,4-alpha-glucan branching enzyme 1

multiple interactions

[Sodium Glutamate co-treated with Trans Fatty Acids] results in increased expression of GBE1 mRNA

NCBI chr 3:81,489,703...81,761,645
Ensembl chr 3:81,489,703...81,761,645

G

glycerophosphodiester phosphodiesterase domain containing 5

decreases expression

Sodium Glutamate results in decreased expression of GDPD5 mRNA

NCBI chr11:75,434,640...75,525,941
Ensembl chr11:75,434,640...75,525,941

G

glial fibrillary acidic protein

increases expression

Sodium Glutamate results in increased expression of GFAP mRNA

NCBI chr17:44,903,159...44,915,500
Ensembl chr17:44,903,159...44,916,937

G

GTP dependent ribosome recycling factor mitochondrial 2

multiple interactions

[Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of GFM2 mRNA; [Fats, Unsaturated co-treated with Sodium Glutamate] affects the expression of GFM2 mRNA

NCBI chr 5:74,721,206...74,767,117
Ensembl chr 5:74,721,206...74,767,147

G

Gfo/Idh/MocA-like oxidoreductase domain containing 2

increases expression

Sodium Glutamate results in increased expression of GFOD2 mRNA

NCBI chr16:67,674,536...67,719,316
Ensembl chr16:67,674,531...67,719,339

G

growth hormone 1

affects expression
decreases expression
decreases secretion
multiple interactions

Sodium Glutamate affects the expression of GH1 protein
Sodium Glutamate results in decreased expression of GH1 mRNA; Sodium Glutamate results in decreased expression of GH1 protein
Sodium Glutamate results in decreased secretion of GH1 protein
[Octreotide co-treated with Sodium Glutamate] results in decreased expression of and results in decreased secretion of GH1 protein; [Sodium Glutamate co-treated with GH1 protein] results in decreased splicing of CYP2C11 mRNA; [Sodium Glutamate co-treated with GH1 protein] results in increased splicing of CYP2C11 mRNA; [Sodium Glutamate co-treated with GH1 protein] results in increased ubiquitination of CYP2C11 protein; GH1 protein affects the reaction [Sodium Glutamate results in decreased activity of CYP2C11 protein]; GH1 protein affects the reaction [Sodium Glutamate results in decreased expression of CYP2C11 mRNA]; GH1 protein inhibits the reaction [Sodium Glutamate results in decreased activity of CYP2C11 protein]; GH1 protein inhibits the reaction [Sodium Glutamate results in decreased expression of and results in decreased activity of CYP3A2 protein]; GH1 protein inhibits the reaction [Sodium Glutamate results in decreased expression of IGF1 mRNA]; GH1 protein inhibits the reaction [Sodium Glutamate results in increased expression of IGF1R mRNA]; GHRH protein affects the reaction [Sodium Glutamate results in decreased expression of GH1 mRNA]; JI-38 inhibits the reaction [Sodium Glutamate results in decreased secretion of GH1 protein]; Sodium Glutamate inhibits the reaction [GH1 protein results in decreased expression of SOCS2 mRNA]; Sodium Glutamate inhibits the reaction [GH1 protein results in increased expression of CYP2C11 protein]; Sodium Glutamate inhibits the reaction [GH1 protein results in increased expression of GHR mRNA]; Sodium Glutamate inhibits the reaction [GH1 protein results in increased expression of GHR protein]; Sodium Glutamate inhibits the reaction [GH1 protein results in increased expression of SOCS2 mRNA]; Sodium Glutamate inhibits the reaction [GH1 protein results in increased expression of SOCS2 protein]; Sodium Glutamate inhibits the reaction [GHRL protein results in increased secretion of GH1 protein]; Sodium Glutamate results in decreased expression of and results in decreased secretion of GH1 protein

PMID:7476908 PMID:7711889 PMID:8368293 PMID:8496838 PMID:9053782 More...

NCBI chr17:63,917,203...63,918,839
Ensembl chr17:63,917,200...63,918,839

G

GH3 domain containing

decreases expression

Sodium Glutamate results in decreased expression of GHDC mRNA

NCBI chr17:42,189,087...42,194,494
Ensembl chr17:42,188,799...42,194,513

G

growth hormone receptor

increases expression
multiple interactions

Sodium Glutamate results in increased expression of GHR mRNA; Sodium Glutamate results in increased expression of GHR protein
Sodium Glutamate inhibits the reaction [GH1 protein results in increased expression of GHR mRNA]; Sodium Glutamate inhibits the reaction [GH1 protein results in increased expression of GHR protein]

NCBI chr 5:42,423,439...42,721,878
Ensembl chr 5:42,423,439...42,721,878

G

growth hormone releasing hormone

multiple interactions
decreases expression

[Sodium Glutamate co-treated with Octreotide] results in decreased expression of GHRH mRNA; GHRH protein affects the reaction [Sodium Glutamate results in decreased expression of GH1 mRNA]
Sodium Glutamate results in decreased expression of GHRH mRNA

PMID:2004597 PMID:8368293 PMID:9053782

NCBI chr20:37,251,086...37,261,814
Ensembl chr20:37,251,086...37,261,819

G

growth hormone releasing hormone receptor

increases expression

Sodium Glutamate results in increased expression of GHRHR mRNA

NCBI chr 7:30,963,953...30,979,528
Ensembl chr 7:30,938,669...30,993,254

G

ghrelin and obestatin prepropeptide

multiple interactions

Sodium Glutamate inhibits the reaction [GHRL protein results in increased secretion of GH1 protein]

NCBI chr 3:10,285,666...10,292,947
Ensembl chr 3:10,285,666...10,292,947

G

growth hormone secretagogue receptor

increases expression

Sodium Glutamate results in increased expression of GHSR mRNA

NCBI chr 3:172,443,291...172,448,456
Ensembl chr 3:172,443,291...172,448,456

G

GRB10 interacting GYF protein 1

multiple interactions
increases expression

[Trans Fatty Acids co-treated with Sodium Glutamate] results in increased expression of GIGYF1 mRNA
Sodium Glutamate results in increased expression of GIGYF1 mRNA

NCBI chr 7:100,679,507...100,694,250
Ensembl chr 7:100,679,507...100,694,250

G

gastric inhibitory polypeptide

multiple interactions

[Fats, Unsaturated co-treated with Sodium Glutamate] results in increased expression of GIP protein; Sodium Glutamate inhibits the reaction [Aspartame promotes the reaction [Fats, Unsaturated results in increased expression of GIP protein]]

NCBI chr17:48,958,554...48,968,596
Ensembl chr17:48,958,554...48,968,596

G

glycerol kinase

multiple interactions
increases expression

[Sodium Glutamate co-treated with Trans Fatty Acids] results in decreased expression of GK mRNA
Sodium Glutamate results in increased expression of GK mRNA

NCBI chr X:30,653,423...30,731,462
Ensembl chr X:30,653,359...30,731,462

G

glutaredoxin

decreases expression
increases expression
multiple interactions

Sodium Glutamate results in decreased expression of GLRX mRNA
Sodium Glutamate results in increased expression of GLRX mRNA
[Sodium Glutamate co-treated with High Fructose Corn Syrup] results in increased expression of GLRX mRNA

PMID:20111022 PMID:22078008

NCBI chr 5:95,813,849...95,822,726
Ensembl chr 5:95,751,319...95,822,726

G

glutamate dehydrogenase 1

multiple interactions

Sodium Glutamate results in decreased expression of and results in decreased activity of GLUD1 protein

NCBI chr10:87,050,202...87,094,843
Ensembl chr10:87,050,202...87,094,843

G

glucocorticoid modulatory element binding protein 2

increases expression

Sodium Glutamate results in increased expression of GMEB2 mRNA

NCBI chr20:63,587,605...63,627,101
Ensembl chr20:63,587,602...63,627,101

G

glia maturation factor beta

multiple interactions

[Trans Fatty Acids co-treated with Sodium Glutamate] results in increased expression of GMFB mRNA

NCBI chr14:54,474,485...54,488,980
Ensembl chr14:54,474,484...54,489,025

G

glyceronephosphate O-acyltransferase

multiple interactions

[Sodium Glutamate co-treated with Trans Fatty Acids] results in increased expression of GNPAT mRNA

NCBI chr 1:231,241,212...231,277,973
Ensembl chr 1:231,241,207...231,277,973

G

glutamic-oxaloacetic transaminase 1

multiple interactions

[Sodium Glutamate co-treated with High Fructose Corn Syrup] results in decreased expression of GOT1 mRNA

NCBI chr10:99,396,870...99,430,624
Ensembl chr10:99,396,870...99,430,624

G

glycerol-3-phosphate acyltransferase 3

multiple interactions

[Sodium Glutamate co-treated with Trans Fatty Acids] results in increased expression of GPAT3 mRNA

NCBI chr 4:83,535,587...83,605,875
Ensembl chr 4:83,535,914...83,605,875

G

glypican 2

increases expression

Sodium Glutamate results in increased expression of GPC2 mRNA

NCBI chr 7:100,169,606...100,177,381
Ensembl chr 7:100,169,606...100,177,381

G

G protein-coupled receptor 85

increases expression

Sodium Glutamate results in increased expression of GPR85 mRNA

NCBI chr 7:113,082,285...113,087,724
Ensembl chr 7:113,078,331...113,087,778

G

G protein-coupled receptor class C group 5 member C

increases expression

Sodium Glutamate results in increased expression of GPRC5C mRNA

NCBI chr17:74,432,088...74,451,658
Ensembl chr17:74,424,851...74,451,653

G

glutamic--pyruvic transaminase

multiple interactions
decreases expression
increases activity
increases expression

2-ethoxy-3-(4-(2-(4-trifluoromethanesulfonyloxyphenyl)ethoxy)phenyl)propionic acid promotes the reaction [Sodium Glutamate results in increased activity of GPT protein]; 3-(4-(4-(3-methyl-1-phenyl-1H-pyrazol-5-yl)piperazin-1-yl)pyrrolidin-2-ylcarbonyl)thiazolidine affects the reaction [[Dietary Fats co-treated with Sodium Glutamate] affects the expression of GPT protein]; [Dietary Fats co-treated with Sodium Glutamate] affects the expression of GPT protein; Bezafibrate promotes the reaction [Sodium Glutamate results in increased expression of GPT protein]; fructooligosaccharide inhibits the reaction [Sodium Glutamate results in increased expression of GPT protein]; Rosiglitazone promotes the reaction [Sodium Glutamate results in increased activity of GPT protein]
Sodium Glutamate results in decreased expression of GPT protein

PMID:18048028 PMID:19724016 PMID:21205225 PMID:21549692 PMID:26670228 More...

NCBI chr 8:144,503,068...144,507,172
Ensembl chr 8:144,502,973...144,507,174

G

glutathione peroxidase 1

decreases expression
increases expression
multiple interactions

Sodium Glutamate results in decreased expression of GPX1 mRNA
Sodium Glutamate results in increased expression of GPX1 mRNA; Sodium Glutamate results in increased expression of GPX1 protein
SRT1720 inhibits the reaction [Sodium Glutamate results in increased expression of GPX1 mRNA]; SRT1720 inhibits the reaction [Sodium Glutamate results in increased expression of GPX1 protein]

PMID:19724016 PMID:30733785

NCBI chr 3:49,357,176...49,358,353
Ensembl chr 3:49,357,174...49,358,605

G

glutathione peroxidase 2

affects expression
decreases expression

Sodium Glutamate affects the expression of GPX2 mRNA
Sodium Glutamate results in decreased expression of GPX2 protein

NCBI chr14:64,939,158...64,942,745
Ensembl chr14:64,939,152...64,942,746

G

glutamate ionotropic receptor AMPA type subunit 2

affects expression
multiple interactions

Sodium Glutamate affects the expression of GRIA2
SB 203580 affects the reaction [Sodium Glutamate affects the expression of GRIA2]
Sodium Glutamate affects the expression of GRIA2 protein

PMID:15139026 PMID:16782274

NCBI chr 4:157,220,120...157,366,075
Ensembl chr 4:157,204,182...157,387,146

G

galectin-related inter-fiber protein

increases expression

Sodium Glutamate results in increased expression of GRIFIN mRNA

NCBI chr 7:2,474,728...2,476,398
Ensembl chr 7:2,474,728...2,476,894

G

glutamate ionotropic receptor kainate type subunit 3

increases expression

Sodium Glutamate results in increased expression of GRIK3 mRNA

NCBI chr 1:36,795,527...37,034,515
Ensembl chr 1:36,795,527...37,034,515

G

glutamate ionotropic receptor kainate type subunit 5

multiple interactions

[Sodium Glutamate co-treated with High Fructose Corn Syrup] results in increased expression of GRIK5 mRNA

NCBI chr19:41,998,324...42,070,206
Ensembl chr19:41,998,321...42,070,206

G

glutamate ionotropic receptor NMDA type subunit 1

increases expression

Sodium Glutamate results in increased expression of GRIN1

NCBI chr 9:137,139,154...137,168,756
Ensembl chr 9:137,138,346...137,168,756

G

glutamate ionotropic receptor NMDA type subunit 2C

increases expression

Sodium Glutamate results in increased expression of GRIN2C mRNA

NCBI chr17:74,842,023...74,861,532
Ensembl chr17:74,842,023...74,861,504

G

glutamate ionotropic receptor NMDA type subunit 2D

decreases expression
increases expression

Sodium Glutamate results in decreased expression of GRIN2D mRNA
Sodium Glutamate results in increased expression of GRIN2D mRNA

PMID:11872244 PMID:20928830

NCBI chr19:48,393,668...48,444,931
Ensembl chr19:48,393,668...48,444,931

G

glutathione-disulfide reductase

decreases activity
multiple interactions

Sodium Glutamate results in decreased activity of GSR protein
Sodium Glutamate results in increased expression of and results in decreased activity of GSR protein; Tea inhibits the reaction [Sodium Glutamate results in decreased activity of GSR protein]

PMID:25473020 PMID:29679905 PMID:30733785

NCBI chr 8:30,678,066...30,727,846
Ensembl chr 8:30,678,066...30,727,846

G

glutathione S-transferase mu 2

increases expression

Sodium Glutamate results in increased expression of GSTM2 mRNA

NCBI chr 1:109,668,057...109,683,997
Ensembl chr 1:109,668,022...109,709,551

G

glutathione S-transferase mu 3

increases expression

Sodium Glutamate results in increased expression of GSTM3 mRNA

PMID:19001666 PMID:25473020

NCBI chr 1:109,733,937...109,741,038
Ensembl chr 1:109,733,932...109,741,038

G

glutathione S-transferase mu 4

multiple interactions
increases expression

[Trans Fatty Acids co-treated with Sodium Glutamate] results in increased expression of GSTM4 mRNA
Sodium Glutamate results in increased expression of GSTM4 mRNA

NCBI chr 1:109,656,099...109,667,727
Ensembl chr 1:109,656,099...109,665,496

G

glutathione S-transferase pi 1

decreases expression

Sodium Glutamate results in decreased expression of GSTP1 protein

NCBI chr11:67,583,812...67,586,653
Ensembl chr11:67,583,742...67,586,656

G

glutathione S-transferase theta 3, pseudogene

increases expression

Sodium Glutamate results in increased expression of GSTT3 mRNA

G

general transcription factor IIB

increases expression
multiple interactions

Sodium Glutamate results in increased expression of GTF2B mRNA
[Trans Fatty Acids co-treated with Sodium Glutamate] results in increased expression of GTF2B mRNA

NCBI chr 1:88,852,633...88,891,567
Ensembl chr 1:88,852,633...88,891,944

G

GTF2H2 family member C

increases expression

Sodium Glutamate results in increased expression of GTF2H2 mRNA

NCBI chr 5:69,560,191...69,595,221
Ensembl chr 5:69,560,191...69,595,221
Ensembl chr 5:69,560,191...69,595,221

G

guanylate cyclase activator 1A

decreases expression

Sodium Glutamate results in decreased expression of GUCA1A mRNA

NCBI chr 6:42,173,364...42,180,056
Ensembl chr 6:42,173,364...42,181,338

G

H1.4 linker histone, cluster member

decreases expression
multiple interactions

Sodium Glutamate results in decreased expression of H1F4 mRNA
[Trans Fatty Acids co-treated with Sodium Glutamate] results in decreased expression of H1F4 mRNA

NCBI chr 6:26,156,329...26,157,115
Ensembl chr 6:26,156,329...26,157,115

G

H2A clustered histone 15

multiple interactions

[Trans Fatty Acids co-treated with Sodium Glutamate] results in increased expression of H2AC15 mRNA

NCBI chr 6:27,837,880...27,838,375
Ensembl chr 6:27,837,880...27,838,375

G

3-hydroxyacyl-CoA dehydratase 2

decreases expression

Sodium Glutamate results in decreased expression of HACD2 mRNA

NCBI chr 3:123,491,554...123,585,053
Ensembl chr 3:123,490,820...123,585,053

G

hydroxyacyl-CoA dehydrogenase trifunctional multienzyme complex subunit alpha

multiple interactions

[Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of HADHA mRNA; [Fats, Unsaturated co-treated with Sodium Glutamate] affects the expression of HADHA mRNA

NCBI chr 2:26,190,635...26,244,632
Ensembl chr 2:26,190,635...26,244,672

G

hydroxyacyl-CoA dehydrogenase trifunctional multienzyme complex subunit beta

multiple interactions

[Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of HADHB mRNA; [Fats, Unsaturated co-treated with Sodium Glutamate] affects the expression of HADHB mRNA

NCBI chr 2:26,244,939...26,290,465
Ensembl chr 2:26,243,170...26,290,465

G

hydroxyacid oxidase 2

decreases expression

Sodium Glutamate results in decreased expression of HAO2 mRNA

NCBI chr 1:119,368,785...119,394,130
Ensembl chr 1:119,368,779...119,394,130

G

hyperpolarization activated cyclic nucleotide gated potassium channel 1

decreases expression
multiple interactions

Sodium Glutamate results in decreased expression of HCN1 mRNA
[Trans Fatty Acids co-treated with Sodium Glutamate] results in increased expression of HCN1 mRNA

NCBI chr 5:45,254,948...45,696,380
Ensembl chr 5:45,254,948...45,696,498

G

histone deacetylase 1

multiple interactions

[Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of HDAC1 mRNA

NCBI chr 1:32,292,083...32,333,626
Ensembl chr 1:32,292,083...32,333,635

G

histone deacetylase 5

multiple interactions

[Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of HDAC5 mRNA

NCBI chr17:44,076,753...44,123,641
Ensembl chr17:44,076,746...44,123,702

G

HD domain containing 2

decreases expression

Sodium Glutamate results in decreased expression of HDDC2 mRNA

NCBI chr 6:125,275,350...125,301,967
Ensembl chr 6:125,219,962...125,302,078

G

HEAT repeat containing 6

decreases expression

Sodium Glutamate results in decreased expression of HEATR6 mRNA

NCBI chr17:60,041,008...60,078,921
Ensembl chr17:60,041,008...60,078,922

G

HEAT repeat containing 9

increases expression

Sodium Glutamate results in increased expression of HEATR9 mRNA

NCBI chr17:35,854,955...35,868,891
Ensembl chr17:35,854,946...35,868,891

G

heme binding protein 1

increases expression

Sodium Glutamate results in increased expression of HEBP1 mRNA

NCBI chr12:12,974,870...13,000,265
Ensembl chr12:12,974,870...13,000,265

G

hes family bHLH transcription factor 2

multiple interactions

[Trans Fatty Acids co-treated with Sodium Glutamate] results in increased expression of HES2 mRNA

NCBI chr 1:6,415,232...6,419,919
Ensembl chr 1:6,412,418...6,424,670

G

hes related family bHLH transcription factor with YRPW motif like

decreases expression

Sodium Glutamate results in decreased expression of HEYL mRNA

NCBI chr 1:39,623,435...39,639,643
Ensembl chr 1:39,623,435...39,639,643

G

hepatocyte growth factor

multiple interactions

[Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of HGF mRNA

NCBI chr 7:81,699,010...81,770,047
Ensembl chr 7:81,699,010...81,770,438

G

major histocompatibility complex, class II, DR beta 1

decreases expression

Sodium Glutamate results in decreased expression of RT1-DB1 mRNA

NCBI chr 6:32,578,775...32,589,848
Ensembl chr 6:32,577,902...32,589,848

G

heme oxygenase 1

decreases expression
multiple interactions

Sodium Glutamate results in decreased expression of HMOX1 mRNA; Sodium Glutamate results in decreased expression of HMOX1 protein
Tea inhibits the reaction [Sodium Glutamate results in decreased expression of HMOX1 mRNA]; Tea inhibits the reaction [Sodium Glutamate results in decreased expression of HMOX1 protein]

NCBI chr22:35,381,096...35,394,207
Ensembl chr22:35,380,361...35,394,214

G

homeobox C10

increases expression

Sodium Glutamate results in increased expression of HOXC10 mRNA

NCBI chr12:53,985,146...53,990,279
Ensembl chr12:53,985,065...53,990,279

G

HRas proto-oncogene, GTPase

decreases expression

Sodium Glutamate results in decreased expression of HRAS mRNA

NCBI chr11:532,242...535,576
Ensembl chr11:532,242...537,321

G

hydroxysteroid 11-beta dehydrogenase 1

multiple interactions

[Sodium Glutamate co-treated with Trans Fatty Acids] results in decreased expression of HSD11B1 mRNA

NCBI chr 1:209,686,179...209,734,929
Ensembl chr 1:209,686,178...209,734,949

G

hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 7

decreases expression

Sodium Glutamate results in decreased expression of HSD3B7 mRNA

NCBI chr16:30,985,207...30,989,147
Ensembl chr16:30,985,207...30,989,147

G

heat shock transcription factor 4

decreases expression

Sodium Glutamate results in decreased expression of HSF4 mRNA

NCBI chr16:67,163,761...67,169,941
Ensembl chr16:67,164,681...67,169,945

G

heat shock protein family A (Hsp70) member 5

increases expression

Sodium Glutamate results in increased expression of HSPA5 mRNA

NCBI chr 9:125,234,853...125,241,343
Ensembl chr 9:125,234,853...125,241,382

G

heat shock protein family B (small) member 1

decreases expression

Sodium Glutamate results in decreased expression of HSPB1 mRNA

NCBI chr 7:76,302,673...76,304,292
Ensembl chr 7:76,302,673...76,304,295

G

heparan sulfate proteoglycan 2

multiple interactions

[Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of HSPG2 mRNA

NCBI chr 1:21,822,244...21,937,310
Ensembl chr 1:21,822,244...21,937,310

G

5-hydroxytryptamine receptor 6

increases expression

Sodium Glutamate results in increased expression of HTR6 mRNA

NCBI chr 1:19,664,875...19,680,966
Ensembl chr 1:19,664,875...19,680,966

G

isocitrate dehydrogenase (NADP(+)) 2

multiple interactions

[Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of IDH2 mRNA; [Fats, Unsaturated co-treated with Sodium Glutamate] affects the expression of IDH2 mRNA; [Sodium Glutamate co-treated with High Fructose Corn Syrup] results in increased expression of IDH2 mRNA

PMID:20111022 PMID:23783067

NCBI chr15:90,083,045...90,102,468
Ensembl chr15:90,083,045...90,102,477

G

isopentenyl-diphosphate delta isomerase 1

multiple interactions

[Sodium Glutamate co-treated with Trans Fatty Acids] results in increased expression of IDI1 mRNA

NCBI chr10:1,039,152...1,056,704
Ensembl chr10:1,039,152...1,049,119

G

intermediate filament family orphan 2

increases expression

Sodium Glutamate results in increased expression of IFFO2 mRNA

NCBI chr 1:18,904,280...18,956,676
Ensembl chr 1:18,904,280...18,956,676

G

interferon alpha 14

decreases expression

Sodium Glutamate results in decreased expression of IFNA14 mRNA

NCBI chr 9:21,239,002...21,240,005
Ensembl chr 9:21,239,002...21,240,005

G

interferon gamma

decreases expression
multiple interactions

Sodium Glutamate results in decreased expression of IFNG protein
Plant Extracts inhibits the reaction [Sodium Glutamate results in decreased expression of IFNG protein]

NCBI chr12:68,154,768...68,159,740
Ensembl chr12:68,154,768...68,159,740

G

insulin like growth factor 1

multiple interactions
decreases secretion
decreases expression

[Sodium Glutamate co-treated with Azoxymethane] affects the expression of IGF1 mRNA
GH1 protein inhibits the reaction [Sodium Glutamate results in decreased expression of IGF1 mRNA]; JI-38 inhibits the reaction [Sodium Glutamate results in decreased secretion of IGF1 protein]
Sodium Glutamate results in decreased expression of IGF1 mRNA; Sodium Glutamate results in decreased expression of IGF1 protein

PMID:7533119 PMID:7711889 PMID:8368293 PMID:10718930 PMID:22223845

NCBI chr12:102,395,874...102,481,839
Ensembl chr12:102,395,874...102,481,744

G

insulin like growth factor 1 receptor

multiple interactions
increases expression

[Sodium Glutamate co-treated with Trans Fatty Acids] results in decreased expression of IGF1R mRNA; Sodium Glutamate affects the reaction [Azoxymethane affects the expression of IGF1R mRNA]
GH1 protein inhibits the reaction [Sodium Glutamate results in increased expression of IGF1R mRNA]

PMID:7711889 PMID:19001666 PMID:22223845

NCBI chr15:98,648,539...98,964,530
Ensembl chr15:98,648,539...98,964,530

G

insulin like growth factor 2

multiple interactions

[Sodium Glutamate co-treated with Azoxymethane] affects the expression of IGF2 mRNA

NCBI chr11:2,129,117...2,149,566
Ensembl chr11:2,129,112...2,158,391

G

insulin like growth factor binding protein 3

decreases expression

Sodium Glutamate results in decreased expression of IGFBP3 mRNA

NCBI chr 7:45,912,245...45,921,272
Ensembl chr 7:45,912,245...45,921,874

G

inhibitor of nuclear factor kappa B kinase subunit beta

multiple interactions
increases phosphorylation

Atorvastatin inhibits the reaction [Sodium Glutamate results in increased phosphorylation of IKBKB protein]

NCBI chr 8:42,271,302...42,332,460
Ensembl chr 8:42,271,302...42,332,460

G

interleukin 10

increases expression

Sodium Glutamate results in increased expression of IL10 protein

NCBI chr 1:206,767,602...206,772,494
Ensembl chr 1:206,767,602...206,774,541

G

interleukin 18 receptor accessory protein

increases expression

Sodium Glutamate results in increased expression of IL18RAP mRNA

NCBI chr 2:102,418,621...102,452,565
Ensembl chr 2:102,418,689...102,452,565

G

interleukin 1 beta

increases response to substance

Sodium Glutamate results in increased susceptibility to IL1B protein

NCBI chr 2:112,829,751...112,836,779
Ensembl chr 2:112,829,751...112,836,816

G

interleukin 1 receptor like 2

multiple interactions

[Sodium Glutamate co-treated with Trans Fatty Acids] results in decreased expression of IL1RL2 mRNA

NCBI chr 2:102,186,973...102,243,086
Ensembl chr 2:102,187,006...102,240,002

G

interleukin 2

increases expression

Sodium Glutamate results in increased expression of IL2 mRNA

NCBI chr 4:122,451,470...122,456,725
Ensembl chr 4:122,451,470...122,456,725

G

interleukin 21

multiple interactions

[Sodium Glutamate co-treated with High Fructose Corn Syrup] results in decreased expression of IL21 mRNA

NCBI chr 4:122,610,108...122,621,066
Ensembl chr 4:122,610,108...122,621,066

G

interleukin 6

multiple interactions
affects expression
increases expression

[Sodium Glutamate co-treated with Pioglitazone] results in decreased expression of IL6 protein; [Sodium Glutamate co-treated with Plant Extracts] results in decreased expression of IL6 protein; Atorvastatin inhibits the reaction [Sodium Glutamate results in increased expression of IL6 mRNA]; Atorvastatin inhibits the reaction [Sodium Glutamate results in increased expression of IL6 protein]; Glycine affects the reaction [Sodium Glutamate affects the expression of IL6 mRNA]; Glycine affects the reaction [Sodium Glutamate affects the expression of IL6 protein]; Pioglitazone inhibits the reaction [Sodium Glutamate results in increased expression of IL6 mRNA]; Plant Extracts inhibits the reaction [Sodium Glutamate results in increased expression of IL6 mRNA]
Sodium Glutamate affects the expression of IL6 mRNA; Sodium Glutamate affects the expression of IL6 protein
Sodium Glutamate results in increased expression of IL6 mRNA; Sodium Glutamate results in increased expression of IL6 protein

PMID:18930730 PMID:19800637 PMID:21205225 PMID:25834641 PMID:27918843 More...

NCBI chr 7:22,727,200...22,731,998
Ensembl chr 7:22,725,884...22,732,002

G

inner membrane mitochondrial protein

multiple interactions

[Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of IMMT mRNA; [Fats, Unsaturated co-treated with Sodium Glutamate] affects the expression of IMMT mRNA

NCBI chr 2:86,143,936...86,195,462
Ensembl chr 2:86,143,932...86,195,472

G

inhibitor of growth family member 4

increases expression
multiple interactions

Sodium Glutamate results in increased expression of ING4 mRNA
[Trans Fatty Acids co-treated with Sodium Glutamate] results in increased expression of ING4 mRNA

NCBI chr12:6,650,301...6,663,119
Ensembl chr12:6,650,301...6,663,142

G

INO80 complex subunit E

multiple interactions

[Trans Fatty Acids co-treated with Sodium Glutamate] results in increased expression of INO80E mRNA

NCBI chr16:29,996,241...30,005,791
Ensembl chr16:29,995,715...30,005,793

G

inositol polyphosphate-5-phosphatase J

decreases expression

Sodium Glutamate results in decreased expression of INPP5J mRNA

NCBI chr22:31,122,614...31,134,697
Ensembl chr22:31,122,731...31,134,697

G

insulin

multiple interactions

[Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] results in increased expression of INS2 protein; [Fats, Unsaturated co-treated with Sodium Glutamate] results in increased expression of INS2 protein

NCBI chr11:2,159,779...2,161,209
Ensembl chr11:2,159,779...2,161,221

G

INS-IGF2 readthrough

multiple interactions
decreases expression
increases secretion
increases expression

Carbenoxolone inhibits the reaction [Sodium Glutamate results in increased secretion of INS1 protein]
Sodium Glutamate results in decreased expression of INS1 protein
Sodium Glutamate results in increased expression of INS1 protein
3,3',4',5,7-pentamethylquercetin inhibits the reaction [Sodium Glutamate results in increased expression of INS1 protein]; [Sodium Glutamate co-treated with gallocatechol co-treated with Catechin co-treated with epigallocatechin gallate co-treated with epicatechin gallate co-treated with gallocatechol co-treated with gallocatechin gallate] affects the expression of INS1 protein; [Sodium Glutamate co-treated with Tea] affects the expression of INS1 protein; Atorvastatin inhibits the reaction [Sodium Glutamate results in increased expression of INS1 protein]; Azoxymethane inhibits the reaction [Sodium Glutamate results in increased expression of INS1 protein]; fructooligosaccharide inhibits the reaction [Sodium Glutamate results in increased expression of INS1 protein]; Rosiglitazone inhibits the reaction [Sodium Glutamate results in increased expression of INS1 protein]

PMID:11319642 PMID:18930730 PMID:19001666 PMID:19800637 PMID:20111022 More...

NCBI chr11:2,129,117...2,161,209
Ensembl chr11:2,132,538...2,161,209

G

IQ motif containing H

decreases expression

Sodium Glutamate results in decreased expression of IQCH mRNA

NCBI chr15:67,254,786...67,501,804
Ensembl chr15:67,254,786...67,502,260

G

iron responsive element binding protein 2

decreases expression

Sodium Glutamate results in decreased expression of IREB2 mRNA

NCBI chr15:78,437,431...78,501,453
Ensembl chr15:78,437,431...78,501,453

G

interferon regulatory factor 2 binding protein 2

decreases expression

Sodium Glutamate results in decreased expression of IRF2BP2 mRNA

NCBI chr 1:234,604,269...234,610,178
Ensembl chr 1:234,604,269...234,610,178

G

insulin receptor substrate 2

decreases expression
multiple interactions

Sodium Glutamate results in decreased expression of IRS2 mRNA
2-ethoxy-3-(4-(2-(4-trifluoromethanesulfonyloxyphenyl)ethoxy)phenyl)propionic acid inhibits the reaction [Sodium Glutamate results in decreased expression of IRS2 mRNA]

NCBI chr13:109,752,695...109,786,583
Ensembl chr13:109,752,695...109,786,583

G

insulin receptor substrate 3, pseudogene

multiple interactions

[Sodium Glutamate co-treated with Trans Fatty Acids] results in increased expression of IRS3 mRNA

NCBI chr 7:100,570,193...100,571,401
Ensembl chr 7:100,570,131...100,571,136

G

integrin alpha FG-GAP repeat containing 2

decreases expression

Sodium Glutamate results in decreased expression of ITFG2 mRNA

NCBI chr12:2,812,668...2,859,791
Ensembl chr12:2,812,622...2,859,791

G

integrin subunit alpha 2b

increases expression
multiple interactions

Sodium Glutamate results in increased expression of ITGA2B mRNA
[Trans Fatty Acids co-treated with Sodium Glutamate] results in decreased expression of ITGA2B mRNA

NCBI chr17:44,372,181...44,389,649
Ensembl chr17:44,372,180...44,389,649

G

integrin subunit alpha 7

multiple interactions

[Sodium Glutamate co-treated with Trans Fatty Acids] results in increased expression of ITGA7 mRNA

NCBI chr12:55,684,568...55,716,400
Ensembl chr12:55,684,568...55,716,404

G

integrin subunit alpha V

decreases expression

Sodium Glutamate results in decreased expression of ITGAV mRNA

NCBI chr 2:186,590,056...186,680,901
Ensembl chr 2:186,590,010...186,680,901

G

integrin subunit beta 3

increases expression

Sodium Glutamate results in increased expression of ITGB3 mRNA

NCBI chr17:47,253,827...47,313,743
Ensembl chr17:47,253,827...47,313,743

G

integral membrane protein 2A

decreases expression
multiple interactions

Sodium Glutamate results in decreased expression of ITM2A mRNA
[Trans Fatty Acids co-treated with Sodium Glutamate] results in increased expression of ITM2A mRNA

NCBI chr X:79,360,384...79,367,334
Ensembl chr X:79,360,384...79,367,667

G

inositol 1,4,5-trisphosphate receptor type 3

multiple interactions
increases expression

[Sodium Glutamate co-treated with High Fructose Corn Syrup] results in increased expression of ITPR3 mRNA
Sodium Glutamate results in increased expression of ITPR3 mRNA

PMID:19001666 PMID:20111022

NCBI chr 6:33,621,322...33,696,562
Ensembl chr 6:33,620,365...33,696,574

G

potassium voltage-gated channel subfamily H member 1

multiple interactions

[Trans Fatty Acids co-treated with Sodium Glutamate] results in increased expression of KCNH1 mRNA

NCBI chr 1:210,678,314...211,134,148
Ensembl chr 1:210,676,823...211,134,165

G

potassium inwardly rectifying channel subfamily J member 12

decreases expression

Sodium Glutamate results in decreased expression of KCNJ12 mRNA

NCBI chr17:21,376,357...21,419,870
Ensembl chr17:21,376,357...21,419,870

G

potassium inwardly rectifying channel subfamily J member 16

increases expression
multiple interactions

Sodium Glutamate results in increased expression of KCNJ16 mRNA
[Sodium Glutamate co-treated with Trans Fatty Acids] results in decreased expression of KCNJ16 mRNA

NCBI chr17:70,075,225...70,135,608
Ensembl chr17:70,053,429...70,135,608

G

potassium two pore domain channel subfamily K member 1

multiple interactions
increases expression

[Sodium Glutamate co-treated with Trans Fatty Acids] results in decreased expression of KCNK1 mRNA
Sodium Glutamate results in increased expression of KCNK1 mRNA

NCBI chr 1:233,614,106...233,672,514
Ensembl chr 1:233,614,106...233,672,514

G

potassium calcium-activated channel subfamily N member 2

decreases expression

Sodium Glutamate results in decreased expression of KCNN2 mRNA

NCBI chr 5:114,055,978...114,496,496
Ensembl chr 5:114,055,926...114,496,500

G

KDEL endoplasmic reticulum protein retention receptor 3

multiple interactions

[Sodium Glutamate co-treated with Trans Fatty Acids] results in decreased expression of KDELR3 mRNA

NCBI chr22:38,468,096...38,483,447
Ensembl chr22:38,468,078...38,483,447

G

kinase insert domain receptor

increases expression
multiple interactions

Sodium Glutamate results in increased expression of KDR protein
[Semaxinib co-treated with Sodium Glutamate] results in increased expression of KDR protein

PMID:28755050 PMID:36732937

NCBI chr 4:55,078,481...55,125,595
Ensembl chr 4:55,078,481...55,125,595

G

kirre like nephrin family adhesion molecule 3

increases expression

Sodium Glutamate results in increased expression of KIRREL3 mRNA

NCBI chr11:126,423,358...127,000,870
Ensembl chr11:126,423,358...127,003,460

G

kelch like family member 3

decreases expression

Sodium Glutamate results in decreased expression of KLHL3 mRNA

NCBI chr 5:137,617,500...137,736,089
Ensembl chr 5:137,617,500...137,736,089

G

KRAS proto-oncogene, GTPase

decreases expression

Sodium Glutamate results in decreased expression of KRAS mRNA

NCBI chr12:25,205,246...25,250,929
Ensembl chr12:25,205,246...25,250,936

G

keratin 19

increases expression

Sodium Glutamate results in increased expression of KRT19 mRNA

NCBI chr17:41,523,617...41,528,308
Ensembl chr17:41,523,617...41,528,308

G

lactate dehydrogenase D

multiple interactions
increases expression

[Sodium Glutamate co-treated with Trans Fatty Acids] results in increased expression of LDHD mRNA
Sodium Glutamate results in increased expression of LDHD mRNA

NCBI chr16:75,111,864...75,116,780
Ensembl chr16:75,111,860...75,116,780

G

low density lipoprotein receptor

multiple interactions

[Sodium Glutamate co-treated with Trans Fatty Acids] results in increased expression of LDLR mRNA

NCBI chr19:11,089,463...11,133,820
Ensembl chr19:11,089,418...11,133,820

G

leptin

multiple interactions
affects expression
increases expression

[Sodium Glutamate co-treated with Aspartame] promotes the reaction [Fats, Unsaturated results in increased expression of LEP protein]; [Sodium Glutamate co-treated with Aurothioglucose] results in increased expression of LEP mRNA; [Sodium Glutamate co-treated with Aurothioglucose] results in increased expression of LEP protein; [Sodium Glutamate co-treated with gallocatechol co-treated with Catechin co-treated with epigallocatechin gallate co-treated with epicatechin gallate co-treated with gallocatechol co-treated with gallocatechin gallate] affects the expression of LEP protein; [Sodium Glutamate co-treated with Tea] affects the expression of LEP protein; [Sodium Glutamate co-treated with Trans Fatty Acids] results in increased expression of LEP mRNA; [Trans Fatty Acids co-treated with Sodium Glutamate] results in increased expression of LEP protein; Bezafibrate inhibits the reaction [Sodium Glutamate results in increased expression of LEP protein]; Glycine affects the reaction [Sodium Glutamate affects the expression of LEP protein]; Sodium Glutamate promotes the reaction [Fats, Unsaturated results in increased expression of LEP protein]
Sodium Glutamate results in increased expression of LEP mRNA; Sodium Glutamate results in increased expression of LEP protein

PMID:7489415 PMID:7657836 PMID:9794456 PMID:14657608 PMID:15809509 More...

NCBI chr 7:128,241,278...128,257,629
Ensembl chr 7:128,241,278...128,257,629

G

galectin 4

increases expression

Sodium Glutamate results in increased expression of LGALS4 mRNA

NCBI chr19:38,801,674...38,812,945
Ensembl chr19:38,801,671...38,812,945

G

luteinizing hormone subunit beta

decreases secretion

Sodium Glutamate results in decreased secretion of LHB protein

NCBI chr19:49,015,980...49,019,498
Ensembl chr19:49,015,980...49,017,091

G

LIM domain kinase 1

decreases expression

Sodium Glutamate results in decreased expression of LIMK1 mRNA

NCBI chr 7:74,083,804...74,122,525
Ensembl chr 7:74,082,933...74,122,525

G

lin-54 DREAM MuvB core complex component

decreases expression

Sodium Glutamate results in decreased expression of LIN54 mRNA

NCBI chr 4:82,924,603...83,012,941
Ensembl chr 4:82,909,973...83,012,926

G

lipase E, hormone sensitive type

decreases activity
decreases expression

Sodium Glutamate results in decreased activity of LIPE protein
Sodium Glutamate results in decreased expression of LIPE mRNA

NCBI chr19:42,401,514...42,427,388
Ensembl chr19:42,401,514...42,427,388

G

lipase G, endothelial type

multiple interactions

[Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of LIPG mRNA

NCBI chr18:49,561,479...49,599,185
Ensembl chr18:49,560,699...49,599,185

G

lysyl oxidase like 1

decreases expression

Sodium Glutamate results in decreased expression of LOXL1 mRNA

NCBI chr15:73,926,462...73,952,136
Ensembl chr15:73,925,989...73,952,137

G

lipin 1

decreases expression

Sodium Glutamate results in decreased expression of LPIN1 mRNA

NCBI chr 2:11,677,544...11,827,409
Ensembl chr 2:11,677,595...11,827,409

G

LDL receptor related protein 1

multiple interactions

[Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of LRP1 mRNA

NCBI chr12:57,128,483...57,213,361
Ensembl chr12:57,128,483...57,213,361

G

LDL receptor related protein 2

multiple interactions

[Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of LRP2 mRNA

NCBI chr 2:169,127,109...169,362,534
Ensembl chr 2:169,127,109...169,362,534

G

LDL receptor related protein 4

multiple interactions

[Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of LRP4 mRNA

NCBI chr11:46,856,717...46,918,550
Ensembl chr11:46,856,717...46,918,642

G

LDL receptor related protein associated protein 1

multiple interactions

[Sodium Glutamate co-treated with Trans Fatty Acids] results in increased expression of LRPAP1 mRNA

NCBI chr 4:3,503,612...3,532,422
Ensembl chr 4:3,503,612...3,532,446

G

leucine rich repeat containing 26

increases expression

Sodium Glutamate results in increased expression of LRRC26 mRNA

NCBI chr 9:137,168,758...137,170,051
Ensembl chr 9:137,168,758...137,170,051

G

leucine rich repeat containing 46

increases expression

Sodium Glutamate results in increased expression of LRRC46 mRNA

NCBI chr17:47,831,670...47,837,719
Ensembl chr17:47,831,634...47,837,719

G

leucine rich repeat containing 73

decreases expression

Sodium Glutamate results in decreased expression of LRRC73 mRNA

NCBI chr 6:43,506,968...43,510,346
Ensembl chr 6:43,506,968...43,510,346

G

LUC7 like

increases expression

Sodium Glutamate results in increased expression of LUC7L mRNA

NCBI chr16:188,990...229,449
Ensembl chr16:188,969...229,463

G

magnesium transporter 1

multiple interactions

[Trans Fatty Acids co-treated with Sodium Glutamate] results in increased expression of MAGT1 mRNA

NCBI chr X:77,825,747...77,895,568
Ensembl chr X:77,825,747...77,899,271

G

monoamine oxidase A

increases expression
multiple interactions

Sodium Glutamate results in increased expression of MAOA mRNA
[Sodium Glutamate co-treated with High Fructose Corn Syrup] results in increased expression of MAOA mRNA

NCBI chr X:43,655,006...43,746,817
Ensembl chr X:43,654,907...43,746,817

G

mitogen-activated protein kinase kinase 1

decreases expression

Sodium Glutamate results in decreased expression of MAP2K1 mRNA

NCBI chr15:66,386,912...66,491,544
Ensembl chr15:66,386,837...66,491,656

G

mitogen-activated protein kinase kinase 2

decreases expression

Sodium Glutamate results in decreased expression of MAP2K2 mRNA

NCBI chr19:4,090,321...4,124,122
Ensembl chr19:4,090,321...4,124,122

G

mitogen-activated protein kinase kinase 3

decreases expression

Sodium Glutamate results in decreased expression of MAP2K3 mRNA

NCBI chr17:21,284,711...21,315,240
Ensembl chr17:21,284,672...21,315,232

G

mitogen-activated protein kinase kinase 4

decreases expression

Sodium Glutamate results in decreased expression of MAP2K4 mRNA

NCBI chr17:12,020,877...12,143,828
Ensembl chr17:12,020,829...12,143,830

G

mitogen-activated protein kinase kinase kinase 1

decreases expression

Sodium Glutamate results in decreased expression of MAP3K1 mRNA

NCBI chr 5:56,815,549...56,896,152
Ensembl chr 5:56,815,549...56,896,152

G

mitogen-activated protein kinase kinase kinase 15

multiple interactions

[Trans Fatty Acids co-treated with Sodium Glutamate] results in decreased expression of MAP3K15 mRNA

NCBI chr X:19,360,059...19,515,508
Ensembl chr X:19,360,056...19,515,508

G

mitogen-activated protein kinase kinase kinase 3

decreases expression

Sodium Glutamate results in decreased expression of MAP3K3 mRNA

NCBI chr17:63,622,417...63,696,305
Ensembl chr17:63,622,415...63,696,305

G

mitogen-activated protein kinase kinase kinase kinase 1

decreases expression

Sodium Glutamate results in decreased expression of MAP4K1 mRNA

NCBI chr19:38,587,641...38,617,953
Ensembl chr19:38,587,641...38,618,882

G

mitogen-activated protein kinase 12

decreases expression

Sodium Glutamate results in decreased expression of MAPK12 mRNA

NCBI chr22:50,252,901...50,261,683
Ensembl chr22:50,245,450...50,261,716

G

mitogen-activated protein kinase 13

affects expression

Sodium Glutamate affects the expression of MAPK13 mRNA

NCBI chr 6:36,130,513...36,144,521
Ensembl chr 6:36,127,809...36,144,524

G

mitogen-activated protein kinase 8

decreases expression

Sodium Glutamate results in decreased expression of MAPK8 mRNA

NCBI chr10:48,306,677...48,439,360
Ensembl chr10:48,306,639...48,439,360

G

mitogen-activated protein kinase 8 interacting protein 1

decreases expression

Sodium Glutamate results in decreased expression of MAPK8IP1 mRNA

NCBI chr11:45,885,651...45,906,465
Ensembl chr11:45,885,651...45,906,465

G

methyl-CpG binding domain 4, DNA glycosylase

increases expression

Sodium Glutamate results in increased expression of MBD4 mRNA

NCBI chr 3:129,430,947...129,439,948
Ensembl chr 3:129,430,947...129,440,179

G

melanocortin 4 receptor

multiple interactions

[Sodium Glutamate co-treated with High Fructose Corn Syrup] results in increased expression of MC4R mRNA

NCBI chr18:60,371,062...60,372,775
Ensembl chr18:60,371,062...60,372,775

G

multiple coagulation factor deficiency 2, ER cargo receptor complex subunit

decreases expression

Sodium Glutamate results in decreased expression of MCFD2 mRNA

NCBI chr 2:46,901,870...46,941,855
Ensembl chr 2:46,901,870...46,941,855

G

mitochondrial calcium uniporter

multiple interactions

[Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of MCU mRNA; [Fats, Unsaturated co-treated with Sodium Glutamate] affects the expression of MCU mRNA

NCBI chr10:72,692,143...72,887,694
Ensembl chr10:72,692,143...72,887,694

G

malate dehydrogenase 1

multiple interactions

[Sodium Glutamate co-treated with High Fructose Corn Syrup] results in decreased expression of MDH1 mRNA

NCBI chr 2:63,588,963...63,607,197
Ensembl chr 2:63,588,609...63,607,197

G

midkine

decreases expression

Sodium Glutamate results in decreased expression of MDK mRNA

NCBI chr11:46,380,784...46,383,837
Ensembl chr11:46,380,756...46,383,837

G

MDM2 proto-oncogene

multiple interactions

[Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of MDM2 mRNA

NCBI chr12:68,808,172...68,850,686
Ensembl chr12:68,808,177...68,845,544

G

mediator complex subunit 12L

decreases expression

Sodium Glutamate results in decreased expression of MED12L mRNA

NCBI chr 3:151,085,664...151,436,653
Ensembl chr 3:151,085,286...151,437,072

G

mediator complex subunit 23

multiple interactions

[Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of MED23 mRNA

NCBI chr 6:131,573,966...131,628,313
Ensembl chr 6:131,573,966...131,628,242

G

mediator complex subunit 31

multiple interactions

[Trans Fatty Acids co-treated with Sodium Glutamate] results in increased expression of MED31 mRNA

NCBI chr17:6,643,311...6,651,605
Ensembl chr17:6,643,311...6,651,634

G

myocyte enhancer factor 2D

multiple interactions

[Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of MEF2D mRNA

NCBI chr 1:156,463,727...156,500,775
Ensembl chr 1:156,463,727...156,500,779

G

multiple EGF like domains 10

increases expression

Sodium Glutamate results in increased expression of MEGF10 mRNA

NCBI chr 5:127,229,300...127,461,222
Ensembl chr 5:127,290,796...127,465,737

G

monoglyceride lipase

multiple interactions

[Sodium Glutamate co-treated with Trans Fatty Acids] results in increased expression of MGLL mRNA

NCBI chr 3:127,689,066...127,823,185
Ensembl chr 3:127,689,062...128,052,190

G

microtubule associated monooxygenase, calponin and LIM domain containing 3

increases expression

Sodium Glutamate results in increased expression of MICAL3 mRNA

NCBI chr22:17,787,649...18,024,561
Ensembl chr22:17,787,649...18,024,561

G

mitochondrial contact site and cristae organizing system subunit 10

multiple interactions

[Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of MINOS1 mRNA; [Fats, Unsaturated co-treated with Sodium Glutamate] affects the expression of MINOS1 mRNA

NCBI chr 1:19,596,979...19,629,820
Ensembl chr 1:19,484,403...19,629,821

G

mitochondrial contact site and cristae organizing system subunit 13

multiple interactions

[Trans Fatty Acids co-treated with Sodium Glutamate] results in increased expression of MICOS13 mRNA

NCBI chr19:5,678,422...5,680,516
Ensembl chr19:5,678,421...5,680,516

G

mitochondrial calcium uptake 1

multiple interactions

[Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of MICU1 mRNA; [Fats, Unsaturated co-treated with Sodium Glutamate] affects the expression of MICU1 mRNA

NCBI chr10:72,367,340...72,626,079
Ensembl chr10:72,367,340...72,626,131

G

microRNA 142

decreases expression

Sodium Glutamate results in decreased expression of MIR142 mRNA

NCBI chr17:58,331,232...58,331,318
Ensembl chr17:58,331,232...58,331,318

G

microRNA 223

decreases expression

Sodium Glutamate results in decreased expression of MIR223 mRNA

NCBI chr X:66,018,870...66,018,979
Ensembl chr X:66,018,870...66,018,979

G

MLX interacting protein like

decreases expression
multiple interactions

Sodium Glutamate results in decreased expression of MLXIPL mRNA
Taurine inhibits the reaction [Sodium Glutamate results in decreased expression of MLXIPL mRNA]

NCBI chr 7:73,593,202...73,647,907
Ensembl chr 7:73,593,194...73,624,543

G

monocyte to macrophage differentiation associated

multiple interactions

[Sodium Glutamate co-treated with Trans Fatty Acids] results in increased expression of MMD mRNA

NCBI chr17:55,392,622...55,421,835
Ensembl chr17:55,392,622...55,421,924

G

matrix metallopeptidase 28

increases expression

Sodium Glutamate results in increased expression of MMP28 mRNA

NCBI chr17:35,756,249...35,795,641
Ensembl chr17:35,756,249...35,795,707

G

M-phase specific PLK1 interacting protein

increases expression

Sodium Glutamate results in increased expression of MPLKIP mRNA

NCBI chr 7:40,126,027...40,134,622
Ensembl chr 7:40,126,027...40,134,622

G

mitochondrial ribosomal protein L20

multiple interactions

[Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of MRPL20 mRNA; [Fats, Unsaturated co-treated with Sodium Glutamate] affects the expression of MRPL20 mRNA

NCBI chr 1:1,401,909...1,407,293
Ensembl chr 1:1,401,909...1,407,293

G

mitochondrial ribosomal protein L3

multiple interactions

[Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of MRPL3 mRNA; [Fats, Unsaturated co-treated with Sodium Glutamate] affects the expression of MRPL3 mRNA

NCBI chr 3:131,462,212...131,502,971
Ensembl chr 3:131,462,212...131,502,983

G

mitochondrial ribosomal protein L35

multiple interactions

[Trans Fatty Acids co-treated with Sodium Glutamate] results in increased expression of MRPL35 mRNA

NCBI chr 2:86,199,433...86,213,794
Ensembl chr 2:86,199,355...86,213,790

G

mitochondrial ribosomal protein S12

multiple interactions

[Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of MRPS12 mRNA; [Fats, Unsaturated co-treated with Sodium Glutamate] affects the expression of MRPS12 mRNA

NCBI chr19:38,930,944...38,933,168
Ensembl chr19:38,930,944...38,933,168

G

mitochondrial ribosomal protein S14

multiple interactions

[Trans Fatty Acids co-treated with Sodium Glutamate] results in increased expression of MRPS14 mRNA

NCBI chr 1:175,012,958...175,023,425
Ensembl chr 1:175,010,789...175,023,425

G

mitochondrial ribosomal protein S24

multiple interactions

[Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of MRPS24 mRNA; [Fats, Unsaturated co-treated with Sodium Glutamate] affects the expression of MRPS24 mRNA

NCBI chr 7:43,866,558...43,869,517
Ensembl chr 7:43,866,558...43,869,893

G

mitochondrial ribosomal protein S27

multiple interactions

[Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of MRPS27 mRNA; [Fats, Unsaturated co-treated with Sodium Glutamate] affects the expression of MRPS27 mRNA

NCBI chr 5:72,219,403...72,320,240
Ensembl chr 5:72,214,953...72,321,717

G

mitochondrial ribosomal protein S7

multiple interactions

[Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of MRPS7 mRNA; [Fats, Unsaturated co-treated with Sodium Glutamate] affects the expression of MRPS7 mRNA

NCBI chr17:75,261,879...75,266,376
Ensembl chr17:75,261,674...75,266,376

G

membrane spanning 4-domains A2

increases expression

Sodium Glutamate results in increased expression of MS4A2 mRNA

NCBI chr11:60,088,259...60,098,467
Ensembl chr11:60,088,261...60,098,467

G

mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 6

decreases expression

Sodium Glutamate results in decreased expression of ND6 mRNA

NCBI chr MT:14,149...14,673
Ensembl chr MT:14,149...14,673

G

mitochondrial fission process 1

multiple interactions

[Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of MTFP1 mRNA; [Fats, Unsaturated co-treated with Sodium Glutamate] affects the expression of MTFP1 mRNA

NCBI chr22:30,425,768...30,429,054
Ensembl chr22:30,425,623...30,429,054

G

myotubularin related protein 12

decreases expression

Sodium Glutamate results in decreased expression of MTMR12 mRNA

NCBI chr 5:32,227,007...32,312,939
Ensembl chr 5:32,226,994...32,312,987

G

microsomal triglyceride transfer protein

decreases expression
multiple interactions

Sodium Glutamate results in decreased expression of MTTP mRNA
Taurine inhibits the reaction [Sodium Glutamate results in decreased expression of MTTP mRNA]

NCBI chr 4:99,564,130...99,623,997
Ensembl chr 4:99,564,081...99,623,997

G

mevalonate kinase

increases expression

Sodium Glutamate results in increased expression of MVK mRNA

NCBI chr12:109,573,272...109,598,125
Ensembl chr12:109,573,255...109,598,125

G

MYCBP associated protein

increases expression

Sodium Glutamate results in increased expression of MYCBPAP mRNA

NCBI chr17:50,507,778...50,531,501
Ensembl chr17:50,508,425...50,531,501

G

myosin VIIA

increases expression
multiple interactions

Sodium Glutamate results in increased expression of MYO7A mRNA
[Trans Fatty Acids co-treated with Sodium Glutamate] results in increased expression of MYO7A mRNA

NCBI chr11:77,128,246...77,215,241
Ensembl chr11:77,128,246...77,215,241

G

non-SMC condensin I complex subunit H

increases expression

Sodium Glutamate results in increased expression of NCAPH mRNA

NCBI chr 2:96,335,766...96,377,091
Ensembl chr 2:96,335,766...96,377,091

G

nuclear receptor corepressor 1

multiple interactions

[Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of NCOR1 mRNA

NCBI chr17:16,029,157...16,215,534
Ensembl chr17:16,029,065...16,218,185

G

NADH:ubiquinone oxidoreductase subunit A10

multiple interactions

[Sodium Glutamate co-treated with Trans Fatty Acids] results in increased expression of NDUFA10 mRNA

NCBI chr 2:239,892,442...240,025,342
Ensembl chr 2:239,892,450...240,025,743

G

NADH:ubiquinone oxidoreductase subunit A12

multiple interactions

[Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of NDUFA12 mRNA; [Fats, Unsaturated co-treated with Sodium Glutamate] affects the expression of NDUFA12 mRNA

NCBI chr12:94,971,333...95,003,697
Ensembl chr12:94,895,297...95,003,748

G

NADH:ubiquinone oxidoreductase subunit A13

multiple interactions

[Sodium Glutamate co-treated with High Fructose Corn Syrup] results in increased expression of NDUFA13 mRNA

NCBI chr19:19,516,225...19,528,198
Ensembl chr19:19,515,736...19,529,054

G

NADH:ubiquinone oxidoreductase subunit A5

multiple interactions
decreases expression

[Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of NDUFA5 mRNA; [Fats, Unsaturated co-treated with Sodium Glutamate] affects the expression of NDUFA5 mRNA; [Sodium Glutamate co-treated with High Fructose Corn Syrup] affects the expression of NDUFA5 mRNA
Sodium Glutamate results in decreased expression of NDUFA5 mRNA

PMID:20111022 PMID:23783067

NCBI chr 7:123,536,997...123,601,651
Ensembl chr 7:123,536,997...123,557,904

G

NADH:ubiquinone oxidoreductase subunit B10

multiple interactions

[Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of NDUFB10 mRNA; [Fats, Unsaturated co-treated with Sodium Glutamate] affects the expression of NDUFB10 mRNA

NCBI chr16:1,959,538...1,961,975
Ensembl chr16:1,959,538...1,961,975

G

NADH:ubiquinone oxidoreductase subunit B2

multiple interactions

[Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of NDUFB2 mRNA; [Fats, Unsaturated co-treated with Sodium Glutamate] affects the expression of NDUFB2 mRNA

NCBI chr 7:140,696,708...140,706,643
Ensembl chr 7:140,690,777...140,722,790

G

NADH:ubiquinone oxidoreductase subunit B4

multiple interactions

[Sodium Glutamate co-treated with Trans Fatty Acids] results in increased expression of NDUFB4 mRNA

NCBI chr 3:120,596,336...120,602,507
Ensembl chr 3:120,596,328...120,602,507

G

NADH:ubiquinone oxidoreductase subunit B6

multiple interactions

[Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of NDUFB6 mRNA; [Fats, Unsaturated co-treated with Sodium Glutamate] affects the expression of NDUFB6 mRNA

NCBI chr 9:32,553,001...32,573,159
Ensembl chr 9:32,553,001...32,573,184

G

NADH:ubiquinone oxidoreductase subunit B8

multiple interactions

[Sodium Glutamate co-treated with High Fructose Corn Syrup] results in increased expression of NDUFB8 mRNA

NCBI chr10:100,523,729...100,529,923
Ensembl chr10:100,523,740...100,530,000

G

NADH:ubiquinone oxidoreductase subunit C1

multiple interactions

[Trans Fatty Acids co-treated with Sodium Glutamate] results in increased expression of NDUFC1 mRNA

NCBI chr 4:139,289,917...139,302,551
Ensembl chr 4:139,266,880...139,302,551

G

NADH:ubiquinone oxidoreductase core subunit S1

multiple interactions
decreases expression

[Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of NDUFS1 mRNA; [Fats, Unsaturated co-treated with Sodium Glutamate] affects the expression of NDUFS1 mRNA
Sodium Glutamate results in decreased expression of NDUFS1 mRNA

PMID:20111022 PMID:23783067

NCBI chr 2:206,114,817...206,159,444
Ensembl chr 2:206,114,817...206,159,509

G

NADH:ubiquinone oxidoreductase subunit S4

multiple interactions
decreases expression
increases expression

[Sodium Glutamate co-treated with High Fructose Corn Syrup] affects the expression of NDUFS4 mRNA
Sodium Glutamate results in decreased expression of NDUFS4 mRNA
Sodium Glutamate results in increased expression of NDUFS4 mRNA

NCBI chr 5:53,560,639...53,683,338
Ensembl chr 5:53,560,633...53,683,338

G

NADH:ubiquinone oxidoreductase subunit S6

multiple interactions

[Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of NDUFS6 mRNA; [Fats, Unsaturated co-treated with Sodium Glutamate] affects the expression of NDUFS6 mRNA

NCBI chr 5:1,801,407...1,816,048
Ensembl chr 5:1,801,407...1,816,048

G

NADH:ubiquinone oxidoreductase core subunit S7

multiple interactions

[Sodium Glutamate co-treated with Trans Fatty Acids] results in increased expression of NDUFS7 mRNA

NCBI chr19:1,383,907...1,395,584
Ensembl chr19:1,383,527...1,395,589

G

NADH:ubiquinone oxidoreductase core subunit V1

multiple interactions

[Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of NDUFV1 mRNA; [Fats, Unsaturated co-treated with Sodium Glutamate] affects the expression of NDUFV1 mRNA

NCBI chr11:67,606,936...67,612,554
Ensembl chr11:67,605,653...67,612,554

G

nebulin

increases expression

Sodium Glutamate results in increased expression of NEB mRNA

NCBI chr 2:151,485,339...151,734,476
Ensembl chr 2:151,485,336...151,734,487

G

NIMA related kinase 11

increases expression

Sodium Glutamate results in increased expression of NEK11 mRNA

NCBI chr 3:131,026,877...131,350,465
Ensembl chr 3:131,026,850...131,350,465

G

neuraminidase 3

increases expression

Sodium Glutamate results in increased expression of NEU3 mRNA

NCBI chr11:74,980,515...75,020,676
Ensembl chr11:74,988,279...75,018,893

G

neurofibromin 1

multiple interactions

[Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of NF1 mRNA

NCBI chr17:31,094,927...31,377,677
Ensembl chr17:31,094,927...31,382,116

G

NFE2 like bZIP transcription factor 2

decreases expression
increases expression
multiple interactions

Sodium Glutamate results in decreased expression of NFE2L2 mRNA; Sodium Glutamate results in decreased expression of NFE2L2 protein
Sodium Glutamate results in increased expression of NFE2L2 mRNA
Tea inhibits the reaction [Sodium Glutamate results in decreased expression of NFE2L2 mRNA]; Tea inhibits the reaction [Sodium Glutamate results in decreased expression of NFE2L2 protein]

PMID:25473020 PMID:29679905

NCBI chr 2:177,230,303...177,264,727
Ensembl chr 2:177,218,667...177,392,756

G

nuclear factor, interleukin 3 regulated

increases expression

Sodium Glutamate results in increased expression of NFIL3 mRNA

NCBI chr 9:91,409,045...91,483,497
Ensembl chr 9:91,409,045...91,423,832

G

nuclear factor kappa B subunit 1

multiple interactions
increases expression

Resveratrol inhibits the reaction [Sodium Glutamate results in increased expression of NFKB1 mRNA]

NCBI chr 4:102,501,359...102,617,302
Ensembl chr 4:102,501,330...102,617,302

G

NFKB inhibitor beta

multiple interactions

[Fenofibrate co-treated with Sodium Glutamate] results in increased expression of NFKBIB mRNA

NCBI chr19:38,899,666...38,908,889
Ensembl chr19:38,899,700...38,908,893

G

nuclear transcription factor Y subunit alpha

multiple interactions

[Trans Fatty Acids co-treated with Sodium Glutamate] results in increased expression of NFYA mRNA

NCBI chr 6:41,072,974...41,102,403
Ensembl chr 6:41,072,974...41,102,403

G

NHERF family PDZ scaffold protein 4

decreases expression

Sodium Glutamate results in decreased expression of NHERF4 mRNA

NCBI chr11:119,185,475...119,190,213
Ensembl chr11:119,185,457...119,190,223

G

NIPA like domain containing 1

increases expression

Sodium Glutamate results in increased expression of NIPAL1 mRNA

NCBI chr 4:48,016,772...48,040,173
Ensembl chr 4:47,914,142...48,040,173

G

nucleolar protein 3

multiple interactions

[Sodium Glutamate co-treated with Trans Fatty Acids] results in increased expression of NOL3 mRNA

NCBI chr16:67,170,538...67,175,737
Ensembl chr16:67,170,154...67,175,737

G

nitric oxide synthase 2

multiple interactions
increases expression

[Fenofibrate co-treated with Sodium Glutamate] results in increased expression of NOS2 mRNA; [Fenofibrate co-treated with Sodium Glutamate] results in increased expression of NOS2 protein
Sodium Glutamate results in increased expression of NOS2 protein

PMID:21999347 PMID:36732937

NCBI chr17:27,756,766...27,800,529
Ensembl chr17:27,756,766...27,800,529

G

notch receptor 1

multiple interactions

[Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of NOTCH1 mRNA

NCBI chr 9:136,494,433...136,546,048
Ensembl chr 9:136,494,433...136,546,048

G

NADPH oxidase 1

multiple interactions

[Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of NOX1 mRNA

NCBI chr X:100,843,324...100,874,359
Ensembl chr X:100,843,324...100,874,359

G

neuronal pentraxin 1

multiple interactions

[Trans Fatty Acids co-treated with Sodium Glutamate] results in increased expression of NPTX1 mRNA

NCBI chr17:80,466,834...80,476,607
Ensembl chr17:80,466,834...80,477,843

G

neuropeptide Y

decreases expression

Sodium Glutamate results in decreased expression of NPY mRNA

PMID:9794456 PMID:19151514

NCBI chr 7:24,284,190...24,291,862
Ensembl chr 7:24,284,188...24,291,862

G

NAD(P)H quinone dehydrogenase 1

multiple interactions
increases expression
decreases expression

[Plant Extracts co-treated with Sodium Glutamate] results in increased activity of NQO1 protein; Sodium Glutamate results in increased expression of and results in increased activity of NQO1 protein; Tea inhibits the reaction [Sodium Glutamate results in decreased expression of NQO1 mRNA]
Sodium Glutamate results in increased expression of NQO1 mRNA

PMID:25473020 PMID:26319613 PMID:29679905

NCBI chr16:69,709,401...69,726,560
Ensembl chr16:69,706,996...69,726,668

G

nuclear receptor subfamily 0 group B member 2

decreases expression
multiple interactions

Sodium Glutamate results in decreased expression of NR0B2 mRNA
[Sodium Glutamate co-treated with Trans Fatty Acids] results in decreased expression of NR0B2 mRNA

NCBI chr 1:26,911,489...26,913,975
Ensembl chr 1:26,911,489...26,913,975

G

nuclear receptor subfamily 1 group H member 3

increases expression
multiple interactions

Sodium Glutamate results in increased expression of NR1H3 mRNA
6-methyl-2-(phenylethynyl)pyridine inhibits the reaction [Sodium Glutamate results in increased expression of NR1H3 mRNA]

NCBI chr11:47,248,300...47,269,033
Ensembl chr11:47,248,300...47,269,033

G

nuclear receptor subfamily 1 group I member 3

multiple interactions
increases expression

[Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of NR1I3 mRNA; [Sodium Glutamate co-treated with High Fructose Corn Syrup] results in decreased expression of NR1I3 mRNA
Sodium Glutamate results in increased expression of NR1I3 mRNA

PMID:20111022 PMID:23783067

NCBI chr 1:161,229,669...161,238,203
Ensembl chr 1:161,229,666...161,238,244

G

nuclear receptor subfamily 4 group A member 2

multiple interactions

[Trans Fatty Acids co-treated with Sodium Glutamate] results in increased expression of NR4A2 mRNA

NCBI chr 2:156,324,437...156,332,721
Ensembl chr 2:156,324,437...156,342,348

G

NSE1 homolog, SMC5-SMC6 complex component

multiple interactions
increases expression

[Trans Fatty Acids co-treated with Sodium Glutamate] results in increased expression of NSMCE1 mRNA
Sodium Glutamate results in increased expression of NSMCE1 mRNA

NCBI chr16:27,224,994...27,268,772
Ensembl chr16:27,224,994...27,268,772

G

nudix hydrolase 17

increases expression

Sodium Glutamate results in increased expression of NUDT17 mRNA

NCBI chr 1:145,845,630...145,848,954
Ensembl chr 1:145,845,630...145,848,954

G

nudix hydrolase 2

increases expression

Sodium Glutamate results in increased expression of NUDT2 mRNA

NCBI chr 9:34,329,569...34,343,699
Ensembl chr 9:34,329,506...34,343,711

G

nudix hydrolase 7

multiple interactions

[Sodium Glutamate co-treated with Trans Fatty Acids] results in increased expression of NUDT7 mRNA

NCBI chr16:77,722,514...77,742,260
Ensembl chr16:77,722,492...77,742,260

G

one cut homeobox 1

multiple interactions

[Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of ONECUT1 mRNA

NCBI chr15:52,755,053...52,790,336
Ensembl chr15:52,755,053...52,791,078

G

opsin 1, medium wave sensitive

increases expression

Sodium Glutamate results in increased expression of OPN1MW mRNA

NCBI chr X:154,182,596...154,196,861
Ensembl chr X:154,182,596...154,196,861

G

olfactory receptor family 4 subfamily C member 11

multiple interactions
decreases expression

[Sodium Glutamate co-treated with High Fructose Corn Syrup] results in decreased expression of OR4C11 mRNA
Sodium Glutamate results in decreased expression of OR4C11 mRNA

NCBI chr11:55,602,360...55,607,645
Ensembl chr11:55,602,360...55,607,645

G

oxysterol binding protein like 6

decreases expression

Sodium Glutamate results in decreased expression of OSBPL6 mRNA

NCBI chr 2:178,193,774...178,402,893
Ensembl chr 2:178,194,481...178,402,893

G

p21 (RAC1) activated kinase 1

decreases expression

Sodium Glutamate results in decreased expression of PAK1 mRNA

NCBI chr11:77,322,017...77,530,009
Ensembl chr11:77,322,017...77,474,635

G

progestin and adipoQ receptor family member 4

multiple interactions

[Sodium Glutamate co-treated with Trans Fatty Acids] results in increased expression of PAQR4 mRNA

NCBI chr16:2,969,348...2,973,484
Ensembl chr16:2,969,270...2,973,484

G

progestin and adipoQ receptor family member 5

increases expression

Sodium Glutamate results in increased expression of PAQR5 mRNA

NCBI chr15:69,298,912...69,407,780
Ensembl chr15:69,298,912...69,407,780

G

progestin and adipoQ receptor family member 7

multiple interactions

[Sodium Glutamate co-treated with Trans Fatty Acids] results in increased expression of PAQR7 mRNA

NCBI chr 1:25,861,484...25,875,708
Ensembl chr 1:25,861,484...25,875,708

G

progestin and adipoQ receptor family member 9

multiple interactions

[Sodium Glutamate co-treated with Trans Fatty Acids] results in increased expression of PAQR9 mRNA

NCBI chr 3:142,949,164...142,964,008
Ensembl chr 3:142,949,164...142,963,674

G

photoreceptor cilium actin regulator

increases expression

Sodium Glutamate results in increased expression of PCARE mRNA

NCBI chr 2:29,061,695...29,074,523
Ensembl chr 2:29,060,976...29,074,523

G

protocadherin 8

increases expression

Sodium Glutamate results in increased expression of PCDH8 mRNA

NCBI chr13:52,842,889...52,848,640
Ensembl chr13:52,842,889...52,848,641

G

phosphoenolpyruvate carboxykinase 1

increases expression
multiple interactions

Sodium Glutamate results in increased expression of PCK1 mRNA
[Sodium Glutamate co-treated with Bezafibrate] results in decreased expression of PCK1 mRNA; Resveratrol inhibits the reaction [Sodium Glutamate results in increased expression of PCK1 mRNA]

PMID:21549692 PMID:28708105

NCBI chr20:57,561,110...57,568,121
Ensembl chr20:57,561,080...57,568,121

G

procollagen C-endopeptidase enhancer

decreases expression

Sodium Glutamate results in decreased expression of PCOLCE mRNA

NCBI chr 7:100,602,363...100,608,175
Ensembl chr 7:100,602,363...100,608,175

G

phosphodiesterase 3B

decreases expression
multiple interactions

Sodium Glutamate results in decreased expression of PDE3B mRNA
[Trans Fatty Acids co-treated with Sodium Glutamate] results in increased expression of PDE3B mRNA

NCBI chr11:14,643,804...14,872,044
Ensembl chr11:14,643,804...14,872,044

G

phosphodiesterase 6A

multiple interactions
decreases expression

[Trans Fatty Acids co-treated with Sodium Glutamate] results in decreased expression of PDE6A mRNA
Sodium Glutamate results in decreased expression of PDE6A mRNA

NCBI chr 5:149,857,953...149,944,793
Ensembl chr 5:149,857,953...149,944,793

G

phosphodiesterase 6C

increases expression

Sodium Glutamate results in increased expression of PDE6C mRNA

NCBI chr10:93,612,537...93,666,010
Ensembl chr10:93,612,537...93,666,010

G

platelet derived growth factor receptor alpha

multiple interactions

[Sodium Glutamate co-treated with Trans Fatty Acids] results in decreased expression of PDGFRA mRNA

NCBI chr 4:54,229,293...54,298,245
Ensembl chr 4:54,229,280...54,298,245

G

platelet derived growth factor receptor like

affects expression

Sodium Glutamate affects the expression of PDGFRL mRNA

NCBI chr 8:17,576,433...17,643,144
Ensembl chr 8:17,576,433...17,644,071

G

pyruvate dehydrogenase E1 subunit alpha 2

multiple interactions

[Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of PDHA2 mRNA; [Fats, Unsaturated co-treated with Sodium Glutamate] affects the expression of PDHA2 mRNA

NCBI chr 4:95,840,093...95,841,464
Ensembl chr 4:95,840,093...95,841,464

G

pyruvate dehydrogenase E1 subunit beta

multiple interactions

[Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of PDHB mRNA; [Fats, Unsaturated co-treated with Sodium Glutamate] affects the expression of PDHB mRNA

NCBI chr 3:58,427,630...58,433,832
Ensembl chr 3:58,427,630...58,433,857

G

pyruvate dehydrogenase complex component X

increases expression
multiple interactions

Sodium Glutamate results in increased expression of PDHX mRNA
[Sodium Glutamate co-treated with High Fructose Corn Syrup] results in increased expression of PDHX mRNA

NCBI chr11:34,915,920...34,996,128
Ensembl chr11:34,915,829...35,020,591

G

protein disulfide isomerase family A member 4

multiple interactions
decreases expression

[Sodium Glutamate co-treated with High Fructose Corn Syrup] results in increased expression of PDIA4 mRNA; [Trans Fatty Acids co-treated with Sodium Glutamate] results in increased expression of PDIA4 mRNA
Sodium Glutamate results in decreased expression of PDIA4 mRNA

PMID:20111022 PMID:22078008

NCBI chr 7:149,003,051...149,028,505
Ensembl chr 7:149,003,062...149,028,662

G

pyruvate dehydrogenase kinase 1

multiple interactions

[Sodium Glutamate co-treated with Trans Fatty Acids] results in increased expression of PDK1 mRNA

NCBI chr 2:172,555,373...172,724,312
Ensembl chr 2:172,555,373...172,608,669

G

pyruvate dehydrogenase kinase 4

increases expression
multiple interactions

Sodium Glutamate results in increased expression of PDK4 mRNA
[Sodium Glutamate co-treated with High Fructose Corn Syrup] results in increased expression of PDK4 mRNA

NCBI chr 7:95,583,499...95,596,516
Ensembl chr 7:95,583,499...95,596,516

G

peroxisomal trans-2-enoyl-CoA reductase

multiple interactions

[Sodium Glutamate co-treated with Trans Fatty Acids] results in increased expression of PECR mRNA

NCBI chr 2:216,029,088...216,081,809
Ensembl chr 2:215,996,329...216,082,955

G

pellino E3 ubiquitin protein ligase 1

decreases expression

Sodium Glutamate results in decreased expression of PELI1 mRNA

NCBI chr 2:64,092,652...64,144,420
Ensembl chr 2:64,092,652...64,144,420

G

phosphatidylethanolamine N-methyltransferase

multiple interactions

[Sodium Glutamate co-treated with Trans Fatty Acids] results in increased expression of PEMT mRNA

NCBI chr17:17,505,563...17,592,142
Ensembl chr17:17,505,563...17,591,708

G

peptidase D

decreases expression

Sodium Glutamate results in decreased expression of PEPD mRNA

NCBI chr19:33,386,950...33,521,791
Ensembl chr19:33,386,950...33,521,823

G

peroxisomal biogenesis factor 1

multiple interactions

[Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of PEX1 mRNA; [Fats, Unsaturated co-treated with Sodium Glutamate] affects the expression of PEX1 mRNA

NCBI chr 7:92,487,025...92,528,520
Ensembl chr 7:92,487,020...92,528,520

G

peroxisomal biogenesis factor 11 alpha

multiple interactions

[Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of PEX11A mRNA; [Fats, Unsaturated co-treated with Sodium Glutamate] affects the expression of PEX11A mRNA

NCBI chr15:89,681,535...89,690,754
Ensembl chr15:89,677,764...89,690,783

G

peroxisomal biogenesis factor 13

multiple interactions

[Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of PEX13 mRNA; [Fats, Unsaturated co-treated with Sodium Glutamate] affects the expression of PEX13 mRNA

NCBI chr 2:61,017,720...61,051,990
Ensembl chr 2:61,017,225...61,051,990

G

peroxisomal biogenesis factor 5

multiple interactions

[Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of PEX5 mRNA; [Fats, Unsaturated co-treated with Sodium Glutamate] affects the expression of PEX5 mRNA

NCBI chr12:7,188,653...7,218,574
Ensembl chr12:7,188,685...7,218,574

G

peroxisomal biogenesis factor 7

multiple interactions

[Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of PEX7 mRNA; [Fats, Unsaturated co-treated with Sodium Glutamate] affects the expression of PEX7 mRNA

NCBI chr 6:136,822,592...136,913,934
Ensembl chr 6:136,822,564...136,913,934

G

6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 2

multiple interactions

[Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of PFKFB2 mRNA; [Fats, Unsaturated co-treated with Sodium Glutamate] affects the expression of PFKFB2 mRNA

NCBI chr 1:207,034,416...207,081,027
Ensembl chr 1:207,034,366...207,081,024

G

6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 4

multiple interactions

[Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of PFKFB4 mRNA; [Fats, Unsaturated co-treated with Sodium Glutamate] affects the expression of PFKFB4 mRNA

NCBI chr 3:48,517,684...48,563,136
Ensembl chr 3:48,517,684...48,562,015

G

phosphoglycerate mutase 1

multiple interactions

[Trans Fatty Acids co-treated with Sodium Glutamate] results in increased expression of PGAM1 mRNA

NCBI chr10:97,426,191...97,433,444
Ensembl chr10:97,426,191...97,433,444

G

phosphorylase kinase regulatory subunit beta

multiple interactions

[Sodium Glutamate co-treated with Trans Fatty Acids] results in increased expression of PHKB mRNA

NCBI chr16:47,461,299...47,701,523
Ensembl chr16:47,461,123...47,701,523

G

PH domain and leucine rich repeat protein phosphatase 2

decreases expression
multiple interactions

Sodium Glutamate results in decreased expression of PHLPP2 mRNA
[Trans Fatty Acids co-treated with Sodium Glutamate] results in increased expression of PHLPP2 mRNA

NCBI chr16:71,644,924...71,724,701
Ensembl chr16:71,637,835...71,724,701

G

peptidase inhibitor 16

decreases expression

Sodium Glutamate results in decreased expression of PI16 mRNA

NCBI chr 6:36,948,296...36,964,837
Ensembl chr 6:36,948,263...36,964,837

G

phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha

increases expression
multiple interactions

Sodium Glutamate results in increased expression of PIK3CA protein
Semaxinib inhibits the reaction [Sodium Glutamate results in increased expression of PIK3CA protein]

NCBI chr 3:179,148,126...179,240,093
Ensembl chr 3:179,148,114...179,240,093

G

protein kinase domain containing, cytoplasmic

decreases expression

Sodium Glutamate results in decreased expression of PKDCC mRNA

NCBI chr 2:42,048,021...42,058,517
Ensembl chr 2:42,048,021...42,058,517

G

pyruvate kinase L/R

increases expression

Sodium Glutamate results in increased expression of PKLR mRNA

NCBI chr 1:155,289,293...155,308,654
Ensembl chr 1:155,289,293...155,301,438

G

phospholipase A2 group XIIB

multiple interactions

[Sodium Glutamate co-treated with High Fructose Corn Syrup] results in increased expression of PLA2G12B mRNA

NCBI chr10:72,934,762...72,954,806
Ensembl chr10:72,934,762...72,954,806

G

phospholipase A2 group XV

increases expression

Sodium Glutamate results in increased expression of PLA2G15 mRNA

NCBI chr16:68,245,373...68,261,058
Ensembl chr16:68,245,304...68,261,058

G

phospholipase A2 group IIE

multiple interactions

[Sodium Glutamate co-treated with Trans Fatty Acids] results in increased expression of PLA2G2E mRNA

NCBI chr 1:19,920,009...19,923,617
Ensembl chr 1:19,920,009...19,923,617

G

PLAG1 like zinc finger 1

decreases expression

Sodium Glutamate results in decreased expression of PLAGL1 mRNA

NCBI chr 6:143,940,300...144,064,599
Ensembl chr 6:143,940,300...144,064,599

G

plasminogen activator, urokinase receptor

multiple interactions

[Sodium Glutamate co-treated with Trans Fatty Acids] results in decreased expression of PLAUR mRNA

NCBI chr19:43,646,095...43,670,169
Ensembl chr19:43,646,095...43,670,547

G

phospholipase B domain containing 1

multiple interactions

[Trans Fatty Acids co-treated with Sodium Glutamate] results in increased expression of PLBD1 mRNA

NCBI chr12:14,503,661...14,567,883
Ensembl chr12:14,503,661...14,567,883

G

phospholipase C gamma 1

multiple interactions

[Sodium Glutamate co-treated with High Fructose Corn Syrup] results in increased expression of PLCG1 mRNA

NCBI chr20:41,137,543...41,177,626
Ensembl chr20:41,136,960...41,196,801

G

phospholipase D2

multiple interactions

[Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of PLD2 mRNA

NCBI chr17:4,807,152...4,823,430
Ensembl chr17:4,807,152...4,823,434

G

pleckstrin homology, MyTH4 and FERM domain containing H1

increases expression

Sodium Glutamate results in increased expression of PLEKHH1 mRNA

NCBI chr14:67,533,290...67,589,612
Ensembl chr14:67,533,290...67,589,612

G

phospholipid phosphatase related 1

increases expression

Sodium Glutamate results in increased expression of PLPPR1 mRNA

NCBI chr 9:101,028,727...101,325,135
Ensembl chr 9:101,028,727...101,325,135

G

plexin D1

multiple interactions

[Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of PLXND1 mRNA

NCBI chr 3:129,555,214...129,606,676
Ensembl chr 3:129,555,214...129,606,676

G

polyamine modulated factor 1

increases expression
multiple interactions

Sodium Glutamate results in increased expression of PMF1 mRNA
[Sodium Glutamate co-treated with High Fructose Corn Syrup] results in increased expression of PMF1 mRNA

NCBI chr 1:156,213,007...156,240,042
Ensembl chr 1:156,212,993...156,240,042

G

phosphomevalonate kinase

multiple interactions

[Sodium Glutamate co-treated with Trans Fatty Acids] results in increased expression of PMVK mRNA

NCBI chr 1:154,924,740...154,942,658
Ensembl chr 1:154,924,740...154,936,719

G

pancreatic lipase

increases expression

Sodium Glutamate results in increased expression of PNLIP mRNA

NCBI chr10:116,545,931...116,567,855
Ensembl chr10:116,545,931...116,567,855

G

patatin like phospholipase domain containing 3

increases expression

Sodium Glutamate results in increased expression of PNPLA3 mRNA

NCBI chr22:43,923,805...43,947,582
Ensembl chr22:43,923,792...43,964,488

G

DNA polymerase gamma, catalytic subunit

multiple interactions

[Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of POLG mRNA; [Fats, Unsaturated co-treated with Sodium Glutamate] affects the expression of POLG mRNA

NCBI chr15:89,316,320...89,334,824
Ensembl chr15:89,305,198...89,334,861

G

DNA polymerase iota

increases expression

Sodium Glutamate results in increased expression of POLI mRNA

NCBI chr18:54,269,479...54,321,266
Ensembl chr18:54,269,517...54,321,266

G

proopiomelanocortin

decreases expression
decreases secretion
increases expression

Sodium Glutamate results in decreased expression of POMC mRNA
Sodium Glutamate results in decreased secretion of POMC protein
Sodium Glutamate results in increased expression of POMC mRNA; Sodium Glutamate results in increased expression of POMC protein

PMID:8071649 PMID:9662721 PMID:9794456

NCBI chr 2:25,160,860...25,168,580
Ensembl chr 2:25,160,853...25,168,903

G

peroxisome proliferator activated receptor alpha

multiple interactions
increases expression
decreases expression

[Bezafibrate co-treated with Sodium Glutamate] results in increased expression of PPARA mRNA; [Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of PPARA mRNA; [Fats, Unsaturated co-treated with Sodium Glutamate] affects the expression of PPARA mRNA
Sodium Glutamate results in increased expression of PPARA mRNA
Sodium Glutamate results in decreased expression of PPARA mRNA

PMID:21205225 PMID:21549692 PMID:21999347 PMID:23783067

NCBI chr22:46,150,526...46,243,756
Ensembl chr22:46,150,521...46,243,755

G

peroxisome proliferator activated receptor delta

multiple interactions

[Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of PPARD mRNA

NCBI chr 6:35,342,558...35,428,178
Ensembl chr 6:35,342,558...35,428,191

G

peroxisome proliferator activated receptor gamma

multiple interactions
affects response to substance
increases expression

[Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of PPARG mRNA
PPARG protein affects the susceptibility to Sodium Glutamate
Sodium Glutamate results in increased expression of PPARG mRNA

PMID:15231871 PMID:21205225 PMID:23783067

NCBI chr 3:12,287,368...12,434,344
Ensembl chr 3:12,287,368...12,434,356

G

PPARG coactivator 1 alpha

increases expression
decreases expression
multiple interactions

Sodium Glutamate results in increased expression of PPARGC1A protein
Sodium Glutamate results in decreased expression of PPARGC1A mRNA
[Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of PPARGC1A mRNA; [Fats, Unsaturated co-treated with Sodium Glutamate] affects the expression of PPARGC1A mRNA; [Sodium Glutamate co-treated with High Fructose Corn Syrup] results in decreased expression of PPARGC1A mRNA; [Sodium Glutamate co-treated with Trans Fatty Acids] results in decreased expression of PPARGC1A mRNA; Sodium Glutamate results in increased expression of and results in increased acetylation of PPARGC1A protein; SRT1720 inhibits the reaction [Sodium Glutamate results in increased acetylation of PPARGC1A protein]; SRT1720 promotes the reaction [Sodium Glutamate results in increased expression of PPARGC1A protein]
[Taurine co-treated with Sodium Glutamate] results in increased expression of PPARGC1A mRNA; [Taurine co-treated with Sodium Glutamate] results in increased expression of PPARGC1A protein; Taurine promotes the reaction [Sodium Glutamate results in increased expression of PPARGC1A protein]

PMID:19001666 PMID:19724016 PMID:20111022 PMID:23783067 PMID:25211138

NCBI chr 4:23,792,021...24,472,905
Ensembl chr 4:23,755,041...23,904,089

G

protein phosphatase 3 regulatory subunit B, alpha

increases expression
multiple interactions

Sodium Glutamate results in increased expression of PPP3R1 mRNA
[Trans Fatty Acids co-treated with Sodium Glutamate] results in increased expression of PPP3R1 mRNA

NCBI chr 2:68,178,857...68,252,532
Ensembl chr 2:68,178,857...68,256,237

G

PPARG related coactivator 1

multiple interactions

[Sodium Glutamate co-treated with High Fructose Corn Syrup] results in decreased expression of PPRC1 mRNA

NCBI chr10:102,119,889...102,150,333
Ensembl chr10:102,132,994...102,150,333

G

peroxiredoxin 2

multiple interactions

[Sodium Glutamate co-treated with High Fructose Corn Syrup] results in increased expression of PRDX2 mRNA

NCBI chr19:12,796,823...12,801,800
Ensembl chr19:12,796,820...12,801,800

G

peroxiredoxin 5

multiple interactions

[Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of PRDX5 mRNA; [Fats, Unsaturated co-treated with Sodium Glutamate] affects the expression of PRDX5 mRNA

NCBI chr11:64,318,121...64,321,811
Ensembl chr11:64,318,121...64,321,811

G

proteoglycan 4

decreases expression
multiple interactions

Sodium Glutamate results in decreased expression of PRG4 mRNA
[Trans Fatty Acids co-treated with Sodium Glutamate] results in increased expression of PRG4 mRNA

NCBI chr 1:186,296,273...186,314,567
Ensembl chr 1:186,296,279...186,314,567

G

serine protease 23

decreases expression

Sodium Glutamate results in decreased expression of PRSS23 mRNA

NCBI chr11:86,791,071...86,952,910
Ensembl chr11:86,791,059...86,952,910

G

phosphoserine aminotransferase 1

increases expression

Sodium Glutamate results in increased expression of PSAT1 mRNA

NCBI chr 9:78,297,125...78,330,093
Ensembl chr 9:78,297,125...78,330,093

G

proteasome 26S subunit, ATPase 2

multiple interactions

[Trans Fatty Acids co-treated with Sodium Glutamate] results in increased expression of PSMC2 mRNA

NCBI chr 7:103,347,524...103,369,395
Ensembl chr 7:103,328,570...103,370,346

G

proteasome 26S subunit, non-ATPase 14

multiple interactions

[Trans Fatty Acids co-treated with Sodium Glutamate] results in increased expression of PSMD14 mRNA

NCBI chr 2:161,308,425...161,411,717
Ensembl chr 2:161,308,425...161,411,717

G

proteasome 26S subunit, non-ATPase 9

multiple interactions

[Trans Fatty Acids co-treated with Sodium Glutamate] results in increased expression of PSMD9 mRNA

NCBI chr12:121,888,790...121,918,297
Ensembl chr12:121,888,732...121,918,297

G

platelet activating factor receptor

decreases expression

Sodium Glutamate results in decreased expression of PTAFR mRNA

NCBI chr 1:28,147,166...28,193,856
Ensembl chr 1:28,147,166...28,193,936

G

prostaglandin E receptor 3

multiple interactions

[Sodium Glutamate co-treated with Trans Fatty Acids] results in increased expression of PTGER3 mRNA

NCBI chr 1:70,852,358...71,047,816
Ensembl chr 1:70,852,353...71,047,816

G

parathymosin

increases expression

Sodium Glutamate results in increased expression of PTMS mRNA

NCBI chr12:6,766,363...6,770,952
Ensembl chr12:6,765,516...6,770,952

G

Pvt1 oncogene

increases expression

Sodium Glutamate results in increased expression of PVT1 mRNA

NCBI chr 8:127,794,524...128,101,256
Ensembl chr 8:127,794,526...128,187,101

G

PWWP domain containing 3B

increases expression

Sodium Glutamate results in increased expression of PWWP3B mRNA

NCBI chr X:106,168,305...106,208,956
Ensembl chr X:106,168,305...106,208,956

G

peroxisomal membrane protein 2

multiple interactions

[Sodium Glutamate co-treated with High Fructose Corn Syrup] results in increased expression of PXMP2 mRNA

NCBI chr12:132,687,587...132,704,985
Ensembl chr12:132,687,587...132,704,985

G

peroxisomal membrane protein 4

multiple interactions

[Sodium Glutamate co-treated with Trans Fatty Acids] results in increased expression of PXMP4 mRNA

NCBI chr20:33,702,758...33,720,310
Ensembl chr20:33,702,758...33,720,319

G

retinoic acid induced 14

decreases expression

Sodium Glutamate results in decreased expression of RAI14 mRNA

NCBI chr 5:34,656,328...34,832,612
Ensembl chr 5:34,656,328...34,832,612

G

RAN, member RAS oncogene family

multiple interactions
increases expression

[Sodium Glutamate co-treated with High Fructose Corn Syrup] results in increased expression of RAN mRNA
Sodium Glutamate results in increased expression of RAN mRNA

NCBI chr12:130,872,066...130,877,678
Ensembl chr12:130,872,037...130,877,678

G

Rap guanine nucleotide exchange factor 6

multiple interactions

[Trans Fatty Acids co-treated with Sodium Glutamate] results in increased expression of RAPGEF6 mRNA

NCBI chr 5:131,423,921...131,635,229
Ensembl chr 5:131,423,921...131,635,231

G

retinoic acid receptor beta

multiple interactions

[Sodium Glutamate co-treated with High Fructose Corn Syrup] results in increased expression of RARB mRNA

NCBI chr 3:24,829,321...25,597,932
Ensembl chr 3:24,687,887...25,597,932

G

RAS guanyl releasing protein 2

increases expression

Sodium Glutamate results in increased expression of RASGRP2 mRNA

NCBI chr11:64,726,911...64,745,456
Ensembl chr11:64,726,911...64,745,456

G

Ras association domain family member 7

affects expression

Sodium Glutamate affects the expression of RASSF7 mRNA

NCBI chr11:560,970...564,025
Ensembl chr11:560,404...564,025

G

RB transcriptional corepressor 1

increases phosphorylation
increases expression

Sodium Glutamate results in increased phosphorylation of RB1 protein
Sodium Glutamate results in increased expression of RB1 mRNA

NCBI chr13:48,303,751...48,481,890
Ensembl chr13:48,303,744...48,599,436

G

RNA binding motif protein 4

increases expression

Sodium Glutamate results in increased expression of RBM4 mRNA

NCBI chr11:66,638,703...66,668,380
Ensembl chr11:66,638,667...66,668,374

G

retinol binding protein 4

multiple interactions
increases expression

[Trans Fatty Acids co-treated with Sodium Glutamate] results in increased expression of RBP4 protein
Sodium Glutamate results in increased expression of RBP4 protein

NCBI chr10:93,591,694...93,601,744
Ensembl chr10:93,591,687...93,601,744

G

recombination signal binding protein for immunoglobulin kappa J region like

increases expression

Sodium Glutamate results in increased expression of RBPJL mRNA

NCBI chr20:45,306,840...45,317,824
Ensembl chr20:45,306,840...45,317,824

G

reticulocalbin 1

multiple interactions

[Trans Fatty Acids co-treated with Sodium Glutamate] results in increased expression of RCN1 mRNA

NCBI chr11:32,091,074...32,105,722
Ensembl chr11:32,091,074...32,105,722

G

reticulocalbin 3

multiple interactions

[Trans Fatty Acids co-treated with Sodium Glutamate] results in increased expression of RCN3 mRNA

NCBI chr19:49,528,003...49,543,633
Ensembl chr19:49,528,003...49,546,962

G

retinol dehydrogenase 16

multiple interactions

[Sodium Glutamate co-treated with High Fructose Corn Syrup] results in increased expression of RDH16 mRNA

NCBI chr12:56,951,431...56,957,608
Ensembl chr12:56,951,431...56,959,374

G

RecQ like helicase

increases expression

Sodium Glutamate results in increased expression of RECQL mRNA

NCBI chr12:21,468,910...21,501,635
Ensembl chr12:21,468,910...21,501,669

G

RELA proto-oncogene, NF-kB subunit

multiple interactions
increases expression

Resveratrol inhibits the reaction [Sodium Glutamate results in increased expression of RELA mRNA]
[Fenofibrate co-treated with Sodium Glutamate] results in increased expression of RELA protein

PMID:21999347 PMID:28708105

NCBI chr11:65,653,601...65,663,857
Ensembl chr11:65,653,599...65,663,090

G

RE1 silencing transcription factor

increases expression
multiple interactions

Sodium Glutamate results in increased expression of REST mRNA
SB 203580 inhibits the reaction [Sodium Glutamate results in increased expression of REST mRNA]

NCBI chr 4:56,907,900...56,935,844
Ensembl chr 4:56,907,876...56,966,808

G

resistin

multiple interactions
decreases expression
affects expression
increases expression
increases secretion

Glycine affects the reaction [Sodium Glutamate affects the expression of RETN protein]; Pioglitazone inhibits the reaction [Sodium Glutamate results in increased expression of RETN mRNA]; Pioglitazone inhibits the reaction [Sodium Glutamate results in increased secretion of RETN protein]; Plant Extracts inhibits the reaction [Sodium Glutamate results in increased expression of RETN mRNA]
Sodium Glutamate results in decreased expression of RETN; Sodium Glutamate results in decreased expression of RETN mRNA
Sodium Glutamate results in increased expression of RETN mRNA; Sodium Glutamate results in increased expression of RETN protein

PMID:12208498 PMID:15809509 PMID:18930730 PMID:21205225 PMID:27918843

NCBI chr19:7,669,049...7,670,455
Ensembl chr19:7,669,049...7,670,455

G

RNA exonuclease 1 homolog

decreases expression

Sodium Glutamate results in decreased expression of REXO1 mRNA

NCBI chr19:1,815,248...1,848,483
Ensembl chr19:1,815,248...1,848,483

G

regulator of G protein signaling 3

increases expression

Sodium Glutamate results in increased expression of RGS3 mRNA

NCBI chr 9:113,444,730...113,597,738
Ensembl chr 9:113,444,731...113,597,743

G

reactive intermediate imine deaminase A homolog

multiple interactions

[Trans Fatty Acids co-treated with Sodium Glutamate] results in increased expression of RIDA mRNA

NCBI chr 8:98,102,344...98,117,171
Ensembl chr 8:98,102,344...98,117,171

G

ribosomal oxygenase 2

decreases expression

Sodium Glutamate results in decreased expression of RIOX2 mRNA

NCBI chr 3:97,941,818...97,972,431
Ensembl chr 3:97,941,818...97,972,457

G

Rho associated coiled-coil containing protein kinase 1

multiple interactions

[Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of ROCK1 mRNA

NCBI chr18:20,946,906...21,111,813
Ensembl chr18:20,944,612...21,111,813

G

reactive oxygen species modulator 1

multiple interactions

[Sodium Glutamate co-treated with Trans Fatty Acids] results in increased expression of ROMO1 mRNA

NCBI chr20:35,699,405...35,700,980
Ensembl chr20:35,699,272...35,700,984

G

ribosomal protein S27 like

multiple interactions

[Trans Fatty Acids co-treated with Sodium Glutamate] results in increased expression of RPS27L mRNA

NCBI chr15:63,148,249...63,157,477
Ensembl chr15:63,125,872...63,158,021

G

ribosomal protein S29

increases expression

Sodium Glutamate results in increased expression of RPS29 mRNA

NCBI chr14:49,570,988...49,598,710
Ensembl chr14:49,570,984...49,599,164

G

RAS related 2

multiple interactions
increases expression

[Trans Fatty Acids co-treated with Sodium Glutamate] results in increased expression of RRAS2 mRNA
Sodium Glutamate results in increased expression of RRAS2 mRNA

NCBI chr11:14,277,920...14,364,506
Ensembl chr11:14,277,922...14,364,506

G

ribosomal RNA processing 9, U3 small nucleolar RNA binding protein

increases expression

Sodium Glutamate results in increased expression of RRP9 mRNA

NCBI chr 3:51,933,429...51,941,904
Ensembl chr 3:51,933,429...51,941,904

G

S100 calcium binding protein A13

multiple interactions

[Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of S100A13 mRNA; [Fats, Unsaturated co-treated with Sodium Glutamate] affects the expression of S100A13 mRNA

NCBI chr 1:153,618,799...153,634,361
Ensembl chr 1:153,618,787...153,631,360

G

S100 calcium binding protein A8

multiple interactions

[Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of S100A8 mRNA; [Fats, Unsaturated co-treated with Sodium Glutamate] affects the expression of S100A8 mRNA

NCBI chr 1:153,390,032...153,422,583
Ensembl chr 1:153,390,032...153,391,073

G

sterile alpha motif domain containing 4B

decreases expression

Sodium Glutamate results in decreased expression of SAMD4B mRNA

NCBI chr19:39,342,421...39,390,764
Ensembl chr19:39,342,421...39,385,710

G

scavenger receptor class B member 1

multiple interactions

[Sodium Glutamate co-treated with Trans Fatty Acids] results in increased expression of SCARB1 mRNA

NCBI chr12:124,776,856...124,863,864
Ensembl chr12:124,776,856...124,882,668

G

small Cajal body-specific RNA 17

increases expression

Sodium Glutamate results in increased expression of SCARNA17 mRNA

NCBI chr18:49,814,023...49,814,443
Ensembl chr18:49,814,133...49,814,276

G

stearoyl-CoA desaturase

increases expression
multiple interactions

Sodium Glutamate results in increased expression of SCD2 mRNA
[Sodium Glutamate co-treated with Trans Fatty Acids] affects the expression of SCD2 mRNA

NCBI chr10:100,347,233...100,364,826
Ensembl chr10:100,347,233...100,364,826

G

secretogranin V

increases expression

Sodium Glutamate results in increased expression of SCG5 mRNA

NCBI chr15:32,641,710...32,697,092
Ensembl chr15:32,641,676...32,697,098

G

sodium voltage-gated channel alpha subunit 9

decreases expression

Sodium Glutamate results in decreased expression of SCN9A mRNA

NCBI chr 2:166,195,185...166,375,987
Ensembl chr 2:166,195,185...166,376,001

G

succinate dehydrogenase complex iron sulfur subunit B

multiple interactions

[Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of SDHB mRNA; [Fats, Unsaturated co-treated with Sodium Glutamate] affects the expression of SDHB mRNA

NCBI chr 1:17,018,722...17,054,032
Ensembl chr 1:17,018,664...17,054,032

G

serine dehydratase

increases expression

Sodium Glutamate results in increased expression of SDS mRNA

NCBI chr12:113,392,445...113,403,887
Ensembl chr12:113,392,445...113,426,301

G

serpin family B member 5

increases expression

Sodium Glutamate results in increased expression of SERPINB5 mRNA

NCBI chr18:63,476,958...63,505,085
Ensembl chr18:63,476,958...63,505,085

G

stratifin

decreases expression

Sodium Glutamate results in decreased expression of SFN mRNA

NCBI chr 1:26,863,149...26,864,456
Ensembl chr 1:26,863,149...26,864,456

G

sphingosine-1-phosphate phosphatase 1

increases expression

Sodium Glutamate results in increased expression of SGPP1 mRNA

NCBI chr14:63,684,216...63,728,065
Ensembl chr14:63,684,216...63,728,065

G

salt inducible kinase 1

decreases expression
multiple interactions

Sodium Glutamate results in decreased expression of SIK1 mRNA
[Trans Fatty Acids co-treated with Sodium Glutamate] results in increased expression of SIK1 mRNA

NCBI chr21:43,414,483...43,427,131
Ensembl chr21:43,414,483...43,427,131

G

sirtuin 1

multiple interactions

[Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of SIRT1 mRNA; [Resveratrol co-treated with Sodium Glutamate] results in increased expression of SIRT1 protein

PMID:23783067 PMID:28708105

NCBI chr10:67,884,656...67,918,390
Ensembl chr10:67,884,656...67,918,390

G

sirtuin 2

multiple interactions

[Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of SIRT2 mRNA

NCBI chr19:38,878,555...38,899,618
Ensembl chr19:38,878,555...38,899,862

G

SKI proto-oncogene

decreases expression

Sodium Glutamate results in decreased expression of SKI mRNA

NCBI chr 1:2,228,319...2,310,213
Ensembl chr 1:2,227,388...2,310,213

G

solute carrier family 13 member 2

increases expression

Sodium Glutamate results in increased expression of SLC13A2 mRNA

NCBI chr17:28,473,644...28,497,781
Ensembl chr17:28,473,293...28,497,781

G

solute carrier family 22 member 1

multiple interactions

[Sodium Glutamate co-treated with Trans Fatty Acids] results in increased expression of SLC22A1 mRNA

NCBI chr 6:160,121,815...160,158,718
Ensembl chr 6:160,121,815...160,158,718

G

solute carrier family 22 member 18

multiple interactions

[Sodium Glutamate co-treated with Trans Fatty Acids] results in increased expression of SLC22A18 mRNA

NCBI chr11:2,899,691...2,925,246
Ensembl chr11:2,899,721...2,925,246

G

solute carrier family 25 member 1

multiple interactions

[Sodium Glutamate co-treated with Trans Fatty Acids] results in increased expression of SLC25A1 mRNA

NCBI chr22:19,175,581...19,178,736
Ensembl chr22:19,175,581...19,178,739

G

solute carrier family 25 member 10

multiple interactions

[Sodium Glutamate co-treated with Trans Fatty Acids] results in increased expression of SLC25A10 mRNA

NCBI chr17:81,712,284...81,721,012
Ensembl chr17:81,712,236...81,721,016

G

solute carrier family 25 member 12

multiple interactions

[Sodium Glutamate co-treated with High Fructose Corn Syrup] results in decreased expression of SLC25A12 mRNA

NCBI chr 2:171,783,405...171,894,244
Ensembl chr 2:171,783,405...171,999,859

G

solute carrier family 25 member 25

decreases expression
multiple interactions

Sodium Glutamate results in decreased expression of SLC25A25 mRNA
[Sodium Glutamate co-treated with High Fructose Corn Syrup] results in decreased expression of SLC25A25 mRNA

NCBI chr 9:128,068,232...128,109,245
Ensembl chr 9:128,068,201...128,109,245

G

solute carrier family 25 member 33

decreases expression
multiple interactions

Sodium Glutamate results in decreased expression of SLC25A33 mRNA
[Sodium Glutamate co-treated with High Fructose Corn Syrup] results in decreased expression of SLC25A33 mRNA

NCBI chr 1:9,539,465...9,585,173
Ensembl chr 1:9,539,465...9,585,173

G

solute carrier family 26 member 4

increases expression

Sodium Glutamate results in increased expression of SLC26A4 mRNA

NCBI chr 7:107,660,828...107,717,809
Ensembl chr 7:107,660,828...107,717,809

G

solute carrier family 27 member 1

multiple interactions

[Sodium Glutamate co-treated with Trans Fatty Acids] results in increased expression of SLC27A1 mRNA

NCBI chr19:17,468,767...17,506,168
Ensembl chr19:17,468,769...17,506,168

G

solute carrier family 28 member 1

decreases expression
multiple interactions

Sodium Glutamate results in decreased expression of SLC28A1 mRNA
[Sodium Glutamate co-treated with High Fructose Corn Syrup] results in decreased expression of SLC28A1 mRNA

NCBI chr15:84,884,662...84,975,649
Ensembl chr15:84,884,654...84,945,798

G

solute carrier family 2 member 1

multiple interactions

[Rosiglitazone co-treated with Sodium Glutamate] results in decreased expression of SLC2A1 mRNA; [Sodium Glutamate co-treated with Trans Fatty Acids] results in decreased expression of SLC2A1 mRNA

PMID:18048028 PMID:19001666

NCBI chr 1:42,925,353...42,958,868
Ensembl chr 1:42,925,353...42,958,893

G

solute carrier family 2 member 12

multiple interactions

[Sodium Glutamate co-treated with Trans Fatty Acids] results in increased expression of SLC2A12 mRNA

NCBI chr 6:133,987,581...134,052,624
Ensembl chr 6:133,987,581...134,052,624

G

solute carrier family 2 member 2

multiple interactions
increases expression

Resveratrol inhibits the reaction [Sodium Glutamate results in increased expression of SLC2A2 mRNA]; Resveratrol inhibits the reaction [Sodium Glutamate results in increased expression of SLC2A2 protein]
Sodium Glutamate results in increased expression of SLC2A2 mRNA; Sodium Glutamate results in increased expression of SLC2A2 protein

NCBI chr 3:170,996,347...171,026,720
Ensembl chr 3:170,996,347...171,026,743

G

solute carrier family 2 member 4

decreases expression
increases expression
multiple interactions
affects expression

Sodium Glutamate results in decreased expression of SLC2A4 mRNA; Sodium Glutamate results in decreased expression of SLC2A4 protein
Sodium Glutamate results in increased expression of SLC2A4 protein
Carbenoxolone affects the reaction [Sodium Glutamate affects the expression of SLC2A4 mRNA]; Carbenoxolone affects the reaction [Sodium Glutamate affects the expression of SLC2A4 protein]
Sodium Glutamate affects the expression of SLC2A4 mRNA; Sodium Glutamate affects the expression of SLC2A4 protein
Atorvastatin inhibits the reaction [Sodium Glutamate results in decreased expression of SLC2A4 mRNA]; Atorvastatin inhibits the reaction [Sodium Glutamate results in decreased expression of SLC2A4 protein]; Atorvastatin inhibits the reaction [Sodium Glutamate results in increased expression of SLC2A4 mRNA]; Atorvastatin inhibits the reaction [Sodium Glutamate results in increased expression of SLC2A4 protein]; Resveratrol inhibits the reaction [Sodium Glutamate results in decreased expression of SLC2A4 mRNA]; Resveratrol inhibits the reaction [Sodium Glutamate results in decreased expression of SLC2A4 protein]; Tea inhibits the reaction [Sodium Glutamate results in decreased expression of SLC2A4 protein]

PMID:11319642 PMID:19800637 PMID:22415589 PMID:25834641 PMID:28708105 More...

NCBI chr17:7,281,718...7,288,257
Ensembl chr17:7,281,718...7,288,257

G

solute carrier family 2 member 8

multiple interactions

[Sodium Glutamate co-treated with Trans Fatty Acids] results in increased expression of SLC2A8 mRNA

NCBI chr 9:127,397,169...127,407,898
Ensembl chr 9:127,397,138...127,408,424

G

solute carrier family 35 member B1

multiple interactions

[Trans Fatty Acids co-treated with Sodium Glutamate] results in increased expression of SLC35B1 mRNA

NCBI chr17:49,700,943...49,708,197
Ensembl chr17:49,700,934...49,709,014

G

solute carrier family 36 member 2

multiple interactions

[Sodium Glutamate co-treated with Trans Fatty Acids] results in increased expression of SLC36A2 mRNA

NCBI chr 5:151,314,972...151,347,559
Ensembl chr 5:151,314,972...151,347,590

G

solute carrier family 38 member 4

multiple interactions
increases expression

[Sodium Glutamate co-treated with Trans Fatty Acids] results in decreased expression of SLC38A4 mRNA
Sodium Glutamate results in increased expression of SLC38A4 mRNA

NCBI chr12:46,764,761...46,832,431
Ensembl chr12:46,764,761...46,832,408

G

solute carrier family 45 member 2

increases expression

Sodium Glutamate results in increased expression of SLC45A2 mRNA

NCBI chr 5:33,944,623...33,984,693
Ensembl chr 5:33,944,623...33,984,693

G

solute carrier family 4 member 1 (Diego blood group)

decreases expression

Sodium Glutamate results in decreased expression of SLC4A1 mRNA

NCBI chr17:44,248,390...44,268,135
Ensembl chr17:44,248,390...44,268,141

G

solute carrier family 4 member 2

multiple interactions

[Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of SLC4A2 mRNA

NCBI chr 7:151,058,200...151,076,527
Ensembl chr 7:151,057,210...151,076,526

G

solute carrier family 4 member 4

decreases expression

Sodium Glutamate results in decreased expression of SLC4A4 mRNA

NCBI chr 4:71,062,660...71,572,083
Ensembl chr 4:71,062,667...71,572,087

G

solute carrier family 6 member 1

decreases expression

Sodium Glutamate results in decreased expression of SLC6A1 mRNA

NCBI chr 3:10,992,748...11,039,247
Ensembl chr 3:10,992,186...11,039,247

G

solute carrier family 6 member 2

increases expression

Sodium Glutamate results in increased expression of SLC6A2 mRNA

NCBI chr16:55,655,988...55,706,192
Ensembl chr16:55,655,988...55,707,645

G

solute carrier family 8 member A1

multiple interactions

[Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of SLC8A1 mRNA; [Fats, Unsaturated co-treated with Sodium Glutamate] affects the expression of SLC8A1 mRNA

NCBI chr 2:40,097,270...40,512,435
Ensembl chr 2:40,097,270...40,611,053

G

solute carrier family 8 member A3

increases expression

Sodium Glutamate results in increased expression of SLC8A3 mRNA; Sodium Glutamate results in increased expression of SLC8A3 protein

NCBI chr14:70,044,215...70,189,405
Ensembl chr14:70,044,215...70,189,480

G

secretory leukocyte peptidase inhibitor

increases expression

Sodium Glutamate results in increased expression of SLPI mRNA

NCBI chr20:45,252,239...45,254,564
Ensembl chr20:45,252,239...45,254,564

G

SMAD family member 4

decreases expression

Sodium Glutamate results in decreased expression of SMAD4 mRNA

NCBI chr18:51,030,213...51,085,042
Ensembl chr18:51,028,528...51,085,045

G

small integral membrane protein 3

increases expression

Sodium Glutamate results in increased expression of SMIM3 mRNA

NCBI chr 5:150,778,757...150,796,734
Ensembl chr 5:150,778,757...150,796,734

G

small nuclear ribonucleoprotein U11/U12 subunit 35

increases expression

Sodium Glutamate results in increased expression of SNRNP35 mRNA

NCBI chr12:123,458,139...123,473,154
Ensembl chr12:123,458,088...123,473,154

G

suppressor of cytokine signaling 2

decreases expression
multiple interactions

Sodium Glutamate results in decreased expression of SOCS2 mRNA; Sodium Glutamate results in decreased expression of SOCS2 protein
Sodium Glutamate inhibits the reaction [GH1 protein results in decreased expression of SOCS2 mRNA]; Sodium Glutamate inhibits the reaction [GH1 protein results in increased expression of SOCS2 mRNA]; Sodium Glutamate inhibits the reaction [GH1 protein results in increased expression of SOCS2 protein]

NCBI chr12:93,569,969...93,626,236
Ensembl chr12:93,569,814...93,583,487

G

suppressor of cytokine signaling 3

increases expression

Sodium Glutamate results in increased expression of SOCS3 protein

NCBI chr17:78,356,778...78,360,925
Ensembl chr17:78,356,778...78,360,077

G

superoxide dismutase 1

decreases expression
increases expression
multiple interactions

Sodium Glutamate results in decreased expression of SOD1 mRNA
Sodium Glutamate results in increased expression of SOD1 mRNA; Sodium Glutamate results in increased expression of SOD1 protein
SRT1720 inhibits the reaction [Sodium Glutamate results in increased expression of SOD1 mRNA]; SRT1720 inhibits the reaction [Sodium Glutamate results in increased expression of SOD1 protein]

PMID:19724016 PMID:30733785

NCBI chr21:31,659,693...31,668,931
Ensembl chr21:31,659,666...31,668,931

G

sortilin related receptor 1

multiple interactions
increases expression

[Sodium Glutamate co-treated with Trans Fatty Acids] results in increased expression of SORL1 mRNA
Sodium Glutamate results in increased expression of SORL1 mRNA

NCBI chr11:121,452,314...121,633,763
Ensembl chr11:121,452,314...121,633,763

G

Sp1 transcription factor

increases expression

Sodium Glutamate results in increased expression of SP1 mRNA

NCBI chr12:53,380,176...53,416,446
Ensembl chr12:53,380,176...53,416,446

G

small regulatory polypeptide of amino acid response

increases expression

Sodium Glutamate results in increased expression of SPAAR mRNA

NCBI chr 9:35,909,490...35,911,686
Ensembl chr 9:35,909,490...35,937,153

G

spondin 2

decreases expression

Sodium Glutamate results in decreased expression of SPON2 mRNA

NCBI chr 4:1,166,932...1,208,844
Ensembl chr 4:1,166,932...1,208,962

G

S1 RNA binding domain 1

increases expression

Sodium Glutamate results in increased expression of SRBD1 mRNA

NCBI chr 2:45,388,680...45,611,267
Ensembl chr 2:45,388,680...45,612,165

G

sterol regulatory element binding transcription factor 1

affects expression
increases expression
multiple interactions
decreases expression

Sodium Glutamate affects the expression of SREBF1 mRNA
Sodium Glutamate results in increased expression of SREBF1 mRNA; Sodium Glutamate results in increased expression of SREBF1 protein
Carbenoxolone affects the reaction [Sodium Glutamate affects the expression of SREBF1 mRNA]
3-(4-(4-(3-methyl-1-phenyl-1H-pyrazol-5-yl)piperazin-1-yl)pyrrolidin-2-ylcarbonyl)thiazolidine affects the reaction [[Dietary Fats co-treated with Sodium Glutamate] affects the expression of SREBF1 mRNA]; [Dietary Fats co-treated with Sodium Glutamate] affects the expression of SREBF1 mRNA; [Sodium Glutamate co-treated with Trans Fatty Acids] results in increased expression of SREBF1 mRNA; SRT1720 inhibits the reaction [Sodium Glutamate results in increased expression of SREBF1 mRNA]; SRT1720 inhibits the reaction [Sodium Glutamate results in increased expression of SREBF1 protein]
Sodium Glutamate results in decreased expression of SREBF1 mRNA

PMID:19001666 PMID:19724016 PMID:26092479 PMID:26670228 PMID:31077719

NCBI chr17:17,811,334...17,836,986
Ensembl chr17:17,810,399...17,837,002

G

sterol regulatory element binding transcription factor 2

decreases expression
increases expression
multiple interactions

Sodium Glutamate results in decreased expression of SREBF2 mRNA
Sodium Glutamate results in increased expression of SREBF2 mRNA
[Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of SREBF2 mRNA; [Sodium Glutamate co-treated with High Fructose Corn Syrup] results in increased expression of SREBF2 mRNA

PMID:20111022 PMID:22078008 PMID:23783067

NCBI chr22:41,833,105...41,907,305
Ensembl chr22:41,833,105...41,907,306

G

serine/arginine repetitive matrix 3

increases expression

Sodium Glutamate results in increased expression of SRRM3 mRNA

NCBI chr 7:76,201,896...76,287,287
Ensembl chr 7:76,201,896...76,287,288

G

SCO-spondin, pseudogene

increases expression

Sodium Glutamate results in increased expression of SSPO mRNA

NCBI chr 7:149,776,042...149,833,965
Ensembl chr 7:149,776,042...149,833,829

G

ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 4

multiple interactions

[Sodium Glutamate co-treated with High Fructose Corn Syrup] results in increased expression of ST6GALNAC4 mRNA

NCBI chr 9:127,907,886...127,917,041
Ensembl chr 9:127,907,886...127,917,041

G

signal transducer and activator of transcription 2

increases expression

Sodium Glutamate results in increased expression of STAT2 mRNA

NCBI chr12:56,341,597...56,360,107
Ensembl chr12:56,341,597...56,360,203

G

signal transducer and activator of transcription 3

multiple interactions
decreases phosphorylation

[Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of STAT3 mRNA
Sodium Glutamate results in decreased phosphorylation of STAT3 protein

PMID:23783067 PMID:24502529

NCBI chr17:42,313,324...42,388,442
Ensembl chr17:42,313,324...42,388,568

G

serine/threonine kinase 26

increases expression
multiple interactions

Sodium Glutamate results in increased expression of STK26 mRNA
[Trans Fatty Acids co-treated with Sodium Glutamate] results in decreased expression of STK26 mRNA

NCBI chr X:132,023,302...132,075,943
Ensembl chr X:132,023,302...132,075,943

G

serine/threonine kinase 35

multiple interactions

[Trans Fatty Acids co-treated with Sodium Glutamate] results in increased expression of STK35 mRNA

NCBI chr20:2,101,827...2,148,555
Ensembl chr20:2,101,827...2,177,038

G

serine/threonine kinase 36

increases expression

Sodium Glutamate results in increased expression of STK36 mRNA

NCBI chr 2:218,672,086...218,702,717
Ensembl chr 2:218,672,069...218,702,716

G

syntaxin 2

increases expression

Sodium Glutamate results in increased expression of STX2 mRNA

NCBI chr12:130,789,600...130,839,250
Ensembl chr12:130,789,600...130,839,254

G

SURF1 cytochrome c oxidase assembly factor

multiple interactions

[Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of SURF1 mRNA; [Fats, Unsaturated co-treated with Sodium Glutamate] affects the expression of SURF1 mRNA

NCBI chr 9:133,351,758...133,356,487
Ensembl chr 9:133,351,758...133,356,676

G

synaptic Ras GTPase activating protein 1

decreases expression

Sodium Glutamate results in decreased expression of SYNGAP1 mRNA

NCBI chr 6:33,418,167...33,453,689
Ensembl chr 6:33,419,661...33,453,689

G

tachykinin precursor 1

decreases expression

Sodium Glutamate results in decreased expression of TAC1 mRNA

NCBI chr 7:97,732,086...97,740,472
Ensembl chr 7:97,732,084...97,740,472

G

TATA-box binding protein associated factor, RNA polymerase I subunit A

multiple interactions

[Trans Fatty Acids co-treated with Sodium Glutamate] results in increased expression of TAF1A mRNA

NCBI chr 1:222,554,105...222,589,933
Ensembl chr 1:222,557,902...222,589,933

G

TAL bHLH transcription factor 2

decreases expression
multiple interactions

Sodium Glutamate results in decreased expression of TAL2 mRNA
[Trans Fatty Acids co-treated with Sodium Glutamate] results in increased expression of TAL2 mRNA

NCBI chr 9:105,662,457...105,663,124
Ensembl chr 9:105,662,457...105,663,124

G

taste 1 receptor member 1

increases expression

Sodium Glutamate results in increased expression of TAS1R1 mRNA

NCBI chr 1:6,555,307...6,579,755
Ensembl chr 1:6,555,307...6,579,755

G

taste 1 receptor member 3

increases expression

Sodium Glutamate results in increased expression of TAS1R3 mRNA

NCBI chr 1:1,331,280...1,335,314
Ensembl chr 1:1,331,280...1,335,314

G

tyrosine aminotransferase

increases expression

Sodium Glutamate results in increased expression of TAT mRNA

NCBI chr16:71,565,660...71,577,092
Ensembl chr16:71,565,660...71,577,092

G

transcription factor A, mitochondrial

multiple interactions

[Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of TFAM mRNA; [Fats, Unsaturated co-treated with Sodium Glutamate] affects the expression of TFAM mRNA

NCBI chr10:58,385,410...58,399,220
Ensembl chr10:58,385,345...58,399,220

G

transferrin receptor 2

multiple interactions

[Sodium Glutamate co-treated with Trans Fatty Acids] results in increased expression of TFR2 mRNA

NCBI chr 7:100,620,420...100,641,552
Ensembl chr 7:100,620,416...100,642,779

G

transferrin receptor

multiple interactions

[Sodium Glutamate co-treated with Trans Fatty Acids] results in increased expression of TFRC mRNA

NCBI chr 3:196,049,284...196,082,090
Ensembl chr 3:196,012,511...196,082,153

G

tyrosine hydroxylase

decreases activity
decreases expression

Sodium Glutamate results in decreased activity of TH protein
Sodium Glutamate results in decreased expression of TH mRNA

NCBI chr11:2,163,929...2,171,815
Ensembl chr11:2,163,929...2,171,815

G

THAP domain containing 2

decreases expression

Sodium Glutamate results in decreased expression of THAP2 mRNA

NCBI chr12:71,664,301...71,680,644
Ensembl chr12:71,664,301...71,680,644

G

thrombospondin 1

multiple interactions

[Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of THBS1 mRNA

NCBI chr15:39,581,079...39,599,466
Ensembl chr15:39,581,079...39,599,466

G

TOR signaling pathway regulator

multiple interactions

[Trans Fatty Acids co-treated with Sodium Glutamate] results in increased expression of TIPRL mRNA

NCBI chr 1:168,178,962...168,202,109
Ensembl chr 1:168,178,962...168,202,109

G

transmembrane channel like 6

multiple interactions

[Trans Fatty Acids co-treated with Sodium Glutamate] results in increased expression of TMC6 mRNA

NCBI chr17:78,107,397...78,132,427
Ensembl chr17:78,107,397...78,132,407

G

transmembrane protein 106A

multiple interactions

[Trans Fatty Acids co-treated with Sodium Glutamate] results in increased expression of TMEM106A mRNA

NCBI chr17:43,211,875...43,220,041
Ensembl chr17:43,211,835...43,220,041

G

transmembrane protein 190

increases expression

Sodium Glutamate results in increased expression of TMEM190 mRNA

NCBI chr19:55,376,826...55,378,246
Ensembl chr19:55,376,826...55,378,246

G

transmembrane protein 260

increases expression

Sodium Glutamate results in increased expression of TMEM260 mRNA

NCBI chr14:56,579,525...56,663,165
Ensembl chr14:56,488,354...56,650,606

G

transmembrane protein 69

multiple interactions
increases expression

[Trans Fatty Acids co-treated with Sodium Glutamate] results in increased expression of TMEM69 mRNA
Sodium Glutamate results in increased expression of TMEM69 mRNA

NCBI chr 1:45,688,181...45,694,436
Ensembl chr 1:45,688,181...45,694,436

G

transmembrane serine protease 11F

affects expression

Sodium Glutamate affects the expression of TMPRSS11F mRNA

NCBI chr 4:68,053,198...68,129,869
Ensembl chr 4:68,053,198...68,129,869

G

tumor necrosis factor

increases expression
affects expression
multiple interactions

Sodium Glutamate results in increased expression of TNF mRNA; Sodium Glutamate results in increased expression of TNF protein
Sodium Glutamate affects the expression of TNF mRNA
[Fenofibrate co-treated with Sodium Glutamate] results in increased expression of TNF protein
[Fats, Unsaturated co-treated with Sodium Glutamate] results in increased expression of TNF protein; [Sodium Glutamate co-treated with Aspartame] promotes the reaction [Fats, Unsaturated results in increased expression of TNF protein]; Atorvastatin inhibits the reaction [Sodium Glutamate results in increased expression of TNF mRNA]; Atorvastatin inhibits the reaction [Sodium Glutamate results in increased expression of TNF protein]; Glycine affects the reaction [Sodium Glutamate affects the expression of TNF mRNA]; Pioglitazone inhibits the reaction [Sodium Glutamate results in increased expression of TNF mRNA]; Plant Extracts inhibits the reaction [Sodium Glutamate results in increased expression of TNF mRNA]; Resveratrol inhibits the reaction [Sodium Glutamate results in increased expression of TNF mRNA]; SRT1720 inhibits the reaction [Sodium Glutamate results in increased expression of TNF mRNA]; SRT1720 inhibits the reaction [Sodium Glutamate results in increased expression of TNF protein]

PMID:18930730 PMID:19724016 PMID:19800637 PMID:21205225 PMID:21999347 More...

NCBI chr 6:31,575,565...31,578,336
Ensembl chr 6:31,575,565...31,578,336

G

TNF receptor superfamily member 10a

multiple interactions

[Sodium Glutamate co-treated with High Fructose Corn Syrup] results in decreased expression of TNFRSF10B mRNA

NCBI chr 8:23,190,452...23,225,102
Ensembl chr 8:23,190,452...23,225,102

G

TNF receptor superfamily member 1B

increases secretion
multiple interactions

Sodium Glutamate results in increased secretion of TNFRSF1B protein
Plant Extracts inhibits the reaction [Sodium Glutamate results in increased secretion of TNFRSF1B protein]

NCBI chr 1:12,166,991...12,209,220
Ensembl chr 1:12,166,991...12,209,228

G

TNF receptor superfamily member 4

decreases expression
multiple interactions

Sodium Glutamate results in decreased expression of TNFRSF4 mRNA
[Sodium Glutamate co-treated with High Fructose Corn Syrup] results in increased expression of TNFRSF4 mRNA

NCBI chr 1:1,211,340...1,214,153
Ensembl chr 1:1,211,326...1,214,153

G

TNF superfamily member 14

increases expression

Sodium Glutamate results in increased expression of TNFSF14 mRNA

NCBI chr19:6,661,253...6,670,588
Ensembl chr19:6,661,253...6,670,588

G

target of myb1 membrane trafficking protein

increases expression

Sodium Glutamate results in increased expression of TOM1 mRNA

NCBI chr22:35,299,275...35,347,973
Ensembl chr22:35,299,275...35,347,992

G

torsin family 3 member A

multiple interactions

[Sodium Glutamate co-treated with Trans Fatty Acids] results in increased expression of TOR3A mRNA

NCBI chr 1:179,082,070...179,095,996
Ensembl chr 1:179,082,070...179,098,023

G

tumor protein p53

multiple interactions

[Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of TRP53 mRNA; [Fats, Unsaturated co-treated with Sodium Glutamate] affects the expression of TRP53 mRNA

NCBI chr17:7,668,421...7,687,490
Ensembl chr17:7,661,779...7,687,538

G

tryptophan hydroxylase 1

increases expression

Sodium Glutamate results in increased expression of TPH1 mRNA

NCBI chr11:18,017,555...18,046,269
Ensembl chr11:18,017,555...18,046,269

G

tropomyosin 4

multiple interactions

[Trans Fatty Acids co-treated with Sodium Glutamate] results in increased expression of TPM4 mRNA

NCBI chr19:16,067,538...16,103,002
Ensembl chr19:16,067,021...16,103,002

G

tubulin polymerization promoting protein family member 3

decreases expression

Sodium Glutamate results in decreased expression of TPPP3 mRNA

NCBI chr16:67,389,809...67,393,498
Ensembl chr16:67,389,809...67,393,518

G

TRAF3 interacting protein 2

decreases expression

Sodium Glutamate results in decreased expression of TRAF3IP2 mRNA

NCBI chr 6:111,555,381...111,605,878
Ensembl chr 6:111,555,381...111,606,906

G

tribbles pseudokinase 1

decreases expression

Sodium Glutamate results in decreased expression of TRIB1 mRNA

NCBI chr 8:125,430,358...125,438,403
Ensembl chr 8:125,430,358...125,438,403

G

tripartite motif containing 25

increases expression

Sodium Glutamate results in increased expression of TRIM25 mRNA

NCBI chr17:56,887,909...56,914,049
Ensembl chr17:56,836,387...56,914,080

G

transient receptor potential cation channel subfamily V member 5

increases expression

Sodium Glutamate results in increased expression of TRPV5 mRNA

NCBI chr 7:142,908,101...142,933,746
Ensembl chr 7:142,908,101...142,933,746

G

tetraspanin 1

increases expression

Sodium Glutamate results in increased expression of TSPAN1 mRNA

NCBI chr 1:46,175,087...46,196,489
Ensembl chr 1:46,175,073...46,185,962

G

tetraspanin 6

multiple interactions

[Trans Fatty Acids co-treated with Sodium Glutamate] results in increased expression of TSPAN6 mRNA

NCBI chr X:100,627,108...100,637,104
Ensembl chr X:100,627,108...100,639,991

G

TELO2 interacting protein 2

multiple interactions

[Trans Fatty Acids co-treated with Sodium Glutamate] results in increased expression of TTI2 mRNA

NCBI chr 8:33,498,722...33,513,135
Ensembl chr 8:33,473,386...33,513,185

G

Tu translation elongation factor, mitochondrial

multiple interactions

[Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of TUFM mRNA; [Fats, Unsaturated co-treated with Sodium Glutamate] affects the expression of TUFM mRNA

NCBI chr16:28,842,411...28,846,348
Ensembl chr16:28,842,411...28,846,348

G

thioredoxin

multiple interactions

[Trans Fatty Acids co-treated with Sodium Glutamate] results in increased expression of TXN1 mRNA

NCBI chr 9:110,243,810...110,256,507
Ensembl chr 9:110,243,810...110,256,507

G

thioredoxin reductase 1

decreases expression

Sodium Glutamate results in decreased expression of TXNRD1 mRNA

NCBI chr12:104,215,779...104,350,307
Ensembl chr12:104,215,779...104,350,307

G

ubiquitin conjugating enzyme E2 I

decreases expression
multiple interactions

Sodium Glutamate results in decreased expression of UBE2I protein
Carbenoxolone inhibits the reaction [Sodium Glutamate results in decreased expression of UBE2I protein]

NCBI chr16:1,309,152...1,327,017
Ensembl chr16:1,291,444...1,327,018

G

uridine-cytidine kinase 2

multiple interactions

[Trans Fatty Acids co-treated with Sodium Glutamate] results in increased expression of UCK2 mRNA

NCBI chr 1:165,827,614...165,911,618
Ensembl chr 1:165,827,614...165,911,618

G

uncoupling protein 2

multiple interactions

[Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of UCP2 mRNA; [Fats, Unsaturated co-treated with Sodium Glutamate] affects the expression of UCP2 mRNA
[Fenofibrate co-treated with Sodium Glutamate] results in increased expression of UCP2 mRNA

PMID:21999347 PMID:23783067

NCBI chr11:73,974,672...73,983,202
Ensembl chr11:73,974,672...73,982,843

G

unc-5 family C-terminal like

decreases expression

Sodium Glutamate results in decreased expression of UNC5CL mRNA

NCBI chr 6:41,026,895...41,039,221
Ensembl chr 6:41,026,895...41,039,221

G

unc-93 homolog A

increases expression

Sodium Glutamate results in increased expression of UNC93A mRNA

NCBI chr 6:167,269,032...167,316,014
Ensembl chr 6:167,271,169...167,316,014

G

ubiquinol-cytochrome c reductase, complex III subunit XI

multiple interactions

[Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of UQCR11 mRNA; [Fats, Unsaturated co-treated with Sodium Glutamate] affects the expression of UQCR11 mRNA

NCBI chr19:1,597,169...1,605,462
Ensembl chr19:1,597,169...1,605,473

G

uroporphyrinogen decarboxylase

increases expression
multiple interactions

Sodium Glutamate results in increased expression of UROD mRNA
[Trans Fatty Acids co-treated with Sodium Glutamate] results in increased expression of UROD mRNA

NCBI chr 1:45,012,254...45,015,575
Ensembl chr 1:45,010,950...45,015,575

G

ubiquitin specific peptidase 54

multiple interactions

[Sodium Glutamate co-treated with Trans Fatty Acids] results in decreased expression of USP54 mRNA

NCBI chr10:73,497,538...73,625,981
Ensembl chr10:73,497,538...73,626,117

G

versican

multiple interactions
decreases expression

[Trans Fatty Acids co-treated with Sodium Glutamate] results in increased expression of VCAN mRNA
Sodium Glutamate results in decreased expression of VCAN mRNA

NCBI chr 5:83,471,744...83,582,302
Ensembl chr 5:83,471,618...83,582,303

G

vascular endothelial growth factor A

increases expression
multiple interactions

Sodium Glutamate results in increased expression of VEGFA mRNA; Sodium Glutamate results in increased expression of VEGFA protein
[Semaxinib co-treated with Sodium Glutamate] results in increased expression of VEGFA protein

PMID:28755050 PMID:36732937

NCBI chr 6:43,770,211...43,786,487
Ensembl chr 6:43,770,184...43,786,487

G

vascular endothelial growth factor B

decreases expression

Sodium Glutamate results in decreased expression of VEGFB protein

NCBI chr11:64,234,584...64,239,264
Ensembl chr11:64,234,584...64,239,264

G

WD repeat and FYVE domain containing 2

increases expression

Sodium Glutamate results in increased expression of WDFY2 mRNA

NCBI chr13:51,584,462...51,767,709
Ensembl chr13:51,584,455...51,767,709

G

WAP four-disulfide core domain 5

increases expression

Sodium Glutamate results in increased expression of WFDC5 mRNA

NCBI chr20:45,109,463...45,116,319
Ensembl chr20:45,109,452...45,115,174

G

WNK lysine deficient protein kinase 3

increases expression
multiple interactions

Sodium Glutamate results in increased expression of WNK3 mRNA
[Trans Fatty Acids co-treated with Sodium Glutamate] results in increased expression of WNK3 mRNA

NCBI chr X:54,192,823...54,358,900
Ensembl chr X:54,192,823...54,358,642

G

xanthine dehydrogenase

multiple interactions

[Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of XDH mRNA

NCBI chr 2:31,334,321...31,414,742
Ensembl chr 2:31,334,321...31,414,742

G

YY1 associated factor 2

multiple interactions

[Trans Fatty Acids co-treated with Sodium Glutamate] results in increased expression of YAF2 mRNA

NCBI chr12:42,157,104...42,238,248
Ensembl chr12:42,157,104...42,238,349

G

YY2 transcription factor

increases expression

Sodium Glutamate results in increased expression of YY2 mRNA

NCBI chr X:21,855,987...21,858,740
Ensembl chr X:21,855,987...21,858,740

G

ZFP42 zinc finger protein

increases expression

Sodium Glutamate results in increased expression of ZFP42 mRNA

NCBI chr 4:187,995,771...188,005,246
Ensembl chr 4:187,995,771...188,005,046

G

zinc finger protein 205

increases expression

Sodium Glutamate results in increased expression of ZFP13 mRNA

NCBI chr16:3,112,586...3,120,517
Ensembl chr16:3,112,560...3,120,517

G

zinc finger protein 239

increases expression

Sodium Glutamate results in increased expression of ZFP239 mRNA

NCBI chr10:43,556,344...43,574,616
Ensembl chr10:43,556,344...43,574,618

G

zinc finger protein 362

decreases expression

Sodium Glutamate results in decreased expression of ZFP362 mRNA

NCBI chr 1:33,127,522...33,300,719
Ensembl chr 1:33,256,492...33,300,719

G

zinc finger protein 423

decreases expression

Sodium Glutamate results in decreased expression of ZFP423 mRNA

NCBI chr16:49,487,524...49,859,279
Ensembl chr16:49,487,524...49,857,919

G

zinc finger protein 674

increases expression

Sodium Glutamate results in increased expression of ZFP819 mRNA

NCBI chr X:46,497,725...46,545,421
Ensembl chr X:46,497,725...46,545,457

Sirius red 4B

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

iodotyrosine deiodinase

multiple interactions

Direct Red 81 inhibits the reaction [IYD protein results in increased metabolism of Monoiodotyrosine]

NCBI chr 6:150,369,012...150,405,969
Ensembl chr 6:150,368,892...150,405,969

sodium acetate trihydrate

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

acyl-CoA oxidase 1

increases expression

Sodium Acetate results in increased expression of ACOX1 mRNA

NCBI chr17:75,941,507...75,979,166
Ensembl chr17:75,941,507...75,979,177

G

acyl-CoA synthetase short chain family member 1

increases expression

Sodium Acetate results in increased expression of ACSS1 mRNA

NCBI chr20:25,006,237...25,058,139
Ensembl chr20:25,006,230...25,058,980

G

acyl-CoA synthetase short chain family member 2

increases expression

Sodium Acetate results in increased expression of ACSS2 mRNA

NCBI chr20:34,874,989...34,927,959
Ensembl chr20:34,872,146...34,927,962

G

adenosine deaminase

multiple interactions

Sodium Acetate inhibits the reaction [Nicotine results in increased activity of ADA protein]

NCBI chr20:44,619,522...44,651,699
Ensembl chr20:44,584,896...44,652,252

G

apolipoprotein B

multiple interactions

[Sodium Acetate co-treated with acetic anhydride] results in increased acetylation of APOB protein

NCBI chr 2:21,001,429...21,044,073
Ensembl chr 2:21,001,429...21,044,073

G

caspase 3

multiple interactions

Sodium Acetate inhibits the reaction [Cisplatin results in increased cleavage of CASP3 protein]

NCBI chr 4:184,627,696...184,649,447
Ensembl chr 4:184,627,696...184,650,062

G

caspase 7

multiple interactions

Sodium Acetate inhibits the reaction [Cisplatin results in increased cleavage of CASP7 protein]

NCBI chr10:113,679,194...113,730,909
Ensembl chr10:113,679,162...113,730,907

G

catalase

multiple interactions

Sodium Acetate inhibits the reaction [Cisplatin results in decreased expression of CAT protein]

NCBI chr11:34,438,934...34,472,060
Ensembl chr11:34,438,934...34,472,060

G

cytochrome P450 family 1 subfamily A member 1

multiple interactions

Sodium Acetate promotes the reaction [biochanin A results in increased expression of CYP1A1 mRNA]; Sodium Acetate promotes the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1A1 mRNA]

NCBI chr15:74,719,542...74,725,528
Ensembl chr15:74,719,542...74,725,536

G

cytochrome P450 family 1 subfamily B member 1

multiple interactions

Sodium Acetate promotes the reaction [biochanin A results in increased expression of CYP1B1 mRNA]; Sodium Acetate promotes the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1B1 mRNA]

NCBI chr 2:38,067,509...38,076,151
Ensembl chr 2:38,066,973...38,109,902

G

gamma-glutamyltransferase 1

multiple interactions

Sodium Acetate inhibits the reaction [Nicotine results in increased activity of GGT1 protein]

NCBI chr22:24,583,750...24,628,996
Ensembl chr22:24,594,811...24,629,005

G

interferon gamma

multiple interactions

[Sodium Acetate co-treated with Butyric Acid co-treated with sodium propionate] inhibits the reaction [Fluorides results in increased expression of IFNG mRNA]

NCBI chr12:68,154,768...68,159,740
Ensembl chr12:68,154,768...68,159,740

G

inhibitor of nuclear factor kappa B kinase subunit beta

multiple interactions

[Sodium Acetate co-treated with Butyric Acid co-treated with sodium propionate] inhibits the reaction [Fluorides results in increased expression of IKBKB mRNA]; [Sodium Acetate co-treated with Butyric Acid co-treated with sodium propionate] inhibits the reaction [Fluorides results in increased expression of IKBKB protein]

NCBI chr 8:42,271,302...42,332,460
Ensembl chr 8:42,271,302...42,332,460

G

interleukin 2

multiple interactions

Sodium Acetate inhibits the reaction [[Ionomycin co-treated with Tetradecanoylphorbol Acetate] results in increased activity of IL2 protein]

NCBI chr 4:122,451,470...122,456,725
Ensembl chr 4:122,451,470...122,456,725

G

interleukin 6

multiple interactions

[Sodium Acetate co-treated with Butyric Acid co-treated with sodium propionate] inhibits the reaction [Fluorides results in increased expression of IL6 mRNA]

NCBI chr 7:22,727,200...22,731,998
Ensembl chr 7:22,725,884...22,732,002

G

INS-IGF2 readthrough

multiple interactions

Sodium Acetate inhibits the reaction [Nicotine results in increased expression of INS1 protein]

NCBI chr11:2,129,117...2,161,209
Ensembl chr11:2,132,538...2,161,209

G

karyopherin subunit beta 1

multiple interactions

Sodium Acetate inhibits the reaction [[Ionomycin co-treated with Tetradecanoylphorbol Acetate] promotes the reaction [NFATC2 protein binds to KPNB1 protein]]

NCBI chr17:47,649,919...47,685,505
Ensembl chr17:47,649,476...47,685,505

G

MYD88 innate immune signal transduction adaptor

multiple interactions

[Sodium Acetate co-treated with Butyric Acid co-treated with sodium propionate] inhibits the reaction [Fluorides results in increased expression of MYD88 mRNA]

NCBI chr 3:38,138,661...38,143,022
Ensembl chr 3:38,138,552...38,143,024

G

N-acetyltransferase 2

increases expression

Sodium Acetate results in increased expression of NAT2 mRNA

NCBI chr 8:18,386,301...18,401,218
Ensembl chr 8:18,391,282...18,401,218

G

nuclear factor of activated T cells 2

multiple interactions

Sodium Acetate inhibits the reaction [[Ionomycin co-treated with Tetradecanoylphorbol Acetate] affects the localization of NFATC2 protein]; Sodium Acetate inhibits the reaction [[Ionomycin co-treated with Tetradecanoylphorbol Acetate] promotes the reaction [NFATC2 protein binds to KPNB1 protein]]; Sodium Acetate inhibits the reaction [[Ionomycin co-treated with Tetradecanoylphorbol Acetate] results in increased activity of NFATC2 protein]

NCBI chr20:51,386,963...51,562,839
Ensembl chr20:51,386,957...51,562,831

G

NFKB inhibitor alpha

multiple interactions

[Sodium Acetate co-treated with Butyric Acid co-treated with sodium propionate] inhibits the reaction [Fluorides results in decreased expression of NFKBIA protein]

NCBI chr14:35,401,513...35,404,749
Ensembl chr14:35,401,079...35,404,749

G

phosphoenolpyruvate carboxykinase 1

increases expression

Sodium Acetate results in increased expression of PCK1 mRNA

NCBI chr20:57,561,110...57,568,121
Ensembl chr20:57,561,080...57,568,121

G

RELA proto-oncogene, NF-kB subunit

multiple interactions

[Sodium Acetate co-treated with Butyric Acid co-treated with sodium propionate] inhibits the reaction [Fluorides results in increased expression of and results in increased phosphorylation of RELA protein]; [Sodium Acetate co-treated with Butyric Acid co-treated with sodium propionate] inhibits the reaction [Fluorides results in increased expression of RELA mRNA]

NCBI chr11:65,653,601...65,663,857
Ensembl chr11:65,653,599...65,663,090

G

superoxide dismutase 2

multiple interactions

Sodium Acetate inhibits the reaction [Cisplatin results in decreased expression of SOD2 protein]

NCBI chr 6:159,669,069...159,762,281
Ensembl chr 6:159,669,069...159,762,529

G

transforming growth factor beta 1

multiple interactions

[Sodium Acetate co-treated with Butyric Acid co-treated with sodium propionate] inhibits the reaction [Fluorides results in increased expression of TGFB1 mRNA]

NCBI chr19:41,330,323...41,353,922
Ensembl chr19:41,301,587...41,353,922

G

toll like receptor 2

multiple interactions

[Sodium Acetate co-treated with Butyric Acid co-treated with sodium propionate] inhibits the reaction [Fluorides results in increased expression of TLR2 mRNA]; [Sodium Acetate co-treated with Butyric Acid co-treated with sodium propionate] inhibits the reaction [Fluorides results in increased expression of TLR2 protein]

NCBI chr 4:153,684,280...153,710,637
Ensembl chr 4:153,684,070...153,706,260

G

toll like receptor 4

multiple interactions

[Sodium Acetate co-treated with Butyric Acid co-treated with sodium propionate] inhibits the reaction [Fluorides results in increased expression of TLR4 mRNA]; [Sodium Acetate co-treated with Butyric Acid co-treated with sodium propionate] inhibits the reaction [Fluorides results in increased expression of TLR4 protein]

NCBI chr 9:117,704,403...117,724,735
Ensembl chr 9:117,704,175...117,724,735

G

tumor necrosis factor

multiple interactions

[Sodium Acetate co-treated with Butyric Acid co-treated with sodium propionate] inhibits the reaction [Fluorides results in increased expression of TNF mRNA]

NCBI chr 6:31,575,565...31,578,336
Ensembl chr 6:31,575,565...31,578,336

G

UDP glucuronosyltransferase family 1 member A1

multiple interactions

Sodium Acetate promotes the reaction [Tetrachlorodibenzodioxin results in increased expression of UGT1A1 mRNA]

NCBI chr 2:233,760,270...233,773,300
Ensembl chr 2:233,760,270...233,773,300

G

xanthine dehydrogenase

multiple interactions

Sodium Acetate inhibits the reaction [Nicotine results in increased activity of XDH protein]

NCBI chr 2:31,334,321...31,414,742
Ensembl chr 2:31,334,321...31,414,742

sodium aurothiomalate

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

atypical chemokine receptor 3

decreases expression

Gold Sodium Thiomalate results in decreased expression of ACKR3 mRNA

NCBI chr 2:236,537,122...236,582,354
Ensembl chr 2:236,567,787...236,582,354

G

adenosine A2a receptor

decreases expression

Gold Sodium Thiomalate results in decreased expression of ADORA2A mRNA

NCBI chr22:24,423,597...24,442,357
Ensembl chr22:24,417,879...24,442,357

G

adhesion molecule with Ig like domain 2

decreases expression

Gold Sodium Thiomalate results in decreased expression of AMIGO2 mRNA

NCBI chr12:47,075,707...47,079,959
Ensembl chr12:47,075,707...47,079,959

G

ANTXR cell adhesion molecule 1

increases expression

Gold Sodium Thiomalate results in increased expression of ANTXR1 mRNA

NCBI chr 2:69,013,144...69,249,327
Ensembl chr 2:69,013,176...69,249,327

G

aldehyde oxidase 1

increases expression

Gold Sodium Thiomalate results in increased expression of AOX1 mRNA

NCBI chr 2:200,586,014...200,682,241
Ensembl chr 2:200,586,014...200,677,064

G

BCL2 related protein A1

decreases expression

Gold Sodium Thiomalate results in decreased expression of BCL2A1 mRNA

NCBI chr15:79,960,892...79,971,196
Ensembl chr15:79,960,892...79,971,196

G

bone marrow stromal cell antigen 2

decreases expression

Gold Sodium Thiomalate results in decreased expression of BST2 mRNA

NCBI chr19:17,402,939...17,405,630
Ensembl chr19:17,402,939...17,405,630

G

C-C motif chemokine ligand 20

decreases expression

Gold Sodium Thiomalate results in decreased expression of CCL20 mRNA; Gold Sodium Thiomalate results in decreased expression of CCL20 protein

NCBI chr 2:227,813,842...227,817,556
Ensembl chr 2:227,805,739...227,817,564

G

cellular communication network factor 1

increases expression

Gold Sodium Thiomalate results in increased expression of CCN1 mRNA

NCBI chr 1:85,580,761...85,583,950
Ensembl chr 1:85,580,761...85,584,589

G

cellular communication network factor 5

increases expression

Gold Sodium Thiomalate results in increased expression of CCN5 mRNA

NCBI chr20:44,714,861...44,727,811
Ensembl chr20:44,714,844...44,728,509

G

CD28 molecule

multiple interactions
affects response to substance

CD28 protein affects the reaction [Gold Sodium Thiomalate results in decreased activity of FBL protein]
CD28 protein affects the susceptibility to Gold Sodium Thiomalate

NCBI chr 2:203,706,482...203,738,912
Ensembl chr 2:203,706,475...203,738,912

G

component of inhibitor of nuclear factor kappa B kinase complex

multiple interactions

Gold Sodium Thiomalate inhibits the reaction [Lipopolysaccharides results in increased activity of CHUK protein]

NCBI chr10:100,186,319...100,229,596
Ensembl chr10:100,188,300...100,229,596

G

calmegin

decreases expression

Gold Sodium Thiomalate results in decreased expression of CLGN mRNA

NCBI chr 4:140,388,453...140,427,648
Ensembl chr 4:140,388,453...140,427,661

G

collagen type I alpha 1 chain

increases expression

Gold Sodium Thiomalate results in increased expression of COL1A1 mRNA

NCBI chr17:50,184,101...50,201,631
Ensembl chr17:50,184,101...50,201,632

G

collectin subfamily member 12

increases expression

Gold Sodium Thiomalate results in increased expression of COLEC12 mRNA

NCBI chr18:316,737...500,701
Ensembl chr18:316,737...500,722

G

C-X-C motif chemokine ligand 1

decreases expression

Gold Sodium Thiomalate results in decreased expression of CXCL1 mRNA

NCBI chr 4:73,869,393...73,871,308
Ensembl chr 4:73,869,393...73,871,308

G

C-X-C motif chemokine ligand 2

decreases expression

Gold Sodium Thiomalate results in decreased expression of CXCL2 mRNA

NCBI chr 4:74,097,040...74,099,195
Ensembl chr 4:74,097,040...74,099,196

G

C-X-C motif chemokine ligand 3

decreases expression

Gold Sodium Thiomalate results in decreased expression of CXCL3 mRNA

NCBI chr 4:74,036,589...74,038,689
Ensembl chr 4:74,036,589...74,038,807

G

C-X-C motif chemokine ligand 8

decreases expression

Gold Sodium Thiomalate results in decreased expression of CXCL8 mRNA; Gold Sodium Thiomalate results in decreased expression of CXCL8 protein

NCBI chr 4:73,740,569...73,743,716
Ensembl chr 4:73,740,519...73,743,716

G

C-X-C motif chemokine receptor 4

decreases expression

Gold Sodium Thiomalate results in decreased expression of CXCR4 mRNA

NCBI chr 2:136,114,349...136,118,149
Ensembl chr 2:136,114,349...136,119,177

G

DEAD-box helicase 10

increases expression

Gold Sodium Thiomalate results in increased expression of DDX10 mRNA

NCBI chr11:108,665,069...108,940,927
Ensembl chr11:108,665,058...108,940,999

G

iodothyronine deiodinase 1

decreases activity

Gold Sodium Thiomalate results in decreased activity of DIO1 protein

NCBI chr 1:53,894,187...53,911,086
Ensembl chr 1:53,891,239...53,911,086

G

EGF containing fibulin extracellular matrix protein 1

increases expression

Gold Sodium Thiomalate results in increased expression of EFEMP1 mRNA

NCBI chr 2:55,865,967...55,923,782
Ensembl chr 2:55,865,967...55,924,139

G

ectonucleotide pyrophosphatase/phosphodiesterase 2

increases expression

Gold Sodium Thiomalate results in increased expression of ENPP2 mRNA

NCBI chr 8:119,557,086...119,673,390
Ensembl chr 8:119,557,086...119,673,453

G

ectonucleoside triphosphate diphosphohydrolase 3

increases expression

Gold Sodium Thiomalate results in increased expression of ENTPD3 mRNA

NCBI chr 3:40,387,184...40,428,744
Ensembl chr 3:40,387,184...40,428,744

G

fibrillarin

affects localization
decreases activity
multiple interactions

Gold Sodium Thiomalate affects the localization of FBL protein
Gold Sodium Thiomalate results in decreased activity of FBL protein
CD28 protein affects the reaction [Gold Sodium Thiomalate results in decreased activity of FBL protein]; IFNG protein affects the reaction [Gold Sodium Thiomalate results in decreased activity of FBL protein]; IL4 protein affects the reaction [Gold Sodium Thiomalate results in decreased activity of FBL protein]; IL6 protein affects the reaction [Gold Sodium Thiomalate results in decreased activity of FBL protein]

PMID:10942594 PMID:19077085

NCBI chr19:39,834,458...39,846,379
Ensembl chr19:39,834,458...39,846,379

G

fibulin 1

increases expression

Gold Sodium Thiomalate results in increased expression of FBLN1 mRNA

NCBI chr22:45,502,883...45,601,135
Ensembl chr22:45,502,238...45,601,135

G

fibroblast growth factor 7

increases expression

Gold Sodium Thiomalate results in increased expression of FGF7 mRNA

NCBI chr15:49,423,242...49,488,775
Ensembl chr15:49,423,237...49,488,775

G

guanylate binding protein 1

decreases expression

Gold Sodium Thiomalate results in decreased expression of GBP1 mRNA

NCBI chr 1:89,052,319...89,065,208
Ensembl chr 1:89,051,882...89,065,360

G

glycoprotein M6B

increases expression

Gold Sodium Thiomalate results in increased expression of GPM6B mRNA

NCBI chr X:13,770,939...13,938,638
Ensembl chr X:13,770,939...13,938,638

G

gasdermin E

decreases expression

Gold Sodium Thiomalate results in decreased expression of GSDME mRNA

NCBI chr 7:24,698,355...24,795,539
Ensembl chr 7:24,698,355...24,757,940

G

HECT and RLD domain containing E3 ubiquitin protein ligase 5

decreases expression

Gold Sodium Thiomalate results in decreased expression of HERC5 mRNA

NCBI chr 4:88,457,119...88,506,163
Ensembl chr 4:88,457,119...88,506,163

G

HECT and RLD domain containing E3 ubiquitin protein ligase family member 6

decreases expression

Gold Sodium Thiomalate results in decreased expression of HERC6 mRNA

NCBI chr 4:88,378,852...88,443,097
Ensembl chr 4:88,378,739...88,443,097

G

hypoxia inducible lipid droplet associated

decreases expression

Gold Sodium Thiomalate results in decreased expression of HILPDA mRNA

NCBI chr 7:128,455,878...128,458,418
Ensembl chr 7:128,455,849...128,458,418

G

hydroxysteroid 11-beta dehydrogenase 1

decreases expression

Gold Sodium Thiomalate results in decreased expression of HSD11B1 mRNA

NCBI chr 1:209,686,179...209,734,929
Ensembl chr 1:209,686,178...209,734,949

G

interferon alpha inducible protein 27

decreases expression

Gold Sodium Thiomalate results in decreased expression of IFI27 mRNA

NCBI chr14:94,105,894...94,116,690
Ensembl chr14:94,104,836...94,116,695

G

interferon induced protein 35

decreases expression

Gold Sodium Thiomalate results in decreased expression of IFI35 mRNA

NCBI chr17:43,006,784...43,014,456
Ensembl chr17:43,006,740...43,014,456

G

interferon induced protein 44

decreases expression

Gold Sodium Thiomalate results in decreased expression of IFI44 mRNA

NCBI chr 1:78,649,789...78,664,078
Ensembl chr 1:78,649,796...78,664,078

G

interferon induced protein 44 like

decreases expression

Gold Sodium Thiomalate results in decreased expression of IFI44L mRNA

NCBI chr 1:78,620,448...78,646,145
Ensembl chr 1:78,619,902...78,646,145

G

interferon alpha inducible protein 6

decreases expression

Gold Sodium Thiomalate results in decreased expression of IFI6 mRNA

NCBI chr 1:27,666,064...27,672,192
Ensembl chr 1:27,666,064...27,672,212

G

interferon induced with helicase C domain 1

decreases expression

Gold Sodium Thiomalate results in decreased expression of IFIH1 mRNA

NCBI chr 2:162,267,074...162,318,684
Ensembl chr 2:162,267,074...162,318,684

G

interferon induced protein with tetratricopeptide repeats 1

decreases expression

Gold Sodium Thiomalate results in decreased expression of IFIT1 mRNA

NCBI chr10:89,392,623...89,406,487
Ensembl chr10:89,392,546...89,406,487

G

interferon induced protein with tetratricopeptide repeats 3

decreases expression

Gold Sodium Thiomalate results in decreased expression of IFIT3 mRNA

NCBI chr10:89,327,997...89,340,968
Ensembl chr10:89,327,307...89,377,473

G

interferon gamma

multiple interactions
affects response to substance

IFNG protein affects the reaction [Gold Sodium Thiomalate results in decreased activity of FBL protein]
IFNG protein affects the susceptibility to Gold Sodium Thiomalate

NCBI chr12:68,154,768...68,159,740
Ensembl chr12:68,154,768...68,159,740

G

inhibitor of nuclear factor kappa B kinase subunit beta

multiple interactions

Gold Sodium Thiomalate inhibits the reaction [Lipopolysaccharides results in increased activity of IKBKB protein]

NCBI chr 8:42,271,302...42,332,460
Ensembl chr 8:42,271,302...42,332,460

G

interleukin 10

multiple interactions

[Gold Sodium Thiomalate co-treated with mercury nitrate analog] results in increased expression of IL10 protein

NCBI chr 1:206,767,602...206,772,494
Ensembl chr 1:206,767,602...206,774,541

G

interleukin 1 beta

multiple interactions

Gold Sodium Thiomalate inhibits the reaction [[IL1B protein results in increased expression of NOS2 protein] which results in increased chemical synthesis of Nitric Oxide]; Gold Sodium Thiomalate inhibits the reaction [IL1B protein results in increased expression of PTGES]

PMID:16393772 PMID:25314295

NCBI chr 2:112,829,751...112,836,779
Ensembl chr 2:112,829,751...112,836,816

G

interleukin 1 receptor antagonist

decreases expression

Gold Sodium Thiomalate results in decreased expression of IL1RN mRNA

NCBI chr 2:113,099,360...113,134,014
Ensembl chr 2:113,099,315...113,134,016

G

interleukin 23 subunit alpha

decreases expression

Gold Sodium Thiomalate results in decreased expression of IL23A mRNA

NCBI chr12:56,338,884...56,340,410
Ensembl chr12:56,334,174...56,340,410

G

interleukin 4

multiple interactions
affects response to substance

IL4 protein affects the reaction [Gold Sodium Thiomalate results in decreased activity of FBL protein]
IL4 protein affects the susceptibility to Gold Sodium Thiomalate

NCBI chr 5:132,673,989...132,682,678
Ensembl chr 5:132,673,986...132,682,678

G

interleukin 6

multiple interactions
decreases expression
affects response to substance

[Gold Sodium Thiomalate co-treated with mercury nitrate analog] results in increased expression of IL6 protein
Gold Sodium Thiomalate results in decreased expression of IL6 mRNA; Gold Sodium Thiomalate results in decreased expression of IL6 protein
IL6 protein affects the susceptibility to Gold Sodium Thiomalate
IL6 protein affects the reaction [Gold Sodium Thiomalate results in decreased activity of FBL protein]

PMID:11824965 PMID:19077085 PMID:19192274

NCBI chr 7:22,727,200...22,731,998
Ensembl chr 7:22,725,884...22,732,002

G

interferon regulatory factor 7

decreases expression

Gold Sodium Thiomalate results in decreased expression of IRF7 mRNA

NCBI chr11:612,555...615,950
Ensembl chr11:612,553...615,983

G

ISG15 ubiquitin like modifier

decreases expression

Gold Sodium Thiomalate results in decreased expression of ISG15 mRNA

NCBI chr 1:1,013,497...1,014,540
Ensembl chr 1:1,001,138...1,014,540

G

interferon stimulated exonuclease gene 20

decreases expression

Gold Sodium Thiomalate results in decreased expression of ISG20 mRNA

NCBI chr15:88,635,632...88,656,483
Ensembl chr15:88,635,670...88,656,483

G

laminin subunit beta 3

decreases expression

Gold Sodium Thiomalate results in decreased expression of LAMB3 mRNA

NCBI chr 1:209,614,870...209,652,425
Ensembl chr 1:209,614,870...209,652,425

G

latexin

increases expression

Gold Sodium Thiomalate results in increased expression of LXN mRNA

NCBI chr 3:158,666,414...158,672,648
Ensembl chr 3:158,645,822...158,672,648

G

lymphocyte antigen 6 family member E

decreases expression

Gold Sodium Thiomalate results in decreased expression of LY6E mRNA

NCBI chr 8:143,018,529...143,022,409
Ensembl chr 8:143,017,982...143,023,832

G

myristoylated alanine rich protein kinase C substrate

decreases expression

Gold Sodium Thiomalate results in decreased expression of MARCKS mRNA

NCBI chr 6:113,857,345...113,863,475
Ensembl chr 6:113,857,345...113,863,475

G

MET proto-oncogene, receptor tyrosine kinase

decreases expression

Gold Sodium Thiomalate results in decreased expression of MET mRNA

NCBI chr 7:116,672,196...116,798,377
Ensembl chr 7:116,672,196...116,798,377

G

microRNA 99b

multiple interactions

Gold Sodium Thiomalate inhibits the reaction [Lipopolysaccharides results in increased expression of MIR99B mRNA]

NCBI chr19:51,692,612...51,692,681
Ensembl chr19:51,692,612...51,692,681

G

matrix metallopeptidase 10

decreases expression

Gold Sodium Thiomalate results in decreased expression of MMP10 mRNA

NCBI chr11:102,770,502...102,780,628
Ensembl chr11:102,770,502...102,780,628

G

MX dynamin like GTPase 1

decreases expression

Gold Sodium Thiomalate results in decreased expression of MX1 mRNA

NCBI chr21:41,420,558...41,459,214
Ensembl chr21:41,420,020...41,470,071

G

matrix remodeling associated 5

increases expression

Gold Sodium Thiomalate results in increased expression of MXRA5 mRNA

NCBI chr X:3,308,565...3,346,652
Ensembl chr X:3,308,565...3,346,652

G

NDUFA4 mitochondrial complex associated like 2

decreases expression

Gold Sodium Thiomalate results in decreased expression of NDUFA4L2 mRNA

NCBI chr12:57,234,903...57,240,762
Ensembl chr12:57,234,903...57,240,715

G

neuromedin B

decreases expression

Gold Sodium Thiomalate results in decreased expression of NMB mRNA

NCBI chr15:84,655,132...84,658,199
Ensembl chr15:84,655,129...84,658,563

G

nitric oxide synthase 2

multiple interactions

Gold Sodium Thiomalate inhibits the reaction [[IL1B protein results in increased expression of NOS2 protein] which results in increased chemical synthesis of Nitric Oxide]

NCBI chr17:27,756,766...27,800,529
Ensembl chr17:27,756,766...27,800,529

G

nuclear receptor subfamily 4 group A member 3

decreases expression

Gold Sodium Thiomalate results in decreased expression of NR4A3 mRNA

NCBI chr 9:99,821,885...99,866,891
Ensembl chr 9:99,821,855...99,866,891

G

2'-5'-oligoadenylate synthetase 1

decreases expression

Gold Sodium Thiomalate results in decreased expression of OAS1 mRNA

NCBI chr12:112,906,962...112,933,219
Ensembl chr12:112,905,856...112,933,219

G

2'-5'-oligoadenylate synthetase like

decreases expression

Gold Sodium Thiomalate results in decreased expression of OASL mRNA

NCBI chr12:121,017,761...121,039,246
Ensembl chr12:121,017,763...121,039,246

G

olfactomedin like 2B

increases expression

Gold Sodium Thiomalate results in increased expression of OLFML2B mRNA

NCBI chr 1:161,983,192...162,023,869
Ensembl chr 1:161,983,192...162,023,869

G

phosphoglycerate dehydrogenase

decreases expression

Gold Sodium Thiomalate results in decreased expression of PHGDH mRNA

NCBI chr 1:119,711,934...119,744,215
Ensembl chr 1:119,648,411...119,744,218

G

phospholipid phosphatase 3

decreases expression

Gold Sodium Thiomalate results in decreased expression of PLPP3 mRNA

NCBI chr 1:56,494,761...56,579,563
Ensembl chr 1:56,494,761...56,645,301

G

protein phosphatase 4 regulatory subunit 2

increases expression

Gold Sodium Thiomalate results in increased expression of PPP4R2 mRNA

NCBI chr 3:72,996,743...73,069,198
Ensembl chr 3:72,996,803...73,069,198

G

prostaglandin E synthase

multiple interactions

Gold Sodium Thiomalate inhibits the reaction [IL1B protein results in increased expression of PTGES]

NCBI chr 9:129,738,349...129,753,042
Ensembl chr 9:129,738,331...129,753,042

G

prostaglandin-endoperoxide synthase 2

decreases expression

Gold Sodium Thiomalate results in decreased expression of PTGS2 mRNA

NCBI chr 1:186,671,791...186,680,423
Ensembl chr 1:186,671,791...186,680,922

G

retinoic acid receptor responder 1

increases expression

Gold Sodium Thiomalate results in increased expression of RARRES1 mRNA

NCBI chr 3:158,696,892...158,732,457
Ensembl chr 3:158,696,892...158,732,489

G

RELA proto-oncogene, NF-kB subunit

multiple interactions

Gold Sodium Thiomalate inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of RELA protein]

NCBI chr11:65,653,601...65,663,857
Ensembl chr11:65,653,599...65,663,090

G

regulator of G protein signaling 4

decreases expression

Gold Sodium Thiomalate results in decreased expression of RGS4 mRNA

NCBI chr 1:163,068,871...163,076,802
Ensembl chr 1:163,068,775...163,076,802

G

RNA sensor RIG-I

decreases expression

Gold Sodium Thiomalate results in decreased expression of RIGI mRNA

NCBI chr 9:32,455,302...32,526,196
Ensembl chr 9:32,455,302...32,526,208

G

receptor interacting serine/threonine kinase 2

decreases expression

Gold Sodium Thiomalate results in decreased expression of RIPK2 mRNA

NCBI chr 8:89,757,816...89,791,064
Ensembl chr 8:89,757,806...89,791,064

G

ring finger protein 19B

decreases expression

Gold Sodium Thiomalate results in decreased expression of RNF19B mRNA

NCBI chr 1:32,929,036...32,964,809
Ensembl chr 1:32,936,445...32,964,809

G

radical S-adenosyl methionine domain containing 2

decreases expression

Gold Sodium Thiomalate results in decreased expression of RSAD2 mRNA

NCBI chr 2:6,865,885...6,898,239
Ensembl chr 2:6,865,557...6,898,239

G

solute carrier family 7 member 11

decreases expression

Gold Sodium Thiomalate results in decreased expression of SLC7A11 mRNA

NCBI chr 4:138,164,097...138,312,671
Ensembl chr 4:138,164,097...138,242,349

G

spermine synthase

decreases expression

Gold Sodium Thiomalate results in decreased expression of SMS mRNA

NCBI chr X:21,940,709...21,994,837
Ensembl chr X:21,940,709...21,994,837

G

superoxide dismutase 2

decreases expression

Gold Sodium Thiomalate results in decreased expression of SOD2 mRNA

NCBI chr 6:159,669,069...159,762,281
Ensembl chr 6:159,669,069...159,762,529

G

spondin 1

increases expression

Gold Sodium Thiomalate results in increased expression of SPON1 mRNA

NCBI chr11:13,962,723...14,268,133
Ensembl chr11:13,962,723...14,268,133

G

signal transducer and activator of transcription 1

decreases expression

Gold Sodium Thiomalate results in decreased expression of STAT1 mRNA

NCBI chr 2:190,969,149...191,014,171
Ensembl chr 2:190,908,460...191,020,960

G

steroid sulfatase

increases expression

Gold Sodium Thiomalate results in increased expression of STS mRNA

NCBI chr X:7,147,290...7,354,641
Ensembl chr X:7,147,237...7,804,358

G

thrombospondin 1

increases expression

Gold Sodium Thiomalate results in increased expression of THBS1 mRNA

NCBI chr15:39,581,079...39,599,466
Ensembl chr15:39,581,079...39,599,466

G

thrombospondin 2

increases expression

Gold Sodium Thiomalate results in increased expression of THBS2 mRNA

NCBI chr 6:169,215,785...169,253,846
Ensembl chr 6:169,215,780...169,254,050

G

toll like receptor 2

decreases expression

Gold Sodium Thiomalate results in decreased expression of TLR2 mRNA

NCBI chr 4:153,684,280...153,710,637
Ensembl chr 4:153,684,070...153,706,260

G

TNF alpha induced protein 2

decreases expression

Gold Sodium Thiomalate results in decreased expression of TNFAIP2 mRNA

NCBI chr14:103,121,469...103,137,439
Ensembl chr14:103,121,476...103,137,439

G

thioredoxin interacting protein

increases expression

Gold Sodium Thiomalate results in increased expression of TXNIP mRNA

NCBI chr 1:145,992,435...145,996,579
Ensembl chr 1:145,992,435...145,996,579

G

thioredoxin reductase 1

multiple interactions
decreases activity

Gold Sodium Thiomalate inhibits the reaction [TXNRD1 protein affects the metabolism of Dithionitrobenzoic Acid]
Gold Sodium Thiomalate results in decreased activity of TXNRD1 protein

PMID:16510263 PMID:17229725

NCBI chr12:104,215,779...104,350,307
Ensembl chr12:104,215,779...104,350,307

G

thioredoxin reductase 2

decreases activity

Gold Sodium Thiomalate results in decreased activity of TXNRD2 protein

NCBI chr22:19,875,522...19,941,818
Ensembl chr22:19,875,517...19,941,820

sodium benzoate

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

acetylcholinesterase (Yt blood group)

multiple interactions
increases activity

Ascorbic Acid inhibits the reaction [Sodium Benzoate results in increased activity of ACHE protein]

NCBI chr 7:100,889,994...100,896,994
Ensembl chr 7:100,889,994...100,896,974

G

aryl hydrocarbon receptor

multiple interactions

Sodium Benzoate inhibits the reaction [[DAO protein results in increased activity of AHR protein] which results in increased expression of CYP1A1 mRNA]

NCBI chr 7:17,298,652...17,346,147
Ensembl chr 7:16,916,359...17,346,152

G

calcium/calmodulin dependent protein kinase II alpha

multiple interactions

Sodium Benzoate promotes the reaction [Cocaine results in increased phosphorylation of and results in increased activity of CAMK2A protein]

NCBI chr 5:150,219,491...150,290,130
Ensembl chr 5:150,219,491...150,290,093

G

caspase 3

multiple interactions
increases expression
increases activity

Sodium Benzoate inhibits the reaction [Asbestos, Amosite results in increased activity of CASP3 protein]
Sodium Benzoate results in increased expression of CASP3 protein
Ascorbic Acid inhibits the reaction [Sodium Benzoate results in increased expression of CASP3 protein]
Sodium Benzoate results in increased activity of CASP3 protein

PMID:11329530 PMID:32911041 PMID:35187746

NCBI chr 4:184,627,696...184,649,447
Ensembl chr 4:184,627,696...184,650,062

G

caspase 9

multiple interactions

Sodium Benzoate inhibits the reaction [Asbestos, Amosite results in increased activity of CASP9 protein]

NCBI chr 1:15,491,401...15,524,912
Ensembl chr 1:15,490,832...15,526,534

G

catalase

decreases activity
multiple interactions

Sodium Benzoate results in decreased activity of CAT protein
Ascorbic Acid inhibits the reaction [Sodium Benzoate results in decreased activity of CAT protein]

PMID:32911041 PMID:35187746

NCBI chr11:34,438,934...34,472,060
Ensembl chr11:34,438,934...34,472,060

G

cytochrome P450 family 1 subfamily A member 1

multiple interactions

Sodium Benzoate inhibits the reaction [[DAO protein results in increased activity of AHR protein] which results in increased expression of CYP1A1 mRNA]

NCBI chr15:74,719,542...74,725,528
Ensembl chr15:74,719,542...74,725,536

G

D-amino acid oxidase

multiple interactions
decreases activity

Sodium Benzoate inhibits the reaction [[DAO protein results in increased activity of AHR protein] which results in increased expression of CYP1A1 mRNA]
Sodium Benzoate results in decreased activity of DAO protein

PMID:19860415 PMID:20952482

NCBI chr12:108,880,092...108,901,043
Ensembl chr12:108,858,932...108,901,043

G

estrogen receptor 1

decreases activity

Sodium Benzoate results in decreased activity of ESR1 protein

NCBI chr 6:151,656,672...152,129,619
Ensembl chr 6:151,656,691...152,129,619

G

follicle stimulating hormone subunit beta

increases expression

Sodium Benzoate results in increased expression of FSHB protein

NCBI chr11:30,231,014...30,235,194
Ensembl chr11:30,231,014...30,235,261

G

interferon gamma

multiple interactions

Sodium Benzoate inhibits the reaction [Lipopolysaccharides results in increased secretion of IFNG protein]
[Food Preservatives results in increased abundance of Sodium Benzoate] which results in increased expression of IFNG mRNA

PMID:26706697 PMID:32179172

NCBI chr12:68,154,768...68,159,740
Ensembl chr12:68,154,768...68,159,740

G

interleukin 10

multiple interactions

[Food Preservatives results in increased abundance of Sodium Benzoate] which results in increased expression of IL10 mRNA

NCBI chr 1:206,767,602...206,772,494
Ensembl chr 1:206,767,602...206,774,541

G

interleukin 1 beta

multiple interactions

[Food Preservatives results in increased abundance of Sodium Benzoate] which results in increased expression of IL1B mRNA

NCBI chr 2:112,829,751...112,836,779
Ensembl chr 2:112,829,751...112,836,816

G

interleukin 6

multiple interactions
increases expression

Sodium Benzoate inhibits the reaction [Lipopolysaccharides results in increased secretion of IL6 protein]
[Food Preservatives results in increased abundance of Sodium Benzoate] which results in increased expression of IL6 mRNA
Sodium Benzoate results in increased expression of IL6 protein

PMID:26706697 PMID:32179172 PMID:32911041

NCBI chr 7:22,727,200...22,731,998
Ensembl chr 7:22,725,884...22,732,002

G

luteinizing hormone subunit beta

increases expression

Sodium Benzoate results in increased expression of LHB protein

NCBI chr19:49,015,980...49,019,498
Ensembl chr19:49,015,980...49,017,091

G

macrophage scavenger receptor 1

multiple interactions

Sodium Benzoate inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of MSR1 mRNA alternative form]; Sodium Benzoate inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of MSR1 mRNA]

NCBI chr 8:16,107,881...16,192,651
Ensembl chr 8:16,107,878...16,567,490

G

ornithine transcarbamylase

multiple interactions

Sodium Benzoate affects the reaction [OTC gene mutant form affects the abundance of Hydroxyindoleacetic Acid]; Sodium Benzoate affects the reaction [OTC gene mutant form affects the metabolism of Glycine]; Sodium Benzoate affects the reaction [OTC gene mutant form affects the metabolism of Serotonin]; Sodium Benzoate affects the reaction [OTC gene mutant form results in increased abundance of Ammonium Compounds]

PMID:3091026 PMID:3374991

NCBI chr X:38,327,684...38,422,928
Ensembl chr X:38,352,586...38,421,446

G

transcription factor A, mitochondrial

increases expression

Sodium Benzoate results in increased expression of TFAM protein

NCBI chr10:58,385,410...58,399,220
Ensembl chr10:58,385,345...58,399,220

G

tumor necrosis factor

multiple interactions
increases expression

Sodium Benzoate inhibits the reaction [Lipopolysaccharides results in increased secretion of TNF protein]
[Food Preservatives results in increased abundance of Sodium Benzoate] which results in increased expression of TNF mRNA; Ascorbic Acid inhibits the reaction [Sodium Benzoate results in increased expression of TNF protein]

PMID:26706697 PMID:32179172 PMID:32911041 PMID:35187746

NCBI chr 6:31,575,565...31,578,336
Ensembl chr 6:31,575,565...31,578,336

G

tumor protein p53

multiple interactions
increases expression

Sodium Benzoate inhibits the reaction [Asbestos, Amosite results in increased expression of TP53 mRNA]
Sodium Benzoate results in increased expression of TP53 protein

PMID:16357363 PMID:32911041

NCBI chr17:7,668,421...7,687,490
Ensembl chr17:7,661,779...7,687,538

G

uncoupling protein 2

increases expression

Sodium Benzoate results in increased expression of UCP2 protein

NCBI chr11:73,974,672...73,983,202
Ensembl chr11:73,974,672...73,982,843

G

xanthine dehydrogenase

increases activity

Sodium Benzoate results in increased activity of XDH protein

NCBI chr 2:31,334,321...31,414,742
Ensembl chr 2:31,334,321...31,414,742

sodium cholate

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

albumin

multiple interactions

[cocoa butter co-treated with Sodium Cholate co-treated with Cholesterol] results in increased expression of ALB protein

NCBI chr 4:73,404,287...73,421,482
Ensembl chr 4:73,397,114...73,421,482

G

alkaline phosphatase, biomineralization associated

multiple interactions

[Cholesterol, Dietary co-treated with Sodium Cholate] results in increased secretion of ALPL protein; MET gene mutant form promotes the reaction [[Cholesterol, Dietary co-treated with Sodium Cholate] results in increased secretion of ALPL protein]

NCBI chr 1:21,508,984...21,578,410
Ensembl chr 1:21,509,397...21,578,410

G

BCL2 associated X, apoptosis regulator

multiple interactions

[Cholesterol, Dietary co-treated with Sodium Cholate] results in increased expression of BAX protein

NCBI chr19:48,954,875...48,961,798
Ensembl chr19:48,954,815...48,961,798

G

BCL2 apoptosis regulator

multiple interactions

[Cholesterol, Dietary co-treated with Sodium Cholate] results in decreased expression of BCL2 protein

NCBI chr18:63,123,346...63,320,090
Ensembl chr18:63,123,346...63,320,128

G

caspase 3

multiple interactions

[Cholesterol, Dietary co-treated with Sodium Cholate] results in increased cleavage of CASP3 protein; MET gene mutant form promotes the reaction [[Cholesterol, Dietary co-treated with Sodium Cholate] results in increased cleavage of CASP3 protein]

NCBI chr 4:184,627,696...184,649,447
Ensembl chr 4:184,627,696...184,650,062

G

C-C motif chemokine ligand 2

multiple interactions

[eicosapentaenoic acid ethyl ester co-treated with Sodium Cholate co-treated with Dietary Fats] results in increased expression of CCL2 mRNA
[cocoa butter co-treated with Sodium Cholate co-treated with Cholesterol] results in increased expression of CCL2 mRNA

PMID:23665937 PMID:26606054

NCBI chr17:34,255,285...34,257,203
Ensembl chr17:34,255,274...34,257,208

G

C-C motif chemokine ligand 5

multiple interactions

[eicosapentaenoic acid ethyl ester co-treated with Sodium Cholate co-treated with Dietary Fats] results in increased expression of CCL5 mRNA

NCBI chr17:35,871,491...35,880,360
Ensembl chr17:35,871,491...35,880,793

G

cyclin D1

multiple interactions

[Cholesterol, Dietary co-treated with Sodium Cholate] results in increased expression of CCND1 protein; MET gene mutant form inhibits the reaction [[Cholesterol, Dietary co-treated with Sodium Cholate] results in increased expression of CCND1 protein]

NCBI chr11:69,641,156...69,654,474
Ensembl chr11:69,641,156...69,654,474

G

carboxylesterase 1

increases expression

Sodium Cholate results in increased expression of CES1 mRNA

NCBI chr16:55,802,851...55,833,096
Ensembl chr16:55,802,851...55,833,337

G

cystatin C

multiple interactions

[cocoa butter co-treated with Sodium Cholate co-treated with Cholesterol] results in increased expression of CST3 protein

NCBI chr20:23,626,706...23,637,955
Ensembl chr20:23,626,706...23,638,473

G

cytochrome b-245 beta chain

multiple interactions

[cocoa butter co-treated with Sodium Cholate co-treated with Cholesterol] results in increased expression of CYBB mRNA

NCBI chr X:37,780,059...37,813,461
Ensembl chr X:37,780,018...37,813,461

G

cytochrome P450 family 3 subfamily A member 4

multiple interactions

[1,2-dilauroylphosphatidylcholine co-treated with 1,2-oleoylphosphatidylcholine co-treated with Phosphatidylserines co-treated with Sodium Cholate] results in increased activity of CYP3A4 protein
[1,2-dilauroylphosphatidylcholine co-treated with 1,2-oleoylphosphatidylcholine co-treated with Phosphatidylserines co-treated with Sodium Cholate] results in increased activity of CYP3A2 protein

NCBI chr 7:99,756,967...99,784,184
Ensembl chr 7:99,756,960...99,784,248

G

cytochrome P450 family 7 subfamily A member 1

multiple interactions

[Sodium Cholate co-treated with Dietary Fats] results in decreased expression of CYP7A1 mRNA

NCBI chr 8:58,490,178...58,500,163
Ensembl chr 8:58,490,178...58,500,163

G

fatty acid binding protein 1

multiple interactions

[cocoa butter co-treated with Sodium Cholate co-treated with Cholesterol] results in increased expression of FABP1 protein

NCBI chr 2:88,122,982...88,128,062
Ensembl chr 2:88,122,982...88,128,062

G

glutamate-cysteine ligase catalytic subunit

multiple interactions

[Cholesterol, Dietary co-treated with Sodium Cholate] results in increased expression of GCLC protein; MET gene mutant form inhibits the reaction [[Cholesterol, Dietary co-treated with Sodium Cholate] results in increased expression of GCLC protein]

NCBI chr 6:53,497,341...53,545,101
Ensembl chr 6:53,497,341...53,616,970

G

glutathione peroxidase 2

multiple interactions

[cocoa butter co-treated with Sodium Cholate co-treated with Cholesterol] results in increased expression of GPX2 mRNA

NCBI chr14:64,939,158...64,942,745
Ensembl chr14:64,939,152...64,942,746

G

hepatitis A virus cellular receptor 1

multiple interactions

[cocoa butter co-treated with Sodium Cholate co-treated with Cholesterol] results in increased expression of HAVCR1 mRNA

NCBI chr 5:157,029,413...157,069,407
Ensembl chr 5:157,026,742...157,069,396

G

hypoxia inducible factor 1 subunit alpha

multiple interactions

[cocoa butter co-treated with Sodium Cholate co-treated with Cholesterol] results in increased expression of HIF1A mRNA

NCBI chr14:61,695,513...61,748,258
Ensembl chr14:61,695,513...61,748,259

G

3-hydroxy-3-methylglutaryl-CoA reductase

multiple interactions

[Sodium Cholate co-treated with Dietary Fats] results in decreased expression of HMGCR mRNA

NCBI chr 5:75,336,529...75,362,116
Ensembl chr 5:75,336,329...75,364,001

G

heme oxygenase 1

multiple interactions

[cocoa butter co-treated with Sodium Cholate co-treated with Cholesterol] results in increased expression of HMOX1 mRNA

NCBI chr22:35,381,096...35,394,207
Ensembl chr22:35,380,361...35,394,214

G

intercellular adhesion molecule 1

multiple interactions

[eicosapentaenoic acid ethyl ester co-treated with Sodium Cholate co-treated with Dietary Fats] results in increased expression of ICAM1 mRNA

NCBI chr19:10,271,120...10,286,615
Ensembl chr19:10,271,093...10,286,615

G

interleukin 1 beta

multiple interactions

[eicosapentaenoic acid ethyl ester co-treated with Sodium Cholate co-treated with Dietary Fats] results in increased expression of IL1B mRNA
[cocoa butter co-treated with Sodium Cholate co-treated with Cholesterol] results in increased expression of IL1B mRNA

PMID:23665937 PMID:26606054

NCBI chr 2:112,829,751...112,836,779
Ensembl chr 2:112,829,751...112,836,816

G

mitogen-activated protein kinase 1

multiple interactions

[Cholesterol, Dietary co-treated with Sodium Cholate] results in increased phosphorylation of MAPK1 protein; MET gene mutant form inhibits the reaction [[Cholesterol, Dietary co-treated with Sodium Cholate] results in increased phosphorylation of MAPK1 protein]

NCBI chr22:21,759,657...21,867,680
Ensembl chr22:21,759,657...21,867,680

G

mitogen-activated protein kinase 3

multiple interactions

[Cholesterol, Dietary co-treated with Sodium Cholate] results in increased phosphorylation of MAPK3 protein; MET gene mutant form inhibits the reaction [[Cholesterol, Dietary co-treated with Sodium Cholate] results in increased phosphorylation of MAPK3 protein]

NCBI chr16:30,114,105...30,123,220
Ensembl chr16:30,114,105...30,123,506

G

MET proto-oncogene, receptor tyrosine kinase

multiple interactions

MET gene mutant form affects the susceptibility to [Cholesterol, Dietary co-treated with Sodium Cholate]; MET gene mutant form inhibits the reaction [[Cholesterol, Dietary co-treated with Sodium Cholate] results in decreased expression of TRP53 protein]; MET gene mutant form inhibits the reaction [[Cholesterol, Dietary co-treated with Sodium Cholate] results in increased expression of CCND1 protein]; MET gene mutant form inhibits the reaction [[Cholesterol, Dietary co-treated with Sodium Cholate] results in increased expression of GCLC protein]; MET gene mutant form inhibits the reaction [[Cholesterol, Dietary co-treated with Sodium Cholate] results in increased expression of NFE2L2 protein]; MET gene mutant form inhibits the reaction [[Cholesterol, Dietary co-treated with Sodium Cholate] results in increased expression of NR1I3 protein]; MET gene mutant form inhibits the reaction [[Cholesterol, Dietary co-treated with Sodium Cholate] results in increased expression of RARA protein]; MET gene mutant form inhibits the reaction [[Cholesterol, Dietary co-treated with Sodium Cholate] results in increased phosphorylation of MAPK1 protein]; MET gene mutant form inhibits the reaction [[Cholesterol, Dietary co-treated with Sodium Cholate] results in increased phosphorylation of MAPK3 protein]; MET gene mutant form promotes the reaction [[[Cholesterol, Dietary co-treated with Sodium Cholate] results in increased oxidation of Lipids] which results in increased abundance of Thiobarbituric Acid Reactive Substances]; MET gene mutant form promotes the reaction [[Cholesterol, Dietary co-treated with Sodium Cholate] results in decreased expression of PPARA protein]; MET gene mutant form promotes the reaction [[Cholesterol, Dietary co-treated with Sodium Cholate] results in increased abundance of Triglycerides]; MET gene mutant form promotes the reaction [[Cholesterol, Dietary co-treated with Sodium Cholate] results in increased cleavage of CASP3 protein]; MET gene mutant form promotes the reaction [[Cholesterol, Dietary co-treated with Sodium Cholate] results in increased cleavage of SREBF1 protein]; MET gene mutant form promotes the reaction [[Cholesterol, Dietary co-treated with Sodium Cholate] results in increased expression of NR1H3 protein]; MET gene mutant form promotes the reaction [[Cholesterol, Dietary co-treated with Sodium Cholate] results in increased oxidation of Glutathione]; MET gene mutant form promotes the reaction [[Cholesterol, Dietary co-treated with Sodium Cholate] results in increased secretion of ALPL protein]; MET gene mutant form promotes the reaction [[Cholesterol, Dietary co-treated with Sodium Cholate] results in increased secretion of Bile Acids and Salts]; MET gene mutant form promotes the reaction [[Cholesterol, Dietary co-treated with Sodium Cholate] results in increased uptake of and results in increased oxidation of Lipids]

NCBI chr 7:116,672,196...116,798,377
Ensembl chr 7:116,672,196...116,798,377

G

N-acetyl-alpha-glucosaminidase

multiple interactions

[cocoa butter co-treated with Sodium Cholate co-treated with Cholesterol] results in increased expression of NAGLU protein

NCBI chr17:42,536,241...42,544,449
Ensembl chr17:42,536,241...42,544,449

G

NFE2 like bZIP transcription factor 2

multiple interactions

[Cholesterol, Dietary co-treated with Sodium Cholate] results in increased expression of NFE2L2 protein; MET gene mutant form inhibits the reaction [[Cholesterol, Dietary co-treated with Sodium Cholate] results in increased expression of NFE2L2 protein]

NCBI chr 2:177,230,303...177,264,727
Ensembl chr 2:177,218,667...177,392,756

G

nuclear receptor subfamily 1 group H member 3

multiple interactions

[Cholesterol, Dietary co-treated with Sodium Cholate] results in increased expression of NR1H3 protein; MET gene mutant form promotes the reaction [[Cholesterol, Dietary co-treated with Sodium Cholate] results in increased expression of NR1H3 protein]

NCBI chr11:47,248,300...47,269,033
Ensembl chr11:47,248,300...47,269,033

G

nuclear receptor subfamily 1 group I member 3

multiple interactions

[Cholesterol, Dietary co-treated with Sodium Cholate] results in increased expression of NR1I3 protein; MET gene mutant form inhibits the reaction [[Cholesterol, Dietary co-treated with Sodium Cholate] results in increased expression of NR1I3 protein]

NCBI chr 1:161,229,669...161,238,203
Ensembl chr 1:161,229,666...161,238,244

G

peroxisome proliferator activated receptor alpha

multiple interactions

[Cholesterol, Dietary co-treated with Sodium Cholate] results in decreased expression of PPARA protein; MET gene mutant form promotes the reaction [[Cholesterol, Dietary co-treated with Sodium Cholate] results in decreased expression of PPARA protein]

NCBI chr22:46,150,526...46,243,756
Ensembl chr22:46,150,521...46,243,755

G

retinoic acid receptor alpha

multiple interactions

[Cholesterol, Dietary co-treated with Sodium Cholate] results in increased expression of RARA protein; MET gene mutant form inhibits the reaction [[Cholesterol, Dietary co-treated with Sodium Cholate] results in increased expression of RARA protein]

NCBI chr17:40,309,180...40,357,643
Ensembl chr17:40,309,180...40,357,643

G

S100 calcium binding protein A8

multiple interactions

[cocoa butter co-treated with Sodium Cholate co-treated with Cholesterol] results in increased expression of S100A8 mRNA

NCBI chr 1:153,390,032...153,422,583
Ensembl chr 1:153,390,032...153,391,073

G

serum amyloid A3, pseudogene

multiple interactions

[eicosapentaenoic acid ethyl ester co-treated with Sodium Cholate co-treated with Dietary Fats] results in increased expression of SAA3 mRNA

NCBI chr11:18,112,472...18,116,132
Ensembl chr11:18,112,472...18,116,132
Ensembl chr11:18,112,472...18,116,132

G

sterol O-acyltransferase 2

multiple interactions

[Sodium Cholate co-treated with Dietary Fats] results in increased expression of SOAT2 mRNA; eicosapentaenoic acid ethyl ester inhibits the reaction [[Sodium Cholate co-treated with Dietary Fats] results in increased expression of SOAT2 mRNA]

NCBI chr12:53,103,486...53,124,535
Ensembl chr12:53,103,486...53,124,535

G

superoxide dismutase 2

multiple interactions

[Sodium Cholate co-treated with Deoxycholic Acid co-treated with Glycocholic Acid co-treated with Taurocholic Acid] results in decreased expression of and results in decreased activity of SOD2 protein; [Sodium Cholate co-treated with Deoxycholic Acid co-treated with Glycocholic Acid co-treated with Taurocholic Acid] results in increased expression of and results in decreased activity of SOD2 protein; Curcumin analog inhibits the reaction [[Sodium Cholate co-treated with Deoxycholic Acid co-treated with Glycocholic Acid co-treated with Taurocholic Acid] results in decreased expression of and results in decreased activity of SOD2 protein]; Curcumin analog inhibits the reaction [[Sodium Cholate co-treated with Deoxycholic Acid co-treated with Glycocholic Acid co-treated with Taurocholic Acid] results in increased expression of and results in decreased activity of SOD2 protein]; Curcumin analog promotes the reaction [[Sodium Cholate co-treated with Deoxycholic Acid co-treated with Glycocholic Acid co-treated with Taurocholic Acid] results in increased expression of SOD2 protein]; manganese(III)-tetrakis(4-benzoic acid)porphyrin inhibits the reaction [[Sodium Cholate co-treated with Deoxycholic Acid co-treated with Glycocholic Acid co-treated with Taurocholic Acid] results in decreased expression of and results in decreased activity of SOD2 protein]; manganese(III)-tetrakis(4-benzoic acid)porphyrin promotes the reaction [[Sodium Cholate co-treated with Deoxycholic Acid co-treated with Glycocholic Acid co-treated with Taurocholic Acid] results in increased expression of SOD2 protein]; Plant Extracts inhibits the reaction [[Sodium Cholate co-treated with Deoxycholic Acid co-treated with Glycocholic Acid co-treated with Taurocholic Acid] results in decreased expression of and results in decreased activity of SOD2 protein]; Plant Extracts inhibits the reaction [[Sodium Cholate co-treated with Deoxycholic Acid co-treated with Glycocholic Acid co-treated with Taurocholic Acid] results in increased expression of and results in decreased activity of SOD2 protein]

NCBI chr 6:159,669,069...159,762,281
Ensembl chr 6:159,669,069...159,762,529

G

sperm microtubule inner protein 11

multiple interactions

[cocoa butter co-treated with Sodium Cholate co-treated with Cholesterol] results in decreased expression of NPHS1 mRNA

NCBI chr12:48,727,435...48,771,459
Ensembl chr12:48,727,435...48,765,790

G

sterol regulatory element binding transcription factor 1

multiple interactions

[Cholesterol, Dietary co-treated with Sodium Cholate] results in increased cleavage of SREBF1 protein; MET gene mutant form promotes the reaction [[Cholesterol, Dietary co-treated with Sodium Cholate] results in increased cleavage of SREBF1 protein]

NCBI chr17:17,811,334...17,836,986
Ensembl chr17:17,810,399...17,837,002

G

transforming growth factor beta 1

multiple interactions

[cocoa butter co-treated with Sodium Cholate co-treated with Cholesterol] results in increased expression of TGFB1 mRNA

NCBI chr19:41,330,323...41,353,922
Ensembl chr19:41,301,587...41,353,922

G

toll like receptor 4

multiple interactions

[cocoa butter co-treated with Sodium Cholate co-treated with Cholesterol] results in increased expression of TLR4 mRNA

NCBI chr 9:117,704,403...117,724,735
Ensembl chr 9:117,704,175...117,724,735

G

tumor necrosis factor

multiple interactions

[cocoa butter co-treated with Sodium Cholate co-treated with Cholesterol] results in increased expression of TNF mRNA

NCBI chr 6:31,575,565...31,578,336
Ensembl chr 6:31,575,565...31,578,336

G

tumor protein p53

multiple interactions

[Cholesterol, Dietary co-treated with Sodium Cholate] results in decreased expression of TRP53 protein; MET gene mutant form inhibits the reaction [[Cholesterol, Dietary co-treated with Sodium Cholate] results in decreased expression of TRP53 protein]

NCBI chr17:7,668,421...7,687,490
Ensembl chr17:7,661,779...7,687,538

G

vascular cell adhesion molecule 1

multiple interactions

[cocoa butter co-treated with Sodium Cholate co-treated with Cholesterol] results in increased expression of VCAM1 mRNA

NCBI chr 1:100,719,742...100,739,045
Ensembl chr 1:100,719,742...100,739,045

sodium citrate

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

ATP binding cassette subfamily G member 8

decreases expression

sodium citrate results in decreased expression of ABCG8 mRNA

NCBI chr 2:43,838,971...43,882,988
Ensembl chr 2:43,831,942...43,882,988

sodium dodecyl sulfate

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

arylacetamide deacetylase like 2

decreases expression

Sodium Dodecyl Sulfate results in decreased expression of AADACL2 mRNA

NCBI chr 3:151,733,927...151,761,339
Ensembl chr 3:151,733,916...151,761,339

G

ATP binding cassette subfamily A member 12

increases expression

Sodium Dodecyl Sulfate results in increased expression of ABCA12 mRNA

NCBI chr 2:214,931,542...215,138,626
Ensembl chr 2:214,931,542...215,138,626

G

ATP binding cassette subfamily A member 6

decreases expression

Sodium Dodecyl Sulfate results in decreased expression of ABCA6 mRNA

NCBI chr17:69,078,702...69,141,895
Ensembl chr17:69,078,702...69,141,895

G

ATP binding cassette subfamily B member 6 (LAN blood group)

decreases expression

Sodium Dodecyl Sulfate results in decreased expression of ABCB6 mRNA

NCBI chr 2:219,209,772...219,218,958
Ensembl chr 2:219,209,772...219,218,994

G

ATP binding cassette subfamily C member 1 (ABCC1 blood group)

multiple interactions

Sodium Dodecyl Sulfate inhibits the reaction [ABCC1 protein results in increased export of 2',7'-bis-(carboxypropyl)-5(6)-carboxyfluorescein]

NCBI chr16:15,949,143...16,143,053
Ensembl chr16:15,949,138...16,143,257

G

ATP binding cassette subfamily C member 2

increases expression

Sodium Dodecyl Sulfate results in increased expression of ABCC2 mRNA

NCBI chr10:99,782,640...99,852,594
Ensembl chr10:99,782,640...99,852,594

G

ATP binding cassette subfamily C member 3

increases expression

Sodium Dodecyl Sulfate results in increased expression of ABCC3 mRNA

NCBI chr17:50,634,881...50,692,253
Ensembl chr17:50,634,777...50,692,253

G

acetyl-CoA carboxylase beta

affects response to substance

ACACB SNP affects the susceptibility to Sodium Dodecyl Sulfate

NCBI chr12:109,111,189...109,268,226
Ensembl chr12:109,116,587...109,268,226

G

atypical chemokine receptor 3

decreases expression

Sodium Dodecyl Sulfate results in decreased expression of ACKR3 mRNA

NCBI chr 2:236,537,122...236,582,354
Ensembl chr 2:236,567,787...236,582,354

G

ADAM metallopeptidase with thrombospondin type 1 motif 3

increases expression

Sodium Dodecyl Sulfate results in increased expression of ADAMTS3 mRNA

NCBI chr 4:72,280,969...72,569,221
Ensembl chr 4:72,280,969...72,569,221

G

ArfGAP with dual PH domains 2

decreases expression

Sodium Dodecyl Sulfate results in decreased expression of ADAP2 mRNA

NCBI chr17:30,921,945...30,959,322
Ensembl chr17:30,906,344...30,959,322

G

adhesion G protein-coupled receptor E5

increases expression

Sodium Dodecyl Sulfate results in increased expression of ADGRE5 mRNA

NCBI chr19:14,381,444...14,408,723
Ensembl chr19:14,380,501...14,408,725

G

adhesion G protein-coupled receptor G2

increases expression

Sodium Dodecyl Sulfate results in increased expression of ADGRG2 mRNA

NCBI chr X:18,989,307...19,122,956
Ensembl chr X:18,989,307...19,122,637

G

adrenoceptor beta 2

decreases expression

Sodium Dodecyl Sulfate results in decreased expression of ADRB2 mRNA

NCBI chr 5:148,826,611...148,828,623
Ensembl chr 5:148,826,611...148,828,623

G

adenylosuccinate synthase 2

decreases expression

Sodium Dodecyl Sulfate results in decreased expression of ADSS2 mRNA

NCBI chr 1:244,408,494...244,452,060
Ensembl chr 1:244,408,494...244,451,909

G

aryl hydrocarbon receptor

decreases expression

Sodium Dodecyl Sulfate results in decreased expression of AHR mRNA

NCBI chr 7:17,298,652...17,346,147
Ensembl chr 7:16,916,359...17,346,152

G

allograft inflammatory factor 1

affects response to substance

AIF1 SNP affects the susceptibility to Sodium Dodecyl Sulfate

NCBI chr 6:31,615,234...31,617,015
Ensembl chr 6:31,615,217...31,617,021

G

adenylate kinase 8

increases expression

Sodium Dodecyl Sulfate results in increased expression of AK8 mRNA

NCBI chr 9:132,725,578...132,879,046
Ensembl chr 9:132,725,578...132,878,777

G

aldo-keto reductase family 1 member B

increases expression

Sodium Dodecyl Sulfate results in increased expression of AKR1B1 mRNA

NCBI chr 7:134,442,350...134,459,239
Ensembl chr 7:134,442,356...134,459,284

G

aldo-keto reductase family 1 member B10

increases expression

Sodium Dodecyl Sulfate results in increased expression of AKR1B10 mRNA

PMID:20566472 PMID:30806763

NCBI chr 7:134,527,567...134,541,412
Ensembl chr 7:134,527,567...134,541,412

G

aldo-keto reductase family 1 member C1

increases expression

Sodium Dodecyl Sulfate results in increased expression of AKR1C1 mRNA

NCBI chr10:4,963,415...4,983,283
Ensembl chr10:4,963,253...4,983,283

G

aldo-keto reductase family 1 member C2

increases expression

Sodium Dodecyl Sulfate results in increased expression of AKR1C2 mRNA

NCBI chr10:4,987,775...5,018,000
Ensembl chr10:4,987,775...5,018,031

G

aldo-keto reductase family 1 member C3

increases expression
decreases expression

Sodium Dodecyl Sulfate results in increased expression of AKR1C3 mRNA
Sodium Dodecyl Sulfate results in decreased expression of AKR1C3 mRNA
Sodium Dodecyl Sulfate results in decreased expression of AKR1C18 mRNA

PMID:12815608 PMID:20566472 PMID:31734321

NCBI chr10:5,048,781...5,107,686
Ensembl chr10:5,035,354...5,107,686

G

AKT serine/threonine kinase 1

increases phosphorylation

Sodium Dodecyl Sulfate results in increased phosphorylation of AKT1 protein

NCBI chr14:104,769,349...104,795,748
Ensembl chr14:104,769,349...104,795,751

G

aldehyde dehydrogenase 3 family member B2

decreases expression

Sodium Dodecyl Sulfate results in decreased expression of ALDH3B2 mRNA

NCBI chr11:67,662,155...67,681,252
Ensembl chr11:67,662,155...67,681,224

G

arachidonate 5-lipoxygenase activating protein

increases expression

Sodium Dodecyl Sulfate results in increased expression of ALOX5AP mRNA

NCBI chr13:30,713,485...30,764,426
Ensembl chr13:30,713,478...30,764,426

G

angiopoietin like 4

increases expression

Sodium Dodecyl Sulfate results in increased expression of ANGPTL4 mRNA

NCBI chr19:8,364,155...8,374,370
Ensembl chr19:8,363,289...8,374,370

G

ankyrin repeat domain containing 50

decreases expression

Sodium Dodecyl Sulfate results in decreased expression of ANKRD50 mRNA

NCBI chr 4:124,664,048...124,712,732
Ensembl chr 4:124,664,048...124,712,732

G

adaptor related protein complex 4 subunit sigma 1

decreases expression

Sodium Dodecyl Sulfate results in decreased expression of AP4S1 mRNA

NCBI chr14:31,025,106...31,096,450
Ensembl chr14:31,025,106...31,130,996

G

apolipoprotein B mRNA editing enzyme catalytic subunit 3B

increases expression

Sodium Dodecyl Sulfate results in increased expression of APOBEC3B mRNA

NCBI chr22:38,982,347...38,992,779
Ensembl chr22:38,982,347...38,992,804

G

amphiregulin

increases secretion

Sodium Dodecyl Sulfate results in increased secretion of AREG protein

NCBI chr 4:74,445,136...74,455,005
Ensembl chr 4:74,445,136...74,455,005

G

ADP ribosylation factor GTPase activating protein 2

decreases expression

Sodium Dodecyl Sulfate results in decreased expression of ARFGAP2 mRNA

NCBI chr11:47,164,301...47,176,879
Ensembl chr11:47,164,299...47,177,125

G

Rho GDP dissociation inhibitor beta

decreases expression

Sodium Dodecyl Sulfate results in decreased expression of ARHGDIB mRNA

NCBI chr12:14,942,015...14,961,601
Ensembl chr12:14,942,031...14,961,728

G

ADP-ribosyltransferase 3 (inactive)

increases expression

Sodium Dodecyl Sulfate results in increased expression of ART3 mRNA

NCBI chr 4:76,011,190...76,112,786
Ensembl chr 4:76,011,184...76,114,048

G

asparagine synthetase (glutamine-hydrolyzing)

decreases expression

Sodium Dodecyl Sulfate results in decreased expression of ASNS mRNA

NCBI chr 7:97,851,677...97,928,441
Ensembl chr 7:97,851,677...97,872,542

G

assembly factor for spindle microtubules

increases expression

Sodium Dodecyl Sulfate results in increased expression of ASPM mRNA

NCBI chr 1:197,084,127...197,146,669
Ensembl chr 1:197,084,121...197,146,694

G

ASXL transcriptional regulator 1

increases expression

Sodium Dodecyl Sulfate results in increased expression of ASXL1 mRNA

NCBI chr20:32,358,331...32,439,319
Ensembl chr20:32,358,330...32,439,319

G

activating transcription factor 3

increases expression

Sodium Dodecyl Sulfate results in increased expression of ATF3 mRNA

NCBI chr 1:212,565,407...212,620,777
Ensembl chr 1:212,565,334...212,620,777

G

autophagy related 9B

decreases expression

Sodium Dodecyl Sulfate results in decreased expression of ATG9B mRNA

NCBI chr 7:151,012,209...151,024,499
Ensembl chr 7:151,012,209...151,024,499

G

ATPase H+/K+ transporting non-gastric alpha2 subunit

increases expression

Sodium Dodecyl Sulfate results in increased expression of ATP12A mRNA

NCBI chr13:24,680,408...24,712,472
Ensembl chr13:24,680,408...24,712,472

G

ATP synthase peripheral stalk subunit d

increases expression

Sodium Dodecyl Sulfate results in increased expression of ATP5PD protein

NCBI chr17:75,038,863...75,046,969
Ensembl chr17:75,038,863...75,046,985

G

beta-1,3-glucuronyltransferase 2

increases expression

Sodium Dodecyl Sulfate results in increased expression of B3GAT2 mRNA

NCBI chr 6:70,856,679...70,957,060
Ensembl chr 6:70,856,679...70,957,060

G

UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3

increases expression

Sodium Dodecyl Sulfate results in increased expression of B3GNT3 mRNA

NCBI chr19:17,794,791...17,813,576
Ensembl chr19:17,794,828...17,813,576

G

BMP and activin membrane bound inhibitor

increases expression

Sodium Dodecyl Sulfate results in increased expression of BAMBI mRNA

NCBI chr10:28,677,521...28,682,932
Ensembl chr10:28,677,510...28,682,932

G

butyrylcholinesterase

decreases expression

Sodium Dodecyl Sulfate results in decreased expression of BCHE mRNA

NCBI chr 3:165,772,904...165,837,423
Ensembl chr 3:165,772,904...165,837,462

G

brain expressed X-linked 5

increases expression

Sodium Dodecyl Sulfate results in increased expression of BEX5 mRNA

NCBI chr X:102,153,712...102,155,977
Ensembl chr X:102,153,708...102,155,977

G

BICD cargo adaptor 1

increases expression

Sodium Dodecyl Sulfate results in increased expression of BICD1 mRNA

NCBI chr12:32,106,847...32,383,633
Ensembl chr12:32,106,835...32,383,633

G

biliverdin reductase A

decreases expression

Sodium Dodecyl Sulfate results in decreased expression of BLVRA protein

NCBI chr 7:43,758,122...43,807,342
Ensembl chr 7:43,758,680...43,807,342

G

biliverdin reductase B

decreases expression

Sodium Dodecyl Sulfate results in decreased expression of BLVRB mRNA

NCBI chr19:40,447,768...40,465,745
Ensembl chr19:40,447,765...40,465,764

G

BMS1 pseudogene 1

decreases expression

Sodium Dodecyl Sulfate results in decreased expression of BMS1P1 mRNA

NCBI chr10:46,786,733...46,811,989
Ensembl chr10:46,786,674...46,811,989
Ensembl chr10:46,786,674...46,811,989

G

BMP/retinoic acid inducible neural specific 1

increases expression

Sodium Dodecyl Sulfate results in increased expression of BRINP1 mRNA

NCBI chr 9:119,166,629...119,369,435
Ensembl chr 9:119,153,458...119,369,435

G

chromosome 16 open reading frame 46

decreases expression

Sodium Dodecyl Sulfate results in decreased expression of C16ORF46 mRNA

NCBI chr16:81,053,497...81,077,238
Ensembl chr16:81,053,497...81,077,267

G

chromosome 18 open reading frame 21

decreases expression

Sodium Dodecyl Sulfate results in decreased expression of C18ORF21 mRNA

NCBI chr18:35,972,679...35,979,278
Ensembl chr18:35,972,625...35,979,286

G

complement C1r

decreases expression

Sodium Dodecyl Sulfate results in decreased expression of C1R mRNA

NCBI chr12:7,080,219...7,092,445
Ensembl chr12:7,080,214...7,092,540

G

complement C2

affects response to substance

C2 SNP affects the susceptibility to Sodium Dodecyl Sulfate

NCBI chr 6:31,897,783...31,945,672
Ensembl chr 6:31,897,785...31,945,673

G

chromosome 5 open reading frame 34

decreases expression

Sodium Dodecyl Sulfate results in decreased expression of C5ORF34 mRNA

NCBI chr 5:43,486,709...43,515,148
Ensembl chr 5:43,486,709...43,515,148

G

carbonic anhydrase 2

decreases expression

Sodium Dodecyl Sulfate results in decreased expression of CA2 mRNA

NCBI chr 8:85,464,007...85,481,493
Ensembl chr 8:85,463,968...85,481,493

G

calcium/calmodulin dependent protein kinase II inhibitor 1

increases expression

Sodium Dodecyl Sulfate results in increased expression of CAMK2N1 mRNA

NCBI chr 1:20,482,391...20,486,210
Ensembl chr 1:20,482,391...20,486,210

G

calcium activated nucleotidase 1

increases expression

Sodium Dodecyl Sulfate results in increased expression of CANT1 mRNA

NCBI chr17:78,991,716...79,009,764
Ensembl chr17:78,991,716...79,009,867

G

calpain 14

increases expression

Sodium Dodecyl Sulfate results in increased expression of CAPN14 mRNA

NCBI chr 2:31,173,056...31,233,957
Ensembl chr 2:31,173,056...31,233,858

G

calpain small subunit 2

decreases expression

Sodium Dodecyl Sulfate results in decreased expression of CAPNS2 mRNA

NCBI chr16:55,566,684...55,567,687
Ensembl chr16:55,566,684...55,567,687

G

Cbl proto-oncogene like 1

decreases expression

Sodium Dodecyl Sulfate results in decreased expression of CBLL1 mRNA

NCBI chr 7:107,744,142...107,761,667
Ensembl chr 7:107,743,073...107,761,667

G

coiled-coil domain containing 8

decreases expression

Sodium Dodecyl Sulfate results in decreased expression of CCDC8 mRNA

NCBI chr19:46,410,329...46,413,564
Ensembl chr19:46,410,329...46,413,564

G

C-C motif chemokine ligand 2

decreases expression
multiple interactions

Sodium Dodecyl Sulfate results in decreased expression of CCL2 mRNA
Sodium Dodecyl Sulfate inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased secretion of CCL2 protein]

PMID:20713136 PMID:36416909

NCBI chr17:34,255,285...34,257,203
Ensembl chr17:34,255,274...34,257,208

G

C-C motif chemokine ligand 20

multiple interactions
increases expression
increases secretion

IL1A protein affects the reaction [Sodium Dodecyl Sulfate results in increased secretion of CCL20 protein]; TNF protein affects the reaction [Sodium Dodecyl Sulfate results in increased secretion of CCL20 protein]
Sodium Dodecyl Sulfate results in increased expression of CCL20 mRNA

PMID:15679580 PMID:30806763 PMID:31734321

NCBI chr 2:227,813,842...227,817,556
Ensembl chr 2:227,805,739...227,817,564

G

C-C motif chemokine ligand 27

increases secretion

Sodium Dodecyl Sulfate results in increased secretion of CCL27 protein

NCBI chr 9:34,661,890...34,662,657
Ensembl chr 9:34,661,880...34,664,048

G

C-C motif chemokine ligand 3

multiple interactions

Sodium Dodecyl Sulfate inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased secretion of CCL3 protein]

NCBI chr17:36,088,256...36,090,143
Ensembl chr17:36,088,256...36,090,169

G

C-C motif chemokine ligand 4

decreases expression

Sodium Dodecyl Sulfate results in decreased expression of CCL4 mRNA

NCBI chr17:36,103,827...36,105,614
Ensembl chr17:36,103,827...36,105,621

G

C-C motif chemokine ligand 5

increases secretion
increases expression

Sodium Dodecyl Sulfate results in increased secretion of CCL5 protein
Sodium Dodecyl Sulfate results in increased expression of CCL5 mRNA

PMID:16099135 PMID:31734321

NCBI chr17:35,871,491...35,880,360
Ensembl chr17:35,871,491...35,880,793

G

cellular communication network factor 1

increases expression

Sodium Dodecyl Sulfate results in increased expression of CCN1 mRNA

NCBI chr 1:85,580,761...85,583,950
Ensembl chr 1:85,580,761...85,584,589

G

cellular communication network factor 2

decreases expression
increases expression

Sodium Dodecyl Sulfate results in decreased expression of CCN2 mRNA
Sodium Dodecyl Sulfate results in increased expression of CCN2 mRNA

PMID:25377654 PMID:31734321

NCBI chr 6:131,948,176...131,951,372
Ensembl chr 6:131,948,176...131,951,372

G

C-C motif chemokine receptor 5

decreases expression

Sodium Dodecyl Sulfate results in decreased expression of CCR5 mRNA

NCBI chr 3:46,370,142...46,376,206
Ensembl chr 3:46,370,946...46,376,206

G

C-C motif chemokine receptor 7

increases expression

Sodium Dodecyl Sulfate results in increased expression of CCR7 mRNA

NCBI chr17:40,553,769...40,565,472
Ensembl chr17:40,553,769...40,565,472

G

CD40 molecule

decreases expression

Sodium Dodecyl Sulfate results in decreased expression of CD40 mRNA

NCBI chr20:46,118,314...46,129,858
Ensembl chr20:46,118,271...46,129,863

G

CD86 molecule

increases expression

Sodium Dodecyl Sulfate results in increased expression of CD86 protein

NCBI chr 3:122,055,362...122,121,136
Ensembl chr 3:122,055,362...122,121,139

G

cell division cycle 25A

increases expression

Sodium Dodecyl Sulfate results in increased expression of CDC25A mRNA

NCBI chr 3:48,157,146...48,188,417
Ensembl chr 3:48,157,146...48,188,417

G

cadherin 26

increases expression

Sodium Dodecyl Sulfate results in increased expression of CDH26 mRNA

NCBI chr20:59,958,423...60,035,934
Ensembl chr20:59,958,423...60,034,011

G

cyclin dependent kinase inhibitor 1C

increases expression

Sodium Dodecyl Sulfate results in increased expression of CDKN1C mRNA

NCBI chr11:2,883,218...2,885,775
Ensembl chr11:2,883,213...2,885,775

G

CUGBP Elav-like family member 6

increases expression

Sodium Dodecyl Sulfate results in increased expression of CELF6 mRNA

NCBI chr15:72,284,727...72,320,157
Ensembl chr15:72,284,727...72,320,157

G

ceramide kinase

increases expression

Sodium Dodecyl Sulfate results in increased expression of CERK mRNA

NCBI chr22:46,684,410...46,738,252
Ensembl chr22:46,684,410...46,738,252

G

ceramide synthase 3

decreases expression

Sodium Dodecyl Sulfate results in decreased expression of CERS3 mRNA

PMID:29155129 PMID:31734321

NCBI chr15:100,400,395...100,544,683
Ensembl chr15:100,400,395...100,544,995

G

cofilin 1

increases expression

Sodium Dodecyl Sulfate results in increased expression of CFL1 mRNA; Sodium Dodecyl Sulfate results in increased expression of CFL1 protein

NCBI chr11:65,854,673...65,858,180
Ensembl chr11:65,823,022...65,862,026

G

ChaC glutathione specific gamma-glutamylcyclotransferase 1

increases expression

Sodium Dodecyl Sulfate results in increased expression of CHAC1 mRNA

NCBI chr15:40,953,471...40,956,512
Ensembl chr15:40,952,962...40,956,512

G

carbohydrate sulfotransferase 11

increases expression

Sodium Dodecyl Sulfate results in increased expression of CHST11 mRNA

NCBI chr12:104,456,948...104,762,014
Ensembl chr12:104,455,295...104,762,014

G

Cbp/p300 interacting transactivator with Glu/Asp rich carboxy-terminal domain 2

increases expression

Sodium Dodecyl Sulfate results in increased expression of CITED2 mRNA

NCBI chr 6:139,371,807...139,374,648
Ensembl chr 6:139,371,807...139,374,648

G

cardiotrophin like cytokine factor 1

increases expression

Sodium Dodecyl Sulfate results in increased expression of CLCF1 mRNA

NCBI chr11:67,364,168...67,374,177
Ensembl chr11:67,364,168...67,374,177

G

claudin 7

increases expression

Sodium Dodecyl Sulfate results in increased expression of CLDN7 mRNA

NCBI chr17:7,259,903...7,263,213
Ensembl chr17:7,259,903...7,263,983

G

CDC like kinase 3

decreases expression

Sodium Dodecyl Sulfate results in decreased expression of CLK3 mRNA

NCBI chr15:74,608,372...74,630,201
Ensembl chr15:74,598,500...74,645,414

G

calmin

increases expression

Sodium Dodecyl Sulfate results in increased expression of CLMN mRNA

NCBI chr14:95,181,940...95,319,908
Ensembl chr14:95,181,940...95,319,908

G

chemerin chemokine-like receptor 2

decreases expression

Sodium Dodecyl Sulfate results in decreased expression of CMKLR2 mRNA

NCBI chr 2:206,175,316...206,217,912
Ensembl chr 2:206,175,316...206,218,047

G

CKLF like MARVEL transmembrane domain containing 8

decreases expression

Sodium Dodecyl Sulfate results in decreased expression of CMTM8 mRNA

NCBI chr 3:32,238,192...32,370,321
Ensembl chr 3:32,238,679...32,370,321

G

cornifelin

increases expression

Sodium Dodecyl Sulfate results in increased expression of CNFN mRNA; Sodium Dodecyl Sulfate results in increased expression of CNFN protein

NCBI chr19:42,387,019...42,390,297
Ensembl chr19:42,387,019...42,390,297

G

cyclin and CBS domain divalent metal cation transport mediator 2

increases expression

Sodium Dodecyl Sulfate results in increased expression of CNNM2 mRNA

NCBI chr10:102,918,294...103,090,222
Ensembl chr10:102,918,294...103,090,222

G

collagen type XI alpha 1 chain

increases expression

Sodium Dodecyl Sulfate results in increased expression of COL11A1 mRNA

NCBI chr 1:102,876,473...103,108,522
Ensembl chr 1:102,876,467...103,108,872

G

collagen type II alpha 1 chain

decreases expression

Sodium Dodecyl Sulfate results in decreased expression of COL2A1 mRNA

NCBI chr12:47,972,967...48,006,212
Ensembl chr12:47,972,967...48,004,554

G

COX10 divergent transcript

decreases expression

Sodium Dodecyl Sulfate results in decreased expression of COX10-DT mRNA

NCBI chr17:14,029,292...14,069,458
Ensembl chr17:13,755,574...14,069,495

G

cytochrome c oxidase assembly factor COX19

decreases expression

Sodium Dodecyl Sulfate results in decreased expression of COX19 mRNA

NCBI chr 7:964,852...975,549
Ensembl chr 7:898,778...975,549

G

carnitine palmitoyltransferase 1A

increases expression

Sodium Dodecyl Sulfate results in increased expression of CPT1A mRNA

NCBI chr11:68,754,620...68,844,277
Ensembl chr11:68,754,620...68,844,410

G

cellular retinoic acid binding protein 2

decreases expression

Sodium Dodecyl Sulfate results in decreased expression of CRABP2 mRNA

NCBI chr 1:156,699,606...156,705,784
Ensembl chr 1:156,699,606...156,705,816

G

cysteine rich C-terminal 1

increases expression

Sodium Dodecyl Sulfate results in increased expression of CRCT1 mRNA

NCBI chr 1:152,514,482...152,516,008
Ensembl chr 1:152,514,482...152,516,008

G

cAMP responsive element binding protein 1

increases expression

Sodium Dodecyl Sulfate results in increased expression of CREB1 mRNA

NCBI chr 2:207,529,962...207,605,988
Ensembl chr 2:207,529,737...207,605,988

G

CREB binding protein

increases expression

Sodium Dodecyl Sulfate results in increased expression of CREBBP mRNA

NCBI chr16:3,725,054...3,880,713
Ensembl chr16:3,725,054...3,880,713

G

cysteine rich with EGF like domains 2

increases expression

Sodium Dodecyl Sulfate results in increased expression of CRELD2 mRNA

NCBI chr22:49,918,634...49,927,537
Ensembl chr22:49,918,167...49,927,540

G

cornulin

increases expression

Sodium Dodecyl Sulfate results in increased expression of CRNN mRNA

NCBI chr 1:152,409,243...152,414,263
Ensembl chr 1:152,409,243...152,414,263

G

cytotoxic and regulatory T cell molecule

increases expression

Sodium Dodecyl Sulfate results in increased expression of CRTAM mRNA

NCBI chr11:122,838,500...122,872,643
Ensembl chr11:122,838,500...122,872,643

G

colony stimulating factor 2

increases expression
increases secretion

Sodium Dodecyl Sulfate results in increased expression of CSF2 mRNA
Sodium Dodecyl Sulfate results in increased secretion of CSF2 protein

PMID:11378323 PMID:22245253

NCBI chr 5:132,073,789...132,076,170
Ensembl chr 5:132,073,789...132,076,170

G

colony stimulating factor 2 receptor subunit beta

increases expression

Sodium Dodecyl Sulfate results in increased expression of CSF2RB mRNA

NCBI chr22:36,913,628...36,940,439
Ensembl chr22:36,913,628...36,940,439

G

cysteine and serine rich nuclear protein 1

increases expression

Sodium Dodecyl Sulfate results in increased expression of CSRNP1 mRNA

NCBI chr 3:39,141,855...39,154,641
Ensembl chr 3:39,141,855...39,154,562

G

CTD nuclear envelope phosphatase 1

increases expression

Sodium Dodecyl Sulfate results in increased expression of CTDNEP1 mRNA

NCBI chr17:7,243,591...7,251,978
Ensembl chr17:7,243,591...7,252,491

G

cathepsin H

decreases expression

Sodium Dodecyl Sulfate results in decreased expression of CTSH mRNA

NCBI chr15:78,921,058...78,945,046
Ensembl chr15:78,921,058...78,949,574

G

cullin 7

increases expression

Sodium Dodecyl Sulfate results in increased expression of CUL7 mRNA

NCBI chr 6:43,037,617...43,053,851
Ensembl chr 6:43,037,617...43,053,943

G

C-X-C motif chemokine ligand 1

increases expression

Sodium Dodecyl Sulfate results in increased expression of CXCL1 mRNA

PMID:28826779 PMID:31734321

NCBI chr 4:73,869,393...73,871,308
Ensembl chr 4:73,869,393...73,871,308

G

C-X-C motif chemokine ligand 10

increases expression

Sodium Dodecyl Sulfate results in increased expression of CXCL10 mRNA

PMID:17936526 PMID:23445166 PMID:31734321

NCBI chr 4:76,021,118...76,023,497
Ensembl chr 4:76,021,118...76,023,497

G

C-X-C motif chemokine ligand 14

decreases expression
multiple interactions

Sodium Dodecyl Sulfate results in decreased expression of CXCL14 mRNA; Sodium Dodecyl Sulfate results in decreased expression of CXCL14 protein
2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Sodium Dodecyl Sulfate results in decreased expression of CXCL14 protein]; WHI P131 inhibits the reaction [Sodium Dodecyl Sulfate results in decreased expression of CXCL14 protein]

NCBI chr 5:135,570,679...135,578,991
Ensembl chr 5:135,570,679...135,579,279

G

C-X-C motif chemokine ligand 2

decreases expression
increases expression

Sodium Dodecyl Sulfate results in decreased expression of CXCL2 protein
Sodium Dodecyl Sulfate results in increased expression of CXCL2 protein

NCBI chr 4:74,097,040...74,099,195
Ensembl chr 4:74,097,040...74,099,196

G

C-X-C motif chemokine ligand 8

decreases expression
increases expression
decreases secretion
increases secretion
multiple interactions

Sodium Dodecyl Sulfate results in decreased expression of CXCL8 mRNA
Sodium Dodecyl Sulfate results in increased expression of CXCL8 mRNA; Sodium Dodecyl Sulfate results in increased expression of CXCL8 protein
Sodium Dodecyl Sulfate results in decreased secretion of CXCL8 protein
Sodium Dodecyl Sulfate results in increased secretion of CXCL8 protein
IL1A protein affects the reaction [Sodium Dodecyl Sulfate results in increased secretion of CXCL8 protein]; Sodium Dodecyl Sulfate inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased secretion of CXCL8 protein]; TNF protein affects the reaction [Sodium Dodecyl Sulfate results in increased secretion of CXCL8 protein]

PMID:8006454 PMID:12781210 PMID:15679580 PMID:16099135 PMID:17936526 More...

NCBI chr 4:73,740,569...73,743,716
Ensembl chr 4:73,740,519...73,743,716

G

C-X-C motif chemokine receptor 4

increases expression

Sodium Dodecyl Sulfate results in increased expression of CXCR4 mRNA

NCBI chr 2:136,114,349...136,118,149
Ensembl chr 2:136,114,349...136,119,177

G

cytochrome b561 family member A3

decreases expression

Sodium Dodecyl Sulfate results in decreased expression of CYB561A3 mRNA

NCBI chr11:61,348,745...61,362,283
Ensembl chr11:61,348,754...61,362,283

G

cytochrome b5 reductase 4

decreases expression

Sodium Dodecyl Sulfate results in decreased expression of CYB5R4 mRNA

NCBI chr 6:83,859,689...83,967,423
Ensembl chr 6:83,859,656...83,967,423

G

cytochrome P450 family 1 subfamily A member 1

increases expression

Sodium Dodecyl Sulfate results in increased expression of CYP1A1 mRNA

PMID:20491607 PMID:30806763

NCBI chr15:74,719,542...74,725,528
Ensembl chr15:74,719,542...74,725,536

G

cytochrome P450 family 27 subfamily A member 1

decreases expression

Sodium Dodecyl Sulfate results in decreased expression of CYP27A1 mRNA

NCBI chr 2:218,782,147...218,815,293
Ensembl chr 2:218,781,749...218,815,293

G

cytochrome P450 family 4 subfamily F member 12

decreases expression

Sodium Dodecyl Sulfate results in decreased expression of CYP4F12 mRNA

NCBI chr19:15,673,087...15,697,174
Ensembl chr19:15,673,018...15,697,174

G

cytochrome P450 family 51 subfamily A member 1

decreases expression

Sodium Dodecyl Sulfate results in decreased expression of CYP51 mRNA

NCBI chr 7:92,112,153...92,134,803
Ensembl chr 7:92,084,987...92,134,803

G

death associated protein like 1

decreases expression

Sodium Dodecyl Sulfate results in decreased expression of DAPL1 mRNA

NCBI chr 2:158,795,317...158,815,990
Ensembl chr 2:158,795,317...158,862,781

G

dicarbonyl and L-xylulose reductase

decreases expression

Sodium Dodecyl Sulfate results in decreased expression of DCXR mRNA

NCBI chr17:82,035,858...82,037,697
Ensembl chr17:82,035,136...82,037,709

G

DNA damage inducible transcript 3

decreases expression

Sodium Dodecyl Sulfate results in decreased expression of DDIT3 mRNA

NCBI chr12:57,516,588...57,520,517
Ensembl chr12:57,516,588...57,521,737

G

DExD/H-box helicase 60

decreases expression

Sodium Dodecyl Sulfate results in decreased expression of DDX60 mRNA

NCBI chr 4:168,216,294...168,325,979
Ensembl chr 4:168,216,291...168,318,883

G

DExD/H-box 60 like

decreases expression

Sodium Dodecyl Sulfate results in decreased expression of DDX60L mRNA

NCBI chr 4:168,356,735...168,480,492
Ensembl chr 4:168,356,735...168,537,786

G

delta 4-desaturase, sphingolipid 1

decreases expression

Sodium Dodecyl Sulfate results in decreased expression of DEGS1 mRNA

NCBI chr 1:224,183,240...224,193,441
Ensembl chr 1:224,175,756...224,193,441

G

DENN domain containing 2D

decreases expression

Sodium Dodecyl Sulfate results in decreased expression of DENND2D mRNA

NCBI chr 1:111,185,969...111,204,578
Ensembl chr 1:111,185,969...111,204,535

G

DNA fragmentation factor subunit beta

increases expression

Sodium Dodecyl Sulfate results in increased expression of DFFB mRNA

NCBI chr 1:3,857,476...3,885,429
Ensembl chr 1:3,857,267...3,885,429

G

7-dehydrocholesterol reductase

decreases expression

Sodium Dodecyl Sulfate results in decreased expression of DHCR7 mRNA

NCBI chr11:71,434,411...71,448,393
Ensembl chr11:71,428,193...71,452,868

G

dihydrodiol dehydrogenase

increases expression

Sodium Dodecyl Sulfate results in increased expression of DHDH mRNA

NCBI chr19:48,932,795...48,944,969
Ensembl chr19:48,933,699...48,944,969

G

DICER1 antisense RNA 1

increases expression

Sodium Dodecyl Sulfate results in increased expression of DICER1-AS1 mRNA

NCBI chr14:95,157,688...95,179,933
Ensembl chr14:95,157,645...95,181,475

G

disco interacting protein 2 homolog C

increases expression

Sodium Dodecyl Sulfate results in increased expression of DIP2C mRNA

NCBI chr10:274,201...689,668
Ensembl chr10:274,201...689,668

G

disrupted in renal carcinoma 3

decreases expression

Sodium Dodecyl Sulfate results in decreased expression of DIRC3 mRNA

NCBI chr 2:217,284,019...217,790,443
Ensembl chr 2:217,284,019...217,756,593

G

DnaJ heat shock protein family (Hsp40) member B4

increases expression

Sodium Dodecyl Sulfate results in increased expression of DNAJB4 mRNA

NCBI chr 1:77,979,175...78,017,964
Ensembl chr 1:77,979,175...78,017,964

G

docking protein 7

increases expression

Sodium Dodecyl Sulfate results in increased expression of DOK7 mRNA

NCBI chr 4:3,463,306...3,501,482
Ensembl chr 4:3,463,306...3,501,473

G

dihydropyrimidinase like 2

increases expression

Sodium Dodecyl Sulfate results in increased expression of DPYSL2 mRNA

NCBI chr 8:26,514,031...26,658,175
Ensembl chr 8:26,514,031...26,658,178

G

desmocollin 1

decreases expression

Sodium Dodecyl Sulfate results in decreased expression of DSC1 mRNA

NCBI chr18:31,129,236...31,162,856
Ensembl chr18:31,129,236...31,162,856

G

desmoglein 1

decreases expression

Sodium Dodecyl Sulfate results in decreased expression of DSG1 mRNA

NCBI chr18:31,318,160...31,359,246
Ensembl chr18:31,318,160...31,359,246

G

dual specificity phosphatase 1

increases expression

Sodium Dodecyl Sulfate results in increased expression of DUSP1 mRNA

NCBI chr 5:172,768,096...172,771,195
Ensembl chr 5:172,768,096...172,771,195

G

dual specificity phosphatase 2

increases expression

Sodium Dodecyl Sulfate results in increased expression of DUSP2 mRNA

NCBI chr 2:96,143,169...96,145,440
Ensembl chr 2:96,143,169...96,145,440

G

E2F transcription factor 8

increases expression

Sodium Dodecyl Sulfate results in increased expression of E2F8 mRNA

NCBI chr11:19,224,063...19,241,655
Ensembl chr11:19,224,063...19,241,620

G

endothelin 1

increases expression

Sodium Dodecyl Sulfate results in increased expression of EDN1 mRNA

NCBI chr 6:12,230,516...12,297,194
Ensembl chr 6:12,290,361...12,297,194

G

EGF containing fibulin extracellular matrix protein 2

increases expression

Sodium Dodecyl Sulfate results in increased expression of EFEMP2 mRNA

NCBI chr11:65,866,441...65,872,800
Ensembl chr11:65,866,441...65,873,592

G

early growth response 1

increases expression

Sodium Dodecyl Sulfate results in increased expression of EGR1 mRNA

PMID:25377654 PMID:31734321

NCBI chr 5:138,465,479...138,469,303
Ensembl chr 5:138,465,479...138,469,303

G

eukaryotic translation initiation factor 2 alpha kinase 1

decreases expression

Sodium Dodecyl Sulfate results in decreased expression of EIF2AK1 mRNA

NCBI chr 7:6,022,247...6,059,175
Ensembl chr 7:6,022,247...6,059,175

G

ETS transcription factor ELK2A, pseudogene

increases expression

Sodium Dodecyl Sulfate results in increased expression of ELK2AP mRNA

NCBI chr14:105,669,577...105,672,807
Ensembl chr14:105,672,308...105,673,314

G

ELOVL fatty acid elongase 1

increases expression

Sodium Dodecyl Sulfate results in increased expression of ELOVL1 mRNA

NCBI chr 1:43,363,401...43,368,011
Ensembl chr 1:43,363,398...43,368,074

G

epithelial membrane protein 1

increases expression

Sodium Dodecyl Sulfate results in increased expression of EMP1 mRNA

NCBI chr12:13,196,726...13,219,941
Ensembl chr12:13,196,723...13,219,941

G

erythroblast membrane associated protein (Scianna blood group)

decreases expression

Sodium Dodecyl Sulfate results in decreased expression of ERMAP mRNA

NCBI chr 1:42,817,122...42,844,991
Ensembl chr 1:42,817,122...42,844,991

G

endogenous retrovirus group MER34 member 1, envelope

increases expression

Sodium Dodecyl Sulfate results in increased expression of ERVMER34-1 mRNA

NCBI chr 4:52,742,553...52,751,425
Ensembl chr 4:52,722,618...52,751,586

G

ezrin

increases expression

Sodium Dodecyl Sulfate results in increased expression of EZR mRNA; Sodium Dodecyl Sulfate results in increased expression of EZR protein

NCBI chr 6:158,765,748...158,819,368
Ensembl chr 6:158,765,741...158,819,368

G

coagulation factor VIII

decreases expression

Sodium Dodecyl Sulfate results in decreased expression of F8 mRNA

NCBI chr X:154,835,792...155,022,723
Ensembl chr X:154,835,788...155,026,940

G

fatty acid binding protein 3

increases expression

Sodium Dodecyl Sulfate results in increased expression of FABP3 mRNA

NCBI chr 1:31,359,588...31,373,076
Ensembl chr 1:31,365,253...31,376,850

G

fatty acid binding protein 4

increases expression

Sodium Dodecyl Sulfate results in increased expression of FABP4 mRNA

NCBI chr 8:81,478,419...81,483,233
Ensembl chr 8:81,478,419...81,483,236

G

fumarylacetoacetate hydrolase

decreases expression

Sodium Dodecyl Sulfate results in decreased expression of FAH mRNA

NCBI chr15:80,152,789...80,186,949
Ensembl chr15:80,152,490...80,186,946

G

family with sequence similarity 171 member A1

increases expression

Sodium Dodecyl Sulfate results in increased expression of FAM171A1 mRNA

NCBI chr10:15,211,643...15,374,554
Ensembl chr10:15,211,643...15,371,289

G

family with sequence similarity 83 member C

decreases expression

Sodium Dodecyl Sulfate results in decreased expression of FAM83C mRNA

NCBI chr20:35,285,731...35,292,425
Ensembl chr20:35,285,731...35,292,425

G

FA complementation group L

decreases expression

Sodium Dodecyl Sulfate results in decreased expression of FANCL mRNA

NCBI chr 2:58,159,243...58,241,380
Ensembl chr 2:58,159,243...58,241,410

G

F-box protein 5

decreases expression

Sodium Dodecyl Sulfate results in decreased expression of FBXO5 mRNA

NCBI chr 6:152,970,535...152,983,579
Ensembl chr 6:152,970,519...152,983,579

G

ferrochelatase

increases expression

Sodium Dodecyl Sulfate results in increased expression of FECH mRNA

NCBI chr18:57,544,377...57,586,702
Ensembl chr18:57,544,377...57,586,732

G

FKBP prolyl isomerase 11

increases expression

Sodium Dodecyl Sulfate results in increased expression of FKBP11 mRNA

NCBI chr12:48,921,963...48,939,034
Ensembl chr12:48,921,518...48,926,474

G

filaggrin

increases expression

Sodium Dodecyl Sulfate results in increased expression of FLG mRNA; Sodium Dodecyl Sulfate results in increased expression of FLG protein

NCBI chr 1:152,302,165...152,325,239
Ensembl chr 1:152,302,165...152,325,239

G

filaggrin 2

increases expression

Sodium Dodecyl Sulfate results in increased expression of FLG2 mRNA

NCBI chr 1:152,348,735...152,360,006
Ensembl chr 1:152,348,735...152,360,006

G

fibronectin 1

decreases expression

Sodium Dodecyl Sulfate results in decreased expression of FN1 mRNA

NCBI chr 2:215,360,865...215,436,068
Ensembl chr 2:215,360,440...215,436,073

G

Fos proto-oncogene, AP-1 transcription factor subunit

decreases expression
increases expression

Sodium Dodecyl Sulfate results in decreased expression of FOS mRNA
Sodium Dodecyl Sulfate results in increased expression of FOS mRNA

PMID:12815608 PMID:31734321

NCBI chr14:75,278,828...75,282,230
Ensembl chr14:75,278,826...75,282,230

G

forkhead box A2

increases expression

Sodium Dodecyl Sulfate results in increased expression of FOXA2 mRNA

NCBI chr20:22,580,998...22,585,490
Ensembl chr20:22,580,998...22,585,455

G

forkhead box N1

decreases expression

Sodium Dodecyl Sulfate results in decreased expression of FOXN1 mRNA

NCBI chr17:28,506,348...28,538,900
Ensembl chr17:28,506,243...28,538,900

G

forkhead box O4

increases expression

Sodium Dodecyl Sulfate results in increased expression of FOXO4 mRNA

NCBI chr X:71,095,851...71,103,532
Ensembl chr X:71,095,851...71,103,532

G

FSHD region gene 1 family member B, pseudogene

decreases expression

Sodium Dodecyl Sulfate results in decreased expression of FRG1BP mRNA

NCBI chr20:30,377,164...30,419,843
Ensembl chr20:30,377,372...30,399,257

G

follistatin

decreases expression

Sodium Dodecyl Sulfate results in decreased expression of FST mRNA

NCBI chr 5:53,480,629...53,487,134
Ensembl chr 5:53,480,626...53,487,134

G

ferritin light chain

increases expression

Sodium Dodecyl Sulfate results in increased expression of FTL mRNA

NCBI chr19:48,965,309...48,966,879
Ensembl chr19:48,965,309...48,966,879

G

frizzled class receptor 7

decreases expression

Sodium Dodecyl Sulfate results in decreased expression of FZD7 mRNA

NCBI chr 2:202,033,855...202,038,441
Ensembl chr 2:202,033,855...202,038,441

G

G0/G1 switch 2

increases expression

Sodium Dodecyl Sulfate results in increased expression of G0S2 mRNA

NCBI chr 1:209,675,412...209,676,390
Ensembl chr 1:209,675,412...209,676,390

G

glucose-6-phosphate dehydrogenase

increases expression

Sodium Dodecyl Sulfate results in increased expression of G6PD mRNA

NCBI chr X:154,531,390...154,547,569
Ensembl chr X:154,517,825...154,547,572

G

growth arrest and DNA damage inducible beta

increases expression

Sodium Dodecyl Sulfate results in increased expression of GADD45B mRNA

NCBI chr19:2,476,127...2,478,257
Ensembl chr19:2,476,122...2,478,259

G

galanin and GMAP prepropeptide

increases expression

Sodium Dodecyl Sulfate results in increased expression of GAL mRNA

NCBI chr11:68,684,544...68,691,175
Ensembl chr11:68,683,779...68,691,175

G

glyceraldehyde-3-phosphate dehydrogenase

decreases expression

Sodium Dodecyl Sulfate results in decreased expression of GAPDH mRNA

NCBI chr12:6,534,517...6,538,371
Ensembl chr12:6,534,512...6,538,374

G

growth arrest specific 2 like 3

increases expression

Sodium Dodecyl Sulfate results in increased expression of GAS2L3 mRNA

NCBI chr12:100,573,684...100,628,288
Ensembl chr12:100,573,683...100,628,288

G

gastrin

increases expression

Sodium Dodecyl Sulfate results in increased expression of GAST mRNA

NCBI chr17:41,712,331...41,715,969
Ensembl chr17:41,712,331...41,715,969

G

guanylate binding protein 1

decreases expression

Sodium Dodecyl Sulfate results in decreased expression of GBP1 mRNA

NCBI chr 1:89,052,319...89,065,208
Ensembl chr 1:89,051,882...89,065,360

G

glutamate-cysteine ligase catalytic subunit

increases expression

Sodium Dodecyl Sulfate results in increased expression of GCLC mRNA

NCBI chr 6:53,497,341...53,545,101
Ensembl chr 6:53,497,341...53,616,970

G

glutamate-cysteine ligase modifier subunit

increases expression

Sodium Dodecyl Sulfate results in increased expression of GCLM mRNA

NCBI chr 1:93,885,199...93,909,430
Ensembl chr 1:93,885,199...93,909,456

G

GTP binding protein overexpressed in skeletal muscle

increases expression

Sodium Dodecyl Sulfate results in increased expression of GEM mRNA

NCBI chr 8:94,249,253...94,262,319
Ensembl chr 8:94,249,253...94,262,350

G

gap junction protein alpha 1

decreases expression

Sodium Dodecyl Sulfate results in decreased expression of GJA1 mRNA

NCBI chr 6:121,435,646...121,449,727
Ensembl chr 6:121,435,595...121,449,727

G

gap junction protein beta 1

decreases expression

Sodium Dodecyl Sulfate results in decreased expression of GJB1 mRNA

NCBI chr X:71,215,239...71,225,516
Ensembl chr X:71,212,811...71,225,516

G

gap junction protein beta 2

increases expression

Sodium Dodecyl Sulfate results in increased expression of GJB2 mRNA

NCBI chr13:20,187,470...20,192,938
Ensembl chr13:20,187,463...20,192,938

G

gap junction protein beta 6

decreases expression

Sodium Dodecyl Sulfate results in decreased expression of GJB6 mRNA

NCBI chr13:20,221,962...20,232,319
Ensembl chr13:20,221,962...20,232,365

G

gap junction protein gamma 1

increases expression

Sodium Dodecyl Sulfate results in increased expression of GJC1 mRNA

NCBI chr17:44,794,104...44,831,364
Ensembl chr17:44,798,448...44,830,816

G

glycine decarboxylase

increases expression

Sodium Dodecyl Sulfate results in increased expression of GLDC mRNA

NCBI chr 9:6,532,467...6,645,729
Ensembl chr 9:6,532,467...6,645,729

G

glutaredoxin 3 pseudogene 2

decreases expression

Sodium Dodecyl Sulfate results in decreased expression of GLRX3P2 mRNA

NCBI chr 6:3,978,041...3,979,369
Ensembl chr 6:3,978,062...3,979,099

G

G-patch domain containing 11

decreases expression

Sodium Dodecyl Sulfate results in decreased expression of GPATCH11 mRNA

NCBI chr 2:37,084,518...37,099,244
Ensembl chr 2:37,084,518...37,099,244

G

growth factor receptor bound protein 7

increases expression

Sodium Dodecyl Sulfate results in increased expression of GRB7 mRNA

NCBI chr17:39,737,938...39,747,285
Ensembl chr17:39,737,927...39,747,291

G

grainyhead like transcription factor 1

decreases expression

Sodium Dodecyl Sulfate results in decreased expression of GRHL1 mRNA

NCBI chr 2:9,951,693...10,002,277
Ensembl chr 2:9,951,693...10,002,277

G

glutathione-disulfide reductase

increases expression

Sodium Dodecyl Sulfate results in increased expression of GSR mRNA

NCBI chr 8:30,678,066...30,727,846
Ensembl chr 8:30,678,066...30,727,846

G

H2A clustered histone 8

increases expression

Sodium Dodecyl Sulfate results in increased expression of H2AC8 mRNA

NCBI chr 6:26,216,921...26,217,437
Ensembl chr 6:26,216,921...26,217,437

G

H2B clustered histone 11

increases expression

Sodium Dodecyl Sulfate results in increased expression of H2BC11 mRNA

NCBI chr 6:27,132,316...27,132,795
Ensembl chr 6:27,125,897...27,132,795

G

H2B clustered histone 21

increases expression

Sodium Dodecyl Sulfate results in increased expression of H2BC21 mRNA

NCBI chr 1:149,884,459...149,886,682
Ensembl chr 1:149,884,459...149,886,682

G

H2B clustered histone 4

increases expression

Sodium Dodecyl Sulfate results in increased expression of H2BC4 mRNA

NCBI chr 6:26,113,170...26,123,926
Ensembl chr 6:26,086,317...26,123,926

G

H3 clustered histone 3

increases expression

Sodium Dodecyl Sulfate results in increased expression of H3C3 mRNA

NCBI chr 6:26,045,384...26,045,869
Ensembl chr 6:26,045,384...26,045,869

G

H4 clustered histone 8

increases expression

Sodium Dodecyl Sulfate results in increased expression of H4C8 mRNA

NCBI chr 6:26,285,126...26,285,534
Ensembl chr 6:26,277,609...26,285,638

G

hyaluronan synthase 3

decreases expression

Sodium Dodecyl Sulfate results in decreased expression of HAS3 mRNA

NCBI chr16:69,083,484...69,118,719
Ensembl chr16:69,105,653...69,118,719

G

hematopoietic cell-specific Lyn substrate 1

increases expression

Sodium Dodecyl Sulfate results in increased expression of HCLS1 mRNA

NCBI chr 3:121,631,399...121,660,903
Ensembl chr 3:121,631,399...121,660,927

G

HECT and RLD domain containing E3 ubiquitin protein ligase family member 6

decreases expression

Sodium Dodecyl Sulfate results in decreased expression of HERC6 mRNA

NCBI chr 4:88,378,852...88,443,097
Ensembl chr 4:88,378,739...88,443,097

G

hes related family bHLH transcription factor with YRPW motif 1

increases expression

Sodium Dodecyl Sulfate results in increased expression of HEY1 mRNA

NCBI chr 8:79,764,010...79,767,767
Ensembl chr 8:79,762,371...79,767,857

G

hexokinase 2

decreases expression

Sodium Dodecyl Sulfate results in decreased expression of HK2 mRNA

NCBI chr 2:74,834,127...74,893,359
Ensembl chr 2:74,834,127...74,893,359

G

major histocompatibility complex, class II, DQ alpha 2

affects response to substance

HLA-DQA2 SNP affects the susceptibility to Sodium Dodecyl Sulfate

NCBI chr 6:32,741,391...32,747,198
Ensembl chr 6:32,741,391...32,747,198

G

heme oxygenase 1

increases expression
affects expression

Sodium Dodecyl Sulfate results in increased expression of HMOX1 mRNA
Sodium Dodecyl Sulfate affects the expression of HMOX1 mRNA

PMID:12815608 PMID:20566472 PMID:22954530 PMID:30806763 PMID:31734321

NCBI chr22:35,381,096...35,394,207
Ensembl chr22:35,380,361...35,394,214

G

heme oxygenase 2

increases expression

Sodium Dodecyl Sulfate results in increased expression of HMOX2 mRNA

NCBI chr16:4,474,736...4,510,347
Ensembl chr16:4,474,690...4,510,347

G

heterogeneous nuclear ribonucleoprotein A/B

decreases expression

Sodium Dodecyl Sulfate results in decreased expression of HNRNPAB protein

NCBI chr 5:178,204,533...178,211,163
Ensembl chr 5:178,204,533...178,211,163

G

heterogeneous nuclear ribonucleoprotein L like

decreases expression

Sodium Dodecyl Sulfate results in decreased expression of HNRNPLL mRNA

NCBI chr 2:38,561,969...38,602,928
Ensembl chr 2:38,561,969...38,603,586

G

HOXD cluster antisense RNA 2

decreases expression

Sodium Dodecyl Sulfate results in decreased expression of HOXD-AS2 mRNA

NCBI chr 2:176,134,841...176,137,098
Ensembl chr 2:176,121,611...176,137,098

G

hippocalcin like 1

increases expression

Sodium Dodecyl Sulfate results in increased expression of HPCAL1 mRNA

NCBI chr 2:10,302,904...10,427,604
Ensembl chr 2:10,302,889...10,427,617

G

heparan sulfate-glucosamine 3-sulfotransferase 2

increases expression

Sodium Dodecyl Sulfate results in increased expression of HS3ST2 mRNA

NCBI chr16:22,814,162...22,916,338
Ensembl chr16:22,814,162...22,916,338

G

HscB mitochondrial iron-sulfur cluster cochaperone

decreases expression

Sodium Dodecyl Sulfate results in decreased expression of HSCB mRNA

NCBI chr22:28,742,032...28,757,510
Ensembl chr22:28,742,039...28,757,515

G

heat shock transcription factor family, X-linked member 3

increases expression

Sodium Dodecyl Sulfate results in increased expression of HSFX3 mRNA

NCBI chr X:149,548,210...149,549,924
Ensembl chr X:149,548,210...149,549,924

G

heat shock protein family A (Hsp70) member 6

increases expression

Sodium Dodecyl Sulfate results in increased expression of HSPA6 mRNA

NCBI chr 1:161,524,540...161,526,894
Ensembl chr 1:161,524,540...161,526,894

G

heat shock protein family B (small) member 1

decreases expression
multiple interactions
increases expression
decreases phosphorylation

Sodium Dodecyl Sulfate results in decreased expression of HSPB1 mRNA
Sodium Dodecyl Sulfate results in decreased expression of and affects the localization of HSPB1 protein
Sodium Dodecyl Sulfate results in increased expression of HSPB1 mRNA; Sodium Dodecyl Sulfate results in increased expression of HSPB1 protein
Sodium Dodecyl Sulfate results in decreased phosphorylation of HSPB1 protein

PMID:12815608 PMID:20332019 PMID:21469165

NCBI chr 7:76,302,673...76,304,292
Ensembl chr 7:76,302,673...76,304,295

G

heat shock protein family B (small) member 8

increases expression

Sodium Dodecyl Sulfate results in increased expression of HSPB8 mRNA

NCBI chr12:119,178,931...119,194,746
Ensembl chr12:119,171,555...119,224,855

G

heat shock protein family H (Hsp110) member 1

increases expression

Sodium Dodecyl Sulfate results in increased expression of HSPH1 mRNA

NCBI chr13:31,134,973...31,162,388
Ensembl chr13:31,134,973...31,162,388

G

inhibitor of Bruton tyrosine kinase

decreases expression

Sodium Dodecyl Sulfate results in decreased expression of IBTK mRNA

NCBI chr 6:82,169,987...82,247,744
Ensembl chr 6:82,169,986...82,247,754

G

intercellular adhesion molecule 1

increases expression

Sodium Dodecyl Sulfate results in increased expression of ICAM1 mRNA

NCBI chr19:10,271,120...10,286,615
Ensembl chr19:10,271,093...10,286,615

G

isocitrate dehydrogenase (NAD(+)) 3 catalytic subunit alpha

decreases expression

Sodium Dodecyl Sulfate results in decreased expression of IDH3A protein

NCBI chr15:78,149,362...78,171,945
Ensembl chr15:78,131,498...78,171,945

G

isopentenyl-diphosphate delta isomerase 1

decreases expression

Sodium Dodecyl Sulfate results in decreased expression of IDI1 protein

NCBI chr10:1,039,152...1,056,704
Ensembl chr10:1,039,152...1,049,119

G

interferon induced protein 35

decreases expression

Sodium Dodecyl Sulfate results in decreased expression of IFI35 mRNA

NCBI chr17:43,006,784...43,014,456
Ensembl chr17:43,006,740...43,014,456

G

interferon gamma

multiple interactions
increases expression

[dibenzothiazyl disulfide co-treated with Sodium Dodecyl Sulfate] results in increased expression of IFNG protein; [diethylamine co-treated with Sodium Dodecyl Sulfate] results in increased expression of IFNG protein
Sodium Dodecyl Sulfate results in increased expression of IFNG protein

PMID:12062936 PMID:28826779

NCBI chr12:68,154,768...68,159,740
Ensembl chr12:68,154,768...68,159,740

G

insulin like growth factor 2 receptor

increases expression

Sodium Dodecyl Sulfate results in increased expression of IGF2R mRNA

NCBI chr 6:159,969,082...160,111,504
Ensembl chr 6:159,969,082...160,113,507

G

IGF like family member 2

decreases expression

Sodium Dodecyl Sulfate results in decreased expression of IGFL2 mRNA

NCBI chr19:46,078,513...46,215,362
Ensembl chr19:46,143,106...46,161,298

G

interleukin 12B

multiple interactions

Sodium Dodecyl Sulfate inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased secretion of IL12B protein]

NCBI chr 5:159,314,780...159,330,487
Ensembl chr 5:159,314,780...159,330,863

G

interleukin 13 receptor subunit alpha 2

increases expression

Sodium Dodecyl Sulfate results in increased expression of IL13RA2 mRNA

NCBI chr X:115,003,982...115,017,616
Ensembl chr X:115,003,975...115,019,977

G

interleukin 16

increases secretion

Sodium Dodecyl Sulfate results in increased secretion of IL16 protein

NCBI chr15:81,182,712...81,314,058
Ensembl chr15:81,159,575...81,314,058

G

interleukin 17A

increases expression

Sodium Dodecyl Sulfate results in increased expression of IL17A mRNA; Sodium Dodecyl Sulfate results in increased expression of IL17A protein

NCBI chr 6:52,186,375...52,190,638
Ensembl chr 6:52,186,375...52,190,638

G

interleukin 1 alpha

multiple interactions
decreases expression
increases expression
increases secretion

IL1A protein affects the reaction [Sodium Dodecyl Sulfate results in increased secretion of CCL20 protein]; IL1A protein affects the reaction [Sodium Dodecyl Sulfate results in increased secretion of CXCL8 protein]; Sodium Dodecyl Sulfate results in increased expression of and results in increased secretion of IL1A protein
Sodium Dodecyl Sulfate results in decreased expression of IL1A protein
Sodium Dodecyl Sulfate results in increased expression of IL1A mRNA; Sodium Dodecyl Sulfate results in increased expression of IL1A protein
Sodium Dodecyl Sulfate results in increased secretion of IL1A protein

PMID:11378323 PMID:12781210 PMID:15679580 PMID:19878710 PMID:21469165 More...

NCBI chr 2:112,773,925...112,784,493
Ensembl chr 2:112,773,925...112,784,493

G

interleukin 1 beta

increases expression

Sodium Dodecyl Sulfate results in increased expression of IL1B mRNA

PMID:9856837 PMID:11378323 PMID:33715048

NCBI chr 2:112,829,751...112,836,779
Ensembl chr 2:112,829,751...112,836,816

G

interleukin 1 receptor type 2

increases expression

Sodium Dodecyl Sulfate results in increased expression of IL1R2 mRNA

NCBI chr 2:101,991,960...102,028,544
Ensembl chr 2:101,991,960...102,028,544

G

interleukin 1 receptor like 1

increases expression

Sodium Dodecyl Sulfate results in increased expression of IL1RL1 mRNA

NCBI chr 2:102,311,563...102,352,356
Ensembl chr 2:102,311,502...102,352,037

G

interleukin 2

multiple interactions
increases expression

[Sodium Dodecyl Sulfate co-treated with Ionomycin co-treated with Tetradecanoylphorbol Acetate] results in decreased expression of IL2 protein
Sodium Dodecyl Sulfate results in increased expression of IL2 protein

PMID:15588918 PMID:22381623

NCBI chr 4:122,451,470...122,456,725
Ensembl chr 4:122,451,470...122,456,725

G

interleukin 24

increases expression

Sodium Dodecyl Sulfate results in increased expression of IL24 protein

NCBI chr 1:206,897,443...206,904,139
Ensembl chr 1:206,897,443...206,904,139

G

interleukin 33

decreases expression

Sodium Dodecyl Sulfate results in decreased expression of IL33 mRNA

NCBI chr 9:6,215,149...6,257,983
Ensembl chr 9:6,215,786...6,257,983

G

interleukin 36 gamma

increases expression

Sodium Dodecyl Sulfate results in increased expression of IL36G mRNA

NCBI chr 2:112,978,006...112,985,658
Ensembl chr 2:112,973,203...112,985,658

G

interleukin 36 receptor antagonist

increases expression

Sodium Dodecyl Sulfate results in increased expression of IL36RN mRNA

NCBI chr 2:113,058,638...113,064,744
Ensembl chr 2:113,058,638...113,065,382

G

interleukin 4

multiple interactions
increases expression

[dibenzothiazyl disulfide co-treated with Sodium Dodecyl Sulfate] results in increased expression of IL4 protein; [diethylamine co-treated with Sodium Dodecyl Sulfate] results in increased expression of IL4 protein
Sodium Dodecyl Sulfate results in increased expression of IL4 mRNA

PMID:12062936 PMID:28826779

NCBI chr 5:132,673,989...132,682,678
Ensembl chr 5:132,673,986...132,682,678

G

interleukin 6

increases expression
multiple interactions

Sodium Dodecyl Sulfate results in increased expression of IL6 mRNA; Sodium Dodecyl Sulfate results in increased expression of IL6 protein
[Tetradecanoylphorbol Acetate co-treated with Sodium Dodecyl Sulfate] results in increased expression of and results in increased secretion of IL6 protein

PMID:11378323 PMID:24964617 PMID:33839235

NCBI chr 7:22,727,200...22,731,998
Ensembl chr 7:22,725,884...22,732,002

G

interleukin 7 receptor

increases expression

Sodium Dodecyl Sulfate results in increased expression of IL7R mRNA

NCBI chr 5:35,856,891...35,879,603
Ensembl chr 5:35,852,695...35,879,603

G

inosine monophosphate dehydrogenase 2

decreases expression

Sodium Dodecyl Sulfate results in decreased expression of IMPDH2 mRNA

NCBI chr 3:49,024,325...49,029,398
Ensembl chr 3:49,024,325...49,029,447

G

inositol 1,4,5-triphosphate receptor associated 1

increases expression

Sodium Dodecyl Sulfate results in increased expression of IRAG1 mRNA

NCBI chr11:10,573,095...10,693,755
Ensembl chr11:10,573,091...10,693,988

G

iroquois homeobox 3

decreases expression

Sodium Dodecyl Sulfate results in decreased expression of IRX3 mRNA

NCBI chr16:54,283,304...54,286,787
Ensembl chr16:54,283,304...54,286,787

G

ITPK1 antisense RNA 1

decreases expression

Sodium Dodecyl Sulfate results in decreased expression of ITPK1-AS1 mRNA

NCBI chr14:93,067,452...93,072,152
Ensembl chr14:93,067,452...93,072,152

G

inositol 1,4,5-trisphosphate receptor type 1

increases expression

Sodium Dodecyl Sulfate results in increased expression of ITPR1 mRNA

NCBI chr 3:4,493,348...4,847,506
Ensembl chr 3:4,493,345...4,847,506

G

involucrin

increases expression

Sodium Dodecyl Sulfate results in increased expression of IVL mRNA; Sodium Dodecyl Sulfate results in increased expression of IVL protein

NCBI chr 1:152,908,546...152,911,886
Ensembl chr 1:152,908,546...152,911,886

G

iodotyrosine deiodinase

multiple interactions

Sodium Dodecyl Sulfate inhibits the reaction [IYD protein results in increased metabolism of Monoiodotyrosine]

NCBI chr 6:150,369,012...150,405,969
Ensembl chr 6:150,368,892...150,405,969

G

junctophilin 2

increases expression

Sodium Dodecyl Sulfate results in increased expression of JPH2 mRNA

NCBI chr20:44,106,590...44,187,188
Ensembl chr20:44,106,590...44,187,188

G

JPX transcript, XIST activator

decreases expression

Sodium Dodecyl Sulfate results in decreased expression of JPX mRNA

NCBI chr X:73,944,324...74,070,384
Ensembl chr X:73,944,182...74,070,408

G

Jrk helix-turn-helix protein

affects expression

Sodium Dodecyl Sulfate affects the expression of JRK mRNA

NCBI chr 8:142,643,682...142,669,967
Ensembl chr 8:142,657,460...142,681,968

G

JunB proto-oncogene, AP-1 transcription factor subunit

increases expression

Sodium Dodecyl Sulfate results in increased expression of JUNB mRNA

NCBI chr19:12,791,486...12,793,315
Ensembl chr19:12,791,486...12,793,315

G

potassium channel tetramerization domain containing 11

decreases expression

Sodium Dodecyl Sulfate results in decreased expression of KCTD11 mRNA

NCBI chr17:7,352,162...7,354,944
Ensembl chr17:7,351,889...7,354,944

G

KIAA1549

increases expression

Sodium Dodecyl Sulfate results in increased expression of KIAA1549 mRNA

NCBI chr 7:138,831,381...138,981,389
Ensembl chr 7:138,831,381...138,981,389

G

KIAA1958

increases expression

Sodium Dodecyl Sulfate results in increased expression of KIAA1958 mRNA

NCBI chr 9:112,486,827...112,669,397
Ensembl chr 9:112,486,827...112,669,397

G

kinesin family member 20B

decreases expression

Sodium Dodecyl Sulfate results in decreased expression of KIF20B mRNA

NCBI chr10:89,701,590...89,774,934
Ensembl chr10:89,701,590...89,774,939

G

kinesin light chain 2

increases expression

Sodium Dodecyl Sulfate results in increased expression of KLC2 mRNA

NCBI chr11:66,243,938...66,267,860
Ensembl chr11:66,257,294...66,267,860

G

kelch like family member 21

increases expression

Sodium Dodecyl Sulfate results in increased expression of KLHL21 mRNA

NCBI chr 1:6,590,724...6,602,869
Ensembl chr 1:6,590,724...6,614,607

G

kallikrein related peptidase 10

decreases expression

Sodium Dodecyl Sulfate results in decreased expression of KLK10 mRNA

NCBI chr19:51,012,739...51,020,097
Ensembl chr19:51,012,739...51,020,175

G

killer cell lectin like receptor G2

decreases expression

Sodium Dodecyl Sulfate results in decreased expression of KLRG2 mRNA

NCBI chr 7:139,427,098...139,483,673
Ensembl chr 7:139,452,690...139,483,673

G

kininogen 1

increases expression

Sodium Dodecyl Sulfate results in increased expression of KNG1 mRNA

NCBI chr 3:186,717,359...186,744,410
Ensembl chr 3:186,717,348...186,744,410

G

KRAB box domain containing 5

decreases expression

Sodium Dodecyl Sulfate results in decreased expression of KRBOX5 mRNA

NCBI chr16:31,713,244...31,761,565
Ensembl chr16:31,713,229...31,794,869

G

keratin 1

decreases expression

Sodium Dodecyl Sulfate results in decreased expression of KRT1 mRNA

NCBI chr12:52,674,736...52,680,407
Ensembl chr12:52,674,736...52,680,407

G

keratin 18

increases expression

Sodium Dodecyl Sulfate results in increased expression of KRT18 mRNA

NCBI chr12:52,948,855...52,952,906
Ensembl chr12:52,948,871...52,952,906

G

keratin 2

increases expression

Sodium Dodecyl Sulfate results in increased expression of KRT2 mRNA

NCBI chr12:52,644,558...52,652,211
Ensembl chr12:52,644,558...52,652,211

G

keratin 37

increases expression

Sodium Dodecyl Sulfate results in increased expression of KRT37 mRNA

NCBI chr17:41,420,547...41,424,585
Ensembl chr17:41,420,547...41,424,585

G

keratin 8

decreases expression

Sodium Dodecyl Sulfate results in decreased expression of KRT8 mRNA

NCBI chr12:52,897,191...52,949,860
Ensembl chr12:52,897,187...52,949,954

G

keratin 80

decreases expression

Sodium Dodecyl Sulfate results in decreased expression of KRT80 mRNA

NCBI chr12:52,168,996...52,192,014
Ensembl chr12:52,168,996...52,192,014

G

keratin 9

decreases expression

Sodium Dodecyl Sulfate results in decreased expression of KRT9 protein

NCBI chr17:41,565,836...41,572,059
Ensembl chr17:41,565,836...41,572,059

G

laminin subunit beta 1

decreases expression

Sodium Dodecyl Sulfate results in decreased expression of LAMB1 mRNA

NCBI chr 7:107,923,799...108,003,161
Ensembl chr 7:107,923,799...108,003,213

G

lysosomal associated membrane protein 3

decreases expression

Sodium Dodecyl Sulfate results in decreased expression of LAMP3 mRNA

NCBI chr 3:183,122,215...183,163,813
Ensembl chr 3:183,122,215...183,163,839

G

late cornified envelope 1E

increases expression

Sodium Dodecyl Sulfate results in increased expression of LCE1E mRNA

NCBI chr 1:152,786,257...152,788,426
Ensembl chr 1:152,786,214...152,788,426

G

late cornified envelope 2B

increases expression

Sodium Dodecyl Sulfate results in increased expression of LCE2B mRNA

PMID:25240866 PMID:31734321

NCBI chr 1:152,686,123...152,687,397
Ensembl chr 1:152,686,123...152,687,397

G

late cornified envelope 3D

increases expression

Sodium Dodecyl Sulfate results in increased expression of LCE3D mRNA

PMID:25240866 PMID:31734321

NCBI chr 1:152,579,381...152,580,516
Ensembl chr 1:152,579,381...152,580,516

G

lipocalin 2

increases expression

Sodium Dodecyl Sulfate results in increased expression of LCN2 mRNA

NCBI chr 9:128,149,453...128,153,453
Ensembl chr 9:128,149,071...128,153,453

G

low density lipoprotein receptor class A domain containing 3

decreases expression

Sodium Dodecyl Sulfate results in decreased expression of LDLRAD3 mRNA

NCBI chr11:35,944,062...36,232,136
Ensembl chr11:35,943,981...36,232,136

G

LEM domain containing 1

decreases expression

Sodium Dodecyl Sulfate results in decreased expression of LEMD1 mRNA

NCBI chr 1:205,381,378...205,449,966
Ensembl chr 1:205,381,378...205,455,954

G

lipoic acid synthetase

increases expression

Sodium Dodecyl Sulfate results in increased expression of LIAS mRNA

NCBI chr 4:39,459,056...39,479,506
Ensembl chr 4:39,459,004...39,485,109

G

LIF interleukin 6 family cytokine

decreases expression

Sodium Dodecyl Sulfate results in decreased expression of LIF protein

NCBI chr22:30,240,453...30,246,759
Ensembl chr22:30,240,453...30,246,759

G

DNA ligase 3

increases expression

Sodium Dodecyl Sulfate results in increased expression of LIG3 mRNA

NCBI chr17:34,980,512...35,010,872
Ensembl chr17:34,980,512...35,009,743

G

long intergenic non-protein coding RNA 472

increases expression

Sodium Dodecyl Sulfate results in increased expression of LINC00472 mRNA

NCBI chr 6:71,407,864...71,420,745
Ensembl chr 6:71,187,161...71,420,745

G

loricrin cornified envelope precursor protein

decreases expression
increases expression

Sodium Dodecyl Sulfate results in decreased expression of LORICRIN protein
Sodium Dodecyl Sulfate results in increased expression of LORICRIN mRNA

PMID:25240866 PMID:33839235

NCBI chr 1:153,259,687...153,262,124
Ensembl chr 1:153,259,687...153,262,124

G

leucine rich repeat containing 8 VRAC subunit E

increases expression

Sodium Dodecyl Sulfate results in increased expression of LRRC8E mRNA

NCBI chr19:7,888,510...7,902,016
Ensembl chr19:7,888,505...7,902,021

G

lactotransferrin

decreases expression

Sodium Dodecyl Sulfate results in decreased expression of LTF mRNA

NCBI chr 3:46,435,645...46,485,234
Ensembl chr 3:46,435,645...46,485,234

G

LYN proto-oncogene, Src family tyrosine kinase

increases expression

Sodium Dodecyl Sulfate results in increased expression of LYN mRNA

NCBI chr 8:55,879,835...56,014,169
Ensembl chr 8:55,879,835...56,014,169

G

lysophospholipase 1

decreases expression

Sodium Dodecyl Sulfate results in decreased expression of LYPLA1 protein

NCBI chr 8:54,046,367...54,101,947
Ensembl chr 8:54,046,367...54,102,017

G

MAF bZIP transcription factor F

increases expression

Sodium Dodecyl Sulfate results in increased expression of MAFF mRNA

NCBI chr22:38,201,994...38,216,511
Ensembl chr22:38,200,767...38,216,507

G

MAF bZIP transcription factor G

increases expression

Sodium Dodecyl Sulfate results in increased expression of MAFG mRNA

NCBI chr17:81,918,270...81,931,244
Ensembl chr17:81,918,270...81,927,735

G

MAGE family member H1

increases expression

Sodium Dodecyl Sulfate results in increased expression of MAGEH1 mRNA

NCBI chr X:55,452,127...55,453,566
Ensembl chr X:55,452,127...55,453,566

G

mago homolog 2, pseudogene

decreases expression

Sodium Dodecyl Sulfate results in decreased expression of MAGOH2P mRNA

NCBI chr17:10,715,943...10,716,582
Ensembl chr17:10,716,076...10,716,511

G

mitogen-activated protein kinase kinase kinase 1

decreases expression

Sodium Dodecyl Sulfate results in decreased expression of MAP3K1 mRNA

NCBI chr 5:56,815,549...56,896,152
Ensembl chr 5:56,815,549...56,896,152

G

mitogen-activated protein kinase kinase kinase 8

increases expression

Sodium Dodecyl Sulfate results in increased expression of MAP3K8 mRNA

NCBI chr10:30,434,021...30,461,833
Ensembl chr10:30,434,021...30,461,833

G

MAP4K3 divergent transcript

decreases expression

Sodium Dodecyl Sulfate results in decreased expression of MAP4K3-DT mRNA

NCBI chr 2:39,437,416...39,601,344
Ensembl chr 2:39,436,530...39,665,343

G

mitogen-activated protein kinase 1

multiple interactions
increases phosphorylation

2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Sodium Dodecyl Sulfate results in increased phosphorylation of MAPK1 protein]

NCBI chr22:21,759,657...21,867,680
Ensembl chr22:21,759,657...21,867,680

G

mitogen-activated protein kinase 14

increases phosphorylation

Sodium Dodecyl Sulfate results in increased phosphorylation of MAPK14 protein

NCBI chr 6:36,027,808...36,124,214
Ensembl chr 6:36,027,782...36,111,236

G

mitogen-activated protein kinase 3

multiple interactions
increases phosphorylation

2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Sodium Dodecyl Sulfate results in increased phosphorylation of MAPK3 protein]

NCBI chr16:30,114,105...30,123,220
Ensembl chr16:30,114,105...30,123,506

G

MARCKS like 1

increases expression

Sodium Dodecyl Sulfate results in increased expression of MARCKSL1 mRNA

NCBI chr 1:32,333,839...32,336,233
Ensembl chr 1:32,333,839...32,336,233

G

metallo-beta-lactamase domain containing 1

increases expression

Sodium Dodecyl Sulfate results in increased expression of MBLAC1 mRNA

NCBI chr 7:100,126,967...100,128,495
Ensembl chr 7:100,126,785...100,128,495

G

multiple C2 and transmembrane domain containing 1

increases expression

Sodium Dodecyl Sulfate results in increased expression of MCTP1 mRNA

NCBI chr 5:94,703,690...95,285,094
Ensembl chr 5:94,703,690...95,285,094

G

malic enzyme 1

increases expression

Sodium Dodecyl Sulfate results in increased expression of ME1 mRNA

NCBI chr 6:83,210,402...83,431,051
Ensembl chr 6:83,210,402...83,431,051

G

mesenchyme homeobox 1

increases expression

Sodium Dodecyl Sulfate results in increased expression of MEOX1 mRNA

NCBI chr17:43,640,389...43,661,922
Ensembl chr17:43,640,389...43,661,922

G

MHC class I polypeptide-related sequence B

increases expression

Sodium Dodecyl Sulfate results in increased expression of MICB mRNA

NCBI chr 6:31,494,918...31,511,124
Ensembl chr 6:31,494,881...31,511,124

G

microRNA 205

decreases expression

Sodium Dodecyl Sulfate results in decreased expression of MIR205 mRNA

NCBI chr 1:209,432,133...209,432,242
Ensembl chr 1:209,432,133...209,432,242

G

MIR205 host gene

decreases expression

Sodium Dodecyl Sulfate results in decreased expression of MIR205HG mRNA

NCBI chr 1:209,428,820...209,432,549
Ensembl chr 1:209,428,817...209,432,848

G

microRNA 302b

decreases expression

Sodium Dodecyl Sulfate results in decreased expression of MIR302B mRNA

NCBI chr 4:112,648,485...112,648,557
Ensembl chr 4:112,648,485...112,648,557

G

metabolism of cobalamin associated A

increases expression

Sodium Dodecyl Sulfate results in increased expression of MMAA mRNA

NCBI chr 4:145,619,385...145,660,033
Ensembl chr 4:145,599,042...145,660,033

G

matrix metallopeptidase 10

increases expression

Sodium Dodecyl Sulfate results in increased expression of MMP10 mRNA

PMID:30806763 PMID:31734321

NCBI chr11:102,770,502...102,780,628
Ensembl chr11:102,770,502...102,780,628

G

matrix metallopeptidase 3

increases expression

Sodium Dodecyl Sulfate results in increased expression of MMP3 mRNA

NCBI chr11:102,835,801...102,843,609
Ensembl chr11:102,835,801...102,843,609

G

modulator of smoothened

decreases expression

Sodium Dodecyl Sulfate results in decreased expression of MOSMO mRNA

NCBI chr16:22,008,111...22,092,652
Ensembl chr16:22,007,638...22,087,534

G

mitochondrial ribosomal protein L38

decreases expression

Sodium Dodecyl Sulfate results in decreased expression of MRPL38 mRNA

NCBI chr17:75,898,644...75,904,884
Ensembl chr17:75,898,644...75,905,093

G

methionine sulfoxide reductase B2

decreases expression

Sodium Dodecyl Sulfate results in decreased expression of MSRB2 mRNA

NCBI chr10:23,095,579...23,122,013
Ensembl chr10:23,095,579...23,122,013

G

metallothionein 1A

increases expression

Sodium Dodecyl Sulfate results in increased expression of MT1A mRNA

NCBI chr16:56,638,666...56,640,087
Ensembl chr16:56,638,666...56,640,087

G

metallothionein 1F

increases expression

Sodium Dodecyl Sulfate results in increased expression of MT1F mRNA

NCBI chr16:56,657,959...56,659,303
Ensembl chr16:56,657,731...56,660,698

G

metallothionein 2A

increases expression

Sodium Dodecyl Sulfate results in increased expression of MT2A mRNA

NCBI chr16:56,608,584...56,609,497
Ensembl chr16:56,608,584...56,609,497

G

mucin 15, cell surface associated

decreases expression

Sodium Dodecyl Sulfate results in decreased expression of MUC15 mRNA

NCBI chr11:26,559,032...26,572,263
Ensembl chr11:26,559,032...26,572,263

G

MAX dimerization protein 1

increases expression

Sodium Dodecyl Sulfate results in increased expression of MXD1 mRNA

NCBI chr 2:69,915,109...69,942,945
Ensembl chr 2:69,897,688...69,942,945

G

matrix remodeling associated 5

decreases expression

Sodium Dodecyl Sulfate results in decreased expression of MXRA5 mRNA

NCBI chr X:3,308,565...3,346,652
Ensembl chr X:3,308,565...3,346,652

G

MYC proto-oncogene, bHLH transcription factor

increases expression

Sodium Dodecyl Sulfate results in increased expression of MYC mRNA

NCBI chr 8:127,735,434...127,742,951
Ensembl chr 8:127,735,434...127,742,951

G

myelin expression factor 2

increases expression

Sodium Dodecyl Sulfate results in increased expression of MYEF2 mRNA

NCBI chr15:48,134,632...48,178,295
Ensembl chr15:48,134,632...48,178,353

G

myosin light chain 12A

increases expression

Sodium Dodecyl Sulfate results in increased expression of MYL12A mRNA

NCBI chr18:3,247,482...3,256,237
Ensembl chr18:3,247,481...3,256,236

G

myosin light chain 5

increases expression

Sodium Dodecyl Sulfate results in increased expression of MYL5 mRNA

NCBI chr 4:674,542...682,028
Ensembl chr 4:673,580...682,028

G

nexilin F-actin binding protein

increases expression

Sodium Dodecyl Sulfate results in increased expression of NEXN mRNA

NCBI chr 1:77,888,624...77,943,895
Ensembl chr 1:77,888,513...77,943,895

G

nuclear factor kappa B subunit 1

affects expression

Sodium Dodecyl Sulfate affects the expression of NFKB1 mRNA

NCBI chr 4:102,501,359...102,617,302
Ensembl chr 4:102,501,330...102,617,302

G

nuclear transcription factor Y subunit alpha

increases expression

Sodium Dodecyl Sulfate results in increased expression of NFYA mRNA

NCBI chr 6:41,072,974...41,102,403
Ensembl chr 6:41,072,974...41,102,403

G

nipsnap homolog 2

decreases expression

Sodium Dodecyl Sulfate results in decreased expression of NIPSNAP2 mRNA

NCBI chr 7:55,964,585...56,000,179
Ensembl chr 7:55,951,793...56,000,181

G

NLR family pyrin domain containing 10

increases expression

Sodium Dodecyl Sulfate results in increased expression of NLRP10 mRNA

NCBI chr11:7,957,537...7,965,447
Ensembl chr11:7,957,537...7,965,447

G

NME/NM23 nucleoside diphosphate kinase 2

decreases expression

Sodium Dodecyl Sulfate results in decreased expression of NME2 protein

NCBI chr17:51,165,536...51,171,744
Ensembl chr17:51,165,435...51,171,744

G

neuromedin U

decreases expression

Sodium Dodecyl Sulfate results in decreased expression of NMU mRNA

NCBI chr 4:55,595,231...55,636,793
Ensembl chr 4:55,595,229...55,636,698

G

NAD(P)H quinone dehydrogenase 1

increases expression

Sodium Dodecyl Sulfate results in increased expression of NQO1 mRNA

PMID:20491607 PMID:20566472

NCBI chr16:69,709,401...69,726,560
Ensembl chr16:69,706,996...69,726,668

G

nuclear receptor subfamily 4 group A member 2

increases expression

Sodium Dodecyl Sulfate results in increased expression of NR4A2 mRNA

NCBI chr 2:156,324,437...156,332,721
Ensembl chr 2:156,324,437...156,342,348

G

neurotrophic receptor tyrosine kinase 2

affects response to substance

NTRK2 SNP affects the susceptibility to Sodium Dodecyl Sulfate

NCBI chr 9:84,668,522...85,027,054
Ensembl chr 9:84,668,375...85,095,751

G

olfactomedin like 2A

decreases expression

Sodium Dodecyl Sulfate results in decreased expression of OLFML2A mRNA

NCBI chr 9:124,777,133...124,814,882
Ensembl chr 9:124,777,133...124,814,885

G

olfactory receptor family 2 subfamily B member 3

affects response to substance

OR2B3 SNP affects the susceptibility to Sodium Dodecyl Sulfate

NCBI chr 6:29,086,208...29,087,313
Ensembl chr 6:29,086,208...29,087,313

G

purinergic receptor P2Y1

decreases expression

Sodium Dodecyl Sulfate results in decreased expression of P2RY1 mRNA

NCBI chr 3:152,835,131...152,841,439
Ensembl chr 3:152,835,131...152,841,439

G

PAS domain containing serine/threonine kinase

decreases expression

Sodium Dodecyl Sulfate results in decreased expression of PASK mRNA

NCBI chr 2:241,106,099...241,150,347
Ensembl chr 2:241,106,099...241,150,264

G

PCBP1 antisense RNA 1

increases expression

Sodium Dodecyl Sulfate results in increased expression of PCBP1-AS1 mRNA

NCBI chr 2:69,962,263...70,088,208
Ensembl chr 2:69,960,104...70,103,220

G

PC-esterase domain containing 1A

decreases expression

Sodium Dodecyl Sulfate results in decreased expression of PCED1A mRNA

NCBI chr20:2,835,314...2,841,151
Ensembl chr20:2,835,314...2,841,190

G

phosphoenolpyruvate carboxykinase 2, mitochondrial

decreases expression

Sodium Dodecyl Sulfate results in decreased expression of PCK2 mRNA

NCBI chr14:24,094,171...24,104,125
Ensembl chr14:24,094,053...24,110,598

G

proprotein convertase subtilisin/kexin type 6

increases expression

Sodium Dodecyl Sulfate results in increased expression of PCSK6 mRNA

NCBI chr15:101,303,933...101,489,707
Ensembl chr15:101,289,784...101,525,202

G

phosphatidylcholine transfer protein

increases expression

Sodium Dodecyl Sulfate results in increased expression of PCTP mRNA

NCBI chr17:55,751,051...55,852,715
Ensembl chr17:55,751,051...55,842,830

G

pyruvate dehydrogenase E1 subunit alpha 1

decreases expression

Sodium Dodecyl Sulfate results in decreased expression of PDHA1 protein

NCBI chr X:19,343,927...19,361,718
Ensembl chr X:19,343,893...19,361,718

G

period circadian regulator 2

decreases expression

Sodium Dodecyl Sulfate results in decreased expression of PER2 mRNA

NCBI chr 2:238,244,044...238,300,065
Ensembl chr 2:238,244,044...238,290,102

G

peroxisomal biogenesis factor 11 gamma

increases expression

Sodium Dodecyl Sulfate results in increased expression of PEX11G mRNA

NCBI chr19:7,476,875...7,494,977
Ensembl chr19:7,476,875...7,497,449

G

phosphogluconate dehydrogenase

increases expression

Sodium Dodecyl Sulfate results in increased expression of PGD mRNA

NCBI chr 1:10,399,064...10,420,511
Ensembl chr 1:10,398,592...10,420,511

G

PH domain containing endocytic trafficking adaptor 1

increases expression

Sodium Dodecyl Sulfate results in increased expression of PHETA1 mRNA

NCBI chr12:111,360,679...111,369,095
Ensembl chr12:111,360,651...111,369,121

G

putative homeodomain transcription factor 1

increases expression

Sodium Dodecyl Sulfate results in increased expression of PHTF1 mRNA

NCBI chr 1:113,696,831...113,759,888
Ensembl chr 1:113,696,831...113,759,489

G

peptidase inhibitor 3

decreases expression
increases expression

Sodium Dodecyl Sulfate results in decreased expression of PI3 mRNA
Sodium Dodecyl Sulfate results in increased expression of PI3 mRNA

PMID:17936526 PMID:31734321

NCBI chr20:45,174,902...45,176,544
Ensembl chr20:45,174,902...45,176,544

G

peptidylprolyl cis/trans isomerase, NIMA-interacting 1 pseudogene 1

increases expression

Sodium Dodecyl Sulfate results in increased expression of PIN1P1 mRNA

NCBI chr 1:69,919,322...69,920,317
Ensembl chr 1:69,919,322...69,920,317
Ensembl chr 1:69,919,322...69,920,317

G

phosphatidylinositol-5-phosphate 4-kinase type 2 beta

increases expression

Sodium Dodecyl Sulfate results in increased expression of PIP4K2B mRNA

NCBI chr17:38,765,691...38,799,556
Ensembl chr17:38,765,691...38,800,126

G

pirin

decreases expression

Sodium Dodecyl Sulfate results in decreased expression of PIR mRNA

NCBI chr X:15,384,799...15,493,333
Ensembl chr X:15,384,799...15,493,564

G

phosphatidylinositol transfer protein beta

decreases expression

Sodium Dodecyl Sulfate results in decreased expression of PITPNB protein

NCBI chr22:27,851,669...27,919,256
Ensembl chr22:27,851,669...27,920,134

G

PITX1 antisense RNA 1

increases expression

Sodium Dodecyl Sulfate results in increased expression of PITX1-AS1 mRNA

NCBI chr 5:135,033,274...135,344,680
Ensembl chr 5:135,033,280...135,358,219

G

piwi like RNA-mediated gene silencing 2

increases expression

Sodium Dodecyl Sulfate results in increased expression of PIWIL2 mRNA

NCBI chr 8:22,275,316...22,357,568
Ensembl chr 8:22,275,316...22,357,568

G

pejvakin

increases expression

Sodium Dodecyl Sulfate results in increased expression of PJVK mRNA

NCBI chr 2:178,451,378...178,462,102
Ensembl chr 2:178,451,346...178,462,102

G

phospholipase A2 group IVA

decreases expression

Sodium Dodecyl Sulfate results in decreased expression of PLA2G4A mRNA

NCBI chr 1:186,828,949...186,988,981
Ensembl chr 1:186,828,949...186,988,981

G

phospholipase A and acyltransferase 4

decreases expression

Sodium Dodecyl Sulfate results in decreased expression of PLAAT4 mRNA

NCBI chr11:63,536,808...63,546,458
Ensembl chr11:63,536,808...63,546,462

G

plasminogen activator, urokinase receptor

increases expression

Sodium Dodecyl Sulfate results in increased expression of PLAUR mRNA

NCBI chr19:43,646,095...43,670,169
Ensembl chr19:43,646,095...43,670,547

G

phospholipase D1

decreases expression

Sodium Dodecyl Sulfate results in decreased expression of PLD1 mRNA

NCBI chr 3:171,600,404...171,810,483
Ensembl chr 3:171,600,404...171,810,950

G

pleckstrin homology domain containing B1

increases expression

Sodium Dodecyl Sulfate results in increased expression of PLEKHB1 mRNA

NCBI chr11:73,646,581...73,662,819
Ensembl chr11:73,646,178...73,662,819

G

pleckstrin homology and RhoGEF domain containing G1

decreases expression

Sodium Dodecyl Sulfate results in decreased expression of PLEKHG1 mRNA

NCBI chr 6:150,599,885...150,843,665
Ensembl chr 6:150,599,883...150,843,665

G

plasminogen receptor with a C-terminal lysine

decreases expression

Sodium Dodecyl Sulfate results in decreased expression of PLGRKT mRNA

NCBI chr 9:5,357,971...5,438,377
Ensembl chr 9:5,357,971...5,437,925

G

polo like kinase 3

increases expression

Sodium Dodecyl Sulfate results in increased expression of PLK3 mRNA

NCBI chr 1:44,800,377...44,805,990
Ensembl chr 1:44,800,377...44,805,990

G

phospholipid phosphatase 3

increases expression

Sodium Dodecyl Sulfate results in increased expression of PLPP3 mRNA

NCBI chr 1:56,494,761...56,579,563
Ensembl chr 1:56,494,761...56,645,301

G

plexin C1

increases expression

Sodium Dodecyl Sulfate results in increased expression of PLXNC1 mRNA

NCBI chr12:94,148,577...94,307,675
Ensembl chr12:94,148,577...94,307,675

G

patatin like phospholipase domain containing 6

increases expression

Sodium Dodecyl Sulfate results in increased expression of PNPLA6 mRNA

NCBI chr19:7,534,164...7,561,767
Ensembl chr19:7,534,004...7,561,764

G

PPFIA binding protein 2

decreases expression

Sodium Dodecyl Sulfate results in decreased expression of PPFIBP2 mRNA

NCBI chr11:7,513,999...7,667,304
Ensembl chr11:7,513,298...7,657,127

G

peptidylprolyl isomerase F

increases expression

Sodium Dodecyl Sulfate results in increased expression of PPIF mRNA

NCBI chr10:79,347,469...79,355,334
Ensembl chr10:79,347,469...79,355,334

G

protein phosphatase 1 catalytic subunit beta

decreases expression

Sodium Dodecyl Sulfate results in decreased expression of PPP1CB protein

NCBI chr 2:28,751,604...28,802,940
Ensembl chr 2:28,751,640...28,802,940

G

protein phosphatase 1 regulatory subunit 10

increases expression

Sodium Dodecyl Sulfate results in increased expression of PPP1R10 mRNA

NCBI chr 6:30,600,413...30,617,243
Ensembl chr 6:30,600,413...30,618,612

G

peroxiredoxin 2

increases expression

Sodium Dodecyl Sulfate results in increased expression of PRDX2 mRNA

NCBI chr19:12,796,823...12,801,800
Ensembl chr19:12,796,820...12,801,800

G

protein arginine methyltransferase 1

decreases expression

Sodium Dodecyl Sulfate results in decreased expression of PRMT1 mRNA

NCBI chr19:49,676,153...49,688,447
Ensembl chr19:49,675,786...49,689,029

G

phosphoribosyl pyrophosphate synthetase 2

decreases expression

Sodium Dodecyl Sulfate results in decreased expression of PRPS2 protein

NCBI chr X:12,791,412...12,824,222
Ensembl chr X:12,791,355...12,824,222

G

proline rich 15

increases expression

Sodium Dodecyl Sulfate results in increased expression of PRR15 mRNA

NCBI chr 7:29,563,835...29,567,295
Ensembl chr 7:29,563,835...29,567,293

G

proline rich 9

increases expression

Sodium Dodecyl Sulfate results in increased expression of PRR9 mRNA

NCBI chr 1:153,217,584...153,219,310
Ensembl chr 1:153,217,584...153,219,310

G

proline rich coiled-coil 2A

affects response to substance

PRRC2A SNP affects the susceptibility to Sodium Dodecyl Sulfate

NCBI chr 6:31,620,715...31,637,771
Ensembl chr 6:31,620,715...31,637,771

G

proline rich and Gla domain 4

decreases expression

Sodium Dodecyl Sulfate results in decreased expression of PRRG4 mRNA

NCBI chr11:32,829,789...32,858,120
Ensembl chr11:32,829,927...32,858,120

G

serine protease 3

decreases expression

Sodium Dodecyl Sulfate results in decreased expression of PRSS3 mRNA

NCBI chr 9:33,750,679...33,799,231
Ensembl chr 9:33,750,679...33,799,231

G

serine protease 8

increases expression

Sodium Dodecyl Sulfate results in increased expression of PRSS8 mRNA

NCBI chr16:31,131,433...31,135,727
Ensembl chr16:31,131,433...31,135,727

G

proteasome 20S subunit alpha 2

decreases expression

Sodium Dodecyl Sulfate results in decreased expression of PSMA2 protein

NCBI chr 7:42,916,861...42,932,174
Ensembl chr 7:42,916,828...42,932,185

G

proteasome 20S subunit beta 10

decreases expression

Sodium Dodecyl Sulfate results in decreased expression of PSMB10 mRNA

NCBI chr16:67,934,506...67,936,850
Ensembl chr16:67,934,506...67,936,864

G

proteasome 20S subunit beta 9

decreases expression

Sodium Dodecyl Sulfate results in decreased expression of PSMB9 mRNA

NCBI chr 6:32,854,192...32,859,851
Ensembl chr 6:32,844,136...32,859,851

G

proteasome activator subunit 3

increases expression

Sodium Dodecyl Sulfate results in increased expression of PSME3 protein

NCBI chr17:42,833,397...42,843,760
Ensembl chr17:42,824,385...42,843,760

G

prostaglandin reductase 1

increases expression

Sodium Dodecyl Sulfate results in increased expression of PTGR1 mRNA

NCBI chr 9:111,549,722...111,599,647
Ensembl chr 9:111,549,722...111,599,893

G

prostaglandin-endoperoxide synthase 2

increases expression

Sodium Dodecyl Sulfate results in increased expression of PTGS2 mRNA

NCBI chr 1:186,671,791...186,680,423
Ensembl chr 1:186,671,791...186,680,922

G

protein tyrosine phosphatase receptor type Z1

decreases expression

Sodium Dodecyl Sulfate results in decreased expression of PTPRZ1 mRNA

NCBI chr 7:121,873,161...122,062,036
Ensembl chr 7:121,873,089...122,062,036

G

pentraxin 3

increases expression

Sodium Dodecyl Sulfate results in increased expression of PTX3 mRNA

NCBI chr 3:157,436,850...157,443,633
Ensembl chr 3:157,436,850...157,443,633

G

peroxidasin

increases expression

Sodium Dodecyl Sulfate results in increased expression of PXDN mRNA

NCBI chr 2:1,631,887...1,744,901
Ensembl chr 2:1,631,887...1,744,852

G

PYD and CARD domain containing

decreases expression

Sodium Dodecyl Sulfate results in decreased expression of PYCARD protein

NCBI chr16:31,201,486...31,202,760
Ensembl chr16:31,201,486...31,203,450

G

RAB33A, member RAS oncogene family

increases expression

Sodium Dodecyl Sulfate results in increased expression of RAB33A mRNA

NCBI chr X:130,110,623...130,184,870
Ensembl chr X:130,171,962...130,184,870

G

RAB7B, member RAS oncogene family

decreases expression

Sodium Dodecyl Sulfate results in decreased expression of RAB7B mRNA

NCBI chr 1:205,976,740...206,003,395
Ensembl chr 1:205,976,740...206,003,461

G

retinoic acid early transcript 1E

decreases expression

Sodium Dodecyl Sulfate results in decreased expression of RAET1E mRNA

NCBI chr 6:149,883,179...149,898,113
Ensembl chr 6:149,883,179...149,898,113

G

retinoic acid receptor alpha

decreases expression

Sodium Dodecyl Sulfate results in decreased expression of RARA mRNA

NCBI chr17:40,309,180...40,357,643
Ensembl chr17:40,309,180...40,357,643

G

RB transcriptional corepressor 1

decreases expression

Sodium Dodecyl Sulfate results in decreased expression of RB1 mRNA

NCBI chr13:48,303,751...48,481,890
Ensembl chr13:48,303,744...48,599,436

G

RCC1 domain containing 1

decreases expression

Sodium Dodecyl Sulfate results in decreased expression of RCCD1 mRNA

NCBI chr15:90,954,884...90,963,125
Ensembl chr15:90,954,881...90,963,125

G

retinol dehydrogenase 12

decreases expression

Sodium Dodecyl Sulfate results in decreased expression of RDH12 mRNA

NCBI chr14:67,701,886...67,734,451
Ensembl chr14:67,701,886...67,734,451

G

replication initiator 1

decreases expression

Sodium Dodecyl Sulfate results in decreased expression of REPIN1 mRNA

NCBI chr 7:150,368,096...150,374,039
Ensembl chr 7:150,368,189...150,374,044

G

RFT1 homolog

decreases expression

Sodium Dodecyl Sulfate results in decreased expression of RFT1 mRNA

NCBI chr 3:53,066,853...53,130,435
Ensembl chr 3:53,088,483...53,130,453

G

regulator of cell cycle

increases expression

Sodium Dodecyl Sulfate results in increased expression of RGCC mRNA

NCBI chr13:41,457,550...41,470,871
Ensembl chr13:41,457,550...41,470,871

G

regulator of G protein signaling 1

increases expression

Sodium Dodecyl Sulfate results in increased expression of RGS1 mRNA

NCBI chr 1:192,575,773...192,580,024
Ensembl chr 1:192,575,763...192,580,024

G

rhomboid 5 homolog 1

decreases expression

Sodium Dodecyl Sulfate results in decreased expression of RHBDF1 mRNA

NCBI chr16:58,059...76,360
Ensembl chr16:58,059...76,355

G

rhomboid like 2

decreases expression

Sodium Dodecyl Sulfate results in decreased expression of RHBDL2 mRNA

NCBI chr 1:38,885,807...38,941,830
Ensembl chr 1:38,885,807...38,941,830

G

RAD9-HUS1-RAD1 interacting nuclear orphan 1

decreases expression

Sodium Dodecyl Sulfate results in decreased expression of RHNO1 mRNA

NCBI chr12:2,876,265...2,889,524
Ensembl chr12:2,876,258...2,889,524

G

ras homolog family member U

decreases expression

Sodium Dodecyl Sulfate results in decreased expression of RHOU mRNA

NCBI chr 1:228,644,647...228,746,669
Ensembl chr 1:228,735,479...228,746,664

G

RNA, 5S ribosomal pseudogene 455

increases expression

Sodium Dodecyl Sulfate results in increased expression of RNA5SP455 mRNA

NCBI chr18:44,071,583...44,071,701
Ensembl chr18:44,071,583...44,071,701

G

Rho family GTPase 1

increases expression

Sodium Dodecyl Sulfate results in increased expression of RND1 mRNA

NCBI chr12:48,857,145...48,865,870
Ensembl chr12:48,857,145...48,865,870

G

ring finger protein 39

increases expression

Sodium Dodecyl Sulfate results in increased expression of RNF39 mRNA

NCBI chr 6:30,070,270...30,075,769
Ensembl chr 6:30,070,266...30,075,849

G

ribosomal protein L22 like 1

decreases expression

Sodium Dodecyl Sulfate results in decreased expression of RPL22L1 mRNA

NCBI chr 3:170,864,875...170,870,195
Ensembl chr 3:170,864,875...170,870,208

G

repetin

decreases expression
increases expression

Sodium Dodecyl Sulfate results in decreased expression of RPTN mRNA
Sodium Dodecyl Sulfate results in increased expression of RPTN mRNA

PMID:25240866 PMID:31734321

NCBI chr 1:152,153,595...152,159,228
Ensembl chr 1:152,153,595...152,159,228

G

RWD domain containing 2B

decreases expression

Sodium Dodecyl Sulfate results in decreased expression of RWDD2B mRNA

NCBI chr21:29,004,384...29,019,349
Ensembl chr21:29,004,384...29,019,360

G

S100 calcium binding protein A1

increases expression

Sodium Dodecyl Sulfate results in increased expression of S100A1 mRNA

NCBI chr 1:153,628,434...153,632,039
Ensembl chr 1:153,627,926...153,632,039

G

S100 calcium binding protein A5

increases expression

Sodium Dodecyl Sulfate results in increased expression of S100A5 mRNA

NCBI chr 1:153,537,147...153,543,685
Ensembl chr 1:153,537,147...153,541,765

G

S100 calcium binding protein A7

increases expression

Sodium Dodecyl Sulfate results in increased expression of S100A7 mRNA

NCBI chr 1:153,457,744...153,460,651
Ensembl chr 1:153,457,744...153,460,651

G

S100 calcium binding protein A7A

decreases expression
increases expression

Sodium Dodecyl Sulfate results in decreased expression of S100A7A mRNA
Sodium Dodecyl Sulfate results in increased expression of S100A7A mRNA

NCBI chr 1:153,416,520...153,423,222
Ensembl chr 1:153,416,520...153,423,222

G

S100 calcium binding protein A9

decreases expression

Sodium Dodecyl Sulfate results in decreased expression of S100A9 mRNA

NCBI chr 1:153,357,854...153,361,023
Ensembl chr 1:153,357,854...153,361,023

G

S100 calcium binding protein B

multiple interactions

Sodium Dodecyl Sulfate results in increased expression of and results in increased secretion of S100B protein

NCBI chr21:46,598,604...46,605,082
Ensembl chr21:46,598,604...46,605,208

G

sterile alpha motif domain containing 4A

increases expression

Sodium Dodecyl Sulfate results in increased expression of SAMD4A mRNA

NCBI chr14:54,565,316...54,793,315
Ensembl chr14:54,566,117...54,793,315

G

sterile alpha motif domain containing 9

decreases expression

Sodium Dodecyl Sulfate results in decreased expression of SAMD9 mRNA

NCBI chr 7:93,099,518...93,117,979
Ensembl chr 7:93,099,513...93,118,023

G

SAS-6 centriolar assembly protein

increases expression

Sodium Dodecyl Sulfate results in increased expression of SASS6 mRNA

NCBI chr 1:100,083,570...100,132,930
Ensembl chr 1:100,083,563...100,132,955

G

SATB homeobox 2

increases expression

Sodium Dodecyl Sulfate results in increased expression of SATB2 mRNA

NCBI chr 2:199,269,500...199,471,266
Ensembl chr 2:199,269,505...199,471,266

G

stabilizer of axonemal microtubules 2

increases expression

Sodium Dodecyl Sulfate results in increased expression of SAXO2 mRNA

NCBI chr15:82,262,818...82,284,927
Ensembl chr15:82,262,810...82,284,930

G

stearoyl-CoA desaturase

decreases expression
increases expression

Sodium Dodecyl Sulfate results in decreased expression of SCD1 mRNA
Sodium Dodecyl Sulfate results in increased expression of SCD mRNA

PMID:12815608 PMID:29155129

NCBI chr10:100,347,233...100,364,826
Ensembl chr10:100,347,233...100,364,826

G

stromal cell derived factor 2 like 1

increases expression

Sodium Dodecyl Sulfate results in increased expression of SDF2L1 mRNA

NCBI chr22:21,642,302...21,644,299
Ensembl chr22:21,642,302...21,644,299

G

SEC14 like lipid binding 1

increases expression

Sodium Dodecyl Sulfate results in increased expression of SEC14L1 mRNA

NCBI chr17:77,088,685...77,217,101
Ensembl chr17:77,088,749...77,217,101

G

SEC22 homolog C, vesicle trafficking protein

increases expression

Sodium Dodecyl Sulfate results in increased expression of SEC22C mRNA

NCBI chr 3:42,547,969...42,601,078
Ensembl chr 3:42,547,969...42,601,080

G

semaphorin 3A

increases expression

Sodium Dodecyl Sulfate results in increased expression of SEMA3A mRNA

NCBI chr 7:83,955,777...84,492,725
Ensembl chr 7:83,955,777...84,492,724

G

serine incorporator 3

increases expression

Sodium Dodecyl Sulfate results in increased expression of SERINC3 mRNA

NCBI chr20:44,496,221...44,522,070
Ensembl chr20:44,496,221...44,522,085

G

serpin family B member 3

decreases expression
increases expression

Sodium Dodecyl Sulfate results in decreased expression of SERPINB3 protein
Sodium Dodecyl Sulfate results in increased expression of SERPINB3 mRNA

PMID:20332019 PMID:30806763

NCBI chr18:63,655,197...63,661,893
Ensembl chr18:63,655,197...63,661,893

G

serpin family E member 1

increases expression

Sodium Dodecyl Sulfate results in increased expression of SERPINE1 mRNA

NCBI chr 7:101,127,104...101,139,247
Ensembl chr 7:101,127,104...101,139,247

G

SERTA domain containing 4

increases expression

Sodium Dodecyl Sulfate results in increased expression of SERTAD4 mRNA

NCBI chr 1:210,232,796...210,246,631
Ensembl chr 1:210,232,796...210,246,631

G

sphingomyelin synthase 2

increases expression

Sodium Dodecyl Sulfate results in increased expression of SGMS2 mRNA

NCBI chr 4:107,824,563...107,915,047
Ensembl chr 4:107,824,563...107,915,047

G

SH3 domain binding protein 4

increases expression

Sodium Dodecyl Sulfate results in increased expression of SH3BP4 mRNA

NCBI chr 2:234,952,017...235,055,714
Ensembl chr 2:234,952,017...235,055,714

G

SH3 domain containing 21

increases expression

Sodium Dodecyl Sulfate results in increased expression of SH3D21 mRNA

NCBI chr 1:36,306,368...36,330,236
Ensembl chr 1:36,306,368...36,329,340

G

shroom family member 3

increases expression

Sodium Dodecyl Sulfate results in increased expression of SHROOM3 mRNA

NCBI chr 4:76,435,229...76,783,253
Ensembl chr 4:76,435,229...76,783,253

G

solute carrier family 20 member 1

increases expression

Sodium Dodecyl Sulfate results in increased expression of SLC20A1 mRNA

NCBI chr 2:112,645,939...112,663,825
Ensembl chr 2:112,645,939...112,663,825

G

solute carrier family 22 member 3

decreases expression

Sodium Dodecyl Sulfate results in decreased expression of SLC22A3 mRNA

NCBI chr 6:160,348,378...160,452,577
Ensembl chr 6:160,348,378...160,452,577

G

solute carrier family 22 member 4

increases expression

Sodium Dodecyl Sulfate results in increased expression of SLC22A4 mRNA

NCBI chr 5:132,294,394...132,344,190
Ensembl chr 5:132,294,394...132,344,190

G

solute carrier family 23 member 2

increases expression

Sodium Dodecyl Sulfate results in increased expression of SLC23A2 mRNA

NCBI chr20:4,852,358...5,010,313
Ensembl chr20:4,852,356...5,010,293

G

SLC25A21 antisense RNA 1

increases expression

Sodium Dodecyl Sulfate results in increased expression of SLC25A21-AS1 mRNA

NCBI chr14:37,172,026...37,173,794
Ensembl chr14:37,171,888...37,173,811

G

solute carrier family 25 member 24

increases expression

Sodium Dodecyl Sulfate results in increased expression of SLC25A24 mRNA

NCBI chr 1:108,134,043...108,200,343
Ensembl chr 1:108,134,043...108,200,849

G

solute carrier family 25 member 43

decreases expression

Sodium Dodecyl Sulfate results in decreased expression of SLC25A43 mRNA

NCBI chr X:119,399,336...119,454,478
Ensembl chr X:119,399,336...119,454,478

G

solute carrier family 27 member 1

increases expression

Sodium Dodecyl Sulfate results in increased expression of SLC27A1 mRNA

NCBI chr19:17,468,767...17,506,168
Ensembl chr19:17,468,769...17,506,168

G

solute carrier family 7 member 11

increases expression

Sodium Dodecyl Sulfate results in increased expression of SLC7A11 mRNA

NCBI chr 4:138,164,097...138,312,671
Ensembl chr 4:138,164,097...138,242,349

G

solute carrier family 9 member A9

decreases expression

Sodium Dodecyl Sulfate results in decreased expression of SLC9A9 mRNA

NCBI chr 3:143,265,222...143,848,468
Ensembl chr 3:143,265,222...143,848,485

G

SPARC related modular calcium binding 1

increases expression

Sodium Dodecyl Sulfate results in increased expression of SMOC1 mRNA

NCBI chr14:69,879,416...70,032,366
Ensembl chr14:69,854,131...70,032,366

G

small nucleolar RNA, H/ACA box 68

increases expression

Sodium Dodecyl Sulfate results in increased expression of SNORA68 mRNA

NCBI chr19:17,862,588...17,862,720
Ensembl chr19:17,862,588...17,862,720

G

superoxide dismutase 1

decreases expression
increases expression

Sodium Dodecyl Sulfate results in decreased expression of SOD1 mRNA
Sodium Dodecyl Sulfate results in decreased expression of SOD1 protein
Sodium Dodecyl Sulfate results in increased expression of SOD1 mRNA

PMID:12815608 PMID:21469165

NCBI chr21:31,659,693...31,668,931
Ensembl chr21:31,659,666...31,668,931

G

SRY-box transcription factor 7

decreases expression

Sodium Dodecyl Sulfate results in decreased expression of SOX7 mRNA

NCBI chr 8:10,723,768...10,730,511
Ensembl chr 8:10,723,768...10,730,511

G

serine peptidase inhibitor Kazal type 6

increases expression

Sodium Dodecyl Sulfate results in increased expression of SPINK6 mRNA

NCBI chr 5:148,202,778...148,215,137
Ensembl chr 5:148,202,794...148,215,137

G

serine peptidase inhibitor Kazal type 7

increases expression

Sodium Dodecyl Sulfate results in increased expression of SPINK7 mRNA

NCBI chr 5:148,312,423...148,315,919
Ensembl chr 5:148,312,419...148,315,922

G

small proline rich protein 2G

increases expression

Sodium Dodecyl Sulfate results in increased expression of SPRR2G mRNA

PMID:25240866 PMID:31734321

NCBI chr 1:153,149,582...153,203,278
Ensembl chr 1:153,149,582...153,150,890

G

small proline rich protein 3

increases expression

Sodium Dodecyl Sulfate results in increased expression of SPRR3 mRNA

NCBI chr 1:153,001,749...153,003,856
Ensembl chr 1:153,001,747...153,003,856

G

small proline rich protein 4

increases expression

Sodium Dodecyl Sulfate results in increased expression of SPRR4 mRNA

NCBI chr 1:152,968,750...152,972,574
Ensembl chr 1:152,970,648...152,972,574

G

SLIT-ROBO Rho GTPase activating protein 2C

decreases expression

Sodium Dodecyl Sulfate results in decreased expression of SRGAP2C mRNA

NCBI chr 1:121,184,975...121,392,874
Ensembl chr 1:121,184,811...121,392,874

G

sulfiredoxin 1

increases expression

Sodium Dodecyl Sulfate results in increased expression of SRXN1 mRNA

NCBI chr20:646,615...653,200
Ensembl chr20:646,615...653,200

G

ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 2

decreases expression

Sodium Dodecyl Sulfate results in decreased expression of ST6GALNAC2 mRNA

NCBI chr17:76,565,377...76,585,860
Ensembl chr17:76,565,377...76,586,956

G

STAM divergent transcript

increases expression

Sodium Dodecyl Sulfate results in increased expression of STAM-DT mRNA

NCBI chr10:17,641,284...17,643,918
Ensembl chr10:17,641,284...17,643,878

G

signal transducer and activator of transcription 6

increases phosphorylation
multiple interactions

Sodium Dodecyl Sulfate results in increased phosphorylation of STAT6 protein
WHI P131 inhibits the reaction [Sodium Dodecyl Sulfate results in increased phosphorylation of STAT6 protein]

NCBI chr12:57,095,408...57,111,362
Ensembl chr12:57,095,408...57,132,139

G

serine/threonine kinase 10

increases expression

Sodium Dodecyl Sulfate results in increased expression of STK10 mRNA

NCBI chr 5:172,042,079...172,188,224
Ensembl chr 5:172,042,079...172,188,224

G

sulfotransferase family 1E member 1

decreases expression

Sodium Dodecyl Sulfate results in decreased expression of SULT1E1 mRNA

NCBI chr 4:69,821,122...69,860,145
Ensembl chr 4:69,841,212...69,860,145

G

sulfotransferase family 2B member 1

decreases expression

Sodium Dodecyl Sulfate results in decreased expression of SULT2B1 mRNA

NCBI chr19:48,552,172...48,599,427
Ensembl chr19:48,552,172...48,599,425

G

sushi domain containing 1

increases expression

Sodium Dodecyl Sulfate results in increased expression of SUSD1 mRNA

NCBI chr 9:112,040,783...112,175,297
Ensembl chr 9:112,040,783...112,175,297

G

synaptogyrin 3

increases expression

Sodium Dodecyl Sulfate results in increased expression of SYNGR3 mRNA

NCBI chr16:1,989,970...1,994,275
Ensembl chr16:1,989,660...1,994,275

G

tachykinin precursor 1

increases expression

Sodium Dodecyl Sulfate results in increased expression of TAC1 mRNA

NCBI chr 7:97,732,086...97,740,472
Ensembl chr 7:97,732,084...97,740,472

G

TAF1A antisense RNA 1

increases expression

Sodium Dodecyl Sulfate results in increased expression of TAF1A-AS1 mRNA

NCBI chr 1:222,589,920...222,592,633
Ensembl chr 1:222,589,825...222,593,843

G

transaldolase 1

decreases expression

Sodium Dodecyl Sulfate results in decreased expression of TALDO1 protein

NCBI chr11:747,464...765,012
Ensembl chr11:747,415...765,012

G

transcription factor 7 like 2

increases expression

Sodium Dodecyl Sulfate results in increased expression of TCF7L2 mRNA

NCBI chr10:112,950,247...113,167,678
Ensembl chr10:112,950,247...113,167,678

G

telomerase reverse transcriptase

decreases expression

Sodium Dodecyl Sulfate results in decreased expression of TERT mRNA

NCBI chr 5:1,253,167...1,295,068
Ensembl chr 5:1,253,147...1,295,068

G

testis expressed 14, intercellular bridge forming factor

increases expression

Sodium Dodecyl Sulfate results in increased expression of TEX14 mRNA

NCBI chr17:58,556,678...58,692,045
Ensembl chr17:58,556,678...58,692,055

G

testis expressed 261

decreases expression

Sodium Dodecyl Sulfate results in decreased expression of TEX261 mRNA

NCBI chr 2:70,985,942...70,994,873
Ensembl chr 2:70,968,325...70,994,873

G

TFAP2A antisense RNA 1

increases expression

Sodium Dodecyl Sulfate results in increased expression of TFAP2A-AS1 mRNA

NCBI chr 6:10,412,318...10,416,169
Ensembl chr 6:10,409,340...10,416,446

G

tissue factor pathway inhibitor 2

increases expression

Sodium Dodecyl Sulfate results in increased expression of TFPI2 mRNA

NCBI chr 7:93,885,396...93,890,753
Ensembl chr 7:93,885,396...93,890,753

G

threonine synthase like 1

decreases expression

Sodium Dodecyl Sulfate results in decreased expression of THNSL1 mRNA

NCBI chr10:24,952,364...25,026,664
Ensembl chr10:25,016,612...25,026,664

G

toll like receptor 2

increases expression

Sodium Dodecyl Sulfate results in increased expression of TLR2 mRNA

NCBI chr 4:153,684,280...153,710,637
Ensembl chr 4:153,684,070...153,706,260

G

transmembrane 4 L six family member 1

increases expression

Sodium Dodecyl Sulfate results in increased expression of TM4SF1 mRNA

NCBI chr 3:149,369,022...149,377,649
Ensembl chr 3:149,369,022...149,377,692

G

transmembrane protein 125

increases expression

Sodium Dodecyl Sulfate results in increased expression of TMEM125 mRNA

NCBI chr 1:43,269,983...43,274,002
Ensembl chr 1:43,269,983...43,274,002

G

transmembrane protein 177

decreases expression

Sodium Dodecyl Sulfate results in decreased expression of TMEM177 mRNA

NCBI chr 2:119,679,201...119,723,618
Ensembl chr 2:119,679,167...119,686,507

G

transmembrane protein 45B

decreases expression

Sodium Dodecyl Sulfate results in decreased expression of TMEM45B mRNA

NCBI chr11:129,815,848...129,860,003
Ensembl chr11:129,815,848...129,860,003

G

tenascin C

increases expression

Sodium Dodecyl Sulfate results in increased expression of TNC mRNA

NCBI chr 9:115,019,575...115,118,157
Ensembl chr 9:115,019,575...115,118,207

G

tumor necrosis factor

increases expression
affects expression
multiple interactions
increases secretion

Sodium Dodecyl Sulfate results in increased expression of TNF mRNA
Sodium Dodecyl Sulfate affects the expression of TNF mRNA
Sodium Dodecyl Sulfate inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased secretion of TNF protein]; TNF protein affects the reaction [Sodium Dodecyl Sulfate results in increased secretion of CCL20 protein]; TNF protein affects the reaction [Sodium Dodecyl Sulfate results in increased secretion of CXCL8 protein]
Sodium Dodecyl Sulfate results in increased secretion of TNF protein

PMID:9856837 PMID:15679580 PMID:20385217 PMID:31734321 PMID:36416909

NCBI chr 6:31,575,565...31,578,336
Ensembl chr 6:31,575,565...31,578,336

G

TNF alpha induced protein 3

increases expression

Sodium Dodecyl Sulfate results in increased expression of TNFAIP3 mRNA

PMID:20146380 PMID:31734321

NCBI chr 6:137,866,349...137,883,312
Ensembl chr 6:137,867,214...137,883,314

G

TNF alpha induced protein 6

decreases expression

Sodium Dodecyl Sulfate results in decreased expression of TNFAIP6 mRNA

NCBI chr 2:151,357,592...151,381,340
Ensembl chr 2:151,357,592...151,380,046

G

TNF receptor superfamily member 10d

increases expression

Sodium Dodecyl Sulfate results in increased expression of TNFRSF10D mRNA

NCBI chr 8:23,135,588...23,164,027
Ensembl chr 8:23,135,588...23,164,027

G

TNF superfamily member 10

decreases expression

Sodium Dodecyl Sulfate results in decreased expression of TNFSF10 mRNA

NCBI chr 3:172,505,508...172,523,430
Ensembl chr 3:172,505,508...172,523,475

G

TNF receptor associated factor 4

increases expression

Sodium Dodecyl Sulfate results in increased expression of TRAF4 mRNA

NCBI chr17:28,744,011...28,750,956
Ensembl chr17:28,744,011...28,750,956

G

tripartite motif containing 6

decreases expression

Sodium Dodecyl Sulfate results in decreased expression of TRIM6 mRNA

NCBI chr11:5,596,111...5,612,952
Ensembl chr11:5,596,109...5,612,958

G

tRNA methyltransferase 12 homolog

decreases expression

Sodium Dodecyl Sulfate results in decreased expression of TRMT12 mRNA

NCBI chr 8:124,450,820...124,453,026
Ensembl chr 8:124,450,820...124,462,150

G

tRNA splicing endonuclease subunit 54

increases expression

Sodium Dodecyl Sulfate results in increased expression of TSEN54 mRNA

NCBI chr17:75,516,528...75,524,735
Ensembl chr17:75,515,944...75,524,735

G

tetratricopeptide repeat domain 32

increases expression

Sodium Dodecyl Sulfate results in increased expression of TTC32 mRNA

NCBI chr 2:19,896,631...19,901,983
Ensembl chr 2:19,896,631...19,901,983

G

thioredoxin

increases expression

Sodium Dodecyl Sulfate results in increased expression of TXN mRNA

NCBI chr 9:110,243,810...110,256,507
Ensembl chr 9:110,243,810...110,256,507

G

thioredoxin reductase 1

increases expression

Sodium Dodecyl Sulfate results in increased expression of TXNRD1 mRNA

NCBI chr12:104,215,779...104,350,307
Ensembl chr12:104,215,779...104,350,307

G

thymidine phosphorylase

decreases expression

Sodium Dodecyl Sulfate results in decreased expression of TYMP mRNA

NCBI chr22:50,525,752...50,530,085
Ensembl chr22:50,525,752...50,530,032

G

ubiquitin conjugating enzyme E2 E2

decreases expression

Sodium Dodecyl Sulfate results in decreased expression of UBE2E2 mRNA

NCBI chr 3:23,203,098...23,591,925
Ensembl chr 3:23,203,020...23,591,794

G

urothelial cancer associated 1

increases expression

Sodium Dodecyl Sulfate results in increased expression of UCA1 mRNA

NCBI chr19:15,828,947...15,836,321
Ensembl chr19:15,828,206...15,836,328

G

ubiquitin like with PHD and ring finger domains 1

increases expression

Sodium Dodecyl Sulfate results in increased expression of UHRF1 mRNA

NCBI chr19:4,903,080...4,962,154
Ensembl chr19:4,903,080...4,962,154

G

unc-51 like kinase 4

increases expression

Sodium Dodecyl Sulfate results in increased expression of ULK4 mRNA

NCBI chr 3:41,246,599...41,962,103
Ensembl chr 3:41,246,599...41,962,130

G

UNC5B antisense RNA 1

decreases expression

Sodium Dodecyl Sulfate results in decreased expression of UNC5B-AS1 mRNA

NCBI chr10:71,217,224...71,218,228
Ensembl chr10:71,217,220...71,218,294

G

ubiquitin specific peptidase 43

increases expression

Sodium Dodecyl Sulfate results in increased expression of USP43 mRNA

NCBI chr17:9,645,260...9,729,687
Ensembl chr17:9,644,698...9,729,687

G

vascular endothelial growth factor A

increases expression

Sodium Dodecyl Sulfate results in increased expression of VEGFA mRNA; Sodium Dodecyl Sulfate results in increased expression of VEGFA protein

PMID:9390328 PMID:25617811 PMID:31734321

NCBI chr 6:43,770,211...43,786,487
Ensembl chr 6:43,770,184...43,786,487

G

vascular endothelial growth factor C

increases expression

Sodium Dodecyl Sulfate results in increased expression of VEGFC mRNA

NCBI chr 4:176,683,538...176,792,922
Ensembl chr 4:176,683,538...176,792,922

G

vascular endothelial growth factor D

increases expression

Sodium Dodecyl Sulfate results in increased expression of VEGFD mRNA

NCBI chr X:15,345,596...15,384,413
Ensembl chr X:15,345,596...15,384,413

G

vacuole membrane protein 1

increases expression

Sodium Dodecyl Sulfate results in increased expression of VMP1 mRNA

NCBI chr17:59,707,654...59,842,255
Ensembl chr17:59,707,192...59,842,255

G

VPS29 retromer complex component

decreases expression

Sodium Dodecyl Sulfate results in decreased expression of VPS29 protein

NCBI chr12:110,491,083...110,502,111
Ensembl chr12:110,491,083...110,502,111

G

vesicle trafficking 1

decreases expression

Sodium Dodecyl Sulfate results in decreased expression of VTA1 protein

NCBI chr 6:142,147,263...142,224,685
Ensembl chr 6:142,147,162...142,224,685

G

von Willebrand factor C and EGF domains

increases expression

Sodium Dodecyl Sulfate results in increased expression of VWCE mRNA

NCBI chr11:61,258,286...61,295,316
Ensembl chr11:61,258,286...61,295,316

G

WAC antisense RNA 1 (head to head)

decreases expression

Sodium Dodecyl Sulfate results in decreased expression of WAC-AS1 mRNA

NCBI chr10:28,519,917...28,532,354
Ensembl chr10:28,522,652...28,533,066

G

WARS2 antisense RNA 1

decreases expression

Sodium Dodecyl Sulfate results in decreased expression of WARS2-AS1 mRNA

NCBI chr 1:119,140,396...119,275,973
Ensembl chr 1:119,140,391...119,275,973

G

WD repeat domain 5B

decreases expression

Sodium Dodecyl Sulfate results in decreased expression of WDR5B mRNA

NCBI chr 3:122,411,846...122,416,062
Ensembl chr 3:122,411,846...122,416,062

G

YOD1 deubiquitinase

increases expression

Sodium Dodecyl Sulfate results in increased expression of YOD1 mRNA

NCBI chr 1:207,043,849...207,053,116
Ensembl chr 1:207,043,849...207,052,980

G

zinc finger and BTB domain containing 26

decreases expression

Sodium Dodecyl Sulfate results in decreased expression of ZBTB26 mRNA

NCBI chr 9:122,915,566...122,931,512
Ensembl chr 9:122,915,566...122,931,512

G

zinc finger CCCH-type containing 13

increases expression

Sodium Dodecyl Sulfate results in increased expression of ZC3H13 mRNA

NCBI chr13:45,954,465...46,052,746
Ensembl chr13:45,954,465...46,052,759

G

zinc finger CCCH-type containing 8

decreases expression

Sodium Dodecyl Sulfate results in decreased expression of ZC3H8 mRNA

NCBI chr 2:112,211,529...112,255,042
Ensembl chr 2:112,211,529...112,255,136

G

zinc finger CCCH-type containing, antiviral 1

increases expression

Sodium Dodecyl Sulfate results in increased expression of ZC3HAV1 mRNA

NCBI chr 7:139,043,515...139,109,720
Ensembl chr 7:139,043,515...139,132,122

G

zinc finger CCCH-type containing, antiviral 1 like

decreases expression

Sodium Dodecyl Sulfate results in decreased expression of ZC3HAV1L mRNA

NCBI chr 7:139,021,498...139,036,042
Ensembl chr 7:139,025,706...139,036,042

G

zinc finger DHHC-type palmitoyltransferase 23

increases expression

Sodium Dodecyl Sulfate results in increased expression of ZDHHC23 mRNA

NCBI chr 3:113,947,901...113,979,508
Ensembl chr 3:113,947,901...113,965,401

G

ZEB1 antisense RNA 1

decreases expression

Sodium Dodecyl Sulfate results in decreased expression of ZEB1-AS1 mRNA

NCBI chr10:31,307,717...31,320,447
Ensembl chr10:31,206,278...31,320,447

G

ZFP57 zinc finger protein

increases expression

Sodium Dodecyl Sulfate results in increased expression of ZFP57 mRNA

NCBI chr 6:29,672,392...29,681,152
Ensembl chr 6:29,672,483...29,681,155

G

zinc finger MIZ-type containing 2

increases expression

Sodium Dodecyl Sulfate results in increased expression of ZMIZ2 mRNA

NCBI chr 7:44,748,571...44,769,881
Ensembl chr 7:44,748,581...44,769,881

G

zinc finger protein 12

decreases expression

Sodium Dodecyl Sulfate results in decreased expression of ZNF12 mRNA

NCBI chr 7:6,688,433...6,706,947
Ensembl chr 7:6,688,433...6,706,947

G

zinc finger protein 165

increases expression

Sodium Dodecyl Sulfate results in increased expression of ZNF165 mRNA

NCBI chr 6:28,080,282...28,089,563
Ensembl chr 6:28,080,568...28,089,563

G

zinc finger protein 185 with LIM domain

decreases expression

Sodium Dodecyl Sulfate results in decreased expression of ZNF185 mRNA

NCBI chr X:152,898,067...152,973,481
Ensembl chr X:152,898,067...152,973,481

G

zinc finger protein 300 pseudogene 1

decreases expression

Sodium Dodecyl Sulfate results in decreased expression of ZNF300P1 mRNA

NCBI chr 5:150,930,436...150,946,584
Ensembl chr 5:150,930,456...150,946,598
Ensembl chr 5:150,930,456...150,946,598

G

zinc finger protein 527

increases expression

Sodium Dodecyl Sulfate results in increased expression of ZNF527 mRNA

NCBI chr19:37,371,099...37,393,066
Ensembl chr19:37,371,061...37,393,066

G

zinc finger protein 547

decreases expression

Sodium Dodecyl Sulfate results in decreased expression of ZNF547 mRNA

NCBI chr19:57,363,551...57,379,565
Ensembl chr19:57,363,477...57,379,565

G

zinc finger protein 607

increases expression

Sodium Dodecyl Sulfate results in increased expression of ZNF607 mRNA

NCBI chr19:37,696,363...37,719,761
Ensembl chr19:37,696,371...37,719,761

G

zinc finger protein 680

decreases expression

Sodium Dodecyl Sulfate results in decreased expression of ZNF680 mRNA

NCBI chr 7:64,499,069...64,563,071
Ensembl chr 7:64,519,878...64,563,075

G

zinc finger protein 785

decreases expression

Sodium Dodecyl Sulfate results in decreased expression of ZFP459 mRNA

NCBI chr16:30,578,361...30,585,697
Ensembl chr16:30,573,740...30,585,769

G

zinc finger and SCAN domain containing 31

decreases expression

Sodium Dodecyl Sulfate results in decreased expression of ZSCAN31 mRNA

NCBI chr 6:28,324,737...28,356,271
Ensembl chr 6:28,324,693...28,356,271

G

zwilch kinetochore protein

decreases expression

Sodium Dodecyl Sulfate results in decreased expression of ZWILCH mRNA

NCBI chr15:66,505,326...66,550,130
Ensembl chr15:66,504,959...66,550,130

sodium hydrogencarbonate

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

ATP binding cassette subfamily C member 2

increases expression

Sodium Bicarbonate results in increased expression of ABCC2 mRNA

NCBI chr10:99,782,640...99,852,594
Ensembl chr10:99,782,640...99,852,594

G

ATP binding cassette subfamily G member 2 (JR blood group)

decreases expression

Sodium Bicarbonate results in decreased expression of ABCG2 mRNA

NCBI chr 4:88,090,264...88,231,626
Ensembl chr 4:88,090,150...88,231,628

G

carbonic anhydrase 2

decreases expression

Sodium Bicarbonate results in decreased expression of CAR2 mRNA

NCBI chr 8:85,464,007...85,481,493
Ensembl chr 8:85,463,968...85,481,493

G

catalase

multiple interactions

[Folic Acid co-treated with Sodium Bicarbonate] results in decreased activity of CAT protein

NCBI chr11:34,438,934...34,472,060
Ensembl chr11:34,438,934...34,472,060

G

fibronectin 1

multiple interactions

Sodium Bicarbonate inhibits the reaction [Doxorubicin results in increased expression of FN1 protein]

NCBI chr 2:215,360,865...215,436,068
Ensembl chr 2:215,360,440...215,436,073

G

neurofilament heavy chain

affects expression

Sodium Bicarbonate affects the expression of NEFH mRNA

NCBI chr22:29,480,218...29,491,390
Ensembl chr22:29,480,218...29,491,390

G

nuclear factor kappa B subunit 2

multiple interactions

[Folic Acid co-treated with Sodium Bicarbonate] results in increased expression of NFKB2 mRNA; pyrrolidine dithiocarbamic acid inhibits the reaction [[Folic Acid co-treated with Sodium Bicarbonate] results in increased expression of NFKB2 mRNA]

NCBI chr10:102,394,110...102,402,529
Ensembl chr10:102,394,110...102,402,524

G

RELA proto-oncogene, NF-kB subunit

multiple interactions

[Folic Acid co-treated with Sodium Bicarbonate] results in increased expression of and affects the localization of RELA protein; [Folic Acid co-treated with Sodium Bicarbonate] results in increased expression of RELA mRNA; pyrrolidine dithiocarbamic acid inhibits the reaction [[Folic Acid co-treated with Sodium Bicarbonate] results in increased expression of and affects the localization of RELA protein]; pyrrolidine dithiocarbamic acid inhibits the reaction [[Folic Acid co-treated with Sodium Bicarbonate] results in increased expression of RELA mRNA]

NCBI chr11:65,653,601...65,663,857
Ensembl chr11:65,653,599...65,663,090

G

solute carrier family 15 member 1

decreases expression

Sodium Bicarbonate results in decreased expression of SLC15A1 mRNA

NCBI chr13:98,683,801...98,752,672
Ensembl chr13:98,683,801...98,752,672

G

solute carrier family 22 member 24

increases expression

Sodium Bicarbonate results in increased expression of SLC22A24 mRNA

NCBI chr11:63,079,940...63,144,221
Ensembl chr11:63,079,940...63,144,221

G

solute carrier family 22 member 6

decreases expression

Sodium Bicarbonate results in decreased expression of SLC22A6 mRNA

NCBI chr11:62,976,597...62,984,967
Ensembl chr11:62,936,385...62,984,967

G

solute carrier family 39 member 8

multiple interactions

SLC39A8 protein affects the reaction [Sodium Bicarbonate results in increased uptake of Cadmium Chloride]; SLC39A8 protein affects the reaction [Sodium Bicarbonate results in increased uptake of manganese chloride]

NCBI chr 4:102,251,041...102,345,482
Ensembl chr 4:102,251,080...102,431,258

G

solute carrier family 4 member 1 (Diego blood group)

decreases expression

Sodium Bicarbonate results in decreased expression of SLC4A1 mRNA

NCBI chr17:44,248,390...44,268,135
Ensembl chr17:44,248,390...44,268,141

G

solute carrier family 4 member 4

increases transport
decreases expression

SLC4A4 protein results in increased transport of Sodium Bicarbonate
Sodium Bicarbonate results in decreased expression of SLC4A4 mRNA

PMID:18614622 PMID:31569818

NCBI chr 4:71,062,660...71,572,083
Ensembl chr 4:71,062,667...71,572,087

G

transforming growth factor beta 1

multiple interactions

Sodium Bicarbonate inhibits the reaction [Doxorubicin results in increased expression of TGFB1 mRNA]

NCBI chr19:41,330,323...41,353,922
Ensembl chr19:41,301,587...41,353,922

G

tumor necrosis factor

multiple interactions

[Folic Acid co-treated with Sodium Bicarbonate] results in increased expression of TNF mRNA; pyrrolidine dithiocarbamic acid inhibits the reaction [[Folic Acid co-treated with Sodium Bicarbonate] results in increased expression of TNF mRNA]

NCBI chr 6:31,575,565...31,578,336
Ensembl chr 6:31,575,565...31,578,336

G

tumor protein p53

multiple interactions

[Folic Acid co-treated with Sodium Bicarbonate] results in increased expression of and affects the localization of TRP53 protein; [Folic Acid co-treated with Sodium Bicarbonate] results in increased expression of TRP53 mRNA; pyrrolidine dithiocarbamic acid inhibits the reaction [[Folic Acid co-treated with Sodium Bicarbonate] results in increased expression of and affects the localization of TRP53 protein]; pyrrolidine dithiocarbamic acid inhibits the reaction [[Folic Acid co-treated with Sodium Bicarbonate] results in increased expression of TRP53 mRNA]

NCBI chr17:7,668,421...7,687,490
Ensembl chr17:7,661,779...7,687,538

G

vimentin

multiple interactions

Sodium Bicarbonate inhibits the reaction [Doxorubicin results in increased expression of VIM protein]

NCBI chr10:17,228,241...17,237,593
Ensembl chr10:17,228,241...17,237,593

sodium propionate

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

BCL2 associated X, apoptosis regulator

multiple interactions

sodium propionate inhibits the reaction [Ethanol results in increased expression of BAX mRNA]

NCBI chr19:48,954,875...48,961,798
Ensembl chr19:48,954,815...48,961,798

G

caspase 3

multiple interactions

sodium propionate inhibits the reaction [Ethanol results in increased expression of and results in increased cleavage of CASP3 mRNA]

NCBI chr 4:184,627,696...184,649,447
Ensembl chr 4:184,627,696...184,650,062

G

caspase 8

multiple interactions

sodium propionate inhibits the reaction [Ethanol results in increased expression of CASP8 mRNA]

NCBI chr 2:201,233,463...201,287,711
Ensembl chr 2:201,233,443...201,361,836

G

claudin 1

multiple interactions

sodium propionate inhibits the reaction [Ethanol results in decreased expression of CLDN1 protein]

NCBI chr 3:190,305,707...190,322,446
Ensembl chr 3:190,305,707...190,322,446

G

cytochrome P450 family 1 subfamily A member 1

multiple interactions

sodium propionate promotes the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1A1 mRNA]

NCBI chr15:74,719,542...74,725,528
Ensembl chr15:74,719,542...74,725,536

G

cytochrome P450 family 1 subfamily B member 1

multiple interactions

sodium propionate promotes the reaction [biochanin A results in increased expression of CYP1B1 mRNA]; sodium propionate promotes the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1B1 mRNA]

NCBI chr 2:38,067,509...38,076,151
Ensembl chr 2:38,066,973...38,109,902

G

histone deacetylase 2

multiple interactions

sodium propionate inhibits the reaction [Ethanol results in increased expression of HDAC2 mRNA]; sodium propionate inhibits the reaction [Ethanol results in increased expression of HDAC2 protein]

NCBI chr 6:113,933,028...113,971,148
Ensembl chr 6:113,933,028...114,011,308

G

histone deacetylase 6

multiple interactions

sodium propionate inhibits the reaction [Ethanol results in increased expression of HDAC6 mRNA]

NCBI chr X:48,801,398...48,824,982
Ensembl chr X:48,801,377...48,824,982

G

interferon gamma

multiple interactions

[Sodium Acetate co-treated with Butyric Acid co-treated with sodium propionate] inhibits the reaction [Fluorides results in increased expression of IFNG mRNA]

NCBI chr12:68,154,768...68,159,740
Ensembl chr12:68,154,768...68,159,740

G

inhibitor of nuclear factor kappa B kinase subunit beta

multiple interactions

[Sodium Acetate co-treated with Butyric Acid co-treated with sodium propionate] inhibits the reaction [Fluorides results in increased expression of IKBKB mRNA]; [Sodium Acetate co-treated with Butyric Acid co-treated with sodium propionate] inhibits the reaction [Fluorides results in increased expression of IKBKB protein]

NCBI chr 8:42,271,302...42,332,460
Ensembl chr 8:42,271,302...42,332,460

G

interleukin 6

multiple interactions

[Sodium Acetate co-treated with Butyric Acid co-treated with sodium propionate] inhibits the reaction [Fluorides results in increased expression of IL6 mRNA]

NCBI chr 7:22,727,200...22,731,998
Ensembl chr 7:22,725,884...22,732,002

G

metallothionein 1A

multiple interactions
increases expression

[sodium propionate co-treated with Cadmium] results in increased expression of MT1A mRNA; [sodium propionate co-treated with Dexamethasone] results in increased expression of MT1A mRNA
sodium propionate results in increased expression of MT1A mRNA

NCBI chr16:56,638,666...56,640,087
Ensembl chr16:56,638,666...56,640,087

G

MYD88 innate immune signal transduction adaptor

multiple interactions

[Sodium Acetate co-treated with Butyric Acid co-treated with sodium propionate] inhibits the reaction [Fluorides results in increased expression of MYD88 mRNA]

NCBI chr 3:38,138,661...38,143,022
Ensembl chr 3:38,138,552...38,143,024

G

NFKB inhibitor alpha

multiple interactions

[Sodium Acetate co-treated with Butyric Acid co-treated with sodium propionate] inhibits the reaction [Fluorides results in decreased expression of NFKBIA protein]

NCBI chr14:35,401,513...35,404,749
Ensembl chr14:35,401,079...35,404,749

G

nitric oxide synthase 2

multiple interactions

sodium propionate inhibits the reaction [Ethanol results in increased expression of NOS2 mRNA]

NCBI chr17:27,756,766...27,800,529
Ensembl chr17:27,756,766...27,800,529

G

NADPH oxidase 1

multiple interactions

sodium propionate inhibits the reaction [Ethanol results in increased expression of NOX1 mRNA]; sodium propionate inhibits the reaction [TNF protein affects the acetylation of NOX1 promoter]

NCBI chr X:100,843,324...100,874,359
Ensembl chr X:100,843,324...100,874,359

G

occludin

multiple interactions

sodium propionate inhibits the reaction [Ethanol results in decreased expression of OCLN protein]

NCBI chr 5:69,492,547...69,558,104
Ensembl chr 5:69,492,292...69,558,104

G

RELA proto-oncogene, NF-kB subunit

multiple interactions

[Sodium Acetate co-treated with Butyric Acid co-treated with sodium propionate] inhibits the reaction [Fluorides results in increased expression of and results in increased phosphorylation of RELA protein]; [Sodium Acetate co-treated with Butyric Acid co-treated with sodium propionate] inhibits the reaction [Fluorides results in increased expression of RELA mRNA]

NCBI chr11:65,653,601...65,663,857
Ensembl chr11:65,653,599...65,663,090

G

transforming growth factor beta 1

multiple interactions

[Sodium Acetate co-treated with Butyric Acid co-treated with sodium propionate] inhibits the reaction [Fluorides results in increased expression of TGFB1 mRNA]

NCBI chr19:41,330,323...41,353,922
Ensembl chr19:41,301,587...41,353,922

G

tight junction protein 1

multiple interactions

sodium propionate inhibits the reaction [Ethanol results in decreased expression of TJP1 protein]

NCBI chr15:29,699,367...29,969,049
Ensembl chr15:29,699,367...29,968,915

G

toll like receptor 2

multiple interactions

[Sodium Acetate co-treated with Butyric Acid co-treated with sodium propionate] inhibits the reaction [Fluorides results in increased expression of TLR2 mRNA]; [Sodium Acetate co-treated with Butyric Acid co-treated with sodium propionate] inhibits the reaction [Fluorides results in increased expression of TLR2 protein]

NCBI chr 4:153,684,280...153,710,637
Ensembl chr 4:153,684,070...153,706,260

G

toll like receptor 4

multiple interactions

[Sodium Acetate co-treated with Butyric Acid co-treated with sodium propionate] inhibits the reaction [Fluorides results in increased expression of TLR4 mRNA]; [Sodium Acetate co-treated with Butyric Acid co-treated with sodium propionate] inhibits the reaction [Fluorides results in increased expression of TLR4 protein]

NCBI chr 9:117,704,403...117,724,735
Ensembl chr 9:117,704,175...117,724,735

G

tumor necrosis factor

multiple interactions

[Sodium Acetate co-treated with Butyric Acid co-treated with sodium propionate] inhibits the reaction [Fluorides results in increased expression of TNF mRNA]; sodium propionate inhibits the reaction [TNF protein affects the acetylation of NOX1 promoter]

PMID:35639301 PMID:37269894

NCBI chr 6:31,575,565...31,578,336
Ensembl chr 6:31,575,565...31,578,336

G

UDP glucuronosyltransferase family 1 member A1

multiple interactions

sodium propionate promotes the reaction [Tetrachlorodibenzodioxin results in increased expression of UGT1A1 mRNA]

NCBI chr 2:233,760,270...233,773,300
Ensembl chr 2:233,760,270...233,773,300

sodium taurocholate

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

interleukin 17A

increases expression

Sodium taurocholate increases expression of Il17a mRNA and protein in the pancreas

RGD

NCBI chr 6:52,186,375...52,190,638
Ensembl chr 6:52,186,375...52,190,638

G

serpin family F member 1

taurocholate decreased activity of Serpinf1 protein in plasma

RGD

NCBI chr17:1,762,060...1,777,565
Ensembl chr17:1,762,029...1,777,565

sodium thiocyanate

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

solute carrier family 5 member 5

multiple interactions

sodium thiocyanate inhibits the reaction [SLC5A5 protein results in increased uptake of Iodine]; sodium thiocyanate inhibits the reaction [SLC5A5 protein results in increased uptake of perrhenate analog]; sodium thiocyanate inhibits the reaction [SLC5A5 protein results in increased uptake of Sodium Iodide analog]; sodium thiocyanate inhibits the reaction [SLC5A5 protein results in increased uptake of Sodium Pertechnetate Tc 99m]

PMID:12488351 PMID:27979590

NCBI chr19:17,871,945...17,895,174
Ensembl chr19:17,871,945...17,895,174

tartrazine

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

ATP binding cassette subfamily B member 1

multiple interactions

[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in decreased expression of ABCB1 mRNA

NCBI chr 7:87,503,017...87,713,295
Ensembl chr 7:87,503,017...87,713,323

G

ATP binding cassette subfamily B member 4

multiple interactions

[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in decreased expression of ABCB4 mRNA

NCBI chr 7:87,365,896...87,476,027
Ensembl chr 7:87,401,696...87,480,435

G

ATP binding cassette subfamily C member 1 (ABCC1 blood group)

multiple interactions

[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in increased expression of ABCC1 mRNA

NCBI chr16:15,949,143...16,143,053
Ensembl chr16:15,949,138...16,143,257

G

ATP binding cassette subfamily C member 2

multiple interactions

[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in decreased expression of ABCC2 mRNA

NCBI chr10:99,782,640...99,852,594
Ensembl chr10:99,782,640...99,852,594

G

ATP binding cassette subfamily C member 3

multiple interactions

[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in decreased expression of ABCC3 mRNA

NCBI chr17:50,634,881...50,692,253
Ensembl chr17:50,634,777...50,692,253

G

ATP binding cassette subfamily C member 4 (PEL blood group)

multiple interactions

[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in increased expression of ABCC4 mRNA

NCBI chr13:95,019,835...95,301,451
Ensembl chr13:95,019,835...95,301,475

G

ATP binding cassette subfamily G member 2 (JR blood group)

multiple interactions

[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in decreased expression of ABCG2 mRNA

NCBI chr 4:88,090,264...88,231,626
Ensembl chr 4:88,090,150...88,231,628

G

ATP binding cassette subfamily G member 5

multiple interactions

[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in decreased expression of ABCG5 mRNA

NCBI chr 2:43,806,211...43,839,231
Ensembl chr 2:43,812,472...43,838,865

G

ATP binding cassette subfamily G member 8

multiple interactions

[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in decreased expression of ABCG8 mRNA

NCBI chr 2:43,838,971...43,882,988
Ensembl chr 2:43,831,942...43,882,988

G

adhesion G protein-coupled receptor G1

multiple interactions

[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in increased expression of ADGRG1 mRNA

NCBI chr16:57,619,738...57,665,567
Ensembl chr16:57,610,652...57,665,580

G

alcohol dehydrogenase 1C (class I), gamma polypeptide

multiple interactions

[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in decreased expression of ADH1C mRNA

NCBI chr 4:99,336,497...99,352,746
Ensembl chr 4:99,336,497...99,352,746

G

alcohol dehydrogenase 4 (class II), pi polypeptide

multiple interactions

[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in decreased expression of ADH4 mRNA

NCBI chr 4:99,123,658...99,144,297
Ensembl chr 4:99,123,657...99,157,792

G

alcohol dehydrogenase 6 (class V)

multiple interactions

[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in decreased expression of ADH6 mRNA

NCBI chr 4:99,202,639...99,219,246
Ensembl chr 4:99,202,638...99,219,537

G

aldo-keto reductase family 1 member C4

multiple interactions

[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in decreased expression of AKR1C4 mRNA

NCBI chr10:5,196,837...5,218,949
Ensembl chr10:5,195,462...5,218,949

G

aldo-keto reductase family 1 member D1

multiple interactions

[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in decreased expression of AKR1D1 mRNA

NCBI chr 7:138,076,459...138,118,305
Ensembl chr 7:138,002,324...138,118,305

G

aldo-keto reductase family 7 member A2

multiple interactions

[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in decreased expression of AKR7A2 mRNA

NCBI chr 1:19,302,708...19,312,146
Ensembl chr 1:19,303,965...19,312,144

G

aldo-keto reductase family 7 member A3

multiple interactions

[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in decreased expression of AKR7A3 mRNA

NCBI chr 1:19,274,229...19,288,770
Ensembl chr 1:19,282,573...19,288,770

G

albumin

multiple interactions

[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in decreased expression of ALB mRNA

NCBI chr 4:73,404,287...73,421,482
Ensembl chr 4:73,397,114...73,421,482

G

adenosine monophosphate deaminase 3

multiple interactions

[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in increased expression of AMPD3 mRNA

NCBI chr11:10,450,388...10,507,579
Ensembl chr11:10,308,313...10,507,579

G

apolipoprotein A1

multiple interactions

[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in decreased expression of APOA1 mRNA

NCBI chr11:116,835,751...116,837,950
Ensembl chr11:116,835,751...116,837,622

G

ATPase phospholipid transporting 8B1

multiple interactions

[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in decreased expression of ATP8B1 mRNA

NCBI chr18:57,646,426...57,803,315
Ensembl chr18:57,646,426...57,803,315

G

bile acid-CoA:amino acid N-acyltransferase

multiple interactions

[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in decreased expression of BAAT mRNA

NCBI chr 9:101,360,417...101,385,006
Ensembl chr 9:101,354,182...101,385,400

G

BTB domain and CNC homolog 1

multiple interactions

[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in increased expression of BACH1 mRNA

NCBI chr21:29,298,922...29,361,894
Ensembl chr21:29,194,071...29,630,751

G

BCL2 like 1

multiple interactions

[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in increased expression of BCL2L1 mRNA

NCBI chr20:31,664,452...31,723,963
Ensembl chr20:31,664,452...31,723,989

G

caspase 9

multiple interactions

[Tartrazine co-treated with Erythrosine] affects the expression of CASP9 mRNA

NCBI chr 1:15,491,401...15,524,912
Ensembl chr 1:15,490,832...15,526,534

G

catalase

decreases activity
multiple interactions

Tartrazine results in decreased activity of CAT protein
[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in decreased expression of CAT mRNA

PMID:20678534 PMID:33819548

NCBI chr11:34,438,934...34,472,060
Ensembl chr11:34,438,934...34,472,060

G

cholinergic receptor nicotinic alpha 4 subunit

multiple interactions

[ponceau 4R co-treated with Allura Red AC Dye co-treated with 6-hydroxy-5-((p- sulfophenyl)azo)-2-naphthalenesulfonic acid disodium salt co-treated with Tartrazine co-treated with Amaranth Dye co-treated with brilliant blue co-treated with Indigo Carmine] results in decreased expression of CHRNA4 protein

NCBI chr20:63,343,223...63,361,349
Ensembl chr20:63,343,223...63,378,401

G

cholinergic receptor nicotinic beta 2 subunit

multiple interactions

[ponceau 4R co-treated with Allura Red AC Dye co-treated with 6-hydroxy-5-((p- sulfophenyl)azo)-2-naphthalenesulfonic acid disodium salt co-treated with Tartrazine co-treated with Amaranth Dye co-treated with brilliant blue co-treated with Indigo Carmine] results in increased expression of CHRNB2 protein

NCBI chr 1:154,567,778...154,580,013
Ensembl chr 1:154,567,778...154,580,013

G

colony stimulating factor 1

multiple interactions

[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in increased expression of CSF1 mRNA

NCBI chr 1:109,910,506...109,930,992
Ensembl chr 1:109,910,242...109,930,992

G

C-X-C motif chemokine ligand 8

multiple interactions

[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in increased expression of CXCL8 mRNA

NCBI chr 4:73,740,569...73,743,716
Ensembl chr 4:73,740,519...73,743,716

G

cytochrome P450 family 2 subfamily A member 6

multiple interactions

[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in decreased expression of CYP2A6 mRNA

NCBI chr19:40,843,541...40,850,447
Ensembl chr19:40,843,541...40,850,447

G

cytochrome P450 family 2 subfamily B member 6

multiple interactions

[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in decreased expression of CYP2B6 mRNA

NCBI chr19:40,991,282...41,018,398
Ensembl chr19:40,991,282...41,018,398

G

cytochrome P450 family 2 subfamily C member 18

multiple interactions

[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in decreased expression of CYP2C18 mRNA

NCBI chr10:94,683,729...94,736,190
Ensembl chr10:94,683,729...94,736,190

G

cytochrome P450 family 2 subfamily C member 9

multiple interactions

[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in decreased expression of CYP2C9 mRNA

NCBI chr10:94,938,658...94,990,091
Ensembl chr10:94,938,658...94,990,091

G

cytochrome P450 family 3 subfamily A member 4

multiple interactions

[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in decreased expression of CYP3A4 mRNA

NCBI chr 7:99,756,967...99,784,184
Ensembl chr 7:99,756,960...99,784,248

G

cytochrome P450 family 3 subfamily A member 5

multiple interactions

[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in decreased expression of CYP3A5 mRNA

NCBI chr 7:99,648,194...99,679,996
Ensembl chr 7:99,648,194...99,679,996

G

cytochrome P450 family 7 subfamily A member 1

multiple interactions

[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in decreased expression of CYP7A1 mRNA

NCBI chr 8:58,490,178...58,500,163
Ensembl chr 8:58,490,178...58,500,163

G

cytochrome P450 family 7 subfamily B member 1

multiple interactions

[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in decreased expression of CYP7B1 mRNA

NCBI chr 8:64,586,575...64,798,737
Ensembl chr 8:64,587,763...64,798,737

G

cytochrome P450 family 8 subfamily B member 1

multiple interactions

[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in decreased expression of CYP8B1 mRNA

NCBI chr 3:42,872,192...42,875,879
Ensembl chr 3:42,856,005...42,875,898

G

DnaJ heat shock protein family (Hsp40) member B9

multiple interactions

[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in decreased expression of DNAJB9 mRNA

NCBI chr 7:108,569,874...108,574,850
Ensembl chr 7:108,569,867...108,574,850

G

DnaJ heat shock protein family (Hsp40) member C10

multiple interactions

[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in increased expression of DNAJC10 mRNA

NCBI chr 2:182,716,257...182,794,464
Ensembl chr 2:182,716,255...182,794,464

G

DnaJ heat shock protein family (Hsp40) member C18

multiple interactions

[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in increased expression of DNAJC18 mRNA

NCBI chr 5:139,410,203...139,439,525
Ensembl chr 5:139,408,588...139,444,491

G

DnaJ heat shock protein family (Hsp40) member C9

multiple interactions

[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in decreased expression of DNAJC9 mRNA

NCBI chr10:73,232,272...73,247,255
Ensembl chr10:73,183,362...73,247,255

G

eukaryotic translation initiation factor 2 alpha kinase 3

multiple interactions

[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in increased expression of EIF2AK3 mRNA

NCBI chr 2:88,556,741...88,628,145
Ensembl chr 2:88,556,741...88,691,518

G

estrogen receptor 1

increases activity
multiple interactions

Tartrazine results in increased activity of ESR1 protein
fulvestrant inhibits the reaction [Tartrazine results in increased activity of ESR1 protein]

NCBI chr 6:151,656,672...152,129,619
Ensembl chr 6:151,656,691...152,129,619

G

flavin containing dimethylaniline monoxygenase 1

multiple interactions

[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in decreased expression of FMO1 mRNA

NCBI chr 1:171,248,494...171,285,978
Ensembl chr 1:171,248,471...171,285,978

G

ferritin heavy chain 1

multiple interactions

[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in increased expression of FTH1 mRNA

NCBI chr11:61,964,285...61,967,634
Ensembl chr11:61,959,718...61,967,634

G

glutamate-cysteine ligase modifier subunit

multiple interactions

[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in increased expression of GCLM mRNA

NCBI chr 1:93,885,199...93,909,430
Ensembl chr 1:93,885,199...93,909,456

G

gap junction protein beta 2

multiple interactions

[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in decreased expression of GJB2 mRNA

NCBI chr13:20,187,470...20,192,938
Ensembl chr13:20,187,463...20,192,938

G

G protein-coupled receptor class C group 5 member B

multiple interactions

[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in increased expression of GPRC5B mRNA

NCBI chr16:19,856,691...19,885,634
Ensembl chr16:19,856,691...19,886,167

G

glutamate ionotropic receptor NMDA type subunit 2A

multiple interactions

[ponceau 4R co-treated with Allura Red AC Dye co-treated with 6-hydroxy-5-((p- sulfophenyl)azo)-2-naphthalenesulfonic acid disodium salt co-treated with Tartrazine co-treated with Amaranth Dye co-treated with brilliant blue co-treated with Indigo Carmine] results in decreased expression of GRIN2A protein; [ponceau 4R co-treated with Allura Red AC Dye co-treated with 6-hydroxy-5-((p- sulfophenyl)azo)-2-naphthalenesulfonic acid disodium salt co-treated with Tartrazine co-treated with Amaranth Dye co-treated with brilliant blue co-treated with Indigo Carmine] results in increased expression of GRIN2A protein

NCBI chr16:9,753,404...10,182,908
Ensembl chr16:9,753,404...10,182,928

G

glutathione S-transferase alpha 1

multiple interactions

[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in decreased expression of GSTA1 mRNA

NCBI chr 6:52,791,371...52,803,816
Ensembl chr 6:52,791,371...52,803,860

G

glutathione S-transferase alpha 3

multiple interactions

[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in decreased expression of GSTA3 mRNA

NCBI chr 6:52,896,646...52,909,698
Ensembl chr 6:52,896,639...52,909,698

G

glutathione S-transferase alpha 4

multiple interactions

[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in decreased expression of GSTA4 mRNA

NCBI chr 6:52,977,953...52,995,284
Ensembl chr 6:52,977,948...52,995,304

G

glutathione S-transferase theta 1

multiple interactions

[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in decreased expression of GSTT1 mRNA

G

hepatitis A virus cellular receptor 1

multiple interactions

[Tartrazine co-treated with Erythrosine] affects the expression of HAVCR1 mRNA

NCBI chr 5:157,029,413...157,069,407
Ensembl chr 5:157,026,742...157,069,396

G

hemopexin

multiple interactions

[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in decreased expression of HPX mRNA

NCBI chr11:6,431,049...6,440,987
Ensembl chr11:6,431,049...6,442,617

G

interferon gamma inducible protein 16

multiple interactions

[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in increased expression of IFI16 mRNA

NCBI chr 1:158,999,976...159,055,151
Ensembl chr 1:158,999,968...159,055,155

G

interferon alpha inducible protein 27

multiple interactions

[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in increased expression of IFI27 mRNA

NCBI chr14:94,105,894...94,116,690
Ensembl chr14:94,104,836...94,116,695

G

interleukin 1 receptor type 1

multiple interactions

[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in increased expression of IL1R1 mRNA

NCBI chr 2:102,070,390...102,179,874
Ensembl chr 2:102,064,544...102,179,874

G

Jun proto-oncogene, AP-1 transcription factor subunit

multiple interactions

[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in decreased expression of JUN mRNA; [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in increased expression of JUN mRNA

NCBI chr 1:58,780,791...58,784,047
Ensembl chr 1:58,776,845...58,784,048

G

lipase C, hepatic type

multiple interactions

[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in decreased expression of LIPC mRNA

NCBI chr15:58,431,991...58,569,844
Ensembl chr15:58,410,569...58,569,844

G

lymphocyte antigen 96

multiple interactions

[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in increased expression of LY96 mRNA

NCBI chr 8:73,991,392...74,099,857
Ensembl chr 8:73,991,392...74,029,079

G

MAF bZIP transcription factor

multiple interactions

[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in decreased expression of MAF mRNA

NCBI chr16:79,202,622...79,600,737
Ensembl chr16:79,585,843...79,600,737

G

MAF bZIP transcription factor F

multiple interactions

[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in increased expression of MAFF mRNA

NCBI chr22:38,201,994...38,216,511
Ensembl chr22:38,200,767...38,216,507

G

mitogen-activated protein kinase kinase 2

multiple interactions

[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in increased expression of MAP2K2 mRNA

NCBI chr19:4,090,321...4,124,122
Ensembl chr19:4,090,321...4,124,122

G

mitogen-activated protein kinase kinase 6

multiple interactions

[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in decreased expression of MAP2K6 mRNA

NCBI chr17:69,414,697...69,553,865
Ensembl chr17:69,414,697...69,553,865

G

mitogen-activated protein kinase kinase kinase 5

multiple interactions

[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in increased expression of MAP3K5 mRNA

NCBI chr 6:136,557,046...136,793,091
Ensembl chr 6:136,557,046...136,793,097

G

MAPK activated protein kinase 3

multiple interactions

[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in increased expression of MAPKAPK3 mRNA

NCBI chr 3:50,611,520...50,649,291
Ensembl chr 3:50,611,520...50,649,291

G

microsomal glutathione S-transferase 1

multiple interactions

[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in increased expression of MGST1 mRNA

NCBI chr12:16,347,115...16,593,331
Ensembl chr12:16,347,142...16,609,259

G

mixed lineage kinase domain like pseudokinase

multiple interactions

[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in increased expression of MLKL mRNA

NCBI chr16:74,671,855...74,700,862
Ensembl chr16:74,671,855...74,700,960

G

methylmalonyl-CoA mutase

multiple interactions

[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in decreased expression of MMUT mRNA

NCBI chr 6:49,430,360...49,463,253
Ensembl chr 6:49,430,360...49,463,253

G

microsomal triglyceride transfer protein

multiple interactions

[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in decreased expression of MTTP mRNA

NCBI chr 4:99,564,130...99,623,997
Ensembl chr 4:99,564,081...99,623,997

G

nuclear receptor subfamily 0 group B member 2

multiple interactions

[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in decreased expression of NR0B2 mRNA

NCBI chr 1:26,911,489...26,913,975
Ensembl chr 1:26,911,489...26,913,975

G

nuclear receptor subfamily 1 group H member 4

multiple interactions

[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in decreased expression of NR1H4 mRNA

NCBI chr12:100,473,866...100,564,414
Ensembl chr12:100,473,708...100,564,414

G

nuclear receptor subfamily 1 group I member 2

multiple interactions

[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in decreased expression of NR1I2 mRNA

NCBI chr 3:119,782,101...119,818,487
Ensembl chr 3:119,780,484...119,818,487

G

nuclear receptor subfamily 1 group I member 3

multiple interactions

[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in decreased expression of NR1I3 mRNA

NCBI chr 1:161,229,669...161,238,203
Ensembl chr 1:161,229,666...161,238,244

G

phenylalanine hydroxylase

multiple interactions

[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in decreased expression of PAH mRNA

NCBI chr12:102,836,889...102,958,441
Ensembl chr12:102,836,889...102,958,410

G

phosphatidylinositol-4-phosphate 3-kinase catalytic subunit type 2 alpha

multiple interactions

[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in increased expression of PIK3C2A mRNA

NCBI chr11:17,086,575...17,207,986
Ensembl chr11:17,077,730...17,207,986

G

phosphatidylinositol-4-phosphate 3-kinase catalytic subunit type 2 gamma

multiple interactions

[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in decreased expression of PIK3C2G mRNA

NCBI chr12:18,242,961...18,726,817
Ensembl chr12:18,242,961...18,648,416

G

phosphoinositide-3-kinase regulatory subunit 3

multiple interactions

[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in increased expression of PIK3R3 mRNA

NCBI chr 1:46,040,140...46,174,901
Ensembl chr 1:46,040,140...46,133,036

G

protein phosphatase 1 regulatory subunit 3C

multiple interactions

[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in decreased expression of PPP1R3C mRNA

NCBI chr10:91,628,442...91,633,071
Ensembl chr10:91,628,442...91,633,071

G

protein kinase D3

multiple interactions

[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in increased expression of PRKD3 mRNA

NCBI chr 2:37,250,502...37,324,833
Ensembl chr 2:37,250,502...37,324,833

G

retinoic acid receptor alpha

multiple interactions

[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in increased expression of RARA mRNA

NCBI chr17:40,309,180...40,357,643
Ensembl chr17:40,309,180...40,357,643

G

ras related dexamethasone induced 1

multiple interactions

[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in increased expression of RASD1 mRNA

NCBI chr17:17,494,437...17,496,395
Ensembl chr17:17,494,437...17,496,395

G

retinol dehydrogenase 16

multiple interactions

[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in decreased expression of RDH16 mRNA

NCBI chr12:56,951,431...56,957,608
Ensembl chr12:56,951,431...56,959,374

G

serpin family E member 1

multiple interactions

[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in increased expression of SERPINE1 mRNA

NCBI chr 7:101,127,104...101,139,247
Ensembl chr 7:101,127,104...101,139,247

G

solute carrier family 10 member 1

multiple interactions

[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in decreased expression of SLC10A1 mRNA

NCBI chr14:69,775,416...69,797,241
Ensembl chr14:69,775,416...69,797,241

G

solute carrier family 22 member 1

multiple interactions

[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in decreased expression of SLC22A1 mRNA

NCBI chr 6:160,121,815...160,158,718
Ensembl chr 6:160,121,815...160,158,718

G

solute carrier organic anion transporter family member 1B1

multiple interactions

[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in decreased expression of SLCO1B1 mRNA

NCBI chr12:21,131,194...21,239,796
Ensembl chr12:21,131,194...21,239,796

G

superoxide dismutase 2

multiple interactions

[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in increased expression of SOD2 mRNA

NCBI chr 6:159,669,069...159,762,281
Ensembl chr 6:159,669,069...159,762,529

G

sortilin related receptor 1

multiple interactions

[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in decreased expression of SORL1 mRNA

NCBI chr11:121,452,314...121,633,763
Ensembl chr11:121,452,314...121,633,763

G

sterol regulatory element binding transcription factor 1

multiple interactions

[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in decreased expression of SREBF1 mRNA

NCBI chr17:17,811,334...17,836,986
Ensembl chr17:17,810,399...17,837,002

G

sulfotransferase family 2A member 1

multiple interactions

[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in decreased expression of SULT2A1 mRNA

NCBI chr19:47,870,467...47,886,315
Ensembl chr19:47,870,467...47,886,315

G

trefoil factor 1

multiple interactions
increases expression

fulvestrant inhibits the reaction [Tartrazine results in increased expression of TFF1 mRNA]

NCBI chr21:42,362,282...42,366,535
Ensembl chr21:42,362,282...42,366,535

G

toll like receptor 3

multiple interactions

[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in increased expression of TLR3 mRNA

NCBI chr 4:186,069,156...186,088,073
Ensembl chr 4:186,068,911...186,088,073

G

toll like receptor 4

multiple interactions

[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in increased expression of TLR4 mRNA

NCBI chr 9:117,704,403...117,724,735
Ensembl chr 9:117,704,175...117,724,735

G

tumor necrosis factor

multiple interactions

[Tartrazine co-treated with Erythrosine] results in increased expression of TNF mRNA

NCBI chr 6:31,575,565...31,578,336
Ensembl chr 6:31,575,565...31,578,336

G

TNF receptor superfamily member 9

multiple interactions

[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in increased expression of TNFRSF9 mRNA

NCBI chr 1:7,915,871...7,940,839
Ensembl chr 1:7,915,871...7,943,165

G

TNF superfamily member 10

multiple interactions

[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in decreased expression of TNFSF10 mRNA

NCBI chr 3:172,505,508...172,523,430
Ensembl chr 3:172,505,508...172,523,475

G

TNF superfamily member 11

multiple interactions

[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in increased expression of TNFSF11 mRNA

NCBI chr13:42,562,736...42,608,013
Ensembl chr13:42,562,736...42,608,013

G

UDP glucuronosyltransferase family 2 member B4

multiple interactions

[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in decreased expression of UGT2B4 mRNA

NCBI chr 4:69,480,165...69,526,014
Ensembl chr 4:69,480,165...69,526,014

Term paths to the root

Path 1
Term	Annotations
CHEBI ontology	26041
role	25957
biological role	25936
biochemical role	25170
cofactor	18008
sodium(1+)	12812
sodium salt	12812
organic sodium salt	1443
(3R,5S)-fluvastatin sodium +	0
(3S,5R)-fluvastatin sodium +	0
(R)-lorglumide sodium +	0
(R)-warfarin sodium +	0
(S)-haloxyfop-sodium +	0
(S)-lorglumide sodium +	0
(S)-warfarin sodium +	0
2-O-alpha-D-mannosyl-1-O-\{1-O-[(10S)-10-methyloctadecanoyl]-2-O-palmitoyl-sn-glycero-3-phosphono\}-5-O-palmitoyl-6-O-(6-O-palmitoyl-alpha-D-mannosyl)-1D-myo-inositol sodium salt	0
2-benzyl-4-sodium oxidomethylene-5-oxazolone	0
8-(4-chlorophenylthio)-cGMP.Na	0
Amido Black 10B	0
Biebrich scarlet	0
Calcofluor White	0
Chrome fast yellow 8GL	0
Congo corinth	0
DY-631	0
DY-632	0
DY-633	0
DY-634	0
DY-636	0
DY-651	0
DY-652	0
DY-676	0
DY-677	0
DY-678	0
DY-681	0
DY-682	0
DY-701	0
DY-731	0
DY-732	0
DY-734	0
DY-751	0
DY-776	0
DY-782	0
Durazol blue 4R	0
EDTA disodium salt (anhydrous) +	0
EDTA trisodium salt	0
Evans blue	0
Fast green FCF	1
Guinee green B	0
Milling yellow 3G	0
Na2[beta-D-GlcA3S-(1->3)-beta-D-Gal-(1->4)-D-GlcNAc]	0
Na2[beta-D-GlcA3S-(1->3)-beta-D-Gal-OC6H4-4-OMe]	0
Na2[beta-D-GlcA3S-(1->3)-beta-D-Gal-OC6H4-4-[CH2]2NHC(O)[CH2]3SH]	0
Na2[beta-D-GlcA3S-(1->3)-beta-D-Gal-OMe]	0
Na[beta-D-GlcA-(1->3)-beta-D-Gal-OC6H4-4-OMe]	0
Ponceau S	0
Pontamine sky blue 5B	0
Sirius red 4B	1
Sirius red F3B	0
Sirius scarlet GG	0
acetazolamide sodium	0
acid fuchsin	0
acid green 5	0
acid red 26	0
acid red 29	1
acid red 4	0
acid red 44	0
adenosine triphosphate disodium	0
alendronate sodium trihydrate	0
alizarin cyanin BBS	0
alizarin red S	0
alkali blue 4B	0
amoxicillin sodium	0
amoxicilloyl-butylamine sodium salt	0
ampicillin sodium	0
apalcillin sodium	0
asulam-sodium	0
avibactam sodium +	0
azidocillin sodium	0
azlocillin sodium	0
azocarmine B	0
azocarmine G	0
azophloxine	0
azumolene sodium	0
balsalazide disodium	0
balsaminolate	0
benzo scarlet 4BNS	0
benzylpenicillin sodium	0
benzylpenicilloyl-butylamine sodium	0
beraprost sodium	0
betamethasone sodium phosphate	0
bictegravir sodium	0
bile salt +	2
bispyribac-sodium	0
brequinar sodium	0
bromfenac sodium salt +	0
bromosulfophthalein sodium	0
cabotegravir sodium	0
callysponginol sulfate A	0
cangrelor tetrasodium	0
carbenicillin disodium	0
carfecillin sodium	0
carindacillin sodium	0
carumonam sodium	0
cefamandole nafate	0
cefamandole sodium	0
cefazolin sodium	0
cefmetazole sodium	0
cefminox sodium	0
cefonicid sodium	0
cefotaxime sodium	0
cefotetan disodium	0
cefpiramide sodium	0
ceftazidime sodium	0
ceftizoxime sodium	0
cefuzonam sodium	0
cephalexin sodium	0
cephalothin sodium	0
cephapirin sodium	0
cerivastatin sodium	0
chloramine T	9
chlorfenac-sodium	0
chrome violet CG	0
chromoxane cyanin R	0
cilastatin sodium	0
clathsterol	0
clodronic acid disodium salt +	0
cloxacillin sodium +	0
cloxacillin sodium monohydrate	0
colistimethate sodium	0
colistin A sodium methanesulfonate +	0
colistin B sodium methanesulfonate +	0
cortisol sodium phosphate	0
dantrolene sodium (anhydrous) +	0
dasabuvir sodium +	0
dexamethasone sodium phosphate	0
dextran sulfate sodium	0
dicamba-sodium	0
diclofenac sodium	0
dicloxacillin sodium +	0
disodium (R)-malate +	0
disodium (S)-malate +	0
disodium (alpha-D-galactopyranosyluronate)-(1->4)-alpha-D-galactopyranuronate	0
disodium 4,7-diphenyl-1,10-phenanthroline 4',4''-disulfonate	0
disodium 4-O-(2-acetamido-2-deoxy-alpha-D-glucosylphospho)-2-acetamido-2-deoxy-alpha-D-glucosyl 3-aminopropyl phosphate	0
disodium 5'-guanylate	0
disodium 6-O-sulfonato-beta-D-glucosyl-(1->3)-[6-O-sulfonato-beta-D-glucosyl-(1->3)-N-acetyl-beta-D-galactosaminyl-(1->6)]-N-acetyl-beta-D-galactosamine	0
disodium L-glutamate	0
disodium L-tyrosinate	0
disodium PIPES	0
disodium acetylide	0
disodium aurothiomalate +	95
disodium cromoglycate	32
disodium cytidine 5'-monophosphate	0
disodium fumarate	0
disodium maleate	0
dolutegravir sodium	0
durlobactam sodium +	0
egualen sodium	0
eosin YS dye	1
eosin b	0
eritoran tetrasodium	0
ertapenem sodium	0
erythrosin B	21
estramustine sodium phosphate	0
estrone sodium sulfate	0
etidronate disodium	0
eurysterol A	0
eurysterol B	0
fast yellow	0
ferrozine monosodium salt	0
flucarbazone-sodium	0
flucloxacillin sodium +	0
fomesafen-sodium	0
fondaparinux sodium	0
fosinopril sodium	0
glufosinate-P-sodium	0
glymidine sodium	0
halistanol sulfate F	0
halistanol sulfate G	0
haloxyfop-P-sodium +	0
holothurin A3	0
holothurin A4	0
impatienolate	0
indigo carmine	5
iofensulfuron sodium	0
lamellarin alpha 20-sulfate	0
lasalocid sodium	0
levothyroxine sodium anhydrous	0
liothyronine sodium	0
lissamine fast red	0
lissamine fast yellow	0
lissamine flavine FF	0
lissamine rhodamine	0
loxoprofen sodium +	0
menadione sodium sulfonate	0
merbromin	3
merocyanine 540	0
metam-sodium	0
metamizole sodium	7
metampicillin sodium	0
metanil yellow	0
methicillin sodium +	0
methohexital sodium	0
methotrexate disodium	0
methotrexate monosodium	0
methyl blue +	0
methylprednisolone suleptanate	0
mezlocillin sodium +	0
micafungin sodium	0
monosodium PIPES	0
monosodium acetylide	0
monosodium aurothiomalate +	95
monosodium benzylpenicilloate	0
monosodium fumarate	0
monosodium glutamate +	747
montelukast sodium	0
mutalomycin sodium salt	0
mycophenolate sodium	0
nabam	0
nafcillin sodium +	0
nafcillin sodium monohydrate	0
naphthalene blue black CS	0
naphthol green B	0
naphthol yellow S	0
naproxen sodium	0
nedocromil sodium	0
nuclear fast red	0
olsalazine sodium	0
orange G	0
oxacillin sodium +	0
pantoprazole sodium	0
pemetrexed disodium +	0
pemetrexed disodium heptahydrate	0
phenobarbital sodium	0
phloxine B	0
piperacillin sodium	0
poly(sodium 4-vinylbenzoate)	0
poly(sodium acrylate) macromolecule +	0
poly(sodium styrenesulfonate) +	0
porfimer sodium	0
potassium sodium L-tartrate	0
pravastatin sodium	0
prednisolone sodium phosphate	0
prednisolone sodium succinate	0
primuline	0
procion yellow MX-4R +	0
pyranine	0
rabeprazole sodium	0
remazole black-GR	0
remazole orange-3R	0
riboflavin sodium	0
rigosertib sodium	0
secobarbital sodium	0
sodium (2-amino-3-benzoylphenyl)acetate +	0
sodium (9xi,14xi,25S)-3beta,5,6beta,16beta,26-pentahydroxy-5alpha,8xi-cholestan-15alpha-yl sulfate	0
sodium (allyl 3-deoxy-7-O-methyl-alpha-D-manno-oct-2-ulopyranosid)onate	0
sodium (allyl 7-azido-3,7-dideoxy-beta-L-gulo-oct-2-ulopyranosid)onate	0
sodium 17beta-estradiol 17-glucosiduronate	0
sodium 2,4-dinitrobenzenesulfonate	0
sodium 2-((125)I)iodohippurate	0
sodium 2-((131)I)iodohippurate	0
sodium 2-(N-morpholino)ethanesulfonate	0
sodium 2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonate	0
sodium 2-acetamido-2-deoxy-3-O-(6-O-sulfonato-beta-D-glucosyl)-beta-D-galactose	0
sodium 2-amino-5-[(1-methoxy-2-methylindolizin-3-yl)carbonyl]benzoate	0
sodium 2-butyloctyl sulfate	0
sodium 2-iodohippurate +	0
sodium 3-(trimethylsilyl)propionate	0
sodium 3-aminopropyl 2-acetamido-2-deoxy-alpha-D-glucose-1-phosphate	0
sodium 3-hydroxybutyrate	0
sodium 3alpha,7alpha-dihydroxy-5beta-cholane-24-sulfonate	0
sodium 4-hydroxybenzoate	0
sodium 8-bromo-3',5'-cyclic GMP	0
sodium 8-methoxypyrene-1,3,6-trisulfonate	0
sodium L-ascorbic acid 2-phosphate	0
sodium L-tartrate	0
sodium N-acetyl-beta-D-galactosaminyl-(1->6)-[6-O-sulfonato-beta-D-glucosyl-(1->3)]-N-acetyl-beta-D-galactosamine	0
sodium acetate +	30
sodium alginate	0
sodium amidotrizoate	0
sodium amoxicilloate	0
sodium arsanilate	0
sodium ascorbate	0
sodium benzoate +	22
sodium butyrate	0
sodium carbonate +	0
sodium cholate	42
sodium citrate +	1
sodium cyanotriphenylborate	0
sodium dehydroepiandrosterone sulfate	0
sodium dibunate	0
sodium dicyanoaurate(1-)	0
sodium dimethylarsinate	0
sodium docusate	0
sodium dodecanoate	0
sodium dodecyl sulfate	533
sodium ethoxide	0
sodium feredetate	0
sodium ferulate	0
sodium fluoroacetate	0
sodium formate	0
sodium gallate	0
sodium globostellatate A	0
sodium globostellatate B	0
sodium globostellatate C	0
sodium globostellatate D	0
sodium gluconate	0
sodium glycerol 2-phosphate +	0
sodium glycochenodeoxycholate	0
sodium glycodeoxycholate	0
sodium glycolate	0
sodium glyoxylate	0
sodium hexacyclonate	0
sodium hexanoate	0
sodium hydrogencarbonate	18
sodium lactate	0
sodium malonate	0
sodium meclofenamate (anhydrous) +	0
sodium methoxyacetate	0
sodium nitrilotriacetate	0
sodium nitroprusside +	0
sodium octadecanoate	0
sodium octanoate	0
sodium orotate	0
sodium oxalate	0
sodium p-aminohippurate	0
sodium phenylbutyrate	0
sodium polyanethol sulfonate macromolecule +	0
sodium propionate	24
sodium pyruvate	0
sodium squarate	0
sodium syringate	0
sodium tetradecyl sulfate	0
sodium thiocyanate	1
sodium thioglycolate	0
sodium valproate +	0
sodium vanillate	0
sodium[alpha-Kdo-(2->8)-alpha-Kdo-OAll II(1),I(7)-lactone]	0
sodium[alpha-Kdo1Me-(2->8)-alpha-Kdo-OAll]	0
sugammadex sodium	0
sulbactam sodium +	0
sulbenicillin disodium	0
sulcofuron-sodium	0
sulfacetamide sodium	0
sulfacetamide sodium anhydrous +	0
sulforhodamine G	0
suramin sodium	0
tartrazine	102
tazobactam sodium +	0
temocillin disodium	0
tetrasodium 5'-phosphonatopyridoxal-6-azobenzene-2,4-disulfonate	0
tetrasulfocyanine	0
thiopental sodium	0
thiosultap disodium	0
thiosultap monosodium	0
ticarcillin disodium	0
tolmetin sodium +	0
tolmetin sodium dihydrate	0
treprostinil sodium	0
trisodium 4-O-[4-O-(2-acetamido-2-deoxy-alpha-D-glucosylphospho)-2-acetamido-2-deoxy-alpha-D-glucosylphospho]-2-acetamido-2-deoxy-alpha-D-glucosyl 3-aminopropyl phosphate	0
trisodium guanosine 5'-[beta,gamma-imido]triphosphate	0
trisodium guanosine 5'-[beta,gamma-methylene]triphosphate	0
trisodium phosphonoformate +	0
trypan blue	0
valproate semisodium	0
water blue +	0
woodstain scarlet	0
zilucoplan sodium	0
Path 2
Term	Annotations
CHEBI ontology	26041
subatomic particle	26016
composite particle	26016
hadron	26016
baryon	26016
nucleon	26016
atomic nucleus	26016
atom	26016
main group element atom	25841
main group molecular entity	25841
s-block molecular entity	25162
alkali metal molecular entity	14451
sodium molecular entity	12812
elemental sodium	12812
sodium(1+)	12812
sodium salt	12812
organic sodium salt	1443
(3R,5S)-fluvastatin sodium +	0
(3S,5R)-fluvastatin sodium +	0
(R)-lorglumide sodium +	0
(R)-warfarin sodium +	0
(S)-haloxyfop-sodium +	0
(S)-lorglumide sodium +	0
(S)-warfarin sodium +	0
2-O-alpha-D-mannosyl-1-O-\{1-O-[(10S)-10-methyloctadecanoyl]-2-O-palmitoyl-sn-glycero-3-phosphono\}-5-O-palmitoyl-6-O-(6-O-palmitoyl-alpha-D-mannosyl)-1D-myo-inositol sodium salt	0
2-benzyl-4-sodium oxidomethylene-5-oxazolone	0
8-(4-chlorophenylthio)-cGMP.Na	0
Amido Black 10B	0
Biebrich scarlet	0
Calcofluor White	0
Chrome fast yellow 8GL	0
Congo corinth	0
DY-631	0
DY-632	0
DY-633	0
DY-634	0
DY-636	0
DY-651	0
DY-652	0
DY-676	0
DY-677	0
DY-678	0
DY-681	0
DY-682	0
DY-701	0
DY-731	0
DY-732	0
DY-734	0
DY-751	0
DY-776	0
DY-782	0
Durazol blue 4R	0
EDTA disodium salt (anhydrous) +	0
EDTA trisodium salt	0
Evans blue	0
Fast green FCF	1
Guinee green B	0
Milling yellow 3G	0
Na2[beta-D-GlcA3S-(1->3)-beta-D-Gal-(1->4)-D-GlcNAc]	0
Na2[beta-D-GlcA3S-(1->3)-beta-D-Gal-OC6H4-4-OMe]	0
Na2[beta-D-GlcA3S-(1->3)-beta-D-Gal-OC6H4-4-[CH2]2NHC(O)[CH2]3SH]	0
Na2[beta-D-GlcA3S-(1->3)-beta-D-Gal-OMe]	0
Na[beta-D-GlcA-(1->3)-beta-D-Gal-OC6H4-4-OMe]	0
Ponceau S	0
Pontamine sky blue 5B	0
Sirius red 4B	1
Sirius red F3B	0
Sirius scarlet GG	0
acetazolamide sodium	0
acid fuchsin	0
acid green 5	0
acid red 26	0
acid red 29	1
acid red 4	0
acid red 44	0
adenosine triphosphate disodium	0
alendronate sodium trihydrate	0
alizarin cyanin BBS	0
alizarin red S	0
alkali blue 4B	0
amoxicillin sodium	0
amoxicilloyl-butylamine sodium salt	0
ampicillin sodium	0
apalcillin sodium	0
asulam-sodium	0
avibactam sodium +	0
azidocillin sodium	0
azlocillin sodium	0
azocarmine B	0
azocarmine G	0
azophloxine	0
azumolene sodium	0
balsalazide disodium	0
balsaminolate	0
benzo scarlet 4BNS	0
benzylpenicillin sodium	0
benzylpenicilloyl-butylamine sodium	0
beraprost sodium	0
betamethasone sodium phosphate	0
bictegravir sodium	0
bile salt +	2
bispyribac-sodium	0
brequinar sodium	0
bromfenac sodium salt +	0
bromosulfophthalein sodium	0
cabotegravir sodium	0
callysponginol sulfate A	0
cangrelor tetrasodium	0
carbenicillin disodium	0
carfecillin sodium	0
carindacillin sodium	0
carumonam sodium	0
cefamandole nafate	0
cefamandole sodium	0
cefazolin sodium	0
cefmetazole sodium	0
cefminox sodium	0
cefonicid sodium	0
cefotaxime sodium	0
cefotetan disodium	0
cefpiramide sodium	0
ceftazidime sodium	0
ceftizoxime sodium	0
cefuzonam sodium	0
cephalexin sodium	0
cephalothin sodium	0
cephapirin sodium	0
cerivastatin sodium	0
chloramine T	9
chlorfenac-sodium	0
chrome violet CG	0
chromoxane cyanin R	0
cilastatin sodium	0
clathsterol	0
clodronic acid disodium salt +	0
cloxacillin sodium +	0
cloxacillin sodium monohydrate	0
colistimethate sodium	0
colistin A sodium methanesulfonate +	0
colistin B sodium methanesulfonate +	0
cortisol sodium phosphate	0
dantrolene sodium (anhydrous) +	0
dasabuvir sodium +	0
dexamethasone sodium phosphate	0
dextran sulfate sodium	0
dicamba-sodium	0
diclofenac sodium	0
dicloxacillin sodium +	0
disodium (R)-malate +	0
disodium (S)-malate +	0
disodium (alpha-D-galactopyranosyluronate)-(1->4)-alpha-D-galactopyranuronate	0
disodium 4,7-diphenyl-1,10-phenanthroline 4',4''-disulfonate	0
disodium 4-O-(2-acetamido-2-deoxy-alpha-D-glucosylphospho)-2-acetamido-2-deoxy-alpha-D-glucosyl 3-aminopropyl phosphate	0
disodium 5'-guanylate	0
disodium 6-O-sulfonato-beta-D-glucosyl-(1->3)-[6-O-sulfonato-beta-D-glucosyl-(1->3)-N-acetyl-beta-D-galactosaminyl-(1->6)]-N-acetyl-beta-D-galactosamine	0
disodium L-glutamate	0
disodium L-tyrosinate	0
disodium PIPES	0
disodium acetylide	0
disodium aurothiomalate +	95
disodium cromoglycate	32
disodium cytidine 5'-monophosphate	0
disodium fumarate	0
disodium maleate	0
dolutegravir sodium	0
durlobactam sodium +	0
egualen sodium	0
eosin YS dye	1
eosin b	0
eritoran tetrasodium	0
ertapenem sodium	0
erythrosin B	21
estramustine sodium phosphate	0
estrone sodium sulfate	0
etidronate disodium	0
eurysterol A	0
eurysterol B	0
fast yellow	0
ferrozine monosodium salt	0
flucarbazone-sodium	0
flucloxacillin sodium +	0
fomesafen-sodium	0
fondaparinux sodium	0
fosinopril sodium	0
glufosinate-P-sodium	0
glymidine sodium	0
halistanol sulfate F	0
halistanol sulfate G	0
haloxyfop-P-sodium +	0
holothurin A3	0
holothurin A4	0
impatienolate	0
indigo carmine	5
iofensulfuron sodium	0
lamellarin alpha 20-sulfate	0
lasalocid sodium	0
levothyroxine sodium anhydrous	0
liothyronine sodium	0
lissamine fast red	0
lissamine fast yellow	0
lissamine flavine FF	0
lissamine rhodamine	0
loxoprofen sodium +	0
menadione sodium sulfonate	0
merbromin	3
merocyanine 540	0
metam-sodium	0
metamizole sodium	7
metampicillin sodium	0
metanil yellow	0
methicillin sodium +	0
methohexital sodium	0
methotrexate disodium	0
methotrexate monosodium	0
methyl blue +	0
methylprednisolone suleptanate	0
mezlocillin sodium +	0
micafungin sodium	0
monosodium PIPES	0
monosodium acetylide	0
monosodium aurothiomalate +	95
monosodium benzylpenicilloate	0
monosodium fumarate	0
monosodium glutamate +	747
montelukast sodium	0
mutalomycin sodium salt	0
mycophenolate sodium	0
nabam	0
nafcillin sodium +	0
nafcillin sodium monohydrate	0
naphthalene blue black CS	0
naphthol green B	0
naphthol yellow S	0
naproxen sodium	0
nedocromil sodium	0
nuclear fast red	0
olsalazine sodium	0
orange G	0
oxacillin sodium +	0
pantoprazole sodium	0
pemetrexed disodium +	0
pemetrexed disodium heptahydrate	0
phenobarbital sodium	0
phloxine B	0
piperacillin sodium	0
poly(sodium 4-vinylbenzoate)	0
poly(sodium acrylate) macromolecule +	0
poly(sodium styrenesulfonate) +	0
porfimer sodium	0
potassium sodium L-tartrate	0
pravastatin sodium	0
prednisolone sodium phosphate	0
prednisolone sodium succinate	0
primuline	0
procion yellow MX-4R +	0
pyranine	0
rabeprazole sodium	0
remazole black-GR	0
remazole orange-3R	0
riboflavin sodium	0
rigosertib sodium	0
secobarbital sodium	0
sodium (2-amino-3-benzoylphenyl)acetate +	0
sodium (9xi,14xi,25S)-3beta,5,6beta,16beta,26-pentahydroxy-5alpha,8xi-cholestan-15alpha-yl sulfate	0
sodium (allyl 3-deoxy-7-O-methyl-alpha-D-manno-oct-2-ulopyranosid)onate	0
sodium (allyl 7-azido-3,7-dideoxy-beta-L-gulo-oct-2-ulopyranosid)onate	0
sodium 17beta-estradiol 17-glucosiduronate	0
sodium 2,4-dinitrobenzenesulfonate	0
sodium 2-((125)I)iodohippurate	0
sodium 2-((131)I)iodohippurate	0
sodium 2-(N-morpholino)ethanesulfonate	0
sodium 2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonate	0
sodium 2-acetamido-2-deoxy-3-O-(6-O-sulfonato-beta-D-glucosyl)-beta-D-galactose	0
sodium 2-amino-5-[(1-methoxy-2-methylindolizin-3-yl)carbonyl]benzoate	0
sodium 2-butyloctyl sulfate	0
sodium 2-iodohippurate +	0
sodium 3-(trimethylsilyl)propionate	0
sodium 3-aminopropyl 2-acetamido-2-deoxy-alpha-D-glucose-1-phosphate	0
sodium 3-hydroxybutyrate	0
sodium 3alpha,7alpha-dihydroxy-5beta-cholane-24-sulfonate	0
sodium 4-hydroxybenzoate	0
sodium 8-bromo-3',5'-cyclic GMP	0
sodium 8-methoxypyrene-1,3,6-trisulfonate	0
sodium L-ascorbic acid 2-phosphate	0
sodium L-tartrate	0
sodium N-acetyl-beta-D-galactosaminyl-(1->6)-[6-O-sulfonato-beta-D-glucosyl-(1->3)]-N-acetyl-beta-D-galactosamine	0
sodium acetate +	30
sodium alginate	0
sodium amidotrizoate	0
sodium amoxicilloate	0
sodium arsanilate	0
sodium ascorbate	0
sodium benzoate +	22
sodium butyrate	0
sodium carbonate +	0
sodium cholate	42
sodium citrate +	1
sodium cyanotriphenylborate	0
sodium dehydroepiandrosterone sulfate	0
sodium dibunate	0
sodium dicyanoaurate(1-)	0
sodium dimethylarsinate	0
sodium docusate	0
sodium dodecanoate	0
sodium dodecyl sulfate	533
sodium ethoxide	0
sodium feredetate	0
sodium ferulate	0
sodium fluoroacetate	0
sodium formate	0
sodium gallate	0
sodium globostellatate A	0
sodium globostellatate B	0
sodium globostellatate C	0
sodium globostellatate D	0
sodium gluconate	0
sodium glycerol 2-phosphate +	0
sodium glycochenodeoxycholate	0
sodium glycodeoxycholate	0
sodium glycolate	0
sodium glyoxylate	0
sodium hexacyclonate	0
sodium hexanoate	0
sodium hydrogencarbonate	18
sodium lactate	0
sodium malonate	0
sodium meclofenamate (anhydrous) +	0
sodium methoxyacetate	0
sodium nitrilotriacetate	0
sodium nitroprusside +	0
sodium octadecanoate	0
sodium octanoate	0
sodium orotate	0
sodium oxalate	0
sodium p-aminohippurate	0
sodium phenylbutyrate	0
sodium polyanethol sulfonate macromolecule +	0
sodium propionate	24
sodium pyruvate	0
sodium squarate	0
sodium syringate	0
sodium tetradecyl sulfate	0
sodium thiocyanate	1
sodium thioglycolate	0
sodium valproate +	0
sodium vanillate	0
sodium[alpha-Kdo-(2->8)-alpha-Kdo-OAll II(1),I(7)-lactone]	0
sodium[alpha-Kdo1Me-(2->8)-alpha-Kdo-OAll]	0
sugammadex sodium	0
sulbactam sodium +	0
sulbenicillin disodium	0
sulcofuron-sodium	0
sulfacetamide sodium	0
sulfacetamide sodium anhydrous +	0
sulforhodamine G	0
suramin sodium	0
tartrazine	102
tazobactam sodium +	0
temocillin disodium	0
tetrasodium 5'-phosphonatopyridoxal-6-azobenzene-2,4-disulfonate	0
tetrasulfocyanine	0
thiopental sodium	0
thiosultap disodium	0
thiosultap monosodium	0
ticarcillin disodium	0
tolmetin sodium +	0
tolmetin sodium dihydrate	0
treprostinil sodium	0
trisodium 4-O-[4-O-(2-acetamido-2-deoxy-alpha-D-glucosylphospho)-2-acetamido-2-deoxy-alpha-D-glucosylphospho]-2-acetamido-2-deoxy-alpha-D-glucosyl 3-aminopropyl phosphate	0
trisodium guanosine 5'-[beta,gamma-imido]triphosphate	0
trisodium guanosine 5'-[beta,gamma-methylene]triphosphate	0
trisodium phosphonoformate +	0
trypan blue	0
valproate semisodium	0
water blue +	0
woodstain scarlet	0
zilucoplan sodium	0

paths to the root